<SEC-DOCUMENT>0000943819-22-000019.txt : 20221028
<SEC-HEADER>0000943819-22-000019.hdr.sgml : 20221028
<ACCEPTANCE-DATETIME>20221027182657
ACCESSION NUMBER:		0000943819-22-000019
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		63
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221028
DATE AS OF CHANGE:		20221027

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RESMED INC
		CENTRAL INDEX KEY:			0000943819
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				980152841
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15317
		FILM NUMBER:		221338567

	BUSINESS ADDRESS:	
		STREET 1:		9001 SPECTRUM CENTER BLVD.
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92123
		BUSINESS PHONE:		8587462400

	MAIL ADDRESS:	
		STREET 1:		9001 SPECTRUM CENTER BLVD.
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92123
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>rmd-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:863cb569-faab-47da-ba4f-c2fd89e0377c,g:b569d9d4-e0e2-497b-a32d-7564d4bc33ab,d:be8ac7a2e13b452cb87e155e752e9393--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:rmd="http://investor.resmed.com/20220930" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rmd-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180L2ZyYWc6NWE3MGM4MzQxMjFjNDVhNmFmYjM3MDk2ZDkwYWNjZTkvdGFibGU6NDU4MzQ4ODA3MzkyNGRhZmE5N2NhZWRmZjljNjVkZTUvdGFibGVyYW5nZTo0NTgzNDg4MDczOTI0ZGFmYTk3Y2FlZGZmOWM2NWRlNV8zLTEtMS0xLTYyMTE5_c63115bf-cd2c-4a46-b283-f69e93770a05">false</ix:nonNumeric><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180L2ZyYWc6NWE3MGM4MzQxMjFjNDVhNmFmYjM3MDk2ZDkwYWNjZTkvdGFibGU6NDU4MzQ4ODA3MzkyNGRhZmE5N2NhZWRmZjljNjVkZTUvdGFibGVyYW5nZTo0NTgzNDg4MDczOTI0ZGFmYTk3Y2FlZGZmOWM2NWRlNV80LTEtMS0xLTYyMTE5_ea07a97f-3851-4b65-abb3-f245b36b8a4d">2023</ix:nonNumeric><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180L2ZyYWc6NWE3MGM4MzQxMjFjNDVhNmFmYjM3MDk2ZDkwYWNjZTkvdGFibGU6NDU4MzQ4ODA3MzkyNGRhZmE5N2NhZWRmZjljNjVkZTUvdGFibGVyYW5nZTo0NTgzNDg4MDczOTI0ZGFmYTk3Y2FlZGZmOWM2NWRlNV81LTEtMS0xLTYyMTE5_1066f961-85a5-4e20-937b-5ea3552e9bb6">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180L2ZyYWc6NWE3MGM4MzQxMjFjNDVhNmFmYjM3MDk2ZDkwYWNjZTkvdGFibGU6NDU4MzQ4ODA3MzkyNGRhZmE5N2NhZWRmZjljNjVkZTUvdGFibGVyYW5nZTo0NTgzNDg4MDczOTI0ZGFmYTk3Y2FlZGZmOWM2NWRlNV82LTEtMS0xLTYyMTE5_df98688d-da63-42df-9481-89cf7771ff61">06-30</ix:nonNumeric><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180L2ZyYWc6NWE3MGM4MzQxMjFjNDVhNmFmYjM3MDk2ZDkwYWNjZTkvdGFibGU6NDU4MzQ4ODA3MzkyNGRhZmE5N2NhZWRmZjljNjVkZTUvdGFibGVyYW5nZTo0NTgzNDg4MDczOTI0ZGFmYTk3Y2FlZGZmOWM2NWRlNV83LTEtMS0xLTYyMTE5_0c03ac2a-cd56-4dc5-818c-d1033cccfc1e">0000943819</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rmd-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29c92ffe566544d486d203907c01034b_I20221024"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ief4927d3a2364a12bd6b170de6d43c70_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="icae7390e292248aea5680eee7705a952_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c309ac73e7e4954ac2e526a95941779_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5e4bee0df6d465bb76a7a14d683ed9e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ec5cd27d9fc4cd1a6b87aaa117fa062_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iced71fbf9d854f909b168ae0c5dc6d3d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if39dcb9003eb460791aab51dde509ee3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i661416e60db0471f9d33a485c88000b8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic75938a78dd84e31a55814a504baa727_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e425ee5a1764ebd9c10b93f28121cc9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07bf4ea60e5c4a4ba7835c9c6b099652_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebae534f8f214c65956df85450291a21_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51a67b36abb34b5db4ef0af0016dec20_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2360ae9649ff48d281a132f80281a277_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0bed1de6d224a628823074853f5cc02_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ided8696a9071487f85d658c6f7894111_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaff681621a6a47ddb2e69a84b657d563_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0edd8bdae674d5cba3df7e0bdab0a13_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if39d380d692046bfac4dd7d9da85fd9e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82486906991d41c1bb227364f4e66f47_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaceb858b79144bdb1473e507f59ebc8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9a3ed59012748f68b30ed7614b16350_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if62ca46e58ff4e1ab852ba34c6e8125d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if778f54978bb489ab25d9277813650fd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4c1bec761d343199bfb5656845fee5a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d6e74c5fb8447bd9b144f2ba9b48825_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie68cba427884448a91f3ab762c19133d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2353812c8d374d0a99adb123069a8c45_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39ae840cff9d4541883d39909be26bdb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d609f79239f44f6b1a7c7d6b7b1bff4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5c16a9474794461b2f4f520cab49c3f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i798ee6146fe04ee0a38f656f451210d4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82b83a0ce15f4487baf7464a93daa021_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3f1b5aa49a4420192a8beece7104061_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee72006a6fb24b64994718e79dad7dfe_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>rmd:segment</xbrli:measure></xbrli:unit><xbrli:context id="i15ed4af6e542498aae586bf6f9ef5374_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:DevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7cbf2f1f9774adaa9291a924a186b8e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:DevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c97b22f44884dc591a2167585ba6e8d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:MasksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa6d64210dc448b9a17c35d3c897c556_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:MasksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e62e9945cad4965bcf36433023bfa68_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eb5f7403b904bc9aab323b65ef846d5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82ea3d05492e4ac98479d3e2ac49f908_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc52733e9d564165bf93a97dacfc17f0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98d3fc3d460b4652ad6b75c8adc858c4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3db47d0b4bae4fcfbccf115899c75152_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02ae09329eef4efb848e53487594187f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:CombinedEuropeAsiaAndOtherMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:DevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2426e6fcaf654da9bb98fe543e2db047_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:CombinedEuropeAsiaAndOtherMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:DevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9911d26ac214b2a8b97be040bea08d3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:CombinedEuropeAsiaAndOtherMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:MasksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b207b56bf2b41e8bebae3064d374c7a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:CombinedEuropeAsiaAndOtherMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:MasksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6da4ff69d9ec4d9abbe4b31ba6f9e9cd_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:CombinedEuropeAsiaAndOtherMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic782a1e47cae42b893165007b949eb54_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:CombinedEuropeAsiaAndOtherMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf87dfd1f7d7454cbbb3fdbfed511f9a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:DevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa348c66adf44ac79c2e1d968c1e940d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:DevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i690f74a8d9e04be4a7acfb5c2e3e6fed_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:MasksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2893d2234624bd1bcd6209e5bd0e3c5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:MasksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice4bd47dac83461983f5e1caf7313368_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i599afb89a0f94887b16e08b956a275a3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6ce4de0cebf48adbeadffe538eee9fd_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9688c0dafa244d73b3ea05467409af36_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i687eebe94bad4f46bc7e06b4c56dc88e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5dc82ad0f3d42b68b84f9f7beb91b53_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64b8ab9a3e3045bdae18cd12d207e6f3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if328dc4c5e254ff8962ff04237432117_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc375d0ba418427f8b2b60d529de7690_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:AccountsReceivableNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3bae8b8d6404de1893a39a0a2fb73d5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:AccountsReceivableNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie987664fe8794b05be297c50f780e4df_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0705b4a48526488d8f80b81d4da788e9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5018235ea25d4087971080bf06c36785_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:PrepaidTaxesAndOtherNonCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a609ca3d66545e89aa80e54d5cbf456_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:PrepaidTaxesAndOtherNonCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i396aafec23c5497f9a9a0124dd672b37_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:DeferredRevenueCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84379be5bb434df49678f14cabe16d60_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:DeferredRevenueCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77c2ddab74374037b8dfa317884bcb87_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:DeferredRevenueNonCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2a02b6469384b2fa69e00189cde926f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:DeferredRevenueNonCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib78c1fac3c4347a38db050a74046fbb0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8c22fc714d74cffb6b2a777dedeb592_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c3bb7515a714bb0922f36fa159ea208_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b9cb77e265a44399ae4e1c4466f9da9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie76543872e91484aae4ea6e093ade66c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94a674e4585d44dfae6658ddd3dfe6fc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i640cd8511e9741ad923b981271756f3a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4b603503f594377ba49d4d341fc0c76_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff46fa3403a545618690423df187e3f2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c07d72c891a46a795fddf79d7928217_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9147d5a65f12434291bdbb355c876cb4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3822bb4d001f4343bad4507eaf24339d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i759637b4e24642d0af3b47249b185359_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69e86a0970d447abaac8ad86f67160f7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rmd:DevelopedOrCoreProductTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84b7e50d4346433e95666fb6afc046da_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rmd:DevelopedOrCoreProductTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1159ad451e6e4aeb9d34a0012448665f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if69726299ae44abb98de417d5a419afa_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0408bf19028f4072a1d8dd44df5a9ea3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72f4980bc58d49c2966d8c1aa7bc905d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14ad6e094e8c4c7a80ada79f330a56c5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92f6ff0f41fd4e56a622577a92df8168_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SaasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cb35257bd8b437e92849ecc0592453e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SaasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15dc957f85fb4fe890100775f942c978_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e9f732c1100497b8985d47b059e8339_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SaasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70a87039741047098a43d0ed149675b0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:NonMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i754cf4a776a241f191b33f0081cd2afe_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:MarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e7b9f80be8c4d2394bb2681a276056a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc6e99edaebb4a609919407282c99506_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:NonMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40e4bbc8f424443797674f57dc109757_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:MarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i670bbe1c2cb64cd2b590c0fadd7844ec_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieadf15b970044d0a838558a15de8430f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:NonMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4eb3627d8824fc0afceae4d64ab2a10_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:MarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40bb05a82f774f53aabc2ee8e712ed5d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifadb68bbd9524af8a7d16266b166a2cf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:NonMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4d7015735be42eb89bbf6e16b348801_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:MarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f2c400950d04ed1912934bd2c201d82_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i398d34a58e00477c83fa76e1309cbf0c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:NonMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i790d1b42ed1c4ff3bb9c53be9acff926_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:MarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id077d5ad4d284fe9b8c598b153545a40_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4567248f80c40ab88a38b16d19ad029_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:NonMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie62277cf19044d9fa1cd841612748260_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:MarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i212dd8da8d734d648e06f65c84619472_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f0fabb698be42fb98ac32d821f1a373_D20210928-20210928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-28</xbrli:startDate><xbrli:endDate>2021-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b783cdf50e346eaa8a19a835c62bd94_I20220629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rmd:MufgUnionBankNaAndWestpacBankingCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if40a26ace8cb428880b197363318cec6_D20220629-20220629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rmd:MufgUnionBankNaAndWestpacBankingCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-29</xbrli:startDate><xbrli:endDate>2022-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="if612b91bc22e4ac586b695411b41fcc0_I20220629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rmd:ResmedLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rmd:MufgUnionBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e7585e7a6994d2f9e4c76acb9f9385c_D20220629-20220629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-29</xbrli:startDate><xbrli:endDate>2022-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f41dcaf8ccd46709b5faa04c5fea871_D20220629-20220629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-29</xbrli:startDate><xbrli:endDate>2022-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f70c29ca1d548b5ae6f93b716b75536_D20220629-20220629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-29</xbrli:startDate><xbrli:endDate>2022-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22e4bb0fad4d40c5af0492d1dc204cbc_D20220629-20220629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-29</xbrli:startDate><xbrli:endDate>2022-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34f25e5e32fb41b9b7fb9e569b16cbdc_D20220629-20220629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:TermLoanCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-29</xbrli:startDate><xbrli:endDate>2022-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1297f32638a142a0ba72932abf60d77d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rmd:MufgUnionBankNaAndWestpacBankingCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:RevolvingCreditFacilityAndTermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a573e957f98484584a0734afd58d57f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rmd:MufgUnionBankNaAndWestpacBankingCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52939f1db3354c2c83c55393bca89e73_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rmd:MufgUnionBankNaAndWestpacBankingCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7d3d056a48b41ffafd0825a2500cd15_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf532dad3c0a4d5cb85816567efdfe50_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:RevolvingCreditFacilityAndTermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a79621ce364424f8da12a47723d1717_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:RevolvingCreditFacilityAndTermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48ec36cab3dc49749081f5531f83adae_I20190710"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rmd:SeniorNotesOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3220e912ac0c4ec792285781acd932a8_I20190710"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rmd:SeniorNotesTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1345482cbeee4a25a7bde5fd11f5d59f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia97609d461e84c708a6451bc44ca5926_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52c4dfffd15a49a6932fb065ffdb3d23_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rmd:RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i543df4c733354c07b6ce1628c05bd511_D20210701-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000943819</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_1"></div><div style="min-height:12.24pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">______________________________________________________________________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNzA1_b1a8b5cd-4f3b-4884-97ee-0882420f883c">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">______________________________________________________________________________________________</span></div><div style="margin-top:3pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(Mark One)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.471%"><tr><td style="width:1.0%"></td><td style="width:2.734%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.066%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6MGI5MTJiMGRhYmZhNDIyZDhkNjQyYjI2NGQ3YTQ1YjYvdGFibGVyYW5nZTowYjkxMmIwZGFiZmE0MjJkOGQ2NDJiMjY0ZDdhNDViNl8wLTAtMS0xLTYyMTE5_79d9e034-332a-4454-98de-a774839748b4">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yMTk5MDIzMjU4MzQ1_5bff343f-9a81-4478-beb3-d309535d60e7">September 30, 2022</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.471%"><tr><td style="width:1.0%"></td><td style="width:2.734%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.066%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6NjA3NjU2MzYwZWU1NDhiMTllNTllZmExMzU5MGZmMTcvdGFibGVyYW5nZTo2MDc2NTYzNjBlZTU0OGIxOWU1OWVmYTEzNTkwZmYxN18wLTAtMS0xLTYyMTE5_2b45e24a-04cf-494c-93bf-a6a8143ef6fa">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from _______to _______</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNzAw_7bd12893-7c17-47a1-b173-afaa0dece12f">001-15317</ix:nonNumeric></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">______________________________________________________________________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNzA2_41d43520-6a42-4f78-b57d-ceae80d97041">ResMed Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">______________________________________________________________________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNjk2_400a4fcc-ce51-4828-9b17-4424f2869f72">Delaware</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(State or other jurisdiction of incorporation or organization)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNzAx_7fcb02e4-25a6-47fe-9c61-4cf9c957bea4">98-0152841</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(I.R.S. Employer Identification No.)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF83ODg_0d0dcd13-e650-4d1a-ac5b-5fd43daced84">9001 Spectrum Center Blvd.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF83OTE_8a1dede5-0441-4575-a296-7c288dfa77cf">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF83OTU_889fb7ec-0f46-48e8-afd0-e8174d5a612a">CA</ix:nonNumeric> <ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF83OTg_9883fcd1-de85-4dcc-a1e6-2b0b57ac6d4d">92123</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNjk0_be1a1a0f-9291-4071-a1ee-a633bbaaf5d5">United States of America</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNzA3_0919a0d5-f600-4990-b006-6bcc73813cc8">858</ix:nonNumeric>) <ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNzAy_edbf3687-9209-4a38-aeb7-ba033e30e921">836-5000</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.5pt;font-weight:400;line-height:120%"> </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">______________________________________________________________________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Exchange Act:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.830%"><tr><td style="width:1.0%"></td><td style="width:34.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6ZDUzZmE1MDUyZDI1NDdmMWEzMjU4MTAzNjA2YzRiMzYvdGFibGVyYW5nZTpkNTNmYTUwNTJkMjU0N2YxYTMyNTgxMDM2MDZjNGIzNl8xLTAtMS0xLTYyMTE5_3c4bbe8b-df9f-44b3-bfac-5acc1221b234">Common Stock, par value $0.004 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6ZDUzZmE1MDUyZDI1NDdmMWEzMjU4MTAzNjA2YzRiMzYvdGFibGVyYW5nZTpkNTNmYTUwNTJkMjU0N2YxYTMyNTgxMDM2MDZjNGIzNl8xLTItMS0xLTYyMTE5_39851989-8141-401e-8ca4-7a2ecfb52283">RMD</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6ZDUzZmE1MDUyZDI1NDdmMWEzMjU4MTAzNjA2YzRiMzYvdGFibGVyYW5nZTpkNTNmYTUwNTJkMjU0N2YxYTMyNTgxMDM2MDZjNGIzNl8xLTQtMS0xLTYyMTE5_e57e3a0c-1876-47e1-9289-15b552d29eff">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNjk3_88c92c98-e37d-48f1-9a89-b07e8173ad73">Yes</ix:nonNumeric> </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNjk4_3c59b255-b1b1-4046-b344-8d9554b94bf1">Yes</ix:nonNumeric> </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.684%"><tr><td style="width:1.0%"></td><td style="width:25.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.918%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6YTM3YjM3ZmExNzFiNDI1MDgwYzdmMmMwNDI4NDc4ZjYvdGFibGVyYW5nZTphMzdiMzdmYTE3MWI0MjUwODBjN2YyYzA0Mjg0NzhmNl8wLTAtMS0xLTYyMTE5_919748fc-981d-4ef8-869b-ab3de9052301">Large Accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accelerated Filer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-Accelerated Filer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Smaller Reporting Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6YTM3YjM3ZmExNzFiNDI1MDgwYzdmMmMwNDI4NDc4ZjYvdGFibGVyYW5nZTphMzdiMzdmYTE3MWI0MjUwODBjN2YyYzA0Mjg0NzhmNl8xLTQtMS0xLTYyMTE5_ee1880d6-7a3e-4771-93f4-6d65feb634eb">o</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Emerging Growth Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6YTM3YjM3ZmExNzFiNDI1MDgwYzdmMmMwNDI4NDc4ZjYvdGFibGVyYW5nZTphMzdiMzdmYTE3MWI0MjUwODBjN2YyYzA0Mjg0NzhmNl8yLTEtMS0xLTYyMTE5_64ea848e-8dcc-45b1-91c6-adda00cf7321">o</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNjk1_b1d8d9d0-321e-44e0-95c7-e10487eaed9d">x</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At October&#160;24, 2022 there were <ix:nonFraction unitRef="shares" contextRef="i29c92ffe566544d486d203907c01034b_I20221024" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF84MjQ2MzM3MjExMDM1_8c90c871-8f6e-41d6-afce-de84055f43d6">146,483,650</ix:nonFraction> shares of Common Stock ($0.004 par value) outstanding. This number excludes 41,836,234 shares held by the registrant as treasury shares. </span></div><div style="height:0pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Part I</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_10">Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_10">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Item 1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_10">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_10">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_10">Condensed Consolidated Balance Sheets (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_10">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_13">Condensed Consolidated Statements of Operations (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_16">Condensed Consolidated Statements of Comprehensive Income (Unaudited) </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_16">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_19">Condensed Consolidated Statements of Changes in Equity (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_19">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#0000FF;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_22">Condensed Consolidated Statements of Cash Flows (Unaudited) </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_22">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_25">Notes to the Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_25">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_61">Item 2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_61">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_61">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_112">Item 3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_112">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_112">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_121">Item 4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_121">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_121">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_124">Part II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_124">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_124">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_127">Item 1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_127">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_127">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_130">Item 1A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_130">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_130">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_133">Item 2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_133">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_133">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_136">Item 3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_136">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_136">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_139">Item 4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_139">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_139">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_142">Item 5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_142">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_142">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_145">Item 6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_145">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_145">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_148">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:none" href="#ibe8ac7a2e13b452cb87e155e752e9393_148">35</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:7pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_10"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheets (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In US$ and in thousands, except share and per share data)</span></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMy0xLTEtMS02MjExOQ_07543377-2b01-4e19-954f-51dc39cf904e">207,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMy0zLTEtMS02MjExOQ_c721f6c8-5fda-4be5-9030-954bc9c3e97d">273,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNC0wLTEtMS02MjExOS90ZXh0cmVnaW9uOmY3YjY2NWU1ZmY5YjQ0ZWJhMDMwYTIyNWQ1MGRkYjI5XzQ2_6b52006d-a9d0-4907-84a7-17c1ce07ba78">23,867</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNC0wLTEtMS02MjExOS90ZXh0cmVnaW9uOmY3YjY2NWU1ZmY5YjQ0ZWJhMDMwYTIyNWQ1MGRkYjI5XzUz_c4c7a304-8ef8-46a1-aec3-e8db4e6ab25d">23,259</ix:nonFraction> at September&#160;30, 2022 and June&#160;30, 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNC0xLTEtMS02MjExOQ_26debdca-ee69-4777-abb6-298d8cb17ba9">620,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNC0zLTEtMS02MjExOQ_53fa2b1e-304e-4403-96fa-523b316c569f">575,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories (note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNS0xLTEtMS02MjExOQ_701c4e0f-ea7c-4d73-90c3-272be2aed0da">864,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNS0zLTEtMS02MjExOQ_1c9a1132-85dd-41ca-a6b6-7cc114b2d50e">743,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets (note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNi0xLTEtMS02MjExOQ_ef03939e-642d-4f5d-9e4e-9fe11955bde9">341,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNi0zLTEtMS02MjExOQ_989b93f4-51f7-4950-be8d-f84ea1ad4706">337,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNy0xLTEtMS02MjExOQ_922f52da-246a-4f91-8427-0d223c7d1755">2,033,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNy0zLTEtMS02MjExOQ_57751311-9e0c-47bb-a96e-e33f99802247">1,931,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-current assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property, plant and equipment, net (note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfOS0xLTEtMS02MjExOQ_b8db1d7b-98a4-48a6-a32a-ef96a011e01e">487,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfOS0zLTEtMS02MjExOQ_c6160885-5435-465d-8104-6d4331dbba59">498,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTAtMS0xLTEtNjIxMTk_c0da16e5-dcaf-4ed3-bf86-2884e953686c">125,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTAtMy0xLTEtNjIxMTk_4d779341-ec98-441d-8e68-1ed5d341bd8a">132,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill (note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTEtMS0xLTEtNjIxMTk_fdf88ed4-67e3-431b-bcf8-f42a9c251b1e">1,938,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTEtMy0xLTEtNjIxMTk_a9fc1ace-3b01-4895-8a48-762170842f2e">1,936,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other intangible assets, net (note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTItMS0xLTEtNjIxMTk_1340381e-b7d4-4cab-8786-356721ac3a40">338,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTItMy0xLTEtNjIxMTk_34671d62-2ebe-4042-83ca-46fe5f320fe3">345,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTMtMS0xLTEtNjIxMTk_300cdb2a-85e6-492d-9756-c5a412be6893">80,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTMtMy0xLTEtNjIxMTk_2784e4a7-c70f-47f9-a965-2e1bd07e4770">79,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid taxes and other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTQtMS0xLTEtNjIxMTk_f953e6a4-e5f1-4583-a38f-e09781e059f7">173,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTQtMy0xLTEtNjIxMTk_aaddf185-97b7-4930-91b5-4096ce3c68f7">171,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total non-current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTUtMS0xLTEtNjIxMTk_921d1c22-26be-4253-81fe-c86cb4e5ac66">3,143,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTUtMy0xLTEtNjIxMTk_5203c8d0-6605-4d0d-b448-03027c9682f7">3,164,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTYtMS0xLTEtNjIxMTk_71921a93-3f11-42b7-b1c0-6b499d6e030a">5,177,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTYtMy0xLTEtNjIxMTk_efbb09e5-5d28-44ae-bccc-835fdfc8ee7e">5,095,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTktMS0xLTEtNjIxMTk_5ef65c8a-a356-4208-bd72-7b1ad3f89425">181,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTktMy0xLTEtNjIxMTk_a50b37b2-93c0-4b0d-b8e8-18eafdb3c488">159,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjAtMS0xLTEtNjIxMTk_3aeca099-2154-4576-aa7a-5727c9cd8555">324,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjAtMy0xLTEtNjIxMTk_fd78704f-b442-4217-97f0-17fe2167197b">344,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjEtMS0xLTEtNjIxMTk_cbaaeb61-41e7-4b0e-93ac-050b844248a1">21,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjEtMy0xLTEtNjIxMTk_e2d37f60-6f25-44c5-a3aa-4c34954a698c">21,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjItMS0xLTEtNjIxMTk_d33b49bd-56ab-4427-b705-75e1ac8d7f4b">108,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjItMy0xLTEtNjIxMTk_9091347e-58cf-4611-97f3-ac09cbe7271c">108,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes payable (note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjMtMS0xLTEtNjIxMTk_6d0e6cfe-f55c-40cf-acae-4ca43ac57330">47,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjMtMy0xLTEtNjIxMTk_91b3d4b9-53f3-4f2f-821f-294ad585fb10">44,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term debt, net (note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjQtMS0xLTEtNjIxMTk_f0cd7e7e-9934-4964-b058-07401b1a30d3">9,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjQtMy0xLTEtNjIxMTk_cc606cbe-5e04-4a67-ad4f-521b75ac7b8d">9,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjUtMS0xLTEtNjIxMTk_1a2f1634-1dc5-4b4c-b413-7d730dc381fb">692,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjUtMy0xLTEtNjIxMTk_9e440391-3f2d-489e-88c1-389f1feda9a8">689,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjctMS0xLTEtNjIxMTk_84e9f2f2-9e46-49e7-b433-938c1a088e56">97,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjctMy0xLTEtNjIxMTk_70810028-e0e3-4087-913a-baefa1e310ed">95,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjgtMS0xLTEtNjIxMTk_71deaea5-d110-4b07-8e2f-2c7a7b2f489a">11,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjgtMy0xLTEtNjIxMTk_0ec4df2a-f283-45a1-b034-49fa95d07776">9,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjktMS0xLTEtNjIxMTk_3f825c61-33b0-4985-8e6d-883eb9e8e64c">114,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjktMy0xLTEtNjIxMTk_49247881-b0aa-48b3-bce0-dc0c0f8ef6ce">120,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzAtMS0xLTEtNjIxMTk_da081197-ff65-40fa-9930-d2ac28cb1f7b">5,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzAtMy0xLTEtNjIxMTk_624cb6e6-5ff4-419d-82cb-ae8c4f58f091">5,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, net (note 8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzEtMS0xLTEtNjIxMTk_1646a496-5a6c-423a-8551-39d48447137d">785,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzEtMy0xLTEtNjIxMTk_14bae321-21f6-4d81-b79a-456734f56a12">765,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term income taxes payable (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzItMS0xLTEtNjIxMTk_822d4c52-8cb6-4124-85c0-4b81b4676b92">37,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzItMy0xLTEtNjIxMTk_8192f9e0-ac0c-4f60-98b1-cf9269e564b9">48,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzMtMS0xLTEtNjIxMTk_e29b6d71-dc93-4a3e-a517-c59ed8c84e77">1,052,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzMtMy0xLTEtNjIxMTk_a2ee0930-ab2b-42e5-8dfe-b82e16e7f910">1,045,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzQtMS0xLTEtNjIxMTk_1572bd19-417a-4a73-88d2-85c291481a7d">1,744,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzQtMy0xLTEtNjIxMTk_970cc1db-6801-430d-b535-c9ef7d94568f">1,735,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies (note 10)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzUtMS0xLTEtNjIxMTk_f0984456-d8be-4d6a-be53-8705d925db24"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzUtMy0xLTEtNjIxMTk_8de1248a-9a63-4919-acb3-ca7eef44b77e"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stockholders&#8217; equity: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo2YzFlYWQ3YTYwZmU0MGRmOWVjMjIxY2JjZWQ5NmRmN18yMQ_3886725d-c1b6-48b4-a89e-47f193340fff"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo2YzFlYWQ3YTYwZmU0MGRmOWVjMjIxY2JjZWQ5NmRmN18yMQ_5fba0dcb-acb3-49f1-82a5-d45695776279">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo2YzFlYWQ3YTYwZmU0MGRmOWVjMjIxY2JjZWQ5NmRmN18zNQ_ab7700eb-5264-4d0c-9768-5945f696e048"><ix:nonFraction unitRef="shares" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo2YzFlYWQ3YTYwZmU0MGRmOWVjMjIxY2JjZWQ5NmRmN18zNQ_b9b199c1-459e-412e-a5c9-2f2dfbe09538">2,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo2YzFlYWQ3YTYwZmU0MGRmOWVjMjIxY2JjZWQ5NmRmN181Nw_1685cf6d-720f-45cd-9647-aa5337eedcdf"><ix:nonFraction unitRef="shares" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo2YzFlYWQ3YTYwZmU0MGRmOWVjMjIxY2JjZWQ5NmRmN181Nw_d6c62e87-a817-4f93-8d12-6b39bfd5c6d0">none</ix:nonFraction></ix:nonFraction> issued</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMS0xLTEtNjIxMTk_501dfc35-bdf7-4cd5-b5b5-e3b75ef9f465">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMy0xLTEtNjIxMTk_74cd39c0-6b2f-4477-9a13-7096c0c41a39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl8xOA_b0556cb0-19e3-438c-bc0d-66038ac9f2e6"><ix:nonFraction unitRef="usdPerShare" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl8xOA_b533dee2-d01c-47b1-86e8-da0ad6805e03">0.004</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl8zMg_45b216e8-7340-4ffc-9777-5c326ba953a3"><ix:nonFraction unitRef="shares" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl8zMg_c24e52b5-2a1d-4819-b790-1096ef00da8b">350,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl81NA_b80fc947-5223-4012-8f20-00475d65f429">188,295,266</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl82OA_46de5c58-ea15-4231-b583-df8b4c7ffd37">146,459,032</ix:nonFraction> outstanding at September&#160;30, 2022 and <ix:nonFraction unitRef="shares" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl85Mw_fdb13184-d7f6-4df2-8ab2-ef735c51f2d0">188,246,955</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl8xMDc_b0d1d6b8-b160-4efb-9987-88d6f0ce1b09">146,410,721</ix:nonFraction> outstanding at June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:CommonStockValueOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMS0xLTEtNjIxMTk_e4bbe9b3-df3f-4bc3-9455-8c6145f33f87">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:CommonStockValueOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMy0xLTEtNjIxMTk_8dbba734-24e9-4474-a110-01e3ec847da7">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzktMS0xLTEtNjIxMTk_cf4dd467-2b56-468b-8782-c1cba98c5108">1,701,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzktMy0xLTEtNjIxMTk_8d982605-4be0-46e6-9342-f7ba23b30d11">1,682,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDAtMS0xLTEtNjIxMTk_f182b8a1-5d64-4523-8f67-b135f8f87d3f">3,759,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDAtMy0xLTEtNjIxMTk_874fcd0b-7e36-45eb-843c-1f1b8d194b9f">3,613,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDEtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjplYzk3NzE2NjkwMWQ0M2U1OTBjNjM1NjZmNzZlODkxMF8yOQ_6919ee21-be8a-47fc-a93a-7a5de688cbcc"><ix:nonFraction unitRef="shares" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDEtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjplYzk3NzE2NjkwMWQ0M2U1OTBjNjM1NjZmNzZlODkxMF8yOQ_d5035632-3b77-44ec-ba9d-ca3e1d02b744">41,836,234</ix:nonFraction></ix:nonFraction> shares at September&#160;30, 2022 and June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDEtMS0xLTEtNjIxMTk_e69dc60f-33ed-46d8-a0df-7bc6ee604ee5">1,623,256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDEtMy0xLTEtNjIxMTk_25372cfe-4877-405f-ab1a-7a6fe65aafa5">1,623,256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDItMS0xLTEtNjIxMTk_5e1f741c-f836-47c4-91ec-52d80473c186">406,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDItMy0xLTEtNjIxMTk_64a6ebda-9b6d-4a6a-be37-6fdb54f3fdba">312,747</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDMtMS0xLTEtNjIxMTk_c6de7844-781f-45f2-8a08-efe0d9a78747">3,432,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDMtMy0xLTEtNjIxMTk_08b19057-6f96-40ae-9633-b8347ec65efd">3,360,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDQtMS0xLTEtNjIxMTk_7c08b4bf-3e8d-4b57-adfa-ed34d13c53d6">5,177,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDQtMy0xLTEtNjIxMTk_b6212ffc-9abd-45f9-a3ed-22807e6726e3">5,095,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to the unaudited condensed consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_13"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Operations (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In US$ and in thousands, except per share data)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.931%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net revenue - Sleep and Respiratory Care products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae7390e292248aea5680eee7705a952_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMi0xLTEtMS02MjExOQ_391ba7ec-4254-4d60-9921-3d48df17044e">844,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c309ac73e7e4954ac2e526a95941779_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMi0zLTEtMS02MjExOQ_7b90802f-b816-4e7a-b647-afda0f42a0c3">806,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net revenue - Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e4bee0df6d465bb76a7a14d683ed9e_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMy0xLTEtMS02MjExOQ_23a5e5f7-e61c-4477-8a12-c02b2767ed11">105,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec5cd27d9fc4cd1a6b87aaa117fa062_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMy0zLTEtMS02MjExOQ_f5747bf3-aca7-408c-81f7-d34ada2c8dec">97,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfNC0xLTEtMS02MjExOQ_d44414fb-3510-4468-a007-bc6f4e0b3e0f">950,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfNC0zLTEtMS02MjExOQ_798812d2-470a-46a0-9e88-079704a3acb3">904,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of sales - Sleep and Respiratory Care products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae7390e292248aea5680eee7705a952_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfNi0xLTEtMS02MjExOQ_d7a624d0-5fb7-402f-ba20-bdde74e5fd7d">363,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c309ac73e7e4954ac2e526a95941779_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfNi0zLTEtMS02MjExOQ_d5364478-dc61-4508-acf6-b68b9400d328">349,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of sales - Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e4bee0df6d465bb76a7a14d683ed9e_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfNy0xLTEtMS02MjExOQ_f74c0dcf-d69a-4672-8346-1bfbe3d517c9">39,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec5cd27d9fc4cd1a6b87aaa117fa062_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfNy0zLTEtMS02MjExOQ_d3b83281-7954-467f-8023-a171eb5538b4">36,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of sales (exclusive of amortization shown separately below)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfOC0xLTEtMS02MjExOQ_98b34e43-47a3-47f1-824e-e9d6cdb0910e">403,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfOC0zLTEtMS02MjExOQ_7143df33-bb00-41df-9973-859e6bf22dc3">386,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets - Sleep and Respiratory Care products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae7390e292248aea5680eee7705a952_D20220701-20220930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTAtMS0xLTEtNjIxMTk_48b3e7b3-2406-4377-b881-bac27b28d4cc">1,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c309ac73e7e4954ac2e526a95941779_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTAtMy0xLTEtNjIxMTk_c7261766-dd16-4970-97b5-a601f3ef2b1d">900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets - Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e4bee0df6d465bb76a7a14d683ed9e_D20220701-20220930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTEtMS0xLTEtNjIxMTk_cef14a78-a81e-47a4-9899-eaf4a5a0a104">5,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ec5cd27d9fc4cd1a6b87aaa117fa062_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTEtMy0xLTEtNjIxMTk_4b8d547a-9be3-4237-b888-87988ceef67f">10,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTItMS0xLTEtNjIxMTk_36edc17f-51c5-4941-aca4-908de547bdec">6,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTItMy0xLTEtNjIxMTk_5cd14597-d94e-49d7-b6fa-ae7bd21e54ba">11,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total cost of sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTMtMS0xLTEtNjIxMTk_0f53b146-dcb5-4b40-9900-2e9978e2433b">409,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTMtMy0xLTEtNjIxMTk_a063d00f-1697-4106-8e27-469a875a3830">397,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTQtMS0xLTEtNjIxMTk_2514d04d-09c0-4d53-9979-d03993d6982d">540,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTQtMy0xLTEtNjIxMTk_33e9c8c3-8d45-46f3-b19d-aa90f3f0ce90">506,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTYtMS0xLTEtNjIxMTk_9d34a9d5-3193-4ce3-a892-f2d537a32856">193,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTYtMy0xLTEtNjIxMTk_33e2a271-cf55-40df-8ab5-5d64cdeeb62e">176,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTctMS0xLTEtNjIxMTk_95d900b6-68b8-4f72-9eb1-131d74d0ccf4">63,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTctMy0xLTEtNjIxMTk_1f3935a4-c51c-407f-a117-3fca537a03f3">59,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="rmd:AmortizationOfAcquiredIntangibleAssets1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTgtMS0xLTEtNjIxMTk_a61d5c9b-4310-45e4-bfdc-908ac50285a5">7,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="rmd:AmortizationOfAcquiredIntangibleAssets1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTgtMy0xLTEtNjIxMTk_6a79fc9d-8c8d-4266-a3c9-3b007803c1e1">7,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjAtMS0xLTEtNjIxMTk_c519b67b-4b42-4f2e-92cb-94bcf1314b1b">265,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjAtMy0xLTEtNjIxMTk_c014de6e-ec49-4ceb-9abf-089e604d6085">244,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjEtMS0xLTEtNjIxMTk_01a8044e-3ce2-44e1-83b4-74d9c0921308">275,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjEtMy0xLTEtNjIxMTk_a3350148-f38b-46c4-8a9f-ee68fb8d4004">261,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (loss), net:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjMtMS0xLTEtNjIxMTk_1402e3b3-65df-4d4f-bc79-27d3f3c4ef80">7,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjMtMy0xLTEtNjIxMTk_a65807fd-ddfe-49fb-8a9d-99997766bf09">5,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss attributable to equity method investments (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjQtMS0xLTEtNjIxMTk_e52b34b8-bd37-4c92-85e4-eaf0ac60d963">2,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjQtMy0xLTEtNjIxMTk_a17699c5-48f6-45b0-afd2-b321b858df33">1,386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) on equity investments (note 5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjUtMS0xLTEtNjIxMTk_af5c750d-935b-4dce-b9ab-e4b0ae22164d">3,280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjUtMy0xLTEtNjIxMTk_ccc6b302-647d-4646-9a76-9f8f913a0577">5,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjYtMS0xLTEtNjIxMTk_eb4016c1-dc42-4552-8720-8042120aa19d">1,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjYtMy0xLTEtNjIxMTk_13d4d488-fdf4-4226-9efc-846a8d9cb018">1,991</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (loss), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjctMS0xLTEtNjIxMTk_fbdf62e5-d94b-4bd6-8867-0e3393cd32e9">13,946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjctMy0xLTEtNjIxMTk_3603176c-d9f7-454e-9b52-11d1cc2196f3">3,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjgtMS0xLTEtNjIxMTk_95214eb9-e51b-4055-b0f4-7bd58c42e0b2">261,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjgtMy0xLTEtNjIxMTk_eb6f7309-ba7a-47a3-94e0-0a54633c8f67">258,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjktMS0xLTEtNjIxMTk_f0d65410-4225-4e8a-a83d-705d915c8f1e">51,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjktMy0xLTEtNjIxMTk_3a882123-72ed-49b1-95dc-e155cdc6b525">55,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzAtMS0xLTEtNjIxMTk_8af084a1-6ae5-4d2e-9125-36a8a2ceb241">210,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzAtMy0xLTEtNjIxMTk_dd4f59ca-6728-4ba6-b75a-af28f84306a9">203,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic earnings per share (note 9)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzEtMS0xLTEtNjIxMTk_84ba5c12-192c-41dd-b396-e5de50bbbe45">1.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzEtMy0xLTEtNjIxMTk_e9a9947d-22cf-4edc-b8f5-5fdf2732568a">1.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted earnings per share (note 9)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzItMS0xLTEtNjIxMTk_7538aa0e-29b6-497b-a75a-806d347be309">1.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzItMy0xLTEtNjIxMTk_0bb31733-df15-4ded-946b-9b1727a25821">1.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividend declared per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzMtMS0xLTEtNjIxMTk_c7063cd8-a81e-4ed7-b844-144f1f9d3b9e">0.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzMtMy0xLTEtNjIxMTk_bb7a0856-9689-44bc-ab0d-b21d81db8c01">0.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic shares outstanding (000's)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzQtMS0xLTEtNjIxMTk_ac02c50d-2dd0-4f01-ad79-52c425e06eea">146,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzQtMy0xLTEtNjIxMTk_64cdbf49-398b-418b-9bc3-c74b7f4af0b6">145,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted shares outstanding (000's)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzUtMS0xLTEtNjIxMTk_74bfc1f8-261e-40f3-8f32-9430757a8789">147,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzUtMy0xLTEtNjIxMTk_f05c91c5-71d7-4e4a-89c8-55eff0e72897">146,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to the unaudited condensed consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_16"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In US$ and in thousands)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xNi9mcmFnOjI3NzU2MTRmN2ZhYzQyMzdhMzU5Y2I4MmNmZGEyMDBiL3RhYmxlOmEzYjA1OGEwYzNjMDRmMmQ4NDRlOTRiMTNlZGJhYTdkL3RhYmxlcmFuZ2U6YTNiMDU4YTBjM2MwNGYyZDg0NGU5NGIxM2VkYmFhN2RfMi0xLTEtMS02MjExOQ_26e600d7-fa70-4eec-b4e9-2d1447a9b462">210,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xNi9mcmFnOjI3NzU2MTRmN2ZhYzQyMzdhMzU5Y2I4MmNmZGEyMDBiL3RhYmxlOmEzYjA1OGEwYzNjMDRmMmQ4NDRlOTRiMTNlZGJhYTdkL3RhYmxlcmFuZ2U6YTNiMDU4YTBjM2MwNGYyZDg0NGU5NGIxM2VkYmFhN2RfMi0zLTEtMS02MjExOQ_86b8f1ce-d406-4c21-a4b4-93c3f4215a9e">203,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation (loss) gain adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xNi9mcmFnOjI3NzU2MTRmN2ZhYzQyMzdhMzU5Y2I4MmNmZGEyMDBiL3RhYmxlOmEzYjA1OGEwYzNjMDRmMmQ4NDRlOTRiMTNlZGJhYTdkL3RhYmxlcmFuZ2U6YTNiMDU4YTBjM2MwNGYyZDg0NGU5NGIxM2VkYmFhN2RfNC0xLTEtMS02MjExOQ_129f1843-47f7-4b36-9c5d-9c49269f26d6">93,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xNi9mcmFnOjI3NzU2MTRmN2ZhYzQyMzdhMzU5Y2I4MmNmZGEyMDBiL3RhYmxlOmEzYjA1OGEwYzNjMDRmMmQ4NDRlOTRiMTNlZGJhYTdkL3RhYmxlcmFuZ2U6YTNiMDU4YTBjM2MwNGYyZDg0NGU5NGIxM2VkYmFhN2RfNC0zLTEtMS02MjExOQ_d0db5ac5-83f4-4324-be43-7751d883fd55">23,516</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xNi9mcmFnOjI3NzU2MTRmN2ZhYzQyMzdhMzU5Y2I4MmNmZGEyMDBiL3RhYmxlOmEzYjA1OGEwYzNjMDRmMmQ4NDRlOTRiMTNlZGJhYTdkL3RhYmxlcmFuZ2U6YTNiMDU4YTBjM2MwNGYyZDg0NGU5NGIxM2VkYmFhN2RfNS0xLTEtMS02MjExOQ_5a1cbb06-224a-4e88-8a77-95dfc21fffe3">117,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xNi9mcmFnOjI3NzU2MTRmN2ZhYzQyMzdhMzU5Y2I4MmNmZGEyMDBiL3RhYmxlOmEzYjA1OGEwYzNjMDRmMmQ4NDRlOTRiMTNlZGJhYTdkL3RhYmxlcmFuZ2U6YTNiMDU4YTBjM2MwNGYyZDg0NGU5NGIxM2VkYmFhN2RfNS0zLTEtMS02MjExOQ_e09fa823-a651-49c2-a1bf-36e18cbbfc4d">180,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to the unaudited condensed consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Changes in Equity (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In US$ and in thousands)</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid-in </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings</span></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Comprehensive </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (Loss)</span></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="iced71fbf9d854f909b168ae0c5dc6d3d_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi0xLTEtMS02MjExOQ_52855efa-33e0-41d8-ad23-6e24422b52d0">188,247</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iced71fbf9d854f909b168ae0c5dc6d3d_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi0yLTEtMS02MjExOQ_11d09724-88af-4ee1-864d-f69a6e4c5322">586</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="if39dcb9003eb460791aab51dde509ee3_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi0zLTEtMS02MjExOQ_90434afb-5d80-49a5-beaf-63cb5c1987f4">1,682,432</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="shares" contextRef="i661416e60db0471f9d33a485c88000b8_I20220630" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi00LTEtMS02MjExOQ_fee64bb4-6c59-4fb2-8397-ec97646e3065">41,836</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i661416e60db0471f9d33a485c88000b8_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi01LTEtMS02MjExOQ_aa8da63a-da01-44fe-8781-c584903bff2e">1,623,256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ic75938a78dd84e31a55814a504baa727_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi02LTEtMS02MjExOQ_811410fe-e654-408c-a688-7d3ca9366a9b">3,613,736</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i2e425ee5a1764ebd9c10b93f28121cc9_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi03LTEtMS02MjExOQ_2c53fcea-0f93-4374-a251-c40171f4c2f1">312,747</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi04LTEtMS02MjExOQ_8700bb24-1c65-4e0d-9a75-c111e4f1992d">3,360,751</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued on exercise of options</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i07bf4ea60e5c4a4ba7835c9c6b099652_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMy0xLTEtMS02MjExOQ_d0bc6f1c-07d0-4b05-b19a-a5a9580a6888">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iebae534f8f214c65956df85450291a21_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMy0zLTEtMS02MjExOQ_ebe2aafe-685a-4a36-8f32-f456de4b36f3">2,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMy04LTEtMS02MjExOQ_f7a661f6-2d7a-4be8-a0e6-c763f58509a0">2,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued on vesting of restricted stock units, net of shares withheld for tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i07bf4ea60e5c4a4ba7835c9c6b099652_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNC0xLTEtMS02MjExOQ_0e172cec-ac08-4ed2-9a21-ebcf680b9cb5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="iebae534f8f214c65956df85450291a21_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNC0zLTEtMS02MjExOQ_8f9b5893-a88e-4681-aa43-6982d341859d">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNC04LTEtMS02MjExOQ_52b6350e-cc4a-4fb5-9369-814c39302299">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iebae534f8f214c65956df85450291a21_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNS0zLTEtMS02MjExOQ_640d7d24-384f-49c6-87dc-d27bf49b3bbf">16,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNS04LTEtMS02MjExOQ_4e9cdb74-f656-433d-90eb-eb219ad33787">16,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i51a67b36abb34b5db4ef0af0016dec20_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNi03LTEtMS02MjExOQ_ffe2d27e-7e63-4d58-8f93-98bda2a20d6a">93,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNi04LTEtMS02MjExOQ_a9bf2382-ec8c-4458-bf7c-353782208008">93,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2360ae9649ff48d281a132f80281a277_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNy02LTEtMS02MjExOQ_0d7f9a8e-af26-4429-a21b-a09e7de3ab89">210,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNy04LTEtMS02MjExOQ_c47315d6-5009-4c39-9503-7e715f71b2e6">210,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOC0wLTEtMS02MjExOS90ZXh0cmVnaW9uOjg0ZTZlNDM4MzQzYjRiNTliYmJhMmVjM2E0NzBhMDA5XzI0_58cf339b-712e-4a8b-81d0-1a3e1c8b5926">0.44</ix:nonFraction> per common share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i2360ae9649ff48d281a132f80281a277_D20220701-20220930" decimals="-3" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOC02LTEtMS02MjExOQ_23fbebe9-99f9-4b8d-b415-9b08df7d792d">64,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOC04LTEtMS02MjExOQ_9b42eb4d-8afe-4bd4-9ed8-dda9a0e8217a">64,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, September 30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="ic0bed1de6d224a628823074853f5cc02_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS0xLTEtMS02MjExOQ_b5591a60-acf4-48c9-bd2d-1af289da32a9">188,295</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ic0bed1de6d224a628823074853f5cc02_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS0yLTEtMS02MjExOQ_44d9cf7a-8194-4353-ad3e-3e041cb4c6be">586</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ided8696a9071487f85d658c6f7894111_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS0zLTEtMS02MjExOQ_d6693e2f-d3ba-4802-bbb1-4ff1edc7cbbd">1,701,902</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="shares" contextRef="iaff681621a6a47ddb2e69a84b657d563_I20220930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS00LTEtMS02MjExOQ_896ccc1f-22d0-48e5-a688-7171fa851688">41,836</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="iaff681621a6a47ddb2e69a84b657d563_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS01LTEtMS02MjExOQ_ccc994bf-ad87-4164-89c5-dab150ecf186">1,623,256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ib0edd8bdae674d5cba3df7e0bdab0a13_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS02LTEtMS02MjExOQ_04d27859-1a22-416b-b320-971fa98d3652">3,759,783</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="if39d380d692046bfac4dd7d9da85fd9e_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS03LTEtMS02MjExOQ_4ffab28d-4db3-49f4-92a4-415124cb912a">406,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS04LTEtMS02MjExOQ_00617a88-1289-449d-b909-04faceea9306">3,432,887</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to the unaudited condensed consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Changes in Equity (Unaudited)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In US$ and in thousands)</span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid-in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings</span></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Comprehensive </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (Loss)</span></div></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, June&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i82486906991d41c1bb227364f4e66f47_I20210630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi0xLTEtMS02MjExOQ_add2cd02-b824-4e4b-9c2a-84eb95ef8d22">187,485</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82486906991d41c1bb227364f4e66f47_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi0yLTEtMS02MjExOQ_e58031f8-e44e-4ee4-9538-8220dc3fc3a4">583</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaceb858b79144bdb1473e507f59ebc8_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi0zLTEtMS02MjExOQ_46529ec2-f2e8-409a-81c5-8e85c4de0f38">1,622,199</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib9a3ed59012748f68b30ed7614b16350_I20210630" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi00LTEtMS02MjExOQ_65d80bd6-2044-47d5-b5fc-1643ab13a6a8">41,836</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9a3ed59012748f68b30ed7614b16350_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi01LTEtMS02MjExOQ_2f2b7fde-47cc-4cf1-b9d8-a5ab776aece3">1,623,256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if62ca46e58ff4e1ab852ba34c6e8125d_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi02LTEtMS02MjExOQ_59b45feb-fd42-4a6c-9395-827fb554b45d">3,079,640</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if778f54978bb489ab25d9277813650fd_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi03LTEtMS02MjExOQ_8b96b2dc-d64b-420c-b760-36d3f59cdf0f">193,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c1bec761d343199bfb5656845fee5a_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi04LTEtMS02MjExOQ_4c203260-c726-48d8-acd0-6e87e05e96a4">2,885,679</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued on exercise of options</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d6e74c5fb8447bd9b144f2ba9b48825_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMy0xLTEtMS02MjExOQ_125b236a-6692-42c8-8ee2-307cfac00cb3">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68cba427884448a91f3ab762c19133d_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMy0zLTEtMS02MjExOQ_6c19e23c-e86e-4f06-8b97-3318023b57ef">4,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMy04LTEtMS02MjExOQ_575b6010-52da-403b-b69d-6f7abfd9e49c">4,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued on vesting of restricted stock units, net of shares withheld for tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d6e74c5fb8447bd9b144f2ba9b48825_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNC0xLTEtMS02MjExOQ_c939c7f4-ff6e-4c28-8ed7-10d64d1463f4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie68cba427884448a91f3ab762c19133d_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNC0zLTEtMS02MjExOQ_6ae9d484-be8b-4de7-979d-b96939fc4917">195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNC04LTEtMS02MjExOQ_9776c9b5-d04b-459a-82d2-f7d1419a6b40">195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68cba427884448a91f3ab762c19133d_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNS0zLTEtMS02MjExOQ_742fbcce-979f-47a0-a3e7-908530845268">17,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNS04LTEtMS02MjExOQ_62a3e394-1453-47d1-bdc5-dcd0353bca66">17,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2353812c8d374d0a99adb123069a8c45_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNi03LTEtMS02MjExOQ_49cf4bc5-07ff-4985-be8b-3337c5017c44">23,516</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNi04LTEtMS02MjExOQ_18c758bb-11d1-4480-8754-453468fc9314">23,516</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ae840cff9d4541883d39909be26bdb_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfOC02LTEtMS02MjExOQ_742972bc-5fe1-4726-9784-6fa5166f0084">203,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfOC04LTEtMS02MjExOQ_042d168e-1f45-4e0c-9c06-756217d3ce31">203,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfOS0wLTEtMS02MjExOS90ZXh0cmVnaW9uOjI0ZDY0MzQwYTNhZjQyNDc5MmI4NTYzMTM5ODUwMzBhXzI0_7be367d5-c08b-4170-8fe0-1397b366bf0b">0.42</ix:nonFraction> per common share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39ae840cff9d4541883d39909be26bdb_D20210701-20210930" decimals="-3" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfOS02LTEtMS02MjExOQ_6d296d2b-a645-4f51-a6a7-fc47f7498fe5">61,189</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfOS04LTEtMS02MjExOQ_137629ea-e7aa-47da-ad10-e9fc3cfa6a71">61,189</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, September 30, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d609f79239f44f6b1a7c7d6b7b1bff4_I20210930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtMS0xLTEtNjIxMTk_b3d1bd81-5ff7-42be-a83b-8c815679072f">187,547</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d609f79239f44f6b1a7c7d6b7b1bff4_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtMi0xLTEtNjIxMTk_185a8d44-2896-4ce2-87fd-cc1b49bb4577">583</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5c16a9474794461b2f4f520cab49c3f_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtMy0xLTEtNjIxMTk_fb3eb526-5685-4834-972d-df8aeddb0614">1,643,661</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i798ee6146fe04ee0a38f656f451210d4_I20210930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtNC0xLTEtNjIxMTk_1cad90bb-448b-464c-9e19-2281a11fb41a">41,836</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i798ee6146fe04ee0a38f656f451210d4_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtNS0xLTEtNjIxMTk_f6ab60f6-f559-44cc-ae32-a9863d4b7e55">1,623,256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b83a0ce15f4487baf7464a93daa021_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtNi0xLTEtNjIxMTk_33887d92-25c9-46cd-85ec-750051a14881">3,222,064</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3f1b5aa49a4420192a8beece7104061_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtNy0xLTEtNjIxMTk_c204bfe3-d792-441d-9d55-7d9291ff14f9">217,003</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee72006a6fb24b64994718e79dad7dfe_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtOC0xLTEtNjIxMTk_40fb7db2-e33a-48ac-9840-3996ba7a01f4">3,026,049</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to the unaudited condensed consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Cash Flows (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In US$ and in thousands)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMy0xLTEtMS02MjExOQ_19414fe4-9c97-4518-8f47-0594b01ab6a4">210,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMy0zLTEtMS02MjExOQ_936a6aa1-4f19-42e8-b54c-bd2f0a29ef5b">203,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustment to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNS0xLTEtMS02MjExOQ_84d2a9be-3c7d-489b-904f-b19dc3dc48f5">36,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNS0zLTEtMS02MjExOQ_12b02e25-5615-445d-8f53-d39dc56653f0">39,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNi0xLTEtMS02MjExOQ_d7f21d69-7c1d-4c02-a2db-bfdd61d9a4ae">7,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNi0zLTEtMS02MjExOQ_e68c997f-8292-4269-a06b-e66d9f68f60f">8,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNy0xLTEtMS02MjExOQ_77945f68-1cbe-479c-ac7c-ad3fa32ff546">16,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNy0zLTEtMS02MjExOQ_84bbc0c1-eea7-4249-bcb2-751616a64c61">17,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss attributable to equity method investments (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfOC0xLTEtMS02MjExOQ_bd5eb568-da9d-4d9c-9174-fd7e0fbd87d2">2,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfOC0zLTEtMS02MjExOQ_fb3334c0-4cbc-4766-aee6-4877ab4f062f">1,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain) loss on equity investments (note 5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfOS0xLTEtMS02MjExOQ_ddbda6f9-cfc2-4089-9b7e-815fb40e3349">3,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfOS0zLTEtMS02MjExOQ_664b50b2-656c-42fb-bcdc-cd0710d291b7">5,612</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTItMS0xLTEtNjIxMTk_bea5a9e5-0118-4d2d-9874-a8c985640eb0">56,238</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTItMy0xLTEtNjIxMTk_d04aaea2-5aa4-4a10-8031-01a1398419b9">33,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTMtMS0xLTEtNjIxMTk_70d4ca77-934a-447a-b758-24cb9c29e80f">147,096</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTMtMy0xLTEtNjIxMTk_40aaad1c-4b75-49cf-b08f-61919780e429">55,976</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses, net deferred income taxes and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTQtMS0xLTEtNjIxMTk_25401ee5-2f10-488a-ac0e-69cc43b16290">36,784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTQtMy0xLTEtNjIxMTk_7763dfbe-92d3-4ddf-a479-efec8f1502bd">14,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses, income taxes payable and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTUtMS0xLTEtNjIxMTk_cbdb0870-a8f4-4ecd-9381-819fb8355539">8,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTUtMy0xLTEtNjIxMTk_7ce0cc34-cee3-4c85-9ce8-02f37843ccf3">293,303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash (used in) / provided by operating activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTYtMS0xLTEtNjIxMTk_cd2458df-41c3-476d-8cc2-84c497b4278b">44,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTYtMy0xLTEtNjIxMTk_f98d84cd-1d05-4e8c-af7e-a228900a2a7b">65,657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTgtMS0xLTEtNjIxMTk_1f019f22-4f0e-4d17-a649-d19fd4c6977d">29,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTgtMy0xLTEtNjIxMTk_c8fcb613-98ee-4222-ba35-42230e884c23">27,340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patent registration and acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTktMS0xLTEtNjIxMTk_7d6007a5-95b2-470b-a7b8-31e35d6558e2">3,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTktMy0xLTEtNjIxMTk_695e590d-29bd-4f7a-b2e5-221314151fbc">4,453</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjAtMS0xLTEtNjIxMTk_585e4dc9-96b0-4d58-91f2-2d67a8d0bca5">19,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjAtMy0xLTEtNjIxMTk_c0a904f0-d27c-4668-af47-dc8525582e27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of investments (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjEtMS0xLTEtNjIxMTk_b11e31f8-dd6e-4a96-a262-e845730d7e18">4,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjEtMy0xLTEtNjIxMTk_4c745291-11f1-4d23-bccf-2b51f364958b">6,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Payments) / proceeds on maturity of foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjMtMS0xLTEtNjIxMTk_1c01ddb7-f5cf-4a21-b02a-ec7d633b6b02">3,042</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjMtMy0xLTEtNjIxMTk_401a6fed-71e2-489b-a4fc-455c998897ad">3,481</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjQtMS0xLTEtNjIxMTk_cde5ce3c-5adc-48a6-9393-57dc347aa718">58,806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjQtMy0xLTEtNjIxMTk_82bf3a51-4627-4b40-824a-faf15b2a09d2">41,874</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjYtMS0xLTEtNjIxMTk_7ccfe779-3af9-4548-ba05-438556039903">2,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjYtMy0xLTEtNjIxMTk_da03d920-5d7a-4902-8036-bf765536f3cd">4,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjctMS0xLTEtNjIxMTk_c78d96cf-e77c-4bff-a59d-17a904c4bd8a">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjctMy0xLTEtNjIxMTk_21f3c3c5-240c-4223-9d17-8dac88e925c7">195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from borrowings, net of borrowing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjktMS0xLTEtNjIxMTk_cf3658d3-1ace-42ca-a4c9-adfc604373ac">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjktMy0xLTEtNjIxMTk_0483f054-f359-4ffc-b010-873c38396f8e">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzAtMS0xLTEtNjIxMTk_5a1f7b15-596a-4d42-b13b-a26197a35688">30,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzAtMy0xLTEtNjIxMTk_e74cd735-909d-435f-9a58-8a6a3dfb3119">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzEtMS0xLTEtNjIxMTk_4803a698-ce74-4b5c-bc78-e463c1fb3b8f">64,431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzEtMy0xLTEtNjIxMTk_0f10aa06-a21c-4e3d-96d2-0ee751f96f3d">61,189</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash (used in) / provided by financing activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzItMS0xLTEtNjIxMTk_578e907e-731b-4efc-bcba-e2daacc59020">41,880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzItMy0xLTEtNjIxMTk_8157c4b6-f062-42cd-8b10-331e19ab2b15">92,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzMtMS0xLTEtNjIxMTk_eb868d01-d7de-43af-92ed-2f2c13bf58c6">10,523</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzMtMy0xLTEtNjIxMTk_aec28888-864a-47e5-91f6-9ca98f60fb64">4,568</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net decrease in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzQtMS0xLTEtNjIxMTk_4dbe1d3e-90a3-45cd-bdc2-49cf3379961c">66,547</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzQtMy0xLTEtNjIxMTk_57022f8a-4f56-4f31-a6c8-7dc8005f6b6d">19,129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzUtMS0xLTEtNjIxMTk_d5e1f014-96d2-4576-9299-9e4b278324dc">273,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c1bec761d343199bfb5656845fee5a_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzUtMy0xLTEtNjIxMTk_d2f8bc86-c70f-437f-80cd-b5e78a5d83ad">295,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzYtMS0xLTEtNjIxMTk_d44c87ef-0908-4778-b7d0-bc9cf64f3781">207,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee72006a6fb24b64994718e79dad7dfe_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzYtMy0xLTEtNjIxMTk_9e02ec63-c8ad-4c56-b745-8a706a6ce0d7">276,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes paid, net of refunds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzgtMS0xLTEtNjIxMTk_6bbc119f-8089-49b3-93b8-a7fd32a9a7c9">53,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzgtMy0xLTEtNjIxMTk_c623cb77-fe03-4f49-9fbe-df6f2725f3a1">345,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzktMS0xLTEtNjIxMTk_f52c4bf6-8cd7-4a2f-9426-04f5767281e9">7,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzktMy0xLTEtNjIxMTk_cf4b365c-34ee-4b32-bffb-212e7c40d370">5,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of assets acquired, excluding cash</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="rmd:NoncashPartOfAcquisitionFairValueOfAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDAtMS0xLTEtNjIxMTk_4a2fc96e-3da8-464a-98ac-d47d4776a406">9,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="rmd:NoncashPartOfAcquisitionFairValueOfAssetsAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDAtMy0xLTEtNjIxMTk_6ecd18c9-30cf-4d78-88c5-f8d5003a07a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDEtMS0xLTEtNjIxMTk_4151943e-9d4e-4c29-88b5-a125fae439cd">3,975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDEtMy0xLTEtNjIxMTk_f5237f64-71ec-4ef0-93e0-ea256157b3bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill on acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="rmd:GoodwillAcquiredDuringPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDItMS0xLTEtNjIxMTk_37fa4e35-bad4-42c1-9efe-fc83c44a7ceb">19,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="rmd:GoodwillAcquiredDuringPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDItMy0xLTEtNjIxMTk_1a0a0228-c13b-4797-8265-80259371a661">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred payments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="rmd:DeferredPaymentObligationsForAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDQtMS0xLTEtNjIxMTk_95866e52-06b0-4d93-8722-7e3965860868">2,856</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="rmd:DeferredPaymentObligationsForAcquisitions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDQtMy0xLTEtNjIxMTk_70a02583-6be6-4f6e-9615-0ad8f9d0bd41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="rmd:BusinessAcquisitionContingentConsiderationRecognizedLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDYtMS0xLTEtNjc1NzE_6437112d-afb4-42df-9738-e26da9dc04c4">2,856</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="rmd:BusinessAcquisitionContingentConsiderationRecognizedLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDYtMy0xLTEtNjc1NzE_511f0a88-3fc3-43f4-b309-dcfdbec4c099">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for acquisitions</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDUtMS0xLTEtNjIxMTk_4b1641f1-a831-436d-a26f-d9adae727bdc">19,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDUtMy0xLTEtNjIxMTk_612acb74-d149-4847-97e6-8901961b0fc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to the unaudited condensed consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_25"></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_28"></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMDk_20e7a72a-6ceb-4e04-96c1-cdec4decdbdd" continuedAt="ibc35cb72218242d4ab5dd6b0935f741c" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ibc35cb72218242d4ab5dd6b0935f741c" continuedAt="i46d72ddb22054908805a3c2c5777e7cb"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="rmd:OrganizationAndBasisOfPresentationPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMTA_7f410af2-2e40-4b69-991c-14b9b682f24b" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ResMed Inc. (referred to herein as &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221;) is a Delaware corporation formed in March 1994 as a holding company for the ResMed Group. Through our subsidiaries, we design, manufacture and market equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea. Our manufacturing operations are located in Australia, Singapore, Malaysia, France, China and the United States. Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, China, Finland, Norway and Sweden. We also operate a Software as a Service (&#8220;SaaS&#8221;) business in the United States that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and the rules of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the fiscal year ending June&#160;30, 2023. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements for the three months ended September&#160;30, 2022 and September&#160;30, 2021 are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K (our &#8220;Form 10-K&#8221;) for the year ended June&#160;30, 2022.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMDQ_99b16c8f-7e4b-414e-8761-4df4b5715d90" continuedAt="i8e1f23bfc7c54d1fba7e9895c5142080" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Accounting Standard Codification (&#8220;ASC&#8221;) Topic 606, &#8220;Revenue from Contracts with Customers&#8221;, we account for a contract with a customer when there is a legally enforceable contract, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We have determined that we have <ix:nonFraction unitRef="segment" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMjQ4MQ_8494bd4f-bd74-4708-989b-45093098dc0a">two</ix:nonFraction> operating segments, which are the sleep and respiratory disorders sector of the medical device industry (&#8220;Sleep and Respiratory Care&#8221;) and the supply of business management software as a service to out-of-hospital health providers (&#8220;SaaS&#8221;). Our Sleep and Respiratory Care revenue relates primarily to the sale of our products that are therapy-based equipment. Some contracts include additional performance obligations such as the provision of extended warranties and provision of data for patient monitoring. Our SaaS revenue relates to the provision of software access with ongoing support and maintenance services as well as professional services such as training and consulting. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i46d72ddb22054908805a3c2c5777e7cb" continuedAt="ia606b5626b9d4630a68187986c661c86"><ix:continuation id="i8e1f23bfc7c54d1fba7e9895c5142080" continuedAt="i3e83cd34e33149c78e3f587a712445a6"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disaggregation of revenue</span></div><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMTE_2277a48a-d0d5-4fd8-be58-b29762d30274" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):  </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S., Canada and Latin America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15ed4af6e542498aae586bf6f9ef5374_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMy0xLTEtMS02MjExOQ_9c099182-e12a-4682-a4ce-ae4a0110407e">339,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cbf2f1f9774adaa9291a924a186b8e_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMy0zLTEtMS02MjExOQ_f4c0084e-4dcd-4769-bb65-1156bbc4a54e">275,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c97b22f44884dc591a2167585ba6e8d_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNC0xLTEtMS02MjExOQ_938b5074-9de4-4ae8-9ec2-f48003e071f5">238,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa6d64210dc448b9a17c35d3c897c556_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNC0zLTEtMS02MjExOQ_9eefacc0-8c33-48fc-80e3-762d50fab34f">215,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e62e9945cad4965bcf36433023bfa68_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNS0xLTEtMS02MjExOQ_b43fd429-5ba9-453a-bf42-ee5d3625630a">578,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb5f7403b904bc9aab323b65ef846d5_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNS0zLTEtMS02MjExOQ_0321b9e3-2d45-40a5-ac3a-2d5f3dc87135">491,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ea3d05492e4ac98479d3e2ac49f908_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNi0xLTEtMS02MjExOQ_a5026575-8aab-4a91-b0b5-3d50cacbb4df">105,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc52733e9d564165bf93a97dacfc17f0_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNi0zLTEtMS02MjExOQ_6acdd006-e7f1-4a8b-abfd-29ba8540d59b">97,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98d3fc3d460b4652ad6b75c8adc858c4_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNy0xLTEtMS02MjExOQ_779dfab2-66b5-4b16-ba9d-9244e055e893">683,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db47d0b4bae4fcfbccf115899c75152_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNy0zLTEtMS02MjExOQ_626855f5-18b8-4c7c-9fa3-1387e8df044d">588,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Combined Europe, Asia and other markets </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02ae09329eef4efb848e53487594187f_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfOS0xLTEtMS02MjExOQ_1152fb12-9dce-43b4-9339-a589df472777">178,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2426e6fcaf654da9bb98fe543e2db047_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfOS0zLTEtMS02MjExOQ_d4bd1aa5-d142-42d7-b0b3-a0fcdc0207cc">218,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9911d26ac214b2a8b97be040bea08d3_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTAtMS0xLTEtNjIxMTk_b958a7df-0f89-46a8-b183-b6488cb5a9b6">88,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b207b56bf2b41e8bebae3064d374c7a_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTAtMy0xLTEtNjIxMTk_602d67ad-0664-45a6-8f4b-e295024bbab7">97,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6da4ff69d9ec4d9abbe4b31ba6f9e9cd_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTEtMS0xLTEtNjIxMTk_d3887143-fb55-4739-a951-9fcba954f45d">266,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic782a1e47cae42b893165007b949eb54_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTEtMy0xLTEtNjIxMTk_aeee60ef-c091-4140-9d68-95e0cf21d9bf">315,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Global revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf87dfd1f7d7454cbbb3fdbfed511f9a_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTMtMS0xLTEtNjIxMTk_8522a1ed-9930-4f80-b9dc-d76bdaa20855">517,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa348c66adf44ac79c2e1d968c1e940d_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTMtMy0xLTEtNjIxMTk_363a8f75-8fcb-41ce-9132-321a1616b841">494,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i690f74a8d9e04be4a7acfb5c2e3e6fed_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTQtMS0xLTEtNjIxMTk_6b535e93-3228-4cd2-813d-8bf11f8d4587">326,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2893d2234624bd1bcd6209e5bd0e3c5_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTQtMy0xLTEtNjIxMTk_f14fee9d-897d-4700-9205-e3769a18072e">312,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4bd47dac83461983f5e1caf7313368_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTUtMS0xLTEtNjIxMTk_b6d2112e-01ea-4d27-a983-df9c875157c9">844,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i599afb89a0f94887b16e08b956a275a3_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTUtMy0xLTEtNjIxMTk_54bfc39f-050b-4f89-ab7f-13b4c004cf94">806,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6ce4de0cebf48adbeadffe538eee9fd_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTYtMS0xLTEtNjIxMTk_b67f1af8-6855-4124-aec5-168005bf84ae">105,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9688c0dafa244d73b3ea05467409af36_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTYtMy0xLTEtNjIxMTk_d6b6a75a-6c8c-42c1-ac2e-36a2e49ede1b">97,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i687eebe94bad4f46bc7e06b4c56dc88e_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTctMS0xLTEtNjIxMTk_d2f8ffae-051e-44a2-83ed-62a69773f5b9">950,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5dc82ad0f3d42b68b84f9f7beb91b53_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTctMy0xLTEtNjIxMTk_e4bd0575-4e6e-4473-ad08-dd6f78112b2d">904,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance obligations and contract balances</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied; generally, this occurs with the transfer of risk and/or control of our products at a point in time. For products in our Sleep and Respiratory Care business, we transfer control and recognize a sale when products are shipped to the customer in accordance with the contractual shipping terms. For our SaaS business, revenue associated with professional services are recognized as they are provided. We defer the recognition of a portion of the consideration received when performance obligations are not yet satisfied. Consideration received from customers in advance of revenue recognition is classified as deferred revenue. Performance obligations resulting in deferred revenue in our Sleep and Respiratory Care business relate primarily to extended warranties on our devices and the provision of data for patient monitoring. Performance obligations resulting in deferred revenue in our SaaS business relate primarily to the provision of software access with maintenance and support over an agreed term and material rights associated with future discounts upon renewal of some SaaS contracts. Generally, deferred revenue will be recognized over a period of <ix:nonNumeric contextRef="i64b8ab9a3e3045bdae18cd12d207e6f3_D20220701-20220930" name="rmd:TermOfContractUnderRevenueRecognition" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfNDYyMA_1e313f14-1614-4d29-a689-aabe31d204cf">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="if328dc4c5e254ff8962ff04237432117_D20220701-20220930" name="rmd:TermOfContractUnderRevenueRecognition" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfNDYyNg_ed533e86-e1b9-4670-9d0c-398f895ffab0">five years</ix:nonNumeric>. Our contracts do not contain significant financing components.</span></div><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMDU_6b23d92a-68ff-4a97-a260-585058fd1f79" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract balances (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.114%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance sheet caption</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc375d0ba418427f8b2b60d529de7690_I20220930" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfMi0xLTEtMS02MjExOQ_6c392028-8fb3-4bd3-a027-5a54be0a4fbb">620,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3bae8b8d6404de1893a39a0a2fb73d5_I20220630" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfMi0zLTEtMS02MjExOQ_03e6d4a4-08ee-42e7-8822-2eb5cf0180de">575,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unbilled revenue, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie987664fe8794b05be297c50f780e4df_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfMy0xLTEtMS02MjExOQ_5a0fc4fe-9a72-4e23-9c72-cebe0bedfac5">23,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0705b4a48526488d8f80b81d4da788e9_I20220630" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfMy0zLTEtMS02MjExOQ_6bbe3f9f-3abf-480c-b07e-92505852065d">25,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unbilled revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5018235ea25d4087971080bf06c36785_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfNC0xLTEtMS02MjExOQ_e9854966-c59a-49b0-a3bf-73c3af25bbc7">8,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a609ca3d66545e89aa80e54d5cbf456_I20220630" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfNC0zLTEtMS02MjExOQ_c6a16dec-4ded-46d5-b990-bd1de7cffb4a">8,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid taxes and other non-current assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i396aafec23c5497f9a9a0124dd672b37_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfNy0xLTEtMS02MjExOQ_348ef6a0-f2f9-423d-acb0-298f458063b5">108,195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84379be5bb434df49678f14cabe16d60_I20220630" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfNy0zLTEtMS02MjExOQ_7cd67e06-747d-45df-8a35-8af0c6d6b5a6">108,667</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue (current liabilities)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77c2ddab74374037b8dfa317884bcb87_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfOC0xLTEtMS02MjExOQ_c718242c-260b-4b07-a76b-febbdd966ac9">97,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2a02b6469384b2fa69e00189cde926f_I20220630" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfOC0zLTEtMS02MjExOQ_0873ced3-f178-4baa-bf61-a8922dd03659">95,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue (non-current liabilities)</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transaction price determination</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. In our Sleep and Respiratory Care segment, the amount of consideration received and revenue recognized varies </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ia606b5626b9d4630a68187986c661c86"><ix:continuation id="i3e83cd34e33149c78e3f587a712445a6"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with changes in marketing incentives (e.g. rebates, discounts, free goods) and returns offered to our customers and their customers. When we give customers the right to return eligible products and receive credit, returns are estimated based on an analysis of historical experience. However, returns of products, excluding warranty-related returns, are infrequent and insignificant. We adjust the estimate of revenue at the earlier of when the most likely amount of consideration can be estimated, the amount expected to be received changes, or when the consideration becomes fixed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer our Sleep and Respiratory Care customers cash or product rebates based on volume or sales targets measured over quarterly or annual periods. We estimate rebates based on each customer&#8217;s expected achievement of its targets. In accounting for these rebate programs, we reduce revenue ratably as sales occur over the rebate period by the expected value of the rebates to be returned to the customer. Rebates measured over a quarterly period are updated based on actual sales results and, therefore, no estimation is required to determine the reduction to revenue. For rebates measured over annual periods, we update our estimates on a quarterly basis based on actual sales results and updated forecasts for the remaining rebate periods. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in programs where we issue credits to our Sleep and Respiratory Care distributors when they are required to sell our products below negotiated list prices if we have preexisting contracts with the distributors' customers. We reduce revenue for future credits at the time of sale to the distributor, which we estimate based on historical experience using the expected value method. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer discounts to both our Sleep and Respiratory Care as well as our SaaS customers as part of normal business practice and these are deducted from revenue when the sale occurs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When Sleep and Respiratory Care or SaaS contracts have multiple performance obligations, we generally use an observable price to determine the stand-alone selling price by reference to pricing and discounting practices for the specific product or service when sold separately to similar customers. Revenue is then allocated proportionately, based on the determined stand-alone selling price, to each performance obligation. An allocation is not required for many of our Sleep and Respiratory Care contracts that have a single performance obligation, which is the shipment of our therapy-based equipment.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting and practical expedient elections</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected to account for shipping and handling activities associated with our Sleep and Respiratory Care segment as a fulfillment cost within cost of sales, and record shipping and handling costs collected from customers in net revenue. We have also elected for all taxes assessed by government authorities that are imposed on and concurrent with revenue-producing transactions, such as sales and value added taxes, to be excluded from revenue and presented on a net basis. We have elected two practical expedients including the &#8220;right to invoice&#8221; practical expedient, which is relevant for some of our SaaS contracts as it allows us to recognize revenue in the amount of the invoice when it corresponds directly with the value of performance completed to date. The second practical expedient adopted permits relief from considering a significant financing component when the payment for the good or service is expected to be one year or less.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="rmd:LeaseRevenuePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMDY_83116f76-a7f5-468a-a8a7-f6ae9341dae9" continuedAt="i0369960ba09c433998a25be1febce150" escape="true">Lease Revenue</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0369960ba09c433998a25be1febce150">We lease Sleep and Respiratory Care medical devices to customers primarily as a means to comply with local health insurer requirements in certain foreign geographies. Device rental contracts include operating leases, and contract terms vary by customer and include options to terminate or extend the contract. When lease contracts also include the sale of masks and accessories, we allocate contract consideration to those items on a relative standalone price basis and recognize revenue when control transfers to the customer.</ix:continuation> Operating lease revenue was $<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfNTQ5NzU1ODI2MTY1_b0a5e2a6-d4ff-40cc-8398-5180819d6f1d">23.7</ix:nonFraction> million for the three months ended September 30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfNTQ5NzU1ODI2MTkx_f73db5de-72ad-460d-8011-889ee10936c7">25.2</ix:nonFraction> million for the three months ended September 30, 2021.</span></div><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:StandardProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMDg_83c66f4f-8510-4ff9-8dfb-d265636a670b" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provision for Warranty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for the estimated cost of product warranties on our Sleep and Respiratory Care products at the time the related revenue is recognized. We determine the amount of this provision by using a financial model, which takes into consideration actual historical expenses and potential risks associated with our different products. We use this financial model to calculate the future probable expenses related to warranty and the required level of the warranty provision. Although we engage in product improvement programs and processes, our warranty obligation is affected by product failure rates and costs incurred to correct those product failures. Should actual product failure rates or estimated costs to repair those product failures differ from our estimates, we would be required to revise our estimated warranty provision.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_31"></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RleHRyZWdpb246ZTY1ODljMGJlNjk3NGNkYzkzNDAyNDExMjAwZTJmYTFfMTM0MA_cd1dc4e2-cd9f-4745-9e6d-a226f0e31032" continuedAt="i76441471e5a84d86b3468ea08eacdd1d" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="i76441471e5a84d86b3468ea08eacdd1d"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have quantitatively and qualitatively determined that we operate in <ix:nonFraction unitRef="segment" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RleHRyZWdpb246ZTY1ODljMGJlNjk3NGNkYzkzNDAyNDExMjAwZTJmYTFfMTAw_daa9e3ef-4910-45bb-84ba-ac269440f436">two</ix:nonFraction> operating segments, which are the Sleep and Respiratory Care segment and the SaaS segment. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate the performance of our segments based on net revenues and income from operations. The accounting policies of the segments are the same as those described in note 2 of our consolidated financial statements included in our Form 10-K for the year ended June&#160;30, 2022. Segment net revenues and segment income from operations do not include inter-segment profits and revenue is allocated to a geographic area based on where the products are shipped to or where the services are performed. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate headquarters costs, stock-based compensation, amortization expense from acquired intangibles, net interest expense (income), loss attributable to equity method investments, gains and losses on equity investments, and other, net. We neither discretely allocate assets to our operating segments, nor does our Chief Operating Decision Maker evaluate the operating segments using discrete asset information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, effective in the first quarter of fiscal year 2023, we updated the extent of allocation and method of attribution of certain shared costs that are principally managed at the corporate level as part of our evaluation of segment operating performance. As a result, certain shared administrative costs, including shared IT, legal and other administrative functions, which were previously included in segment operating results, are now reported in Corporate costs within our reconciliation of segment operating profit to income before income taxes. The financial information presented herein reflects the impact of the preceding reporting change for all periods presented.</span></div><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RleHRyZWdpb246ZTY1ODljMGJlNjk3NGNkYzkzNDAyNDExMjAwZTJmYTFfMTM0MQ_4d050007-5d1b-429e-b73b-6a68bfc0cd60" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents a reconciliation of net revenues and net operating profit by reportable segments (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net revenue by segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib78c1fac3c4347a38db050a74046fbb0_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMy0xLTEtMS02MjExOQ_44cad4d3-3074-46b8-9d11-922ce2621e7d">844,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8c22fc714d74cffb6b2a777dedeb592_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMy0zLTEtMS02MjExOQ_3cb8df4e-1927-4eb7-8b78-cb4d58dcd2d8">806,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c3bb7515a714bb0922f36fa159ea208_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfNC0xLTEtMS02MjExOQ_c08cce73-8878-461e-87f3-ae21c18ba81a">105,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b9cb77e265a44399ae4e1c4466f9da9_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfNC0zLTEtMS02MjExOQ_136bad03-3b54-45ad-8bb9-87095df2dcbc">97,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfNS0xLTEtMS02MjExOQ_54adcbab-fc94-4e85-8e34-15ff7ca2a70e">950,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfNS0zLTEtMS02MjExOQ_dfd55e62-1aec-4945-a488-08d1a73e7c14">904,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Depreciation and amortization by segment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sleep and Respiratory Care</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie76543872e91484aae4ea6e093ade66c_D20220701-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfOC0xLTEtMS02MjExOQ_9452d438-a8c4-484f-85ba-200c91d89cfa">19,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94a674e4585d44dfae6658ddd3dfe6fc_D20210701-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfOC0zLTEtMS02MjExOQ_0fe521c3-0c82-451c-b17c-03ab1f52ed5a">18,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640cd8511e9741ad923b981271756f3a_D20220701-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfOS0xLTEtMS02MjExOQ_8fabc69f-1097-4084-a3d2-1583a54ba3cb">1,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b603503f594377ba49d4d341fc0c76_D20210701-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfOS0zLTEtMS02MjExOQ_3e785b07-6325-4218-9fdd-1aab61403551">1,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets and corporate assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff46fa3403a545618690423df187e3f2_D20220701-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTAtMS0xLTEtNjIxMTk_62274861-2323-44ac-88a8-73af35d24ea2">14,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c07d72c891a46a795fddf79d7928217_D20210701-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTAtMy0xLTEtNjIxMTk_f826c737-8e8b-492a-b348-b217c605e312">19,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTEtMS0xLTEtNjIxMTk_4009531a-71fb-4a4e-990a-a029e1f86e44">36,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTEtMy0xLTEtNjIxMTk_22a937ef-3fc5-41a2-892b-f1f369870772">39,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net operating profit by segment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sleep and Respiratory Care</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie76543872e91484aae4ea6e093ade66c_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTQtMS0xLTEtNjIxMTk_74f8b687-3eaf-4287-8671-a8c2573e8d72">352,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94a674e4585d44dfae6658ddd3dfe6fc_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTQtMy0xLTEtNjIxMTk_41b3d86f-0478-437b-acd2-a3c938a2c1d3">336,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640cd8511e9741ad923b981271756f3a_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTUtMS0xLTEtNjIxMTk_44cadc5a-3bd0-443f-9857-5b25ad6119ba">24,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b603503f594377ba49d4d341fc0c76_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTUtMy0xLTEtNjIxMTk_e28b6ed7-9903-44d8-8084-b5eef04b5187">21,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9147d5a65f12434291bdbb355c876cb4_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTYtMS0xLTEtNjIxMTk_5d77e139-9d59-4998-8648-551953d2c2c9">377,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3822bb4d001f4343bad4507eaf24339d_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTYtMy0xLTEtNjIxMTk_9677b7fc-3d01-43fa-99f2-c1835f573af7">358,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reconciling items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930" decimals="-3" name="rmd:UnallocatedCorporateCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTktMS0xLTEtNjIxMTk_633921c7-67e5-4c45-88a8-7d0b6e4c4532">86,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930" decimals="-3" name="rmd:UnallocatedCorporateCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTktMy0xLTEtNjIxMTk_283b94c5-9677-42c0-9e21-8ab45b7dfaa8">78,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930" decimals="-3" name="rmd:AmortizationOfAcquiredIntangibleAssets1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjAtMS0xLTEtNjIxMTk_4dc3a377-e676-4bfd-ba4e-a4f2ac989369">14,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930" decimals="-3" name="rmd:AmortizationOfAcquiredIntangibleAssets1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjAtMy0xLTEtNjIxMTk_399f1013-68fc-40c2-b556-c351ea330825">18,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjItMS0xLTEtNjIxMTk_7f6dad1c-8726-4d9a-9ed3-fc3cdbb0981b">7,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjItMy0xLTEtNjIxMTk_74a23a27-5c58-4922-a38a-816e0b44683e">5,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss attributable to equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjMtMS0xLTEtNjIxMTk_64ba380d-69d8-4722-a7b1-2779935b8506">2,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjMtMy0xLTEtNjIxMTk_e997c47b-c603-44c0-bc15-febe53308cb2">1,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain) loss on equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjQtMS0xLTEtNjIxMTk_096c2645-bdfa-46bf-9305-6dd03b734bbd">3,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930" decimals="-3" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjQtMy0xLTEtNjIxMTk_7661db0e-6df3-4df9-9e56-18a881c44431">5,612</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjUtMS0xLTEtNjIxMTk_c9093f50-c5bf-4e26-93bb-9b00536299a9">1,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjUtMy0xLTEtNjIxMTk_8f8cd0dd-d3f6-4a90-9f9d-71daa0a1835a">1,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjYtMS0xLTEtNjIxMTk_0b4af4c1-d2c1-4ea7-93f7-bdcb7971b735">261,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjYtMy0xLTEtNjIxMTk_c44d713c-0319-4f0d-9882-31009dd8074f">258,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_34"></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="rmd:SupplementalBalanceSheetInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfNDc4_c667307b-26e0-470a-b986-f500a3b42921" continuedAt="ibb7ce786cae246b3a1500d7b1bb8b8fc" escape="true">Supplemental Balance Sheet Information</ix:nonNumeric></span></div><ix:continuation id="ibb7ce786cae246b3a1500d7b1bb8b8fc"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfNDc5_66767b5d-7e5d-4819-b3a7-925b782deb22" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the condensed consolidated balance sheets consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfMS0xLTEtMS02MjExOQ_7af373f6-2f5e-48e8-b373-7dddd7a3efd5">398,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfMS0zLTEtMS02MjExOQ_ccabfe0f-dc28-4b05-8f13-466b0b477cd2">355,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfMi0xLTEtMS02MjExOQ_e5551609-1d31-4f57-8f2f-562114451796">4,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfMi0zLTEtMS02MjExOQ_7f473995-a033-4c7b-9b29-af0103ff02bd">3,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfMy0xLTEtMS02MjExOQ_e066f7de-0de8-4eb3-b020-98abc624ccf8">461,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfMy0zLTEtMS02MjExOQ_64323b2b-ae95-460f-8eb2-b93bcda7de54">385,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfNC0xLTEtMS02MjExOQ_ca3b96e4-9a84-4cc4-af18-db8756440a69">864,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfNC0zLTEtMS02MjExOQ_29821c1e-a50b-446d-9f14-c045fc55c3cb">743,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfMjE5OTAyMzI1NjAzNg_2ab2a46a-8183-46c1-b2fa-3b41ac4e3b51" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfMS0xLTEtMS02NDU5Ng_271d2b1f-6f8c-4d86-b3e3-f25a18e06a42">92,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfMS0zLTEtMS02NDU5Ng_29ddee1c-1b13-4721-8291-924801f88bf2">99,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="rmd:PrepaidInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfMi0xLTEtMS02NDU5Ng_907a79c7-fc87-4af2-8836-f77e51b23ac9">122,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="rmd:PrepaidInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfMi0zLTEtMS02NDU5Ng_77268b46-63dc-4cc1-adad-40e93eb4a870">107,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other prepaid expenses and current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfMy0xLTEtMS02NDU5Ng_b2e7477c-41d3-4aa8-ac2d-203e94754a17">126,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfMy0zLTEtMS02NDU5Ng_b3fc4187-742a-4a9e-80d0-c28b7fba225d">131,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfNC0xLTEtMS02NDU5Ng_aa60b06f-5da6-4b3e-9159-ba2fc005389c">341,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfNC0zLTEtMS02NDU5Ng_6d90e827-d194-487d-8301-e7f9456928d3">337,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:6pt"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfNDc2_35b70b62-c8be-47a9-a2c4-82f43cf2f516" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property, Plant and Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjVmYWY3MTNkYTYxNDQ0M2FhNzA1MWJjOWNhODM4ODBlL3RhYmxlcmFuZ2U6NWZhZjcxM2RhNjE0NDQzYWE3MDUxYmM5Y2E4Mzg4MGVfMS0xLTEtMS02MjExOQ_d75aa0de-e90b-437c-a583-2ca46073e6a1">1,107,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjVmYWY3MTNkYTYxNDQ0M2FhNzA1MWJjOWNhODM4ODBlL3RhYmxlcmFuZ2U6NWZhZjcxM2RhNjE0NDQzYWE3MDUxYmM5Y2E4Mzg4MGVfMS0zLTEtMS02MjExOQ_928b850b-d9e7-49a7-ab6c-fbd7b307d54c">1,131,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjVmYWY3MTNkYTYxNDQ0M2FhNzA1MWJjOWNhODM4ODBlL3RhYmxlcmFuZ2U6NWZhZjcxM2RhNjE0NDQzYWE3MDUxYmM5Y2E4Mzg4MGVfMi0xLTEtMS02MjExOQ_006ec7bb-74f5-482b-9f4a-5d9750368ee8">620,188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjVmYWY3MTNkYTYxNDQ0M2FhNzA1MWJjOWNhODM4ODBlL3RhYmxlcmFuZ2U6NWZhZjcxM2RhNjE0NDQzYWE3MDUxYmM5Y2E4Mzg4MGVfMi0zLTEtMS02MjExOQ_c5f7f889-dbe3-4413-b631-8fec48658b4f">633,114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjVmYWY3MTNkYTYxNDQ0M2FhNzA1MWJjOWNhODM4ODBlL3RhYmxlcmFuZ2U6NWZhZjcxM2RhNjE0NDQzYWE3MDUxYmM5Y2E4Mzg4MGVfMy0xLTEtMS02MjExOQ_d8e99e59-b875-445b-94bd-f514d904e23c">487,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjVmYWY3MTNkYTYxNDQ0M2FhNzA1MWJjOWNhODM4ODBlL3RhYmxlcmFuZ2U6NWZhZjcxM2RhNjE0NDQzYWE3MDUxYmM5Y2E4Mzg4MGVfMy0zLTEtMS02MjExOQ_75ef903b-23dc-4e9b-8ad6-98327b0e6062">498,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:6pt"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfNDc3_d5a741e5-7b37-42d4-b42b-b9483fd24245" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Intangible Assets </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed/core product technology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69e86a0970d447abaac8ad86f67160f7_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMS0xLTEtMS02MjExOQ_47f652ae-ee0d-40f9-930e-efdc1bcb5b2b">354,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b7e50d4346433e95666fb6afc046da_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMS0zLTEtMS02MjExOQ_b4ea6727-b9a2-4c7a-be25-9bc5eb9e05fa">350,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69e86a0970d447abaac8ad86f67160f7_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMi0xLTEtMS02MjExOQ_5fd73f42-135a-4cda-a0d0-8f9b4766c70d">244,255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84b7e50d4346433e95666fb6afc046da_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMi0zLTEtMS02MjExOQ_e8e1d8a8-b6cb-4512-bfec-4583e1bd4a76">239,647</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed/core product technology, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69e86a0970d447abaac8ad86f67160f7_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMy0xLTEtMS02MjExOQ_d1238895-a944-4be6-9833-0d84f52d0fb6">110,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b7e50d4346433e95666fb6afc046da_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMy0zLTEtMS02MjExOQ_6863ba6f-a5c1-45bf-ab8c-e8f541385399">111,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1159ad451e6e4aeb9d34a0012448665f_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNC0xLTEtMS02MjExOQ_a7086172-2c5c-47c1-9c4b-7f7dff545515">258,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if69726299ae44abb98de417d5a419afa_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNC0zLTEtMS02MjExOQ_5718226a-6474-4192-8690-e70a9203db88">257,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1159ad451e6e4aeb9d34a0012448665f_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNS0xLTEtMS02MjExOQ_1c023d24-83b5-4c46-808b-44072406afdb">97,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if69726299ae44abb98de417d5a419afa_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNS0zLTEtMS02MjExOQ_9d737d77-b0bb-4b12-95fc-663ccf62bc4a">91,731</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1159ad451e6e4aeb9d34a0012448665f_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNi0xLTEtMS02MjExOQ_05af9cb1-0674-4a19-8035-50c7353d918b">161,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if69726299ae44abb98de417d5a419afa_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNi0zLTEtMS02MjExOQ_9727dfbf-35c3-41d5-bde1-47b0fda289c3">165,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other intangibles</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0408bf19028f4072a1d8dd44df5a9ea3_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNy0xLTEtMS02MjExOQ_306a5ae3-7b87-45ea-9c30-273e6238e3e6">194,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72f4980bc58d49c2966d8c1aa7bc905d_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNy0zLTEtMS02MjExOQ_47de8c7f-b05a-4d69-8ec3-a5d3227ea498">204,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0408bf19028f4072a1d8dd44df5a9ea3_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfOC0xLTEtMS02MjExOQ_6112a773-242e-44f7-b9a0-00da6d9dc5ad">128,503</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72f4980bc58d49c2966d8c1aa7bc905d_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfOC0zLTEtMS02MjExOQ_c72931b8-5e74-44fb-8d20-1c07fa7f64b2">134,963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other intangibles, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0408bf19028f4072a1d8dd44df5a9ea3_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfOS0xLTEtMS02MjExOQ_016d4109-4597-442b-b5c6-3c38fff36d99">66,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72f4980bc58d49c2966d8c1aa7bc905d_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfOS0zLTEtMS02MjExOQ_27c7b19d-db33-4811-95bf-763bb141f6cc">69,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other intangibles, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMTAtMS0xLTEtNjIxMTk_ac322193-71b2-4f07-9d04-43abfefbeb7a">338,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMTAtMy0xLTEtNjIxMTk_26886218-98eb-44b3-bc5c-bf42e46e069d">345,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of developed/core product technology, trade names, non-compete agreements, customer relationships, and patents, which we amortize over the estimated useful life of the assets, generally between <ix:nonNumeric contextRef="i64b8ab9a3e3045bdae18cd12d207e6f3_D20220701-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfMzk0_fb1225b3-9a29-4bfd-8b0a-d99dd87a6a53">two years</ix:nonNumeric> to <ix:nonNumeric contextRef="if328dc4c5e254ff8962ff04237432117_D20220701-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfNDAw_982ce830-020f-4478-8f70-10ada9262ff0">fifteen years</ix:nonNumeric>. There are no expected residual values related to these intangible assets.</span></div></ix:continuation><div id="ibe8ac7a2e13b452cb87e155e752e9393_37"></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:GoodwillDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RleHRyZWdpb246OWQ0ODFmYmYzZTgzNGU5ZmEzNzdkYTJjZTJmZTY3YjdfMTE1_9c5c861c-fad7-4452-9ef8-c9988655e505" continuedAt="i1f47a65ac7d34d59b0be2492ae451429" escape="true">Goodwill </ix:nonNumeric></span></div><ix:continuation id="i1f47a65ac7d34d59b0be2492ae451429"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RleHRyZWdpb246OWQ0ODFmYmYzZTgzNGU5ZmEzNzdkYTJjZTJmZTY3YjdfMTE2_7b372e1a-126d-4f1d-baed-a2a16342e8f1" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of changes in our goodwill by reportable segment is as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sleep and <br/>Respiratory Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SaaS</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14ad6e094e8c4c7a80ada79f330a56c5_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfMi0xLTEtMS02MjExOQ_05162d92-8abe-4308-9653-52946507a562">641,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92f6ff0f41fd4e56a622577a92df8168_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfMi0zLTEtMS02MjExOQ_6e366b92-b53e-410b-b0d4-cdae56546693">1,294,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfMi01LTEtMS02MjExOQ_41765919-6aea-43a6-b471-5d1e9e3acdb8">1,936,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib78c1fac3c4347a38db050a74046fbb0_D20220701-20220930" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfMy0xLTEtMS02MjExOQ_e98b089c-451f-4dbb-a357-373955d042ec">19,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cb35257bd8b437e92849ecc0592453e_D20220701-20220930" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfMy0zLTEtMS02MjExOQ_9bc6685d-f8f5-4366-89c7-97f0f39149c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfMy01LTEtMS02MjExOQ_1319cfe5-6a5e-42f0-9627-a5a9dcbcf9fe">19,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib78c1fac3c4347a38db050a74046fbb0_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfNC0xLTEtMS02MjExOQ_8e36075a-e46a-4d3d-a129-536ccceb2362">16,880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cb35257bd8b437e92849ecc0592453e_D20220701-20220930" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfNC0zLTEtMS02MjExOQ_a561709f-8d46-4cc9-84e6-4e49c648cb04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfNC01LTEtMS02MjExOQ_efae9698-079a-415a-b4d9-5caa6138cce6">16,880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15dc957f85fb4fe890100775f942c978_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfNS0xLTEtMS02MjExOQ_d9b92fad-2d24-421a-8cbb-349d28689ad3">644,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e9f732c1100497b8985d47b059e8339_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfNS0zLTEtMS02MjExOQ_919e42c7-9e04-44d7-b108-a4788e20922d">1,294,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfNS01LTEtMS02MjExOQ_f03b86e8-7379-402c-adcd-4a6063498228">1,938,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_40"></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(5)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:InvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RleHRyZWdpb246NDgwN2Q4MzFhZWU0NDZlOWE1ZDAxZDRjYjAxNTNlZDFfMjkyOQ_3fabf0ac-4073-4114-808a-79b589f38e9c" continuedAt="i616247c2cda549a29cc075fd520f2742" escape="true">Investments</ix:nonNumeric></span></div><ix:continuation id="i616247c2cda549a29cc075fd520f2742" continuedAt="i3a66f7165f4c49edbf80859dcb3e3c00"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have equity investments in privately and publicly held companies that are unconsolidated entities. The following discusses our investments in marketable equity securities, non-marketable equity securities, and investments accounted for under the equity method.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketable equity securities are publicly traded stocks measured at fair value and classified within Level 1 in the fair value hierarchy because we use quoted prices for identical assets in active markets. Marketable equity securities are recorded in prepaid expenses and other current assets on the condensed consolidated balance sheets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values and are recorded in prepaid taxes and other non-current assets on the condensed consolidated balance sheets. Non-marketable equity securities are reported at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. We assess non-marketable equity securities at least quarterly for impairment and consider qualitative and quantitative factors including the investee's financial metrics, product and commercial outlook and cash usage. All gains and losses on marketable and non-marketable equity securities, realized and unrealized, are recognized in gain (loss) on equity investments as a component of other income (loss), net on the condensed consolidated statements of operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments whereby we have significant influence, but not control over the investee and are not the primary beneficiary of the investee&#8217;s activities, are accounted for under the equity method. Under this method, we record our share of gains or losses attributable to equity method investments as a component of other income (loss), net on the condensed consolidated statements of operations. </span></div><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="rmd:ScheduleOfInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RleHRyZWdpb246NDgwN2Q4MzFhZWU0NDZlOWE1ZDAxZDRjYjAxNTNlZDFfMjkzMA_e26600db-b876-4238-8ab9-8fc141dbf126" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments by measurement category were as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement category</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="rmd:MarketableEquityInvestmentsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfMS0xLTEtMS02MjExOQ_96a31994-a42b-4a82-954a-3cee839dbd6b">5,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="rmd:MarketableEquityInvestmentsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfMS0zLTEtMS02MjExOQ_d19536c0-de24-4201-b3bc-0644f68ed8d8">9,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Measurement alternative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfMi0xLTEtMS02MjExOQ_81e4e6c6-1d74-4ac5-800d-3ce42f59cf46">43,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfMi0zLTEtMS02MjExOQ_6e1f9460-32b1-40e1-868c-e77b1db6e68e">39,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfMy0xLTEtMS02MjExOQ_52f67564-aa8e-4ce7-ae95-9556eee25b73">7,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfMy0zLTEtMS02MjExOQ_1d9cb857-86e0-4722-8aa1-97d90b6e4b4b">9,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="rmd:EquityInvestmentsTotalByMeasurementCategory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfNC0xLTEtMS02MjExOQ_dedc2050-83c6-4baf-ab1b-c5cb5d1ab8b3">57,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="rmd:EquityInvestmentsTotalByMeasurementCategory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfNC0zLTEtMS02MjExOQ_ae225cc3-21b0-4818-b977-c98f810d5373">58,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i3a66f7165f4c49edbf80859dcb3e3c00"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="rmd:ScheduleOfChangesInEquityInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RleHRyZWdpb246NDgwN2Q4MzFhZWU0NDZlOWE1ZDAxZDRjYjAxNTNlZDFfMjkzMQ_39ed5e20-bd5a-42d5-938d-08f03cb4edc7" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show a reconciliation of the changes in our equity investments (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-marketable securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marketable securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a87039741047098a43d0ed149675b0_I20220630" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfMi0xLTEtMS02MjExOQ_fd70cb8d-faaf-4237-8d1e-da9f06f1ce88">39,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i754cf4a776a241f191b33f0081cd2afe_I20220630" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfMi0zLTEtMS02MjExOQ_63151e66-5fe2-4da7-91b2-5236b1a560aa">9,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e7b9f80be8c4d2394bb2681a276056a_I20220630" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfMi01LTEtMS02MjExOQ_e4c4904c-ae4b-4c4e-8203-6755b8a381c1">9,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfMi03LTEtMS02MjExOQ_09ddce1a-e42e-4155-a1b4-e955b42b0e58">58,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions to investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc6e99edaebb4a609919407282c99506_D20220701-20220930" decimals="-3" name="rmd:AdditionalEquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfMy0xLTEtMS02MjExOQ_38992657-41d3-44bb-9d45-14cda6823206">4,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="rmd:AdditionalEquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfMy03LTEtMS02MjExOQ_ac8c33b0-ef4e-4e75-b7bb-9d477ac7b89f">4,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized losses on marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e4bbc8f424443797674f57dc109757_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfNS0zLTEtMS02MjExOQ_d64bf72b-6675-4cdf-8e61-2d1abfdf5b97">3,280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfNS03LTEtMS02MjExOQ_ef077a47-2a72-4598-b760-391683bf6e69">3,280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss attributable to equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i670bbe1c2cb64cd2b590c0fadd7844ec_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfOC01LTEtMS02MjExOQ_00859a95-0751-4995-bbfe-5d6b514d43d2">2,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfOC03LTEtMS02MjExOQ_1dd7e753-e0ac-4499-afbb-b8658c103c1b">2,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying value at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieadf15b970044d0a838558a15de8430f_I20220930" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfOS0xLTEtMS02MjExOQ_9b0bf5e2-9415-402e-9405-8b3148f33ade">43,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4eb3627d8824fc0afceae4d64ab2a10_I20220930" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfOS0zLTEtMS02MjExOQ_f686bf17-0739-4749-b62d-4042d0a70bff">5,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40bb05a82f774f53aabc2ee8e712ed5d_I20220930" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfOS01LTEtMS02MjExOQ_e0ae5a62-fbe0-4b7c-a201-41072535af8d">7,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfOS03LTEtMS02MjExOQ_3b41154b-0929-4164-930e-942a1310e6b0">57,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-marketable securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marketable securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifadb68bbd9524af8a7d16266b166a2cf_I20210630" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMi0xLTEtMS02MjExOQ_543bacef-782f-492a-b056-94d25973d910">23,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4d7015735be42eb89bbf6e16b348801_I20210630" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMi0zLTEtMS02MjExOQ_b63f3c85-e0e1-472a-b2c1-e0761e3a4809">29,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f2c400950d04ed1912934bd2c201d82_I20210630" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMi01LTEtMS02MjExOQ_dd567264-5dd9-4c48-813c-e32ddb9575e3">17,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c1bec761d343199bfb5656845fee5a_I20210630" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMi03LTEtMS02MjExOQ_3c2968d9-1734-467d-bc1f-9d8b3ebc26d9">69,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions to investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398d34a58e00477c83fa76e1309cbf0c_D20210701-20210930" decimals="-3" name="rmd:AdditionalEquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMy0xLTEtMS02MjExOQ_5b0fea08-9911-4178-8ce1-8263a1258a02">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i790d1b42ed1c4ff3bb9c53be9acff926_D20210701-20210930" decimals="-3" name="rmd:AdditionalEquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMy0zLTEtMS02MjExOQ_d2d83def-34f1-46e6-b642-6c8af6d25670">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="rmd:AdditionalEquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMy03LTEtMS02MjExOQ_d45e76dd-d974-4031-9ec4-dd4b905c154d">6,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Observable price adjustments on non-marketable equity securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398d34a58e00477c83fa76e1309cbf0c_D20210701-20210930" decimals="-3" name="rmd:ObservablePriceAdjustmentsOnNonMarketableEquitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNC0xLTEtMS02MjExOQ_516d3190-be6c-4dec-abec-4e5a1932b881">5,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="rmd:ObservablePriceAdjustmentsOnNonMarketableEquitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNC03LTEtMS02MjExOQ_9d86a0f4-4820-40bb-adcb-dff1e395ff67">5,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gains on marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i790d1b42ed1c4ff3bb9c53be9acff926_D20210701-20210930" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNS0zLTEtMS02MjExOQ_291d4559-9674-4788-9065-0979d393811d">454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNS03LTEtMS02MjExOQ_7645971e-3352-4084-b950-c765af303c9f">454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of investments</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i398d34a58e00477c83fa76e1309cbf0c_D20210701-20210930" decimals="-3" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNi0xLTEtMS02MjExOQ_99258b06-58bf-42cc-9320-97193fe4e6d8">209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNi03LTEtMS02MjExOQ_ac923b30-1a71-437a-87e4-e8dee2a4ab65">209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss attributable to equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id077d5ad4d284fe9b8c598b153545a40_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNy01LTEtMS02MjExOQ_b1b56edb-cc58-4dd8-ba8a-7bb1049ac505">1,386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNy03LTEtMS02MjExOQ_6d237f15-63b6-4b84-80fc-35401d8b398b">1,386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying value at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4567248f80c40ab88a38b16d19ad029_I20210930" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfOC0xLTEtMS02MjExOQ_023ae869-a1ec-4239-8a98-fd4cd94bd537">31,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie62277cf19044d9fa1cd841612748260_I20210930" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfOC0zLTEtMS02MjExOQ_b31643c7-4742-41bd-a72f-3bfb29287544">33,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i212dd8da8d734d648e06f65c84619472_I20210930" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfOC01LTEtMS02MjExOQ_50074cab-e3af-4c96-8138-ef52f43cea35">15,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee72006a6fb24b64994718e79dad7dfe_I20210930" decimals="-3" name="rmd:EquityInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfOC03LTEtMS02MjExOQ_998e6279-1977-4dcf-8f22-270e24f6aaaf">80,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net unrealized losses recognized for equity investments in non-marketable and marketable securities held as of September&#160;30, 2022 for the three months ended September&#160;30, 2022 were $<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RleHRyZWdpb246NDgwN2Q4MzFhZWU0NDZlOWE1ZDAxZDRjYjAxNTNlZDFfMjczNg_dc6a9817-5c78-4465-b065-b4aa21941c57">3.3</ix:nonFraction> million. Net unrealized gains recognized for equity investments in non-marketable and marketable securities held as of September&#160;30, 2021 for the three months ended September&#160;30, 2021 were $<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-5" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RleHRyZWdpb246NDgwN2Q4MzFhZWU0NDZlOWE1ZDAxZDRjYjAxNTNlZDFfMjkwNg_bbdec40c-a6c1-4254-9249-b1be65e99eeb">5.6</ix:nonFraction> million.</span></div></ix:continuation><div id="ibe8ac7a2e13b452cb87e155e752e9393_43"></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180My9mcmFnOjQ0MzlhZmRjYmE5MjQyN2E5ZTU2NjU3N2E5ODAwYzliL3RleHRyZWdpb246NDQzOWFmZGNiYTkyNDI3YTllNTY2NTc3YTk4MDBjOWJfMTUzNw_7831d07a-e436-4d08-8daf-a430ce70d9c1" continuedAt="i0042dd7e285f4fed8d8aa14ec2ba80c8" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i0042dd7e285f4fed8d8aa14ec2ba80c8"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, each interim reporting period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 19, 2021, we concluded the settlement agreement with the Australian Taxation Office (&#8220;ATO&#8221;) in relation to the previously disclosed transfer pricing dispute for the tax years 2009 through 2018 (&#8220;ATO settlement&#8221;). The ATO settlement fully resolved the dispute for all prior years, with no admission of liability and provides clarity in relation to certain future taxation principles.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;28, 2021, we remitted final payment to the ATO of $<ix:nonFraction unitRef="usd" contextRef="i5f0fabb698be42fb98ac32d821f1a373_D20210928-20210928" decimals="-5" name="rmd:IncomeTaxExaminationRemittedFinalPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180My9mcmFnOjQ0MzlhZmRjYmE5MjQyN2E5ZTU2NjU3N2E5ODAwYzliL3RleHRyZWdpb246NDQzOWFmZGNiYTkyNDI3YTllNTY2NTc3YTk4MDBjOWJfMTQ0MA_a72c672b-a35c-48c0-a530-40e362adbaf1">284.8</ix:nonFraction> million, consisting of the agreed settlement amount of $<ix:nonFraction unitRef="usd" contextRef="i5f0fabb698be42fb98ac32d821f1a373_D20210928-20210928" decimals="-5" name="rmd:IncomeTaxExaminationGrossSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180My9mcmFnOjQ0MzlhZmRjYmE5MjQyN2E5ZTU2NjU3N2E5ODAwYzliL3RleHRyZWdpb246NDQzOWFmZGNiYTkyNDI3YTllNTY2NTc3YTk4MDBjOWJfMTQ5MA_2d65a419-6170-4670-a102-545fc2a90806">381.7</ix:nonFraction> million less prior remittances made to the ATO of $<ix:nonFraction unitRef="usd" contextRef="i5f0fabb698be42fb98ac32d821f1a373_D20210928-20210928" decimals="-5" name="rmd:IncomeTaxExaminationPriorRemittancePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180My9mcmFnOjQ0MzlhZmRjYmE5MjQyN2E5ZTU2NjU3N2E5ODAwYzliL3RleHRyZWdpb246NDQzOWFmZGNiYTkyNDI3YTllNTY2NTc3YTk4MDBjOWJfMTUzNQ_f2fa8362-5d24-4ff0-9ae5-0e37b86aaca1">96.9</ix:nonFraction> million.</span></div></ix:continuation><div id="ibe8ac7a2e13b452cb87e155e752e9393_46"></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(7)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:ProductWarrantyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RleHRyZWdpb246ODQ0MTFkN2VjODIxNGNjMDhmNDExOWRhN2IxYjM5MmNfMTg4_203ad088-5bc3-43a6-84a8-9334704ed8fe" continuedAt="i7cd6e8a113bf44fc943d4b71f4630a1a" escape="true">Product Warranties</ix:nonNumeric></span></div><ix:continuation id="i7cd6e8a113bf44fc943d4b71f4630a1a"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RleHRyZWdpb246ODQ0MTFkN2VjODIxNGNjMDhmNDExOWRhN2IxYjM5MmNfMTg5_7a2c1f32-80f0-4329-ad16-f6a13f8c572b" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the liability for warranty costs, which is included in accrued expenses in our condensed consolidated balance sheets, are as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:ProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfMi0xLTEtMS02MjExOQ_c9673b3e-b338-40fb-8e55-b8e5013eb3ce">25,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c1bec761d343199bfb5656845fee5a_I20210630" decimals="-3" name="us-gaap:ProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfMi0zLTEtMS02MjExOQ_2fdb0b9b-6e9c-49aa-9a42-98c2d5b2e7b6">22,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warranty accruals for the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfMy0xLTEtMS02MjExOQ_2b3b30e5-ae96-4bd1-bd79-4cdfd6ae5197">2,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfMy0zLTEtMS02MjExOQ_f20fe125-ab3c-4118-9c2e-e438cbe918c9">5,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warranty costs incurred for the period </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:ProductWarrantyAccrualPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfNC0xLTEtMS02MjExOQ_debf09da-e84a-427d-9195-15bfcec4a560">2,612</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:ProductWarrantyAccrualPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfNC0zLTEtMS02MjExOQ_398a713f-9dbc-4243-8df7-a278714843ba">3,972</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfNS0xLTEtMS02MjExOQ_c04e7dd5-a044-4225-a532-461a047a5df8">1,272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfNS0zLTEtMS02MjExOQ_3ce42e28-db26-4e11-8a49-231c03aabd64">513</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:ProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfNi0xLTEtMS02MjExOQ_d6332fdc-c8f3-4581-ae12-347650e7c0a6">24,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee72006a6fb24b64994718e79dad7dfe_I20210930" decimals="-3" name="us-gaap:ProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfNi0zLTEtMS02MjExOQ_0245d77d-7b02-4959-a7b4-7052dd3eb0bc">22,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_49"></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNjMzOA_ef7528e4-f959-4e01-9f92-09bc53c0363c" continuedAt="id624785ca031463a8389919e76c54e0b" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="id624785ca031463a8389919e76c54e0b" continuedAt="i29faff9df4774edc9e0e48737ac0be4b"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNjMzOQ_6d83af72-b83e-43d9-995c-42c30ea7cd5b" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consisted of the following (in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term debt </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="rmd:ShortTermDebtGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMS0xLTEtMS02MjExOQ_caa1f0d7-90a4-474f-86e1-9d2485fce9cc">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="rmd:ShortTermDebtGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMS0zLTEtMS02MjExOQ_51f29391-3ea7-4a35-be66-b39ba2b4a488">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred borrowing costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:DeferredFinanceCostsCurrentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMi0xLTEtMS02NzcwMQ_422839e9-20a2-420b-8014-5d969f307f94">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsCurrentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMi0zLTEtMS02NzcwMQ_036c129d-4bae-4319-a1aa-b47f7b05b167">84</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMy0xLTEtMS02NzcwMQ_31b2fc06-2a86-417b-81ae-3c83a835c036">9,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMy0zLTEtMS02NzcwMQ_e8482e30-04d0-4bb1-bc31-7f4e2cc83f90">9,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMy0xLTEtMS02MjExOQ_c4a7dab9-746b-4281-9687-ac51bdcefdde">790,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMy0zLTEtMS02MjExOQ_6ee232d1-531e-44be-b40c-670f3275a6ec">770,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred borrowing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfNC0xLTEtMS02MjExOQ_d028af45-dc1c-4532-bb61-826697abfa53">4,564</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfNC0zLTEtMS02MjExOQ_0697965b-4e33-4f87-a568-af39db45f852">4,675</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfNS0xLTEtMS02MjExOQ_5badff6f-9fe5-4f87-a3c7-d48d624f8c44">785,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfNS0zLTEtMS02MjExOQ_1fafa85b-09f7-4dd6-9d9b-8360e2b8bd40">765,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-3" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfNi0xLTEtMS02MjExOQ_f55c0b41-9e58-4893-8a44-f89aa4dd8c9c">795,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-3" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfNi0zLTEtMS02MjExOQ_758bf7b5-0698-4848-99fb-b92fb027b336">775,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facility</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;29, 2022, we entered into a second amended and restated credit agreement (the &#8220;Revolving Credit Agreement&#8221;), as borrower, with lenders MUFG Union Bank, N.A., as administrative agent, joint lead arranger, sole book runner, swing line lender and letter of credit issuer, Westpac Banking Corporation, as syndication agent and joint lead arranger, HSBC Bank USA, National Association, as syndication agent and joint lead arranger, and Wells Fargo Bank, National Association, as documentation agent. The Revolving Credit Agreement, among other things, provided a senior unsecured revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="i5b783cdf50e346eaa8a19a835c62bd94_I20220629" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNTQ5_68ab2297-540c-4faa-a5eb-cbc20613cfb7">1,500.0</ix:nonFraction> million, with an uncommitted option to increase the revolving credit facility by an additional amount equal to the greater of $<ix:nonFraction unitRef="usd" contextRef="if40a26ace8cb428880b197363318cec6_D20220629-20220629" decimals="INF" name="rmd:UncommittedOptionToIncreaseCreditFacility" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNjM5_92714ca5-5646-4ced-8cac-10dc8e0d3ca4">1,000.0</ix:nonFraction> million and <ix:nonFraction unitRef="number" contextRef="i5b783cdf50e346eaa8a19a835c62bd94_I20220629" decimals="INF" name="rmd:DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMjE5OTAyMzI2ODUxMw_2f4bd6da-5a79-4baa-b069-fba2d6e5bf35">1.00</ix:nonFraction> times the EBITDA (as defined in the Revolving Credit Agreement) for the trailing twelve-month measurement period. The Revolving Credit Agreement amends and restates that certain Amended and Restated Credit Agreement, dated as of April 17, 2018, among ResMed, MUFG Union Bank, N.A., Westpac Banking Corporation and the lenders party thereto.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on June&#160;29, 2022, ResMed Pty Limited entered into a Second Amendment to the Syndicated Facility Agreement and First Amendment to Unconditional Guaranty Agreement (the &#8220;Term Credit Agreement&#8221;), as borrower, with lenders MUFG Union Bank, N.A., as administrative agent, joint lead arranger and joint book runner, and Westpac Banking Corporation, as syndication agent, joint lead arranger and joint book runner, which amends that certain Syndicated Facility Agreement dated as of April 17, 2018. The Term Credit Agreement, among other things, provides ResMed Pty a senior unsecured term credit facility of $<ix:nonFraction unitRef="usd" contextRef="if612b91bc22e4ac586b695411b41fcc0_I20220629" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMTA4NQ_1c1a5b25-e77c-42ca-a7dd-a1818f699da0">200.0</ix:nonFraction> million. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Revolving Credit Agreement are guaranteed by certain of our direct and indirect U.S. subsidiaries, and ResMed Pty Limited&#8217;s obligations under the Term Credit Agreement are guaranteed by us and certain of our direct and indirect U.S. subsidiaries. The Revolving Credit Agreement and Term Credit Agreement contain customary covenants, including, in each case, a financial covenant that requires that we maintain a maximum leverage ratio of funded debt to EBITDA (as defined in the Revolving Credit Agreement and Term Credit Agreement, as applicable). The entire principal amounts of the revolving credit facility and term credit facility, and, in each case, any accrued but unpaid interest may be declared immediately due and payable if an event of default occurs, as defined in the Revolving Credit Agreement and the Term Credit Agreement, as applicable. Events of default under the Revolving Credit Agreement and the Term Credit Agreement include, in each case, failure to make payments when due, the occurrence of a default in the performance of any covenants in the respective agreements or related documents, or certain changes of control of us, or the respective guarantors of the obligations borrowed under the Revolving Credit Agreement and Term Credit Agreement. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Agreement and Term Credit Agreement each terminate on June&#160;29, 2027, when all unpaid principal and interest under the loans must be repaid. Amounts borrowed under the Term Credit Agreement will also amortize on a semi-annual basis, with a $<ix:nonFraction unitRef="usd" contextRef="i3e7585e7a6994d2f9e4c76acb9f9385c_D20220629-20220629" decimals="-5" name="us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMjg5OQ_4f1ef8dd-7226-4b68-a0db-eb8dd6e122f8">5.0</ix:nonFraction> million principal payment required on each such semi-annual amortization date. The outstanding principal amounts will bear interest at a rate equal to the Adjusted Term SOFR (as defined in the Revolving Credit Facility) plus <ix:nonFraction unitRef="number" contextRef="i5f41dcaf8ccd46709b5faa04c5fea871_D20220629-20220629" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzA1MQ_9ba468e9-ac6e-47c5-9d16-390034e626aa">0.75</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i9f70c29ca1d548b5ae6f93b716b75536_D20220629-20220629" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzA1Nw_e0e40e9c-5ef3-4c27-89c4-d01e3525f292">1.50</ix:nonFraction>% (depending on the then-applicable leverage ratio) or the Base Rate (as defined in the Revolving Credit Agreement and the Term Credit Agreement, as applicable) plus <ix:nonFraction unitRef="number" contextRef="i22e4bb0fad4d40c5af0492d1dc204cbc_D20220629-20220629" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzIyNA_0f31b16d-f802-413d-9125-1fb2a3528bea">0.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i34f25e5e32fb41b9b7fb9e569b16cbdc_D20220629-20220629" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzIzMA_420fb4f1-3da9-4f6e-848d-3f71da4fd796">0.50</ix:nonFraction>% (depending on the then-applicable leverage ratio). At September&#160;30, 2022, the interest rate that was being charged on the outstanding principal amounts was <ix:nonFraction unitRef="number" contextRef="i1297f32638a142a0ba72932abf60d77d_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzM3Mw_d01a8b23-8993-4b1c-9341-37e0789e4066">3.5</ix:nonFraction>%. An applicable commitment fee of <ix:nonFraction unitRef="number" contextRef="i8a573e957f98484584a0734afd58d57f_D20220701-20220930" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzQwOQ_fc769db2-1172-4b8d-aa5b-d2f346c496a0">0.075</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i52939f1db3354c2c83c55393bca89e73_D20220701-20220930" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzQxNQ_7d6a18c8-40ed-4095-84a4-1852a6e9a4e0">0.150</ix:nonFraction>% (depending on the then-applicable leverage ratio) applies on the unused portion of the revolving credit facility. As of September&#160;30, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="ib7d3d056a48b41ffafd0825a2500cd15_I20220930" decimals="-8" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzU0OQ_eae11480-6837-4c63-9fd8-890c6d828be9">1.4</ix:nonFraction> billion available for draw down under the revolving credit facility.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i29faff9df4774edc9e0e48737ac0be4b" continuedAt="iee060ded569f4e5dbbb610633fc32643"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. As the Revolving Credit and Term Credit Agreements&#8217; interest rate is calculated as Adjusted Term SOFR plus the spreads described above, its carrying amount is equivalent to its fair value as at September&#160;30, 2022 and June&#160;30, 2022, which was $<ix:nonFraction unitRef="usd" contextRef="iaf532dad3c0a4d5cb85816567efdfe50_I20220930" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNDAzMw_0b1d7198-ead2-412a-a68d-a4f0550477ca">300.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0a79621ce364424f8da12a47723d1717_I20220630" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNDA0MA_723a1d56-97d1-479c-92e6-a62df763d21a">280.0</ix:nonFraction> million, respectively. Quoted market prices in active markets for similar liabilities based inputs (Level 2) were used to estimate fair value.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 10, 2019, we entered into a Note Purchase Agreement with the purchasers to that agreement, in connection with the issuance and sale of $<ix:nonFraction unitRef="usd" contextRef="i48ec36cab3dc49749081f5531f83adae_I20190710" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNDMzNA_e410f610-7207-4d04-8f07-aae0bb1e7b74">250.0</ix:nonFraction> million principal amount of our <ix:nonFraction unitRef="number" contextRef="i48ec36cab3dc49749081f5531f83adae_I20190710" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNDM2MQ_9061028c-f35a-407e-8748-16795680dcaf">3.24</ix:nonFraction>% senior notes due July&#160;10, 2026, and $<ix:nonFraction unitRef="usd" contextRef="i3220e912ac0c4ec792285781acd932a8_I20190710" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNDM4OQ_8740b83e-e710-4dbb-a211-adfeba08b204">250.0</ix:nonFraction> million principal amount of our <ix:nonFraction unitRef="number" contextRef="i3220e912ac0c4ec792285781acd932a8_I20190710" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNDQxNg_d1c616ca-fe8f-48b6-99a8-282168d7e8bd">3.45</ix:nonFraction>% senior notes due July&#160;10, 2029 (collectively referred to as the &#8220;Senior Notes&#8221;). Our obligations under the Note Purchase Agreement and the Senior Notes are unconditionally and irrevocably guaranteed by certain of our direct and indirect U.S. subsidiaries. The net proceeds from this transaction were used to pay down borrowings on our Revolving Credit Agreement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Note Purchase Agreement, we agreed to customary covenants including with respect to our corporate existence, transactions with affiliates, and mergers and other extraordinary transactions. We also agreed that, subject to limited exceptions, we will maintain a ratio of consolidated funded debt to consolidated EBITDA (as defined in the Note Purchase Agreement) of no more than <ix:nonFraction unitRef="number" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="INF" name="rmd:DebtToConsolidatedEbitdaRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNTE3MQ_c6950e6c-d092-41ae-9fe5-4365324811cb">3.50</ix:nonFraction> to 1.00 as of the last day of any fiscal quarter, and will not at any time permit the amount of all priority secured and unsecured debt of us and our subsidiaries to exceed <ix:nonFraction unitRef="number" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="INF" name="rmd:LineOfCreditFacilityCollateralPercentageOfCompany" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNTM0Nw_2222b2ae-2c71-4db5-bce7-6ff47c47cef8">10</ix:nonFraction>% of our consolidated tangible assets, determined as of the end of our most recently ended fiscal quarter. This ratio is calculated at the end of each reporting period for which the Note Purchase Agreement requires us to deliver financial statements, using the results of the 12 consecutive month period ending with such reporting period.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. As of September&#160;30, 2022 and June&#160;30, 2022, the Senior Notes had a carrying amount of $<ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNTk2Mw_c29eb759-75dd-4605-b9cb-c391cf11c00e"><ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-5" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNTk2Mw_fcb73fe4-d7f1-4bb6-996f-c61db741685c">500.0</ix:nonFraction></ix:nonFraction> million, excluding deferred borrowing costs, and an estimated fair value of $<ix:nonFraction unitRef="usd" contextRef="i1345482cbeee4a25a7bde5fd11f5d59f_I20220930" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNjAzNA_4f4377b8-d3a7-4ca6-9ac1-2eaf3e85dffb">455.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia97609d461e84c708a6451bc44ca5926_I20220630" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNjA0MQ_2877f495-c6c6-4fff-beca-9fdeeb5a37f1">477.7</ix:nonFraction> million, respectively. Quoted market prices in active markets for similar liabilities based inputs (Level 2) were used to estimate fair value.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iee060ded569f4e5dbbb610633fc32643">At September&#160;30, 2022, we were in compliance with our debt covenants and there was $<ix:nonFraction unitRef="usd" contextRef="i52c4dfffd15a49a6932fb065ffdb3d23_I20220930" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNjI0Ng_a45df58e-a180-4d31-908f-5ac3b4acb3b5">800.0</ix:nonFraction> million outstanding under the Revolving Credit Agreement, Term Credit Agreement and Senior Notes.</ix:continuation> </span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_52"></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RleHRyZWdpb246MjY2YzZiMWFiZGFmNGRhOTk2ZWIwMGY0ZjdmZmZhZmVfMTA3Mg_28f61624-06a2-4826-bc53-2758f46e6450" continuedAt="i331573f042fd41369fc78e3907f803fe" escape="true">Earnings Per Share</ix:nonNumeric></span></div><ix:continuation id="i331573f042fd41369fc78e3907f803fe" continuedAt="i3cdb5397c5e34515b73ad6310a854cdb"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing the net income available to common stockholders by the weighted average number of shares of common stock outstanding. For purposes of calculating diluted earnings per share, the denominator includes both the weighted average number of shares of common stock outstanding and the number of dilutive common stock equivalents such as stock options and restricted stock units. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average number of outstanding stock options and restricted stock units not included in the computation of diluted earnings per share were <ix:nonFraction unitRef="shares" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RleHRyZWdpb246MjY2YzZiMWFiZGFmNGRhOTk2ZWIwMGY0ZjdmZmZhZmVfODAx_b0b6eaaf-876e-4a25-8c3b-4ace4f7ca259">113,167</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RleHRyZWdpb246MjY2YzZiMWFiZGFmNGRhOTk2ZWIwMGY0ZjdmZmZhZmVfODA4_21f19137-a382-4e30-9ddf-d9bbe0f88ba2">1,322</ix:nonFraction> for the three months ended September&#160;30, 2022 and 2021, respectively, as the effect would have been anti-dilutive.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i3cdb5397c5e34515b73ad6310a854cdb"><ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RleHRyZWdpb246MjY2YzZiMWFiZGFmNGRhOTk2ZWIwMGY0ZjdmZmZhZmVfMTA3Mw_74c81ab9-ac65-4ed3-bf9c-a2c281678c9a" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings per share are calculated as follows (in thousands except per share data):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfMy0xLTEtMS02MjExOQ_bd62ef60-5504-42de-ba88-0a036add620a">210,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfMy0zLTEtMS02MjExOQ_8efc67ab-0f68-4d0d-975c-f0d626bb86a3">203,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfNS0xLTEtMS02MjExOQ_c4f21b77-35f6-4a15-96ba-180aaa0d0117">146,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfNS0zLTEtMS02MjExOQ_4a2db0a5-aa4c-499f-8eee-3a5e6dff6753">145,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock options and restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfNy0xLTEtMS02MjExOQ_362a1854-b57c-4380-a1fa-f0a671c7bbd2">703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfNy0zLTEtMS02MjExOQ_b77c3a74-9137-42f5-8f3e-873e8306a811">1,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted weighted average shares </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfOC0xLTEtMS02MjExOQ_46f7e21e-dfea-4a49-8592-bae364210336">147,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfOC0zLTEtMS02MjExOQ_0047c3b6-1e4c-4679-b311-dc81e761701e">146,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfOS0xLTEtMS02MjExOQ_29b00252-3c9d-4798-ba84-91b1393b8121">1.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfOS0zLTEtMS02MjExOQ_92ca737e-e373-4e62-bdb4-77cee6f8e779">1.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfMTAtMS0xLTEtNjIxMTk_f14fc46a-d371-4dfa-b831-ade69d0fd5c2">1.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfMTAtMy0xLTEtNjIxMTk_34f38a52-8c5d-4255-b78f-a501be372d94">1.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ibe8ac7a2e13b452cb87e155e752e9393_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNTI1NA_a1b5dd2a-99f0-47c9-99ca-e3abba6a5103" continuedAt="i1fb8a727abef4c608d1f5589378bcf8f" escape="true">Legal Actions, Contingencies and Commitments</ix:nonNumeric></span></div><ix:continuation id="i1fb8a727abef4c608d1f5589378bcf8f" continuedAt="i3a245052a48046b99c95606264662a1e"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are subject to routine litigation incidental to our business. While the results of this litigation cannot be predicted with certainty, we believe that their final outcome will not, individually or in aggregate, have a material adverse effect on our consolidated financial statements taken as a whole.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2021, New York University ("NYU") filed a complaint for patent infringement in the United States District Court, District of Delaware against ResMed Inc., case no. 1:21-cv-00813 (JPM). The complaint alleges that the AutoSet or AutoRamp features of ResMed&#8217;s AirSense 10 AutoSet flow generators infringe one or more claims of various NYU patents, including U.S. Patent Nos. 6,988,994; 9,108,009; 9,168,344; 9,427,539; 9,533,115; 9,867,955; and 10,384,024. According to the complaint, the NYU patents are directed to systems and methods for diagnosis and treating sleeping disorders during different sleep states. The complaint seeks monetary damages and attorneys&#8217; fees. We answered the complaint on September 30, 2021 and filed a motion to dismiss the complaint on the basis that the patents are invalid because the subject matter of the patents is not patentable under the Supreme Court and Federal Circuit precedent. The motion to dismiss was granted in part and denied in part. We have also requested that the court dismiss the case based on NYU&#8217;s license of the patents to Fisher &amp; Paykel and Fisher &amp; Paykel&#8217;s prior settlement with us. The matter is proceeding to discovery while the court considers our request. We have also filed petitions for inter partes review with the Patent Trial and Appeal Board (&#8220;PTAB&#8221;) of the United States Patent and Trademark Office seeking to invalidate the asserted claims of the patents-in-suit. A determination by the PTAB whether to institute the petitions is expected by early December 2022. If the petitions are instituted by the PTAB, a final written decision determining the invalidity of the challenged claims is expected by December 2023. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 27, 2021, the International Trade Commission ("ITC") instituted In Re Certain UMTS and LTE Cellular Communications Modules and Products Containing the Same, Investigation No. 337-TA-1240, by complainants Philips RS North America, LLC and Koninklijke Philips N.V. (collectively &#8220;Philips&#8221;) against Quectel Wireless Solutions Co., Ltd; Thales DIS AIS USA, LLC, Thales DIS AIS Deutschland GmbH; Telit Wireless Solutions, Inc., Telit Communications PLC, CalAmp. Corp., Xirgo Technologies, LLC, and Laird Connectivity, Inc. (collectively &#8220;respondents&#8221;). In the ITC investigation, Philips seeks an order excluding communications modules, and products that contain them, from importation into the United States based on alleged infringement of 3G and 4G standard essential patents held by Philips. On October 6-14, 2021, the administrative law judge held a hearing on the merits. The administrative law judge issued an initial determination on April 1, 2022, finding no violation of any of the Philips' patents asserted in the ITC. Philips sought review by the full ITC. On July 6, 2022, the Commission affirmed the administrative law judge&#8217;s determination that there was no violation of asserted Philips' patents. The Commission terminated the ITC proceedings. Philips did not appeal the ITC&#8217;s decision. On December 17, 2020, Philips filed companion cases for patent infringement against the same defendants in the United States District Court for the District of Delaware, case nos. 1:20-cv-01707, 01708, 01709, 01710, 01711, and 01713 (CFC) seeking damages, an injunction, and a declaration from the court on the amount of a fair reasonable and non-discriminatory license rate for the standard essential patents it is asserting against the communications module defendants. The district court cases have been stayed pending the resolution of the ITC proceedings. Philips has not yet moved to lift </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i3a245052a48046b99c95606264662a1e" continuedAt="ie543d619f132446abe7ed0c6078c61f6"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the stay following the termination of the ITC Investigation. We are not a party to the ITC investigation or the district court cases, but we sell products that incorporate some of the communications modules at issue in the cases. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2022, Cleveland Medical Devices Inc. ("Cleveland Medical") filed suit for patent infringement against ResMed Inc. in the United States District Court for the District of Delaware, case no. 1:22-cv-00794. Cleveland Medical asserts that numerous ResMed connected devices, when combined with certain ResMed data platforms and/or software, including AirView and ResScan, infringe one or more of eight Cleveland Medical patents, including U.S. Patent Nos. 10,076,269; 10,426,399; 10,925,535; 11,064,937; 10,028,698; 10,478,118; 11,202,603; and 11,234,637. We have moved to dismiss the action because Cleveland Medical sued the wrong ResMed entity. We have also moved to dismiss all claims based on U.S. Patent No. 10,076,269, as well as indirect and willful infringement allegations as to the remaining patents asserted against ResMed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on currently available information, we are unable to make a reasonable estimate of loss or range of losses, if any, arising from matters that remain open.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Obligations Under Recourse Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use independent financing institutions to offer some of our customers financing for the purchase of some of our products. Under these arrangements, if the customer qualifies under the financing institutions&#8217; credit criteria and finances the transaction, the customers repay the financing institution on a fixed payment plan. For some of these arrangements, the customer&#8217;s receivable balance is with limited recourse whereby we are responsible for repaying the financing company should the customer default. We record a contingent provision, which is estimated based on historical default rates. This is applied to receivables sold with recourse and is recorded in accrued expenses.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2022 and September&#160;30, 2021, receivables sold with limited recourse were $<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-5" name="rmd:ReceivablesSoldWithLimitedRecourse" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNDk2Nw_b42db16a-0afc-4f08-ba18-8f6f7e348a9e">39.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930" decimals="-5" name="rmd:ReceivablesSoldWithLimitedRecourse" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNDk3NA_9c40c550-0bfc-4a50-8121-0f67457e4dda">49.5</ix:nonFraction> million, respectively. As of September&#160;30, 2022, the maximum exposure on outstanding receivables sold with recourse and contingent provision were $<ix:nonFraction unitRef="usd" contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930" decimals="-5" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNTA5OQ_e1a205b1-195e-4abb-8e55-ed5d75a32931">22.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930" decimals="-5" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNTEwNg_07c57796-0466-4fd4-a334-4cfb52e765aa">1.2</ix:nonFraction> million, respectively. As of June&#160;30, 2022, the maximum exposure on outstanding receivables sold with recourse and contingent provision were $<ix:nonFraction unitRef="usd" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-5" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNTIzMQ_a50ce6b7-52d4-4f96-9286-f836feeee6c0">24.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i543df4c733354c07b6ce1628c05bd511_D20210701-20220630" decimals="-5" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNTIzOA_b8921fec-0103-4ab2-94ed-f9f851eedcf2">2.1</ix:nonFraction> million, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie543d619f132446abe7ed0c6078c61f6">In June 2022 we signed a definitive agreement to acquire MEDIFOX DAN which is expected to close during our fiscal year 2023. The MEDIFOX DAN acquisition remains subject to regulatory clearances and other customary closing conditions. Upon closing, acquisition consideration of EUR <ix:nonFraction unitRef="eur" contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630" decimals="-6" name="us-gaap:ContractualObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfMjE5OTAyMzMxMDQ4NQ_978c72ef-7178-4c04-b813-c4584396c892">950</ix:nonFraction>&#160;million will be paid, in part, with funds available for draw under our Revolving Credit Agreement.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_61"></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:120%">.</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_64"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Note Regarding Forward-Looking Statements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report contains or may contain certain forward-looking statements and information that are based on the beliefs of our management as well as estimates and assumptions made by, and information currently available to, our management. All statements other than statements regarding historical facts are forward-looking statements. The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;anticipate,&#8221; &#8220;will continue,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;future&#8221; and other similar expressions, and negative statements of such expressions, generally identify forward-looking statements, including, in particular, statements regarding expectations of future revenue or earnings, expenses, new product development, new product launches, new markets for our products, litigation, tax outlook </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the effects of competition and public health crises (including the COVID-19 pandemic) on our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These forward-looking statements are made in accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements reflect the views of our management at the time the statements are made and are subject to a number of risks, uncertainties, estimates and assumptions, including, without limitation, and in addition to those identified in the text surrounding such statements, those identified in our annual report on Form 10-K for the fiscal year ended June&#160;30, 2022 and elsewhere in this report. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry, business, market, and other data from reports, research surveys, studies, and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data, and similar sources. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, important factors to consider in evaluating such forward-looking statements include changes or developments in healthcare reform, social, economic, market, legal or regulatory circumstances, including the impact of public health crises such as the novel strain of coronavirus (COVID-19) that has spread globally, changes in our business or growth strategy or an inability to execute our strategy due to changes in our industry or the economy generally, the emergence of new or growing competitors, the actions or omissions of third parties, including suppliers, customers, competitors and governmental authorities and various other factors. If any one or more of these risks or uncertainties materialize, or underlying estimates or assumptions prove incorrect, actual results may vary significantly from those expressed in our forward-looking statements, and there can be no assurance that the forward-looking statements contained in this report will in fact occur.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before deciding to purchase, hold or sell our common stock, you should carefully consider the risks described in our annual report on Form 10-K for the fiscal year ended June&#160;30, 2022, in addition to the other cautionary statements and risks described elsewhere in this report and in our other filings with the Securities and Exchange Commission (&#8220;SEC&#8221;), including our subsequent reports on Forms 10-Q and 8-K. These risks and uncertainties are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business. If any of these known or unknown risks or uncertainties actually occurs with material adverse effects on us, our business, financial condition and results of operations could be seriously harmed. In that event, the market price for our common stock will likely decline and you may lose all or part of your investment.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_67"></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is an overview of our results of operations for the three months ended September 30, 2022. Management&#8217;s discussion and analysis of financial condition and results of operations (&#8220;MD&amp;A&#8221;) is intended to help the reader understand our results of operations and financial condition. Management&#8217;s discussion and analysis is provided as a supplement to, and should be read in conjunction with, the condensed consolidated financial statements and notes included in this report.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a global leader in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (&#8220;SDB&#8221;), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Our products and solutions are designed to improve patient quality of life, reduce the impact of chronic disease and lower healthcare costs as global healthcare systems continue to drive a shift in care from hospitals to the home and lower cost settings. Our cloud-based software digital health applications, along with our devices, are designed to provide connected care to improve patient outcomes and efficiencies for our customers. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the development of continuous positive airway pressure therapy, we have expanded our business by developing or acquiring a number of products and solutions for a broader range of respiratory disorders including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes and customer and provider business processes. Our growth has been fueled by geographic expansion, our research and product development efforts, acquisitions and an increasing awareness of SDB and respiratory conditions like chronic obstructive pulmonary disease as significant health concerns. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to ongoing investment in research and development and product enhancements. During the three months ended September 30, 2022, we invested $63.2 million on research and development activities, which represents 6.6% of net revenues, with a continued focus on the development and commercialization of new, innovative products and solutions that improve patient outcomes, create efficiencies for our customers and help physicians and providers better manage chronic disease and lower healthcare costs. During the three months ended September 30, 2022 we continued the launch of AirSense 11, which introduces new features such as a touch screen, algorithms for patients new to therapy and digital enhancements and over-the-air update capabilities as well as continued to expand our global offering of devices to include Card-to-Cloud ("C2C") versions of our prior model AirSense 10 and AirCurve 10 products that do not incorporate a communications module. We introduced these C2C models to address the growing backlog of patients waiting for therapy with our devices due to the global semiconductor supply shortage. Due to multiple acquisitions, including Brightree in April 2016, HEALTHCAREfirst in July 2018 and MatrixCare in November 2018, and our pending acquisition of MEDIFOX DAN which is expected to close during fiscal year 2023 subject to regulatory clearances, our operations now include out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. These platforms comprise our SaaS business. These products, our cloud-based remote monitoring and therapy management system, and a robust product pipeline, should continue to provide us with a strong platform for future growth. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that we have two operating segments, which are the sleep and respiratory disorders sector of the medical device industry (&#8220;Sleep and Respiratory Care&#8221;) and the supply of business management software as a service to out-of-hospital health providers (&#8220;SaaS&#8221;).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue for the three months ended September 30, 2022 was $950.3 million, an increase of 5% compared to the three months ended September 30, 2021. Gross margin was 56.9% for the three months ended September 30, 2022 compared to 56.0% for the three months ended September 30, 2021. Diluted earnings per share was $1.43 for the three months ended September 30, 2022, compared to diluted loss per share of $1.39 for the three months ended September 30, 2021. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, our cash and cash equivalents totaled $207.2 million, our total assets were $5.2 billion and our stockholders&#8217; equity was $3.4 billion. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to provide a framework for assessing how our underlying businesses performed excluding the effect of foreign currency fluctuations, we provide certain financial information on a &#8220;constant currency&#8221; basis, which is in addition to the actual financial information presented. In order to calculate our constant currency information, we translate the current </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period financial information using the foreign currency exchange rates that were in effect during the previous comparable period. However, constant currency measures should not be considered in isolation or as an alternative to U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_73"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended September&#160;30, 2022 Compared to the Three Months Ended September&#160;30, 2021</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue for the three months ended September 30, 2022 increased to $950.3 million from $904.0 million for the three months ended September 30, 2021, an increase of $46.3 million or 5% (a 9% increase on a constant currency basis). The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant Currency*</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S., Canada and Latin America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">339,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">238,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">578,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">491,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">683,956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">588,554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Combined Europe, Asia and other markets </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">218,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">315,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Global revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">517,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">494,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">326,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">844,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">806,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950,294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">904,015&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31pt">Constant currency numbers exclude the impact of movements in international currencies.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sleep and Respiratory Care</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue from our Sleep and Respiratory Care business for the three months ended September 30, 2022 was $844.4 million, an increase of 5% compared to net revenue for the three months ended September 30, 2021. Movements in international currencies against the U.S. dollar negatively impacted net revenue by approximately $36.2&#160;million for the three months ended September 30, 2022. Excluding the impact of currency movements, total Sleep and Respiratory Care net revenue for the three months ended September 30, 2022 increased by 9% compared to the three months ended September 30, 2021. The increase in net revenue was primarily attributable to an increase in unit sales of our devices and masks.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue from our Sleep and Respiratory Care business in the U.S., Canada and Latin America for the three months ended September 30, 2022 increased to $578.1 million from $491.0 million for the three months ended September 30, 2021, an increase of $87.1 million or 18%. The increase was primarily due to an increase in unit sales of our devices, including incremental sales of the C2C devices, and masks.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue in combined Europe, Asia and other markets decreased for the three months ended September 30, 2022 to $266.3 million from $315.5 million for the three months ended September 30, 2021, a decrease of $49.1 million or 16% (a 6% decrease on a constant currency basis). The constant currency decrease in sales in combined Europe, Asia and other </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">markets predominantly reflects a decrease in unit sales of our devices, which have been negatively impacted by the continued shortages in electronic components.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue from devices for the three months ended September 30, 2022 increased to $517.6 million from $494.2 million for the three months ended September 30, 2021, an increase of $23.4 million or 5%, including an increase of 23% in the U.S., Canada and Latin America and a decrease of 18% in combined Europe, Asia and other markets (a 10% decrease on a constant currency basis). Excluding the impact of foreign currency movements, device sales for the three months ended September 30, 2022 increased by 9%.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue from masks and other for the three months ended September 30, 2022 increased to $326.9 million from $312.3 million for the three months ended September 30, 2021, an increase of $14.5 million or 5%, including an increase of 11% in the U.S., Canada and Latin America and a decrease of 9% in combined Europe, Asia and other markets (a 3% increase on a constant currency basis). Excluding the impact of foreign currency movements, masks and other sales increased by 8%, compared to the three months ended September 30, 2021.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Software as a Service</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue from our SaaS business for the three months ended September 30, 2022 was $105.9 million, an increase of 9% compared to the three months ended September 30, 2021. The increase was predominantly due to continued growth in the HME vertical within our SaaS business.</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_76"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit and Gross Margin</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased for the three months ended September 30, 2022 to $540.8 million from $506.3 million for the three months ended September 30, 2021, an increase of $34.5 million or 7%. Gross margin, which is gross profit as a percentage of net revenue, for the three months ended September 30, 2022 was 56.9% compared to 56.0% for the three months ended September 30, 2021. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in gross margin for the three months ended September 30, 2022 compared to the three months ended September 30, 2021 was due primarily to increases in average selling prices and a decrease in the amortization of acquired intangible assets, partially offset by unfavorable product mix and foreign currency movements.</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_79"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our operating expenses (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.932%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant Currency</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">as a % of net revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">as a % of net revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Selling, General, and Administrative Expenses</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general, and administrative expenses increased for the three months ended September 30, 2022 to $193.9 million from $176.7 million for the three months ended September 30, 2021, an increase of $17.2 million or 10%. Selling, general, and administrative expenses were favorably impacted by the movement of international currencies against the U.S. dollar, which decreased our expenses by approximately $10.2 million, as reported in U.S. dollars. Excluding the impact of foreign currency movements, selling, general, and administrative expenses for the three months ended September 30, 2022 increased by 16% compared to the three months ended September 30, 2021. As a percentage of net revenue, selling, general, and administrative expenses were 20.4% for the three months ended September 30, 2022, compared to 19.5% for the three months ended September 30, 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The constant currency increase in selling, general, and administrative expenses was primarily due to increases in employee-related costs and travel and entertainment expenses during the three months ended September 30, 2022 compared to the three months ended September 30, 2021.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Research and Development Expenses</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased for the three months ended September 30, 2022 to $63.2 million from $60.0 million for the three months ended September 30, 2021, an increase of $3.2 million, or 5%. Research and development expenses were favorably impacted by the movement of international currencies against the U.S. dollar, which decreased our expenses by approximately $2.0 million for the three months ended September 30, 2022, as reported in U.S. dollars. Excluding the impact of foreign currency movements, research and development expenses increased by 9% compared to the three months ended September 30, 2021. As a percentage of net revenue, research and development expenses were consistent at 6.6% for the three months ended September 30, 2022 and September&#160;30, 2021. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amortization of Acquired Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of acquired intangible assets for the three months ended September 30, 2022 totaled $8.0 million compared to $7.7 million for the three months ended September 30, 2021. </span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_82"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Other Income (Loss), Net</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our other income (loss) (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest (expense) income, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,360)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,774)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss attributable to equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) on equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,991)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (loss), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,946)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,821)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income (loss), net for the three months ended September 30, 2022 was a loss of $13.9 million compared to a loss of $3.1 million for the three months ended September 30, 2021. The increase in loss was primarily due to losses associated with our investments in marketable and non-marketable equity securities, which were a loss of $3.3 million for the three months ended September 30, 2022 compared to a gain of $5.6 million for the three months ended September 30, 2021. We recorded higher losses attributable to equity method investments for the three months ended September 30, 2022 of $2.0 million compared to $1.4 million for the three months ended September 30, 2021. Additionally, interest expense, net, increased to $7.1 million for the three months ended September 30, 2022 compared to $5.4 million for the three months ended September 30, 2021. </span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_85"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our effective income tax rate for the three months ended September 30, 2022 was 19.6% as compared to 21.3% for the three months ended September 30, 2021. Our effective rate of 19.6% for three months ended September 30, 2022 differs from the statutory rate of 21.0% primarily due to research credits, foreign operations and windfall tax benefits related to the vesting or settlement of employee share-based awards. The decrease in our effective tax rate for the three months ended September 30, 2022 was primarily related to a change in the Company&#8217;s global mix of earnings. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Singapore operations operate under certain tax holidays and tax incentive programs that will expire in whole or in part at various dates through June 30, 2030. As a result of the U.S. Tax Act, we treated all non-U.S. historical earnings as taxable during the year ended June 30, 2018. Therefore, future repatriation of cash held by our non-U.S. subsidiaries will generally not be subject to U.S. federal tax, if repatriated.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 19, 2021, we concluded the settlement agreement with the Australian Taxation Office (&#8220;ATO") in relation to the previously disclosed transfer pricing dispute for the tax years 2009 through 2018 (&#8220;ATO settlement&#8221;). The ATO settlement fully resolved the dispute for all prior years, with no admission of liability and provides clarity in relation to certain future taxation principles.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2021, we remitted final payment to the ATO of $284.8 million, consisting of the agreed settlement amount of $381.7 million less prior remittances made to the ATO of $96.9 million.</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_88"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income and Earnings per Share</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the factors above, our net income for the three months ended September 30, 2022 was $210.5 million compared to a net income of $203.6 million for the three months ended September 30, 2021, an increase of $6.9 million, or 3%. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diluted earnings per share for the three months ended September 30, 2022 was $1.43 per diluted share compared to diluted earnings per share of $1.39 for the three months ended September 30, 2021, an increase of 3%.  </span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_91"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Non-GAAP Financial Measures</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to financial information prepared in accordance with GAAP, our management uses certain non-GAAP financial measures, such as non-GAAP revenue, non-GAAP cost of sales, non-GAAP gross profit, non-GAAP gross margin, non-GAAP income from operations, non-GAAP net income, and non-GAAP diluted earnings per share, in evaluating the performance of our business. We believe that these non-GAAP financial measures, when reviewed in conjunction with GAAP financial measures, can provide investors better insight when evaluating our performance from core operations and can provide more consistent financial reporting across periods. For these reasons, we use non-GAAP information internally in planning, forecasting, and evaluating the results of operations in the current period and in comparing it to past periods. These non-GAAP financial measures should be considered in addition to, and not superior to or as a substitute for, GAAP financial measures. We strongly encourage investors and shareholders to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure. Non-GAAP financial measures as presented herein may not be comparable to similarly titled measures used by other companies. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measure &#8220;non-GAAP cost of sales&#8221; is equal to GAAP cost of sales less amortization of acquired intangible assets relating to cost of sales. The measure &#8220;non-GAAP gross profit&#8221; is the difference between GAAP net revenue and non-GAAP cost of sales, and &#8220;non-GAAP gross margin&#8221; is the ratio of non-GAAP gross profit to GAAP net revenue. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These non-GAAP measures are reconciled to their most directly comparable GAAP financial measures below (in thousands, except percentages):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">904,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP Cost of sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">397,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Less:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Amortization of acquired intangibles</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">403,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">386,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">540,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">506,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP gross margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">547,184&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">517,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP gross margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measure &#8220;non-GAAP income from operations&#8221; is equal to GAAP income from operations once adjusted for amortization of acquired intangibles and acquisition-related expenses. Non-GAAP income from operations is reconciled with GAAP income from operations below (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangibles - cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangibles - operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition-related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP income from operations </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">290,808&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,679&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measure &#8220;non-GAAP net income&#8221; is equal to GAAP net income once adjusted for amortization of acquired intangibles (net of tax), acquisition-related expenses and reserve for disputed tax positions. The measure &#8220;non-GAAP diluted earnings per share&#8221; is the ratio of non-GAAP net income to diluted shares outstanding. These non-GAAP measures are reconciled to their most directly comparable GAAP financial measures below (in thousands, except for per share amounts):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">210,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangibles - cost of sales, net of tax </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangibles - operating expenses, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition-related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reserve for disputed tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,089&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222,037&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147,134&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">146,860&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP diluted earnings per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.43&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.39&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-GAAP diluted earnings per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal sources of liquidity are our existing cash and cash equivalents, cash generated from operations and access to our revolving credit facility. Our primary uses of cash have been for research and development activities, selling and marketing activities, capital expenditures, strategic acquisitions and investments, dividend payments and repayment of debt obligations. We expect that cash provided by operating activities may fluctuate in future periods as a result of several factors, including fluctuations in our operating results, which include impacts from supply chain disruptions, working capital requirements and capital deployment decisions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors including our growth rate in net revenue, third-party reimbursement of our products for our customers, the timing and extent of spending to support research development efforts, the expansion of selling, general and administrative activities, the timing of introductions of new products, and the expenditures associated with possible future acquisitions, investments or other business combination transactions, including our pending acquisition of MEDIFOX DAN. As we assess inorganic growth strategies, we may need to supplement our internally generated cash flow with outside sources. If we are required to access the debt market, we believe that we will be able to secure reasonable borrowing rates. As part of our liquidity strategy, we will continue to monitor our current level of earnings and cash flow generation as well as our ability to access the market considering those earning levels. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and June&#160;30, 2022, we had cash and cash equivalents of $207.2 million and $273.7 million, respectively. Our cash and cash equivalents held within the United States at September&#160;30, 2022 and June&#160;30, 2022 were $60.6 million and $70.0 million, respectively. Our remaining cash and cash equivalent balances at September&#160;30, 2022 and June&#160;30, 2022, were $146.6 million and $203.7 million, respectively. Our cash and cash equivalent balances are held at highly rated financial institutions</span><span style="color:#0070c0;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we had $1.4 billion available for draw down under the revolver credit facility and a combined total of $1.6 billion in cash and available liquidity under the revolving credit facility. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the U.S. Tax Act, we treated all non-U.S. historical earnings as taxable, which resulted in additional tax expense of $126.9 million which was payable over the proceeding eight years. Therefore, future repatriation of cash held by our non-U.S. subsidiaries will generally not be subject to U.S. federal tax if repatriated. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our current sources of liquidity will be sufficient to fund our operations, including expected capital expenditures, for the next 12 months and beyond.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Agreement, Term Credit Agreement and Senior Notes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;29, 2022, we entered into a second amended and restated credit agreement (as amended from time to time, the &#8220;Revolving Credit Agreement&#8221;). The Revolving Credit Agreement, among other things, provided a senior unsecured revolving credit facility of $1,500.0 million, with an uncommitted option to increase the revolving credit facility by an additional amount equal to the greater of $1,000.0 million and 1.00 times the EBITDA for the trailing twelve-month measurement period. Additionally, on June&#160;29, 2022, ResMed Pty Limited entered into a Second Amendment to the Syndicated Facility Agreement (the &#8220;Term Credit Agreement&#8221;). The Term Credit Agreement, among other things, provides ResMed Limited a senior unsecured term credit facility of $200.0 million. The Revolving Credit Agreement and Term Credit Agreement each terminate on June&#160;29, 2027, when all unpaid principal and interest under the loans must be repaid. As of September&#160;30, 2022, we had $1.4 billion available for draw down under the revolving credit facility.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 10, 2019, we entered into a Note Purchase Agreement with the purchasers to that agreement, in connection with the issuance and sale of $250.0 million principal amount of our 3.24% senior notes due July&#160;10, 2026, and $250.0 million principal amount of our 3.45% senior notes due July&#160;10, 2029 (&#8220;Senior Notes&#8221;). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;30, 2022, there was a total of $800.0 million outstanding under the Revolving Credit Agreement, Term Credit Agreement and Senior Notes. We expect to satisfy all of our liquidity and long-term debt requirements through a combination of cash on hand, cash generated from operations and debt facilities.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Flow Summary</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flow activity (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash (used in) / provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(65,657)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(58,806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41,874)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash (used in) / provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41,880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,568)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net decrease in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(66,547)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19,129)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities was $44.7 million for the three months ended September 30, 2022, compared to cash used of $65.7 million for the three months ended September 30, 2021. The $110.3 million increase in cash flow from operations was primarily due to the payment of our tax settlement with the ATO of $284.8 million during the three months ended September 30, 2021, partially offset by greater purchases of inventory to secure adequate components for increasing sales demand and other net changes in working capital balances during the three months ended September 30, 2022 compared to the three months ended September 30, 2021. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities was $58.8 million for the three months ended September 30, 2022, compared to cash used of $41.9 million for the three months ended September 30, 2021. The $16.9 million decrease in cash flow from investing activities was primarily due to cash used to acquire Germany-based digital health company mementor.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in financing activities was $41.9 million for the three months ended September 30, 2022, compared to cash provided of $93.0 million for the three months ended September 30, 2021. The $134.9 million decrease in cash flow from financing activities was primarily due to borrowing activity under our Revolving Credit Agreement.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2022, we paid cash dividends of $0.44 per common share totaling $64.4 million. On October&#160;27, 2022, our board of directors declared a cash dividend of $0.44 per common share, to be paid on December&#160;15, 2022, to shareholders of record as of the close of business on November&#160;10, 2022. Future dividends are subject to approval by our board of directors.</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_97"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the inception of our share repurchase programs and through September&#160;30, 2022, we have repurchased a total of 41.8 million shares for an aggregate of $1.6 billion. We have temporarily suspended our share repurchase program due to recent acquisitions and as a response to the COVID-19 pandemic. Accordingly, we did not repurchase any shares during the three months ended September 30, 2022 and 2021. Shares that are repurchased are classified as treasury stock pending future use and reduce the number of shares of common stock outstanding used in calculating earnings (loss) per share. There is no expiration date for this program, and the program may be accelerated, suspended, delayed or discontinued at any time at the discretion of our board of directors. At September&#160;30, 2022, 12.9 million additional shares can be repurchased under the approved share repurchase program.</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_100"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Principles and Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect our reported amounts of assets and liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. On an ongoing basis we evaluate our estimates, including those related to allowance for doubtful accounts, inventory reserves, warranty obligations, goodwill, potentially impaired assets, intangible assets, income taxes and contingencies.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We state these accounting policies in the notes to the financial statements and at relevant sections in this discussion and analysis. The estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could vary from those estimates under different assumptions or conditions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a full discussion of our critical accounting policies, see our Annual Report on Form 10-K for the year ended June&#160;30, 2022.</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_103"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See note 1 to the unaudited condensed consolidated financial statements for a description of recently issued accounting pronouncements, including the expected dates of adoption and estimated effects on our results of operations, financial positions and cash flows.</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_106"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase obligations as of September&#160;30, 2022 were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payments Due by September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,777,740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,422,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">336,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MEDIFOX DAN acquisition consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">929,843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">929,843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,707,583&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,352,455&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">336,783&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,122&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than for purchase obligations, there have been no material changes outside the ordinary course of business in our outstanding contractual obligations from those disclosed within &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_109"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we are not involved in any significant off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K promulgated by the SEC. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_112"></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_115"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Market Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reporting currency is the U.S. dollar, although the financial statements of our non-U.S. subsidiaries are maintained in their respective local currencies. We transact business in various foreign currencies, including a number of major European currencies as well as the Australian and Singapore dollars. We have significant foreign currency exposure through our Australian and Singapore manufacturing activities and our international sales operations. We have established a foreign currency hedging program using purchased currency options and forward contracts to hedge foreign-currency-denominated financial assets, liabilities and manufacturing cash flows. The goal of this hedging program is to economically manage the financial impact of foreign currency exposures predominantly denominated in euros, Australian dollars and Singapore dollars. Under this program, increases or decreases in our foreign-currency-denominated financial assets, liabilities, and firm commitments are partially offset by gains and losses on the hedging instruments. We do not enter into financial instruments for trading or speculative purposes. The foreign currency derivatives portfolio is recorded in the condensed consolidated balance sheets at fair value and included in other assets or other liabilities. All movements in the fair value of the foreign currency derivatives are recorded within other income, net, on our condensed consolidated statements of operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information (in U.S. dollars) on our foreign currency denominated operating assets and liabilities and after considering our foreign currency hedging activities as of September&#160;30, 2022 (in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">U.S.<br/>Dollar<br/>(USD)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Euro<br/>(EUR)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Canadian<br/>Dollar<br/>(CAD)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Chinese<br/>Yuan<br/>(CNY)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AUD Functional:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net Assets/(Liabilities)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(63,466)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(110,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(34,103)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USD Functional:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net Assets/(Liabilities)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,180)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SGD Functional:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net Assets/(Liabilities)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">443,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(475,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(31,322)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,984&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information about our material foreign currency derivative financial instruments and presents the information in U.S. dollar equivalents. The table summarizes information on instruments and transactions that are sensitive to foreign currency exchange rates, including foreign currency call options, collars and forward contracts held at September&#160;30, 2022. The table presents the notional amounts and weighted average exchange rates by contractual maturity dates for our foreign currency derivative financial instruments, including the forward contracts used to hedge our foreign currency denominated assets and liabilities. These notional amounts generally are used to calculate payments to be exchanged under the contracts (in thousands, except exchange rates). </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Assets / (Liabilities)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">USD/AUD</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract amount</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ave. contractual exchange rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">USD 1 = <br/>AUD 0.6897</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">USD 1 = <br/>AUD 0.6897</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AUD/Euro</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract amount</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88,090</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,363</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117,453</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ave. contractual exchange rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">AUD 1 = <br/>EUR 0.6933</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">AUD 1 = <br/>EUR 0.6998</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SGD/Euro</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract amount</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,788</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,363</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,151</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ave. contractual exchange rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">SGD 1 =<br/>Euro 0.7117</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SGD 1 =<br/>Euro 0.7435</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">SGD 1 =<br/>Euro 0.7353</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SGD/USD</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract amount</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">475,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">475,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,364)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ave. contractual exchange rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">SGD 1 =<br/>USD 0.7176</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">SGD 1 =<br/>USD 0.7176</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AUD/CNY</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract amount</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,242</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,242</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ave. contractual exchange rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">AUD 1 =<br/>CNY 4.6449</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">AUD 1 =<br/>CNY 4.6449</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">USD/CAD</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract amount</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,180</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,180</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ave. contractual exchange rate</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">USD 1 =<br/>CAD 1.2902</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">USD 1 =<br/>CAD 1.2902</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_118"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to risk associated with changes in interest rates affecting the return on our cash and cash equivalents and debt. At September&#160;30, 2022, we held cash and cash equivalents of $207.2 million, principally comprised of bank term deposits and at-call accounts, and are invested at both short-term fixed interest rates and variable interest rates. At September&#160;30, 2022, there was $300.0 million outstanding under the Revolving Credit Agreement and Term Credit Agreement, which are subject to variable interest rates. A hypothetical 10% change in interest rates during the three months ended September 30, 2022, would not have had a material impact on pretax income. We have no interest rate hedging agreements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inflation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflationary factors such as increases in the cost of our products, freight, overhead costs or wage rates may adversely affect our operating results. Sustained inflationary pressures in the future may have an adverse effect on our ability to maintain current levels of gross margin and operating expenses as a percentage of net revenue if we are unable to offset such higher costs through price increases.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_121"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:10pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our reports made pursuant to the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and in reaching a reasonable level of assurance management necessarily was required to apply its judgment in evaluating the cost benefit relationship of possible controls and procedures.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Rule 13a-15(b) of the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of September&#160;30, 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_124"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">PART II &#8211; OTHER INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Item 1-6</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_127"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in various legal proceedings, claims, investigations and litigation that arise in the ordinary course of our business. We investigate these matters as they arise, and accrue estimates for resolution of legal and other contingencies in accordance with Accounting Standard Codification Topic 450, &#8220;Contingencies&#8221;. See note 10 to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation is inherently uncertain. Accordingly, we cannot predict with certainty the outcome of these matters. But we do not expect the outcome of these matters to have a material adverse effect on our consolidated financial statements when taken as a whole. </span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_130"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A&#160;&#160;&#160;&#160;Risk Factors</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion of our business and operations should be read together with the risk factors and contained in our annual report on Form 10-K for the fiscal year ended June&#160;30, 2022, which was filed with the SEC and describe various material risks and uncertainties to which we are or may become subject. As of September&#160;30, 2022, there have been no further material changes to such risk factors.</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_133"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of equity securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On February 21, 2014, our board of directors approved our current share repurchase program, authorizing us to acquire up to an aggregate of 20.0 million shares of our common stock. The program allows us to repurchase shares of our common stock from time to time for cash in the open market, or in negotiated or block transactions, as market and business conditions warrant and subject to applicable legal requirements. There is no expiration date for this program, and the program may be accelerated, suspended, delayed or discontinued at any time at the discretion of our board of directors. All share repurchases after February 21, 2014 have been executed under this program.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We temporarily suspended our share repurchase program due to recent acquisitions and as a response to the COVID-19 pandemic. As a result, we did not repurchase any shares during the three months ended September&#160;30, 2022. However, there is no expiration date for this program, and we may, at any time, elect to resume the share repurchase program as the circumstances allow. Since the inception of the share buyback programs, we have repurchased 41.8 million shares at a total cost of $1.6 billion. At September&#160;30, 2022, 12.9 million additional shares of common stock can be repurchased under the approved share repurchase program.</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_136"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_139"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4&#160;&#160;&#160;&#160;Mine Safety Disclosures</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_142"></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5&#160;&#160;&#160;&#160;Other Information</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_145"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">PART II &#8211; OTHER INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Item 1-6</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div></div><div style="-sec-extract:summary;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6&#160;&#160;&#160;&#160;Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits (numbered in accordance with Item 601 of Regulation S-K)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3.1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/943819/000119312513416916/d604032dex31.htm">First Restated Certificate of Incorporation of ResMed Inc., as amended. (Incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Report on Form 10-Q for the quarter ended September 30, 2013)</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/943819/000119312521271405/d215540dex31.htm">Seventh Amended and Restated Bylaws of ResMed Inc., a Delaware Corporation (as Approved and Adopted by Board Resolution September 10, 2021) (Incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Report on Form 8-K filed on September 13, 2021)</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">31.1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="rmd-20220930xex311.htm">Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">31.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="rmd-20220930xex312.htm">Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">32*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="rmd-20220930xex32.htm">Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">101</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">The following financial statements from ResMed Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2022, filed on October&#160;27, 2022, formatted in XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Cash Flows, (v) the Notes to the Condensed Consolidated Financial Statements.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:108%">In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 33-8238 and 34-47986, Final Rule: Management&#8217;s Reports on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished in Exhibit 32 hereto are deemed to accompany this Form 10-Q and will not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.</span></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="ibe8ac7a2e13b452cb87e155e752e9393_148"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ibe8ac7a2e13b452cb87e155e752e9393_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">PART II &#8211; OTHER INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Signatures</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESMED INC. AND SUBSIDIARIES</span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:6pt;padding-left:28.8pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;27, 2022</span></div><div style="margin-top:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ResMed Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">MICHAEL J. FARRELL</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Michael J. Farrell</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Chief executive officer </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">/s/ BRETT A. SANDERCOCK</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Brett A. Sandercock</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:-0.01pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Chief financial officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;text-indent:-0.01pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>rmd-20220930xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3796cac4c7f3465593b6b03047f54a45_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ERTIFICATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">HIEF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">XECUTIVE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">FFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael J. Farrell, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this quarterly report on Form 10-Q of ResMed Inc.&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;27, 2022</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:91%">&#47;s&#47; MICHAEL J. FARRELL</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:91%">Michael J. Farrell</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:91%">Chief executive officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:91%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>rmd-20220930xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia46740d66eb24836aea952b67170ba7f_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ERTIFICATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">HIEF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">INANCIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">FFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brett A. Sandercock, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this quarterly report on Form 10-Q of ResMed Inc.&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;27, 2022</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:91%">&#47;s&#47; BRETT A. SANDERCOCK</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:91%">Brett A. Sandercock</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:91%">Chief financial officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:91%">(Principal Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>rmd-20220930xex32.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia62a558babd24bc0836ae107b04cc545_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 32</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ESMED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ERTIFICATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">HIEF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">XECUTIVE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">FFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">URSUANT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">TO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ECTION </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">906</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">THE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ARBANES-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">XLEY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of ResMed Inc., a Delaware corporation (the &#8220;Company&#8221;), hereby certifies, to his knowledge, that&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">the accompanying Quarterly Report on Form 10-Q of the Company for the period ended September&#160;30, 2022 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt"> the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;27, 2022</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:91%">&#47;s&#47; MICHAEL J. FARRELL</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:91%">Michael J. Farrell</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:91%">Chief executive officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:91%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to ResMed Inc. and will be retained by ResMed Inc. and furnished to the Securities and Exchange Commission or its staff upon request. These certifications will not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor will these certifications be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates them by reference. </font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ERTIFICATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">HIEF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">INANCIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">FFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">URSUANT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">TO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ECTION </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">906</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">THE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ARBANES-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">XLEY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of ResMed Inc., a Delaware corporation (the &#8220;Company&#8221;), hereby certifies, to his knowledge, that&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">the accompanying Quarterly Report on Form 10-Q of the Company for the period ended September&#160;30, 2022 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;27, 2022</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:91%">&#47;s&#47; BRETT A. SANDERCOCK</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:91%">Brett A. Sandercock</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:91%">Chief financial officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:91%">(Principal Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to ResMed Inc. and will be retained by ResMed Inc. and furnished to the Securities and Exchange Commission or its staff upon request. These certifications will not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor will these certifications be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates them by reference.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>rmd-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:863cb569-faab-47da-ba4f-c2fd89e0377c,g:b569d9d4-e0e2-497b-a32d-7564d4bc33ab-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rmd="http://investor.resmed.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://investor.resmed.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rmd-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rmd-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rmd-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rmd-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://investor.resmed.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsUnaudited" roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited" roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements Of Comprehensive Income (Loss) (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfChangesInEquityUnaudited" roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements Of Changes In Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfChangesInEquityUnauditedParenthetical" roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnauditedParenthetical">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements Of Changes In Equity (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfCashFlowsUnaudited" roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements Of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPolicies" roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Summary Of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://investor.resmed.com/role/SegmentInformation">
        <link:definition>2107102 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformation" roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformation">
        <link:definition>2111103 - Disclosure - Supplemental Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://investor.resmed.com/role/Goodwill">
        <link:definition>2117104 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://investor.resmed.com/role/Investments">
        <link:definition>2120105 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://investor.resmed.com/role/IncomeTaxes">
        <link:definition>2125106 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarranties" roleURI="http://investor.resmed.com/role/ProductWarranties">
        <link:definition>2127107 - Disclosure - Product Warranties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://investor.resmed.com/role/Debt">
        <link:definition>2130108 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://investor.resmed.com/role/EarningsPerShare">
        <link:definition>2134109 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalActionsContingenciesandCommitments" roleURI="http://investor.resmed.com/role/LegalActionsContingenciesandCommitments">
        <link:definition>2138110 - Disclosure - Legal Actions, Contingencies and Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary Of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesTables" roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Summary Of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://investor.resmed.com/role/SegmentInformationTables">
        <link:definition>2308302 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationTables" roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationTables">
        <link:definition>2312303 - Disclosure - Supplemental Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://investor.resmed.com/role/GoodwillTables">
        <link:definition>2318304 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://investor.resmed.com/role/InvestmentsTables">
        <link:definition>2321305 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesTables" roleURI="http://investor.resmed.com/role/ProductWarrantiesTables">
        <link:definition>2328306 - Disclosure - Product Warranties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://investor.resmed.com/role/DebtTables">
        <link:definition>2331307 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://investor.resmed.com/role/EarningsPerShareTables">
        <link:definition>2335308 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesNarrativeDetails" roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404401 - Disclosure - Summary Of Significant Accounting Policies (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails" roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails">
        <link:definition>2405402 - Disclosure - Summary Of Significant Accounting Policies (Summary Of Net Revenue Disaggregated By Product And Region) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails" roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails">
        <link:definition>2406403 - Disclosure - Summary Of Significant Accounting Policies (Summary Of Contract Balances) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://investor.resmed.com/role/SegmentInformationNarrativeDetails">
        <link:definition>2409404 - Disclosure - Segment Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails" roleURI="http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails">
        <link:definition>2410405 - Disclosure - Segment Information (Summary Of Revenue By Segment And Reconciling Items) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationScheduleOfInventoriesDetails" roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails">
        <link:definition>2413406 - Disclosure - Supplemental Balance Sheet Information (Schedule Of Inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails">
        <link:definition>2414407 - Disclosure - Supplemental Balance Sheet Information (Schedule Of Prepaid Expenses and Other Current Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails" roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails">
        <link:definition>2415408 - Disclosure - Supplemental Balance Sheet Information (Components Of Property, Plant And Equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails" roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails">
        <link:definition>2416409 - Disclosure - Supplemental Balance Sheet Information (Schedule Of Other Intangible Assets, Net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails" roleURI="http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails">
        <link:definition>2419410 - Disclosure - Goodwill (Schedule Of Changes In Carrying Amount Of Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleOfInvestmentsDetails" roleURI="http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails">
        <link:definition>2422411 - Disclosure - Investments (Schedule Of Investments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleOfChangesInEquityInvestmentsDetails" roleURI="http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails">
        <link:definition>2423412 - Disclosure - Investments (Schedule Of Changes In Equity Investments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://investor.resmed.com/role/InvestmentsNarrativeDetails">
        <link:definition>2424413 - Disclosure - Investments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://investor.resmed.com/role/IncomeTaxesDetails">
        <link:definition>2426414 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesScheduleOfChangesInLiabilityForWarrantyCostsDetails" roleURI="http://investor.resmed.com/role/ProductWarrantiesScheduleOfChangesInLiabilityForWarrantyCostsDetails">
        <link:definition>2429415 - Disclosure - Product Warranties (Schedule Of Changes In Liability For Warranty Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofDebtDetails" roleURI="http://investor.resmed.com/role/DebtScheduleofDebtDetails">
        <link:definition>2432416 - Disclosure - Debt (Schedule of Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://investor.resmed.com/role/DebtNarrativeDetails">
        <link:definition>2433417 - Disclosure - Debt (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareNarrativeDetails" roleURI="http://investor.resmed.com/role/EarningsPerShareNarrativeDetails">
        <link:definition>2436418 - Disclosure - Earnings Per Share (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails" roleURI="http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails">
        <link:definition>2437419 - Disclosure - Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalActionsContingenciesandCommitmentsNarrativeDetails" roleURI="http://investor.resmed.com/role/LegalActionsContingenciesandCommitmentsNarrativeDetails">
        <link:definition>2439420 - Disclosure - Legal Actions, Contingencies and Commitments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="rmd_MarketableSecuritiesMember" abstract="false" name="MarketableSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember" abstract="false" name="RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_ShortTermDebtGross" abstract="false" name="ShortTermDebtGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_SupplementalBalanceSheetInformationAbstract" abstract="true" name="SupplementalBalanceSheetInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rmd_DeferredPaymentObligationsForAcquisitions" abstract="false" name="DeferredPaymentObligationsForAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_ContractWithCustomerAssetAndLiabilityTable" abstract="true" name="ContractWithCustomerAssetAndLiabilityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="rmd_TermLoanCreditAgreementMember" abstract="false" name="TermLoanCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_SupplementalBalanceSheetInformationTextBlock" abstract="false" name="SupplementalBalanceSheetInformationTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rmd_SummaryOfSignificantAccountingPoliciesTable" abstract="true" name="SummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="rmd_DeferredRevenueNonCurrentLiabilitiesMember" abstract="false" name="DeferredRevenueNonCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_UsCanadaAndLatinAmericaMember" abstract="false" name="UsCanadaAndLatinAmericaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_SummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="SummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired" abstract="false" name="NoncashPartOfAcquisitionFairValueOfAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_LeaseRevenuePolicyTextBlock" abstract="false" name="LeaseRevenuePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rmd_PrepaidInventory" abstract="false" name="PrepaidInventory" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_CombinedEuropeAsiaAndOtherMarketsMember" abstract="false" name="CombinedEuropeAsiaAndOtherMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_SleepAndRespiratoryMember" abstract="false" name="SleepAndRespiratoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_AdditionalEquityInvestments" abstract="false" name="AdditionalEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability" abstract="false" name="BusinessAcquisitionContingentConsiderationRecognizedLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities" abstract="false" name="ObservablePriceAdjustmentsOnNonMarketableEquitySecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_MarketableEquityInvestmentsFairValue" abstract="false" name="MarketableEquityInvestmentsFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_ContractWithCustomerAssetAndLiabilityLineItems" abstract="true" name="ContractWithCustomerAssetAndLiabilityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rmd_MufgUnionBankNaAndWestpacBankingCorporationMember" abstract="true" name="MufgUnionBankNaAndWestpacBankingCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_UncommittedOptionToIncreaseCreditFacility" abstract="false" name="UncommittedOptionToIncreaseCreditFacility" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_IncomeTaxExaminationGrossSettlement" abstract="false" name="IncomeTaxExaminationGrossSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock" abstract="false" name="OrganizationAndBasisOfPresentationPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rmd_DebtToConsolidatedEbitdaRatio" abstract="false" name="DebtToConsolidatedEbitdaRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease" abstract="false" name="GoodwillAcquiredDuringPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember" abstract="false" name="RevolvingCreditFacilityAndTermLoanCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_ScheduleOfInvestmentsTableTextBlock" abstract="false" name="ScheduleOfInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rmd_SaasMember" abstract="false" name="SaasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_IncomeTaxExaminationPriorRemittancePayments" abstract="false" name="IncomeTaxExaminationPriorRemittancePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_GlobalMember" abstract="false" name="GlobalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_LineOfCreditFacilityCollateralPercentageOfCompany" abstract="false" name="LineOfCreditFacilityCollateralPercentageOfCompany" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rmd_DevicesMember" abstract="false" name="DevicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_DebtAndEquityInvestmentsRollForward" abstract="true" name="DebtAndEquityInvestmentsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rmd_ResmedLimitedMember" abstract="false" name="ResmedLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_UnallocatedCorporateCosts" abstract="false" name="UnallocatedCorporateCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_SeniorNotesOneMember" abstract="false" name="SeniorNotesOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_AmortizationOfAcquiredIntangibleAssets1" abstract="false" name="AmortizationOfAcquiredIntangibleAssets1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock" abstract="false" name="ScheduleOfChangesInEquityInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rmd_DeferredRevenueCurrentLiabilitiesMember" abstract="false" name="DeferredRevenueCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_EquityInvestmentsTotalByMeasurementCategory" abstract="false" name="EquityInvestmentsTotalByMeasurementCategory" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_DevelopedOrCoreProductTechnologyMember" abstract="false" name="DevelopedOrCoreProductTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_MufgUnionBankMember" abstract="true" name="MufgUnionBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod" abstract="false" name="DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember" abstract="false" name="PrepaidTaxesAndOtherNonCurrentAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_AccountsReceivableNetMember" abstract="false" name="AccountsReceivableNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_ReceivablesSoldWithLimitedRecourse" abstract="false" name="ReceivablesSoldWithLimitedRecourse" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_SoftwareAsServiceMember" abstract="false" name="SoftwareAsServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_NonMarketableSecuritiesMember" abstract="false" name="NonMarketableSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_IncomeTaxExaminationRemittedFinalPayment" abstract="false" name="IncomeTaxExaminationRemittedFinalPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_TermOfContractUnderRevenueRecognition" abstract="false" name="TermOfContractUnderRevenueRecognition" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rmd_EquityInvestments" abstract="false" name="EquityInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rmd_MasksMember" abstract="false" name="MasksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rmd_SeniorNotesTwoMember" abstract="false" name="SeniorNotesTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>rmd-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:863cb569-faab-47da-ba4f-c2fd89e0377c,g:b569d9d4-e0e2-497b-a32d-7564d4bc33ab-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="rmd-20220930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_63d4ca6d-0645-49b2-8509-faff8afdcdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_78a4d4ce-6c85-4fa6-8b99-0d049e3943da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_63d4ca6d-0645-49b2-8509-faff8afdcdd5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_78a4d4ce-6c85-4fa6-8b99-0d049e3943da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_bad96f77-f00a-4cbc-8e77-97c043e43a00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_63d4ca6d-0645-49b2-8509-faff8afdcdd5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_bad96f77-f00a-4cbc-8e77-97c043e43a00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_656ee16b-ad54-4617-b27b-27c4e6d41ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_63d4ca6d-0645-49b2-8509-faff8afdcdd5" xlink:to="loc_us-gaap_Goodwill_656ee16b-ad54-4617-b27b-27c4e6d41ee7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_227094a6-c217-4c2d-8d81-7977c46915b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_63d4ca6d-0645-49b2-8509-faff8afdcdd5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_227094a6-c217-4c2d-8d81-7977c46915b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_d643dfd1-aa94-41be-b538-14108daaa699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_63d4ca6d-0645-49b2-8509-faff8afdcdd5" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_d643dfd1-aa94-41be-b538-14108daaa699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_03b3bf95-2e74-4cb9-8213-4e9ecea3ca7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_63d4ca6d-0645-49b2-8509-faff8afdcdd5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_03b3bf95-2e74-4cb9-8213-4e9ecea3ca7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0ee930b4-e152-46ce-8b45-63e71006aa6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f43c45b4-511e-4244-ab3f-0087e0a94986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0ee930b4-e152-46ce-8b45-63e71006aa6b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f43c45b4-511e-4244-ab3f-0087e0a94986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f94b9968-6515-47c2-ad1b-19929e2f5d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0ee930b4-e152-46ce-8b45-63e71006aa6b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f94b9968-6515-47c2-ad1b-19929e2f5d1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_27748bc7-6c6a-44fb-b1d4-44eb51dc063b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0ee930b4-e152-46ce-8b45-63e71006aa6b" xlink:to="loc_us-gaap_InventoryNet_27748bc7-6c6a-44fb-b1d4-44eb51dc063b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_949d8d47-4c7f-483a-bc11-b06d685459aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0ee930b4-e152-46ce-8b45-63e71006aa6b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_949d8d47-4c7f-483a-bc11-b06d685459aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_be32f118-61c4-42c4-ada8-8fcd448e8d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_eca4f5a6-acd2-479e-8e83-9f3b7f9c2cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_be32f118-61c4-42c4-ada8-8fcd448e8d8a" xlink:to="loc_us-gaap_Liabilities_eca4f5a6-acd2-479e-8e83-9f3b7f9c2cfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e1cdb625-7988-423f-b3b3-b29c1acc3b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_be32f118-61c4-42c4-ada8-8fcd448e8d8a" xlink:to="loc_us-gaap_StockholdersEquity_e1cdb625-7988-423f-b3b3-b29c1acc3b88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_3c1cd045-a61f-4ae2-b1a7-5c0eab530326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c1492bcd-8042-4989-9dba-6744373d9c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_3c1cd045-a61f-4ae2-b1a7-5c0eab530326" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c1492bcd-8042-4989-9dba-6744373d9c57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_d2563990-68dc-4de5-b2a3-8ff9028d0442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_3c1cd045-a61f-4ae2-b1a7-5c0eab530326" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_d2563990-68dc-4de5-b2a3-8ff9028d0442" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8ab13de9-7d68-4b63-8f06-b82b1a7037b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_3c1cd045-a61f-4ae2-b1a7-5c0eab530326" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8ab13de9-7d68-4b63-8f06-b82b1a7037b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_dc9b55b3-10d4-4289-8a63-456a453850fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_3c1cd045-a61f-4ae2-b1a7-5c0eab530326" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_dc9b55b3-10d4-4289-8a63-456a453850fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d7ed0f17-2e19-40c2-8ec6-1a4f07a767f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_3c1cd045-a61f-4ae2-b1a7-5c0eab530326" xlink:to="loc_us-gaap_LongTermDebt_d7ed0f17-2e19-40c2-8ec6-1a4f07a767f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a413719c-6608-465e-98d7-ea4c4a491cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_3c1cd045-a61f-4ae2-b1a7-5c0eab530326" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a413719c-6608-465e-98d7-ea4c4a491cb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1554e061-14ac-448c-94df-a9facaf03c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cfe97b70-a081-4453-9ba3-b86dcaa81731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1554e061-14ac-448c-94df-a9facaf03c21" xlink:to="loc_us-gaap_LiabilitiesCurrent_cfe97b70-a081-4453-9ba3-b86dcaa81731" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_c46714fc-b424-4198-9629-bffc9c9c435f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1554e061-14ac-448c-94df-a9facaf03c21" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_c46714fc-b424-4198-9629-bffc9c9c435f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c98cd786-aad2-489d-8210-de6ae95ee8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ad094d55-b27e-40f4-a97e-e9f86394fcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c98cd786-aad2-489d-8210-de6ae95ee8a5" xlink:to="loc_us-gaap_AccountsPayableCurrent_ad094d55-b27e-40f4-a97e-e9f86394fcb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b32ec271-0dce-4dbc-a0d7-d0b831185bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c98cd786-aad2-489d-8210-de6ae95ee8a5" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_b32ec271-0dce-4dbc-a0d7-d0b831185bf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_11718443-02c8-475f-8a05-05fc44c6318b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c98cd786-aad2-489d-8210-de6ae95ee8a5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_11718443-02c8-475f-8a05-05fc44c6318b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5b9dfad8-4eb6-4c5b-bce7-9595cd7b155b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c98cd786-aad2-489d-8210-de6ae95ee8a5" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5b9dfad8-4eb6-4c5b-bce7-9595cd7b155b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_326a1163-aab4-49ca-9ea3-41277f3056eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c98cd786-aad2-489d-8210-de6ae95ee8a5" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_326a1163-aab4-49ca-9ea3-41277f3056eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_a550f3e7-feb4-4666-acc1-72bc9edc9c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c98cd786-aad2-489d-8210-de6ae95ee8a5" xlink:to="loc_us-gaap_ShortTermBorrowings_a550f3e7-feb4-4666-acc1-72bc9edc9c78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6fce342f-ab3b-4b5d-85f0-e132400aa1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_5f0571a6-8815-4b8c-8e44-14a3fc3db360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6fce342f-ab3b-4b5d-85f0-e132400aa1e4" xlink:to="loc_us-gaap_PreferredStockValue_5f0571a6-8815-4b8c-8e44-14a3fc3db360" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_2427146f-437b-4bd1-b170-a0a164578079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6fce342f-ab3b-4b5d-85f0-e132400aa1e4" xlink:to="loc_us-gaap_CommonStockValueOutstanding_2427146f-437b-4bd1-b170-a0a164578079" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_33d9cde3-35a5-4561-a60b-0c30a5798445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6fce342f-ab3b-4b5d-85f0-e132400aa1e4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_33d9cde3-35a5-4561-a60b-0c30a5798445" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_658a95dc-1f65-4406-976d-68bdc2ebb016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6fce342f-ab3b-4b5d-85f0-e132400aa1e4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_658a95dc-1f65-4406-976d-68bdc2ebb016" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_366dcb23-d41b-4e06-9c79-5ebf6616f7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6fce342f-ab3b-4b5d-85f0-e132400aa1e4" xlink:to="loc_us-gaap_TreasuryStockCommonValue_366dcb23-d41b-4e06-9c79-5ebf6616f7e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d8dab176-ffa9-4f69-9a46-1a83a7281b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6fce342f-ab3b-4b5d-85f0-e132400aa1e4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d8dab176-ffa9-4f69-9a46-1a83a7281b40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_91403ed4-90ac-4128-b37b-9be5679fbb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_be7d2432-8e72-4a8f-865e-a2e914eea152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_91403ed4-90ac-4128-b37b-9be5679fbb5d" xlink:to="loc_us-gaap_AssetsCurrent_be7d2432-8e72-4a8f-865e-a2e914eea152" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_10e01df7-7b97-4eac-a54b-d5f57871a2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_91403ed4-90ac-4128-b37b-9be5679fbb5d" xlink:to="loc_us-gaap_AssetsNoncurrent_10e01df7-7b97-4eac-a54b-d5f57871a2a8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="rmd-20220930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_15379386-8790-4f48-9859-e2ac1ba9a9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_323b63e6-e21b-4005-a4bf-dfcf76deea48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_15379386-8790-4f48-9859-e2ac1ba9a9ad" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_323b63e6-e21b-4005-a4bf-dfcf76deea48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4f723dcc-80c0-4f40-9ae7-eeb2dd2b918f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_15379386-8790-4f48-9859-e2ac1ba9a9ad" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4f723dcc-80c0-4f40-9ae7-eeb2dd2b918f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ef2ab454-99d9-4685-b1c6-92049ffdc19e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_787f5812-4ab1-4bb2-b682-b003cee0ca3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ef2ab454-99d9-4685-b1c6-92049ffdc19e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_787f5812-4ab1-4bb2-b682-b003cee0ca3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c4f4c2c1-7ed7-43d4-956e-33f8851124d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ef2ab454-99d9-4685-b1c6-92049ffdc19e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c4f4c2c1-7ed7-43d4-956e-33f8851124d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4b0e017a-0641-4336-bc92-4fe0a1bfeabb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f7846037-a193-4122-b351-af8fe5a95844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_4b0e017a-0641-4336-bc92-4fe0a1bfeabb" xlink:to="loc_us-gaap_GrossProfit_f7846037-a193-4122-b351-af8fe5a95844" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_5194240a-2b64-4c20-88c5-77c085cacbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_4b0e017a-0641-4336-bc92-4fe0a1bfeabb" xlink:to="loc_us-gaap_OperatingExpenses_5194240a-2b64-4c20-88c5-77c085cacbd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_cd449236-3e97-4261-aeef-c0a12591a6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_72529d4a-448d-43a7-9fe4-31210f2faeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold_cd449236-3e97-4261-aeef-c0a12591a6b6" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_72529d4a-448d-43a7-9fe4-31210f2faeb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_827625d5-2190-4db9-b153-ac3e4ba7d624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold_cd449236-3e97-4261-aeef-c0a12591a6b6" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_827625d5-2190-4db9-b153-ac3e4ba7d624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1ecbd551-b705-4a71-a40b-e4b8f397b5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_eba7ad84-db34-4b8e-a4d3-d514a0f8c75c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1ecbd551-b705-4a71-a40b-e4b8f397b5d4" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_eba7ad84-db34-4b8e-a4d3-d514a0f8c75c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5f535cd4-c257-4f32-91d4-086b049b46e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1ecbd551-b705-4a71-a40b-e4b8f397b5d4" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5f535cd4-c257-4f32-91d4-086b049b46e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0532e0f1-4739-468b-bced-4cc93d2ec654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1ecbd551-b705-4a71-a40b-e4b8f397b5d4" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0532e0f1-4739-468b-bced-4cc93d2ec654" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4787c65c-2082-4b67-8ec1-089559da957f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1ecbd551-b705-4a71-a40b-e4b8f397b5d4" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4787c65c-2082-4b67-8ec1-089559da957f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0a511450-5638-4422-b196-c71a024d3c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1feefb3f-0e6f-4027-9b51-2e98c53e47d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0a511450-5638-4422-b196-c71a024d3c00" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1feefb3f-0e6f-4027-9b51-2e98c53e47d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_dd52d37f-716b-4863-922e-d7ecdb05825b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0a511450-5638-4422-b196-c71a024d3c00" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_dd52d37f-716b-4863-922e-d7ecdb05825b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_AmortizationOfAcquiredIntangibleAssets1_9fa4a9ea-4c33-4bdb-97e0-8a333c7060d3" xlink:href="rmd-20220930.xsd#rmd_AmortizationOfAcquiredIntangibleAssets1"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0a511450-5638-4422-b196-c71a024d3c00" xlink:to="loc_rmd_AmortizationOfAcquiredIntangibleAssets1_9fa4a9ea-4c33-4bdb-97e0-8a333c7060d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_001d16ca-02c1-4884-b573-f48e2d99045c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b9592eca-358d-46f7-a7ad-c8b7246893f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_001d16ca-02c1-4884-b573-f48e2d99045c" xlink:to="loc_us-gaap_OperatingIncomeLoss_b9592eca-358d-46f7-a7ad-c8b7246893f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_724e13a5-ee67-41c0-89a8-df28d128473e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_001d16ca-02c1-4884-b573-f48e2d99045c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_724e13a5-ee67-41c0-89a8-df28d128473e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="rmd-20220930.xsd#CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited"/>
  <link:calculationLink xlink:role="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_29617abb-0073-47c8-a116-c1d46d75d05e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0d8f902a-31eb-4c2b-a787-f033b3c2bf90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_29617abb-0073-47c8-a116-c1d46d75d05e" xlink:to="loc_us-gaap_NetIncomeLoss_0d8f902a-31eb-4c2b-a787-f033b3c2bf90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_eabf34fa-bdd2-4700-8418-14bb94917d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_29617abb-0073-47c8-a116-c1d46d75d05e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_eabf34fa-bdd2-4700-8418-14bb94917d3d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" xlink:href="rmd-20220930.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c0db890-9f7f-4721-b295-64a2a4cf2636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_dbb59c80-3c7e-4fc6-9b29-4c66b574d24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c0db890-9f7f-4721-b295-64a2a4cf2636" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_dbb59c80-3c7e-4fc6-9b29-4c66b574d24a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7b284107-1426-439c-89dc-6b2a85d66223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c0db890-9f7f-4721-b295-64a2a4cf2636" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7b284107-1426-439c-89dc-6b2a85d66223" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_50f4ecef-5a70-43a3-8021-c9125e6100dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c0db890-9f7f-4721-b295-64a2a4cf2636" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_50f4ecef-5a70-43a3-8021-c9125e6100dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9ab9bd65-87b3-4ef9-a6ad-0f97ced024ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c0db890-9f7f-4721-b295-64a2a4cf2636" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9ab9bd65-87b3-4ef9-a6ad-0f97ced024ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_2dda9cc4-080f-48eb-91a9-80fb39ff51ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1c0db890-9f7f-4721-b295-64a2a4cf2636" xlink:to="loc_us-gaap_PaymentsOfDividends_2dda9cc4-080f-48eb-91a9-80fb39ff51ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8bdfe63f-69a6-4de5-a2aa-41bf0813e7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_31434972-a547-4458-b943-a0ff2ee2bcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8bdfe63f-69a6-4de5-a2aa-41bf0813e7a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_31434972-a547-4458-b943-a0ff2ee2bcf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a71ab5e0-8572-4799-94c5-224508ca79bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8bdfe63f-69a6-4de5-a2aa-41bf0813e7a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a71ab5e0-8572-4799-94c5-224508ca79bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b351e863-4d31-41db-9a8f-125d5bfbde77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8bdfe63f-69a6-4de5-a2aa-41bf0813e7a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b351e863-4d31-41db-9a8f-125d5bfbde77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_83f7ced1-7717-4118-b8de-a62071b82658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8bdfe63f-69a6-4de5-a2aa-41bf0813e7a1" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_83f7ced1-7717-4118-b8de-a62071b82658" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed1963e6-7198-4b5a-a24f-c609035329f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c1ade8de-05ad-45fd-b2bc-24246c862f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed1963e6-7198-4b5a-a24f-c609035329f3" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c1ade8de-05ad-45fd-b2bc-24246c862f28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_1c6fca62-4b04-4e49-86bc-2bae47ce4a28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed1963e6-7198-4b5a-a24f-c609035329f3" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_1c6fca62-4b04-4e49-86bc-2bae47ce4a28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1220dcb5-8219-40a9-b903-cfbf137dbc99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed1963e6-7198-4b5a-a24f-c609035329f3" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1220dcb5-8219-40a9-b903-cfbf137dbc99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_8b1f0ac2-41cf-4162-b718-2ac68ee667be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed1963e6-7198-4b5a-a24f-c609035329f3" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_8b1f0ac2-41cf-4162-b718-2ac68ee667be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_67a86232-e116-42f8-bb55-0b1dde095563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ed1963e6-7198-4b5a-a24f-c609035329f3" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_67a86232-e116-42f8-bb55-0b1dde095563" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_60949d28-1472-4670-8932-b976a3e0615c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d07e8cf7-c9fd-4a91-9c47-8a0e5891f763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_60949d28-1472-4670-8932-b976a3e0615c" xlink:to="loc_us-gaap_NetIncomeLoss_d07e8cf7-c9fd-4a91-9c47-8a0e5891f763" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b71b5cf2-4218-430d-a4de-4454fc4fa460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_60949d28-1472-4670-8932-b976a3e0615c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b71b5cf2-4218-430d-a4de-4454fc4fa460" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_211dd7d2-f162-4fa5-8184-e5c7a51a746a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_60949d28-1472-4670-8932-b976a3e0615c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_211dd7d2-f162-4fa5-8184-e5c7a51a746a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c6b5be67-14be-4191-ae76-5a1ea6e8598d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_60949d28-1472-4670-8932-b976a3e0615c" xlink:to="loc_us-gaap_ShareBasedCompensation_c6b5be67-14be-4191-ae76-5a1ea6e8598d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1d7f273b-b7f1-40b1-bd0c-130bda7b52f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_60949d28-1472-4670-8932-b976a3e0615c" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1d7f273b-b7f1-40b1-bd0c-130bda7b52f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_4bc40d11-51ff-4bae-b2bb-2b5373f2f142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_60949d28-1472-4670-8932-b976a3e0615c" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_4bc40d11-51ff-4bae-b2bb-2b5373f2f142" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ea98f1c1-ab05-4088-8050-dc7c9a4ad19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_60949d28-1472-4670-8932-b976a3e0615c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ea98f1c1-ab05-4088-8050-dc7c9a4ad19f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_314696f2-f21f-4bb3-ad2d-95a4fd573445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_60949d28-1472-4670-8932-b976a3e0615c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_314696f2-f21f-4bb3-ad2d-95a4fd573445" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a7c2f1f0-b6c2-4b4f-aaf9-d49981fa4a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_60949d28-1472-4670-8932-b976a3e0615c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a7c2f1f0-b6c2-4b4f-aaf9-d49981fa4a69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_23a21d15-b920-4dcb-82a1-91b50cc89a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_60949d28-1472-4670-8932-b976a3e0615c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_23a21d15-b920-4dcb-82a1-91b50cc89a13" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SupplementalBalanceSheetInformationScheduleOfInventoriesDetails"/>
  <link:calculationLink xlink:role="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4587afb3-13d9-4749-b49c-e90d33e0681f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_ec2a8556-5ece-4823-9c97-8d28e3d98678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4587afb3-13d9-4749-b49c-e90d33e0681f" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_ec2a8556-5ece-4823-9c97-8d28e3d98678" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_84418f78-736b-4274-9c64-6465a54290b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4587afb3-13d9-4749-b49c-e90d33e0681f" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_84418f78-736b-4274-9c64-6465a54290b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_333c7561-76b0-4589-a548-68f570ebc839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_4587afb3-13d9-4749-b49c-e90d33e0681f" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_333c7561-76b0-4589-a548-68f570ebc839" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_340c2387-bbc7-4c0d-af0e-d6fcb060bb06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_a88818d5-df75-40a0-af86-5cbde550b939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_340c2387-bbc7-4c0d-af0e-d6fcb060bb06" xlink:to="loc_us-gaap_PrepaidTaxes_a88818d5-df75-40a0-af86-5cbde550b939" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_PrepaidInventory_22a6e7c3-2ccf-4134-b649-35a95162944e" xlink:href="rmd-20220930.xsd#rmd_PrepaidInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_340c2387-bbc7-4c0d-af0e-d6fcb060bb06" xlink:to="loc_rmd_PrepaidInventory_22a6e7c3-2ccf-4134-b649-35a95162944e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_ed2b5660-6b90-4006-86b4-369d0d437334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_340c2387-bbc7-4c0d-af0e-d6fcb060bb06" xlink:to="loc_us-gaap_OtherAssetsCurrent_ed2b5660-6b90-4006-86b4-369d0d437334" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails"/>
  <link:calculationLink xlink:role="http://investor.resmed.com/role/SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_dd60daac-728e-4605-8e81-1345ba4da2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b71aec6d-e100-4003-8a4b-8b866079704c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_dd60daac-728e-4605-8e81-1345ba4da2ba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_b71aec6d-e100-4003-8a4b-8b866079704c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6398d764-b21a-41f4-8c53-6fb93aeeb96d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_dd60daac-728e-4605-8e81-1345ba4da2ba" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6398d764-b21a-41f4-8c53-6fb93aeeb96d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"/>
  <link:calculationLink xlink:role="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cc1e8a84-817a-4d3d-9184-db421d85b4de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e053643b-a0a6-40a9-888a-062cd7c4f468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cc1e8a84-817a-4d3d-9184-db421d85b4de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e053643b-a0a6-40a9-888a-062cd7c4f468" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8e3b0b1e-c4a8-4a19-bcb7-8af4dd5b6070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cc1e8a84-817a-4d3d-9184-db421d85b4de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8e3b0b1e-c4a8-4a19-bcb7-8af4dd5b6070" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#InvestmentsScheduleOfInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rmd_EquityInvestmentsTotalByMeasurementCategory_5a26410a-571f-4b86-b2ca-625cab7ede85" xlink:href="rmd-20220930.xsd#rmd_EquityInvestmentsTotalByMeasurementCategory"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MarketableEquityInvestmentsFairValue_ec241674-f63b-4b1b-8eb7-1566b05b6b12" xlink:href="rmd-20220930.xsd#rmd_MarketableEquityInvestmentsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rmd_EquityInvestmentsTotalByMeasurementCategory_5a26410a-571f-4b86-b2ca-625cab7ede85" xlink:to="loc_rmd_MarketableEquityInvestmentsFairValue_ec241674-f63b-4b1b-8eb7-1566b05b6b12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_5e3815f8-716b-425b-b93b-3da944cbb5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rmd_EquityInvestmentsTotalByMeasurementCategory_5a26410a-571f-4b86-b2ca-625cab7ede85" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_5e3815f8-716b-425b-b93b-3da944cbb5ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_32836d86-7c17-47b2-8c0b-d6d5466b87df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rmd_EquityInvestmentsTotalByMeasurementCategory_5a26410a-571f-4b86-b2ca-625cab7ede85" xlink:to="loc_us-gaap_EquityMethodInvestments_32836d86-7c17-47b2-8c0b-d6d5466b87df" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#DebtScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://investor.resmed.com/role/DebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_049b2e86-0422-4015-92c7-a96b023060db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_a80e2f0b-284f-4728-ae14-49f39bba317b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_049b2e86-0422-4015-92c7-a96b023060db" xlink:to="loc_us-gaap_ShortTermBorrowings_a80e2f0b-284f-4728-ae14-49f39bba317b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2c66f13a-7341-4729-9539-883e81db2831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_049b2e86-0422-4015-92c7-a96b023060db" xlink:to="loc_us-gaap_LongTermDebt_2c66f13a-7341-4729-9539-883e81db2831" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_01456f42-d073-45b8-bc38-9976efb11d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ShortTermDebtGross_30f1c581-6ead-4fde-be61-a906a1a40cc3" xlink:href="rmd-20220930.xsd#rmd_ShortTermDebtGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_01456f42-d073-45b8-bc38-9976efb11d20" xlink:to="loc_rmd_ShortTermDebtGross_30f1c581-6ead-4fde-be61-a906a1a40cc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet_fff90f92-2c00-41af-a1a1-d06685feda96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsCurrentNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_01456f42-d073-45b8-bc38-9976efb11d20" xlink:to="loc_us-gaap_DeferredFinanceCostsCurrentNet_fff90f92-2c00-41af-a1a1-d06685feda96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7976d0fb-5175-4d55-ba92-f6d9a6e8daa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_507d8e30-ad4f-467a-9b51-2090304bd686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7976d0fb-5175-4d55-ba92-f6d9a6e8daa6" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_507d8e30-ad4f-467a-9b51-2090304bd686" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_f26c489c-4db1-4f4c-a0d4-d1811b4c25c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7976d0fb-5175-4d55-ba92-f6d9a6e8daa6" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_f26c489c-4db1-4f4c-a0d4-d1811b4c25c8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_52fdc8ea-4add-4c4a-94bc-57b6ac416929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b974aa7c-9981-4898-97a2-624243488f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_52fdc8ea-4add-4c4a-94bc-57b6ac416929" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b974aa7c-9981-4898-97a2-624243488f0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_8e2da7a1-644c-44fd-872c-7ef614bbe4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_52fdc8ea-4add-4c4a-94bc-57b6ac416929" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_8e2da7a1-644c-44fd-872c-7ef614bbe4e5" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>rmd-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:863cb569-faab-47da-ba4f-c2fd89e0377c,g:b569d9d4-e0e2-497b-a32d-7564d4bc33ab-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="rmd-20220930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:definitionLink xlink:role="http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended" id="i0c90f58f2c3345bea902e28ea4367d38_CondensedConsolidatedStatementsofOperationsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26113334-2855-4492-9530-102ea18e4019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26113334-2855-4492-9530-102ea18e4019" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_e3c29ff4-f848-417d-9a34-ac76b588f9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_e3c29ff4-f848-417d-9a34-ac76b588f9cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_fbbb50b6-1d98-4cc4-845a-b1b99f14a444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_fbbb50b6-1d98-4cc4-845a-b1b99f14a444" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_09bcaf1a-a810-4967-b135-d31e5a410a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_09bcaf1a-a810-4967-b135-d31e5a410a3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2e3a57dd-eb1c-47ef-977d-1c076926fa56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_GrossProfit_2e3a57dd-eb1c-47ef-977d-1c076926fa56" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_add2c4d0-51eb-49ed-9512-a88ccbf324c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_OperatingExpensesAbstract_add2c4d0-51eb-49ed-9512-a88ccbf324c9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8acac313-828b-4e70-939d-7f893499c11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_add2c4d0-51eb-49ed-9512-a88ccbf324c9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8acac313-828b-4e70-939d-7f893499c11b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_91e82485-d9b8-4d46-9751-20f68df91f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_add2c4d0-51eb-49ed-9512-a88ccbf324c9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_91e82485-d9b8-4d46-9751-20f68df91f56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_AmortizationOfAcquiredIntangibleAssets1_cc6ab7f6-2669-40d3-84c1-20eb4fdf310e" xlink:href="rmd-20220930.xsd#rmd_AmortizationOfAcquiredIntangibleAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_add2c4d0-51eb-49ed-9512-a88ccbf324c9" xlink:to="loc_rmd_AmortizationOfAcquiredIntangibleAssets1_cc6ab7f6-2669-40d3-84c1-20eb4fdf310e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_23413b24-2202-4c14-b703-6a62c29ee290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_add2c4d0-51eb-49ed-9512-a88ccbf324c9" xlink:to="loc_us-gaap_OperatingExpenses_23413b24-2202-4c14-b703-6a62c29ee290" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b3b18761-928e-48c7-b4bb-6df9cfafc0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_OperatingIncomeLoss_b3b18761-928e-48c7-b4bb-6df9cfafc0b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_671e361b-240f-41a4-81cf-b69f98dd3093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_671e361b-240f-41a4-81cf-b69f98dd3093" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1af51019-6287-4317-9ba8-f312c9868812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1af51019-6287-4317-9ba8-f312c9868812" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_68527f5a-460a-4935-ae3c-c42a2bd319fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_68527f5a-460a-4935-ae3c-c42a2bd319fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_42807491-8226-415c-8d60-380c6cbdeae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_42807491-8226-415c-8d60-380c6cbdeae2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f749ccf1-197c-4cf7-92ca-3a879fdf98c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f749ccf1-197c-4cf7-92ca-3a879fdf98c9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1168d7a7-9251-4ccd-b418-31d1b4389d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1168d7a7-9251-4ccd-b418-31d1b4389d9b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d83136b8-e53a-4b8c-8880-7945dc0d990d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d83136b8-e53a-4b8c-8880-7945dc0d990d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_677c80a3-8fa0-48ff-b96a-e60139d50eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_NetIncomeLoss_677c80a3-8fa0-48ff-b96a-e60139d50eb0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9cdba3b5-0516-413e-a63c-1afd3638e6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_EarningsPerShareBasic_9cdba3b5-0516-413e-a63c-1afd3638e6d4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_567a4d29-b6d4-4935-afc3-bfc8dec0e13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_EarningsPerShareDiluted_567a4d29-b6d4-4935-afc3-bfc8dec0e13a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_18c3cb42-0cff-49e2-b654-6092437d1230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_18c3cb42-0cff-49e2-b654-6092437d1230" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_322bce69-0dbf-4e34-bc25-e1ecdf2e348c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_322bce69-0dbf-4e34-bc25-e1ecdf2e348c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6e466d98-2775-4cb9-aed5-a8dfadc75ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6e466d98-2775-4cb9-aed5-a8dfadc75ab0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8729695a-b61c-4849-84c3-06a2bae78426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_StatementTable_8729695a-b61c-4849-84c3-06a2bae78426" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ad40b605-3c57-4781-bfbe-471adb48cd55" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8729695a-b61c-4849-84c3-06a2bae78426" xlink:to="loc_srt_ProductOrServiceAxis_ad40b605-3c57-4781-bfbe-471adb48cd55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ad40b605-3c57-4781-bfbe-471adb48cd55_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ad40b605-3c57-4781-bfbe-471adb48cd55" xlink:to="loc_srt_ProductsAndServicesDomain_ad40b605-3c57-4781-bfbe-471adb48cd55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1273eedf-f03d-41bb-a7a0-688af19c7500" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ad40b605-3c57-4781-bfbe-471adb48cd55" xlink:to="loc_srt_ProductsAndServicesDomain_1273eedf-f03d-41bb-a7a0-688af19c7500" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SleepAndRespiratoryMember_01e27c10-4ffb-4a72-8169-4501d73a9ec5" xlink:href="rmd-20220930.xsd#rmd_SleepAndRespiratoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1273eedf-f03d-41bb-a7a0-688af19c7500" xlink:to="loc_rmd_SleepAndRespiratoryMember_01e27c10-4ffb-4a72-8169-4501d73a9ec5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SoftwareAsServiceMember_b19a5ce8-b56c-4ed8-ad81-3ef3648f645a" xlink:href="rmd-20220930.xsd#rmd_SoftwareAsServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1273eedf-f03d-41bb-a7a0-688af19c7500" xlink:to="loc_rmd_SoftwareAsServiceMember_b19a5ce8-b56c-4ed8-ad81-3ef3648f645a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited" xlink:type="simple" xlink:href="rmd-20220930.xsd#CondensedConsolidatedStatementsOfChangesInEquityUnaudited"/>
  <link:definitionLink xlink:role="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited" xlink:type="extended" id="idaf0677cb1714b91a6e97f80bab1925c_CondensedConsolidatedStatementsOfChangesInEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b1b34137-36a2-4113-82ee-aea05932effa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b1b34137-36a2-4113-82ee-aea05932effa" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c4bc74fe-4075-4c38-be9c-799d6e25468c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c4bc74fe-4075-4c38-be9c-799d6e25468c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6f9d5e0e-37d5-474f-a23b-feeed2ea304a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_StockholdersEquity_6f9d5e0e-37d5-474f-a23b-feeed2ea304a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_367fbc1f-b674-4cc2-8248-d1a34adc507e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_TreasuryStockCommonShares_367fbc1f-b674-4cc2-8248-d1a34adc507e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_674ce11f-2d1f-4790-ad02-c84f3ae6db6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_674ce11f-2d1f-4790-ad02-c84f3ae6db6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e957d37e-0933-4135-8b08-328cb7e5bb35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e957d37e-0933-4135-8b08-328cb7e5bb35" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3ff5a29c-577f-4e9e-9616-4128a86a1c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3ff5a29c-577f-4e9e-9616-4128a86a1c5e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a3b993f7-2e4f-4cba-9d11-b7c09dcedc90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a3b993f7-2e4f-4cba-9d11-b7c09dcedc90" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_326bebe6-aaba-4f8d-a764-8ee515434bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_326bebe6-aaba-4f8d-a764-8ee515434bb1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c2f9ff3a-2189-4c08-a3ff-bac0fd04cd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c2f9ff3a-2189-4c08-a3ff-bac0fd04cd8d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a79d8e04-1723-4741-be5e-be8585b6f1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_NetIncomeLoss_a79d8e04-1723-4741-be5e-be8585b6f1c1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_ca9ce96e-6d1c-4ea8-b204-0638dc84d46b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_Dividends_ca9ce96e-6d1c-4ea8-b204-0638dc84d46b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9c645fa7-dca2-4ce2-940b-ff0a6a9d76cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5fd67d1c-5f74-4fb6-b10b-cce755e0bfef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_448e8b14-1075-48cb-886c-17c4e9d7e704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1ed9e59f-08e0-419e-8ea4-7c60fa83724d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b1b34137-36a2-4113-82ee-aea05932effa" xlink:to="loc_us-gaap_StatementTable_1ed9e59f-08e0-419e-8ea4-7c60fa83724d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_07c0bc87-469d-4daf-928f-b4e5f235a751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1ed9e59f-08e0-419e-8ea4-7c60fa83724d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_07c0bc87-469d-4daf-928f-b4e5f235a751" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_07c0bc87-469d-4daf-928f-b4e5f235a751_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_07c0bc87-469d-4daf-928f-b4e5f235a751" xlink:to="loc_us-gaap_EquityComponentDomain_07c0bc87-469d-4daf-928f-b4e5f235a751_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_07c0bc87-469d-4daf-928f-b4e5f235a751" xlink:to="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bf9c38fd-a204-49ce-bee4-5859acd985ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:to="loc_us-gaap_CommonStockMember_bf9c38fd-a204-49ce-bee4-5859acd985ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_658b6021-198d-4819-8074-fa271d3d3d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_658b6021-198d-4819-8074-fa271d3d3d27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_6b21d9a8-2889-4d74-97c6-791965dd2089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:to="loc_us-gaap_TreasuryStockMember_6b21d9a8-2889-4d74-97c6-791965dd2089" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f2e27af5-0eb6-49a6-93a4-9a47f4f51595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:to="loc_us-gaap_RetainedEarningsMember_f2e27af5-0eb6-49a6-93a4-9a47f4f51595" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_febb303c-1453-4617-8843-55c2e21ca22f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_febb303c-1453-4617-8843-55c2e21ca22f" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SummaryOfSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i064f45fa29f54b9daea41b9da49865bd_SummaryOfSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SummaryOfSignificantAccountingPoliciesLineItems_a2c83da4-e2d3-4256-bec4-5d9c87dacbab" xlink:href="rmd-20220930.xsd#rmd_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_b62bd159-0ac9-4d31-8ecc-4d8cc1fab63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rmd_SummaryOfSignificantAccountingPoliciesLineItems_a2c83da4-e2d3-4256-bec4-5d9c87dacbab" xlink:to="loc_us-gaap_NumberOfOperatingSegments_b62bd159-0ac9-4d31-8ecc-4d8cc1fab63e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_TermOfContractUnderRevenueRecognition_0385c991-7da3-4694-9224-349b07734935" xlink:href="rmd-20220930.xsd#rmd_TermOfContractUnderRevenueRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rmd_SummaryOfSignificantAccountingPoliciesLineItems_a2c83da4-e2d3-4256-bec4-5d9c87dacbab" xlink:to="loc_rmd_TermOfContractUnderRevenueRecognition_0385c991-7da3-4694-9224-349b07734935" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_3af61473-1bfb-4850-bce2-0acdbb1947a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rmd_SummaryOfSignificantAccountingPoliciesLineItems_a2c83da4-e2d3-4256-bec4-5d9c87dacbab" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_3af61473-1bfb-4850-bce2-0acdbb1947a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SummaryOfSignificantAccountingPoliciesTable_db71e46b-1bcb-4101-96db-9715cfbe5fec" xlink:href="rmd-20220930.xsd#rmd_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rmd_SummaryOfSignificantAccountingPoliciesLineItems_a2c83da4-e2d3-4256-bec4-5d9c87dacbab" xlink:to="loc_rmd_SummaryOfSignificantAccountingPoliciesTable_db71e46b-1bcb-4101-96db-9715cfbe5fec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5dd30977-c23b-46d7-9714-cf39c5707597" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rmd_SummaryOfSignificantAccountingPoliciesTable_db71e46b-1bcb-4101-96db-9715cfbe5fec" xlink:to="loc_srt_RangeAxis_5dd30977-c23b-46d7-9714-cf39c5707597" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5dd30977-c23b-46d7-9714-cf39c5707597_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5dd30977-c23b-46d7-9714-cf39c5707597" xlink:to="loc_srt_RangeMember_5dd30977-c23b-46d7-9714-cf39c5707597_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a3c3264a-f8f7-464c-bdfd-708e46b49639" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5dd30977-c23b-46d7-9714-cf39c5707597" xlink:to="loc_srt_RangeMember_a3c3264a-f8f7-464c-bdfd-708e46b49639" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b0147196-b328-46b8-ba71-3208895dc92e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a3c3264a-f8f7-464c-bdfd-708e46b49639" xlink:to="loc_srt_MinimumMember_b0147196-b328-46b8-ba71-3208895dc92e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a4766c60-0cb3-423b-8ad2-6930b2991f93" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a3c3264a-f8f7-464c-bdfd-708e46b49639" xlink:to="loc_srt_MaximumMember_a4766c60-0cb3-423b-8ad2-6930b2991f93" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"/>
  <link:definitionLink xlink:role="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails" xlink:type="extended" id="ife77285388954d45814b75ac77f8dce2_SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_46730dc7-8bf2-49e9-ac6f-057116e9ab98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_327ddf0f-2793-4f51-ad32-a3446b1389f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_46730dc7-8bf2-49e9-ac6f-057116e9ab98" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_327ddf0f-2793-4f51-ad32-a3446b1389f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c5c16cf1-2bf5-4ae1-ae73-3d18e09b12a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_46730dc7-8bf2-49e9-ac6f-057116e9ab98" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c5c16cf1-2bf5-4ae1-ae73-3d18e09b12a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0e5079fd-fc1e-40b6-93d7-ef7de7f53702" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c5c16cf1-2bf5-4ae1-ae73-3d18e09b12a5" xlink:to="loc_srt_StatementGeographicalAxis_0e5079fd-fc1e-40b6-93d7-ef7de7f53702" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0e5079fd-fc1e-40b6-93d7-ef7de7f53702_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0e5079fd-fc1e-40b6-93d7-ef7de7f53702" xlink:to="loc_srt_SegmentGeographicalDomain_0e5079fd-fc1e-40b6-93d7-ef7de7f53702_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e1c96f3e-8a27-4c52-b14e-e59e8262e15c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0e5079fd-fc1e-40b6-93d7-ef7de7f53702" xlink:to="loc_srt_SegmentGeographicalDomain_e1c96f3e-8a27-4c52-b14e-e59e8262e15c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_UsCanadaAndLatinAmericaMember_70175b48-0adf-4126-af43-3d782c4fb37c" xlink:href="rmd-20220930.xsd#rmd_UsCanadaAndLatinAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e1c96f3e-8a27-4c52-b14e-e59e8262e15c" xlink:to="loc_rmd_UsCanadaAndLatinAmericaMember_70175b48-0adf-4126-af43-3d782c4fb37c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_CombinedEuropeAsiaAndOtherMarketsMember_cb9f87be-d33d-4bba-a3d7-fbfc852d6547" xlink:href="rmd-20220930.xsd#rmd_CombinedEuropeAsiaAndOtherMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e1c96f3e-8a27-4c52-b14e-e59e8262e15c" xlink:to="loc_rmd_CombinedEuropeAsiaAndOtherMarketsMember_cb9f87be-d33d-4bba-a3d7-fbfc852d6547" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_GlobalMember_68916e03-0c6a-4b6b-9a70-0607f7ae90b1" xlink:href="rmd-20220930.xsd#rmd_GlobalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e1c96f3e-8a27-4c52-b14e-e59e8262e15c" xlink:to="loc_rmd_GlobalMember_68916e03-0c6a-4b6b-9a70-0607f7ae90b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_938b79c0-81c7-4ac4-a7bb-a7d86cc7c17b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c5c16cf1-2bf5-4ae1-ae73-3d18e09b12a5" xlink:to="loc_srt_ProductOrServiceAxis_938b79c0-81c7-4ac4-a7bb-a7d86cc7c17b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_938b79c0-81c7-4ac4-a7bb-a7d86cc7c17b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_938b79c0-81c7-4ac4-a7bb-a7d86cc7c17b" xlink:to="loc_srt_ProductsAndServicesDomain_938b79c0-81c7-4ac4-a7bb-a7d86cc7c17b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ad170275-9b53-4bbe-aca3-c657b100158e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_938b79c0-81c7-4ac4-a7bb-a7d86cc7c17b" xlink:to="loc_srt_ProductsAndServicesDomain_ad170275-9b53-4bbe-aca3-c657b100158e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DevicesMember_2ceb1325-0d7b-4035-b89b-ec79eedcdbcf" xlink:href="rmd-20220930.xsd#rmd_DevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ad170275-9b53-4bbe-aca3-c657b100158e" xlink:to="loc_rmd_DevicesMember_2ceb1325-0d7b-4035-b89b-ec79eedcdbcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MasksMember_9c7fbccd-5762-4521-9893-59d23c8f77c6" xlink:href="rmd-20220930.xsd#rmd_MasksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ad170275-9b53-4bbe-aca3-c657b100158e" xlink:to="loc_rmd_MasksMember_9c7fbccd-5762-4521-9893-59d23c8f77c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SleepAndRespiratoryMember_e9edc602-7745-4fc5-b989-7a960a4db15d" xlink:href="rmd-20220930.xsd#rmd_SleepAndRespiratoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ad170275-9b53-4bbe-aca3-c657b100158e" xlink:to="loc_rmd_SleepAndRespiratoryMember_e9edc602-7745-4fc5-b989-7a960a4db15d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SoftwareAsServiceMember_ce8a5ea2-0a34-45af-bc24-e695d075e2b7" xlink:href="rmd-20220930.xsd#rmd_SoftwareAsServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ad170275-9b53-4bbe-aca3-c657b100158e" xlink:to="loc_rmd_SoftwareAsServiceMember_ce8a5ea2-0a34-45af-bc24-e695d075e2b7" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"/>
  <link:definitionLink xlink:role="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails" xlink:type="extended" id="if9d9ea8cbc7d4429bd3f6fcd9b73d067_SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ContractWithCustomerAssetAndLiabilityLineItems_e10c3f57-8aaa-4686-a296-905b8e09a759" xlink:href="rmd-20220930.xsd#rmd_ContractWithCustomerAssetAndLiabilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetAbstract_f61fe4c4-2c1e-4ccb-88f0-f8b73abd9a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rmd_ContractWithCustomerAssetAndLiabilityLineItems_e10c3f57-8aaa-4686-a296-905b8e09a759" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetAbstract_f61fe4c4-2c1e-4ccb-88f0-f8b73abd9a47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1e86bd9c-930b-4b6b-bfde-9a4117851ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetAbstract_f61fe4c4-2c1e-4ccb-88f0-f8b73abd9a47" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1e86bd9c-930b-4b6b-bfde-9a4117851ae7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_f90a555e-2822-429e-8865-afb624fb42f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetAbstract_f61fe4c4-2c1e-4ccb-88f0-f8b73abd9a47" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_f90a555e-2822-429e-8865-afb624fb42f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_ff265bf1-a0b8-40c3-a451-525e3cb85bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetAbstract_f61fe4c4-2c1e-4ccb-88f0-f8b73abd9a47" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_ff265bf1-a0b8-40c3-a451-525e3cb85bc7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract_ee18ddd6-0e18-4157-8495-abe424caeefb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rmd_ContractWithCustomerAssetAndLiabilityLineItems_e10c3f57-8aaa-4686-a296-905b8e09a759" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityAbstract_ee18ddd6-0e18-4157-8495-abe424caeefb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_852b6545-2102-473a-ab10-05ec9bf528e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_ee18ddd6-0e18-4157-8495-abe424caeefb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_852b6545-2102-473a-ab10-05ec9bf528e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_d33e3ba5-39cb-48c0-aab1-c00b6e463021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_ee18ddd6-0e18-4157-8495-abe424caeefb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_d33e3ba5-39cb-48c0-aab1-c00b6e463021" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ContractWithCustomerAssetAndLiabilityTable_cd72ef2d-18fe-4f82-9817-cdc0964101be" xlink:href="rmd-20220930.xsd#rmd_ContractWithCustomerAssetAndLiabilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rmd_ContractWithCustomerAssetAndLiabilityLineItems_e10c3f57-8aaa-4686-a296-905b8e09a759" xlink:to="loc_rmd_ContractWithCustomerAssetAndLiabilityTable_cd72ef2d-18fe-4f82-9817-cdc0964101be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_47a37c28-a2ef-4403-8471-fa5cd7ec3436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rmd_ContractWithCustomerAssetAndLiabilityTable_cd72ef2d-18fe-4f82-9817-cdc0964101be" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_47a37c28-a2ef-4403-8471-fa5cd7ec3436" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_47a37c28-a2ef-4403-8471-fa5cd7ec3436_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_47a37c28-a2ef-4403-8471-fa5cd7ec3436" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_47a37c28-a2ef-4403-8471-fa5cd7ec3436_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_47a37c28-a2ef-4403-8471-fa5cd7ec3436" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_AccountsReceivableNetMember_27d6767b-93dc-4f94-9e39-24a953475d5f" xlink:href="rmd-20220930.xsd#rmd_AccountsReceivableNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:to="loc_rmd_AccountsReceivableNetMember_27d6767b-93dc-4f94-9e39-24a953475d5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ce142926-afc1-4c3c-ad47-3543cb6e5e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ce142926-afc1-4c3c-ad47-3543cb6e5e70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember_24c25123-ccdf-482d-abcc-bc5dd5303d5d" xlink:href="rmd-20220930.xsd#rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:to="loc_rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember_24c25123-ccdf-482d-abcc-bc5dd5303d5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DeferredRevenueCurrentLiabilitiesMember_3655eccf-59eb-4863-9d37-2ebb4d6547df" xlink:href="rmd-20220930.xsd#rmd_DeferredRevenueCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:to="loc_rmd_DeferredRevenueCurrentLiabilitiesMember_3655eccf-59eb-4863-9d37-2ebb4d6547df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DeferredRevenueNonCurrentLiabilitiesMember_300d7172-721f-494e-958f-f55893f424c7" xlink:href="rmd-20220930.xsd#rmd_DeferredRevenueNonCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:to="loc_rmd_DeferredRevenueNonCurrentLiabilitiesMember_300d7172-721f-494e-958f-f55893f424c7" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"/>
  <link:definitionLink xlink:role="http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails" xlink:type="extended" id="i05ade16b56f0422c94db73ee93417355_SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_35df8dbb-56ab-44d8-9dfb-b30915522aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_35df8dbb-56ab-44d8-9dfb-b30915522aac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_509a73d7-61b2-4d20-b022-5ca9a2fef283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_509a73d7-61b2-4d20-b022-5ca9a2fef283" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9caf4fe1-398b-4a98-a60b-08c7477ae112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_OperatingIncomeLoss_9caf4fe1-398b-4a98-a60b-08c7477ae112" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_UnallocatedCorporateCosts_c9adf584-1503-4844-8a46-853ab82887fb" xlink:href="rmd-20220930.xsd#rmd_UnallocatedCorporateCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_rmd_UnallocatedCorporateCosts_c9adf584-1503-4844-8a46-853ab82887fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_AmortizationOfAcquiredIntangibleAssets1_fe3f087f-93fd-429c-b8cb-fdf0ff2835ef" xlink:href="rmd-20220930.xsd#rmd_AmortizationOfAcquiredIntangibleAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_rmd_AmortizationOfAcquiredIntangibleAssets1_fe3f087f-93fd-429c-b8cb-fdf0ff2835ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_26f1a987-39d2-4a93-894d-acdc889bc498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_InterestExpense_26f1a987-39d2-4a93-894d-acdc889bc498" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9523f1e3-54de-4e9f-a284-61c99e7b3656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9523f1e3-54de-4e9f-a284-61c99e7b3656" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_83ed00c7-4077-4b73-ba24-dc8d4eff6400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_83ed00c7-4077-4b73-ba24-dc8d4eff6400" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6d560520-76b1-4f30-bd1c-b5fc6e7274e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6d560520-76b1-4f30-bd1c-b5fc6e7274e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_37a5a9bd-a973-486e-ab98-9e313b3e61fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_37a5a9bd-a973-486e-ab98-9e313b3e61fe" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3b1b94e-7fc4-40d6-a365-618b1e16a526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3b1b94e-7fc4-40d6-a365-618b1e16a526" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ce485317-a1ad-4f3f-8e4b-ee6e42e7b1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3b1b94e-7fc4-40d6-a365-618b1e16a526" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ce485317-a1ad-4f3f-8e4b-ee6e42e7b1cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ce485317-a1ad-4f3f-8e4b-ee6e42e7b1cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ce485317-a1ad-4f3f-8e4b-ee6e42e7b1cd" xlink:to="loc_us-gaap_SegmentDomain_ce485317-a1ad-4f3f-8e4b-ee6e42e7b1cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b099dc7d-5720-47c3-8358-e039121ed5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ce485317-a1ad-4f3f-8e4b-ee6e42e7b1cd" xlink:to="loc_us-gaap_SegmentDomain_b099dc7d-5720-47c3-8358-e039121ed5d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SleepAndRespiratoryMember_52522e8f-4111-459a-b893-39bf1b876f47" xlink:href="rmd-20220930.xsd#rmd_SleepAndRespiratoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b099dc7d-5720-47c3-8358-e039121ed5d2" xlink:to="loc_rmd_SleepAndRespiratoryMember_52522e8f-4111-459a-b893-39bf1b876f47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SoftwareAsServiceMember_93cf72fc-5233-483d-81cf-5ac7dc216ce4" xlink:href="rmd-20220930.xsd#rmd_SoftwareAsServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b099dc7d-5720-47c3-8358-e039121ed5d2" xlink:to="loc_rmd_SoftwareAsServiceMember_93cf72fc-5233-483d-81cf-5ac7dc216ce4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a6072e25-0247-4873-8976-8f02366568f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3b1b94e-7fc4-40d6-a365-618b1e16a526" xlink:to="loc_srt_ConsolidationItemsAxis_a6072e25-0247-4873-8976-8f02366568f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a6072e25-0247-4873-8976-8f02366568f0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_a6072e25-0247-4873-8976-8f02366568f0" xlink:to="loc_srt_ConsolidationItemsDomain_a6072e25-0247-4873-8976-8f02366568f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_1d8e59a0-43e5-48b8-bb11-0bfc2d97a164" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_a6072e25-0247-4873-8976-8f02366568f0" xlink:to="loc_srt_ConsolidationItemsDomain_1d8e59a0-43e5-48b8-bb11-0bfc2d97a164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_5bdec908-bdb6-436d-a1e3-1291c270618e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_1d8e59a0-43e5-48b8-bb11-0bfc2d97a164" xlink:to="loc_us-gaap_OperatingSegmentsMember_5bdec908-bdb6-436d-a1e3-1291c270618e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c447e2f2-c295-48ef-afbd-c2c28bde2f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_1d8e59a0-43e5-48b8-bb11-0bfc2d97a164" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c447e2f2-c295-48ef-afbd-c2c28bde2f2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_ce9a6c61-5d17-4183-a58b-87033788ebbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_1d8e59a0-43e5-48b8-bb11-0bfc2d97a164" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_ce9a6c61-5d17-4183-a58b-87033788ebbf" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"/>
  <link:definitionLink xlink:role="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails" xlink:type="extended" id="ic885ca82a3ed478b962db94642f0d7e2_SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3df0dacf-1e13-4d9d-b2d6-0df52d54e7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8a6aa239-3d48-45f6-b5ef-4ec3691efedf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3df0dacf-1e13-4d9d-b2d6-0df52d54e7d3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8a6aa239-3d48-45f6-b5ef-4ec3691efedf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ff64c65b-2305-48b5-a582-38a88b1abc1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3df0dacf-1e13-4d9d-b2d6-0df52d54e7d3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ff64c65b-2305-48b5-a582-38a88b1abc1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_856c2b11-35c2-4baa-b3d1-a73739835ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3df0dacf-1e13-4d9d-b2d6-0df52d54e7d3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_856c2b11-35c2-4baa-b3d1-a73739835ad8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_17f5e244-6aea-44ac-aa0a-1db88ce69f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3df0dacf-1e13-4d9d-b2d6-0df52d54e7d3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_17f5e244-6aea-44ac-aa0a-1db88ce69f93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_48a93a88-60a1-4710-b3e0-424c460ed080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3df0dacf-1e13-4d9d-b2d6-0df52d54e7d3" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_48a93a88-60a1-4710-b3e0-424c460ed080" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1e7483a0-812d-45fb-949c-5b8aeef2d899" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_48a93a88-60a1-4710-b3e0-424c460ed080" xlink:to="loc_srt_RangeAxis_1e7483a0-812d-45fb-949c-5b8aeef2d899" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1e7483a0-812d-45fb-949c-5b8aeef2d899_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1e7483a0-812d-45fb-949c-5b8aeef2d899" xlink:to="loc_srt_RangeMember_1e7483a0-812d-45fb-949c-5b8aeef2d899_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a04cf0e2-1f90-461e-af7a-dc32d1c398de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1e7483a0-812d-45fb-949c-5b8aeef2d899" xlink:to="loc_srt_RangeMember_a04cf0e2-1f90-461e-af7a-dc32d1c398de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ea900896-0b07-41ef-95ee-d989640a0858" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a04cf0e2-1f90-461e-af7a-dc32d1c398de" xlink:to="loc_srt_MinimumMember_ea900896-0b07-41ef-95ee-d989640a0858" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ce9c4558-c68f-4c40-a989-6a9ae6ea1e6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a04cf0e2-1f90-461e-af7a-dc32d1c398de" xlink:to="loc_srt_MaximumMember_ce9c4558-c68f-4c40-a989-6a9ae6ea1e6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cac986e-96d3-48b3-8c10-6b4be11f1186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_48a93a88-60a1-4710-b3e0-424c460ed080" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cac986e-96d3-48b3-8c10-6b4be11f1186" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cac986e-96d3-48b3-8c10-6b4be11f1186_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cac986e-96d3-48b3-8c10-6b4be11f1186" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cac986e-96d3-48b3-8c10-6b4be11f1186_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f25f8bc-f328-4cf5-8b2c-701e86ab8a41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cac986e-96d3-48b3-8c10-6b4be11f1186" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f25f8bc-f328-4cf5-8b2c-701e86ab8a41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DevelopedOrCoreProductTechnologyMember_209df9f1-0593-4cc5-82a8-80c1dbe1bced" xlink:href="rmd-20220930.xsd#rmd_DevelopedOrCoreProductTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f25f8bc-f328-4cf5-8b2c-701e86ab8a41" xlink:to="loc_rmd_DevelopedOrCoreProductTechnologyMember_209df9f1-0593-4cc5-82a8-80c1dbe1bced" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_28e4fdc6-e89a-4075-87a4-76bf2cec7e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f25f8bc-f328-4cf5-8b2c-701e86ab8a41" xlink:to="loc_us-gaap_CustomerRelationshipsMember_28e4fdc6-e89a-4075-87a4-76bf2cec7e83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_b37c15de-1f3e-487e-8535-aedf736a8cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f25f8bc-f328-4cf5-8b2c-701e86ab8a41" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_b37c15de-1f3e-487e-8535-aedf736a8cf9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails"/>
  <link:definitionLink xlink:role="http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails" xlink:type="extended" id="iceca1cb691ef4f4f81cf1d509c970b97_GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_6a4cb5e3-5fec-4c76-bfa4-1aea6eef7f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_4aa0d9bf-8c58-481e-9996-e418447e771a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_6a4cb5e3-5fec-4c76-bfa4-1aea6eef7f51" xlink:to="loc_us-gaap_GoodwillRollForward_4aa0d9bf-8c58-481e-9996-e418447e771a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6aff3ccb-1f32-4ddb-b21d-9caf24fdccc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4aa0d9bf-8c58-481e-9996-e418447e771a" xlink:to="loc_us-gaap_Goodwill_6aff3ccb-1f32-4ddb-b21d-9caf24fdccc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8d16f995-5216-44d0-801c-cda33d496e66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4aa0d9bf-8c58-481e-9996-e418447e771a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8d16f995-5216-44d0-801c-cda33d496e66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3aa07c1e-7b2f-4724-99ee-c9af332d9591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_4aa0d9bf-8c58-481e-9996-e418447e771a" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3aa07c1e-7b2f-4724-99ee-c9af332d9591" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b965d661-84b0-4847-9484-29cfe549f9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ded4cb4e-f0c4-41c9-8019-6b841d6cf242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_6a4cb5e3-5fec-4c76-bfa4-1aea6eef7f51" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ded4cb4e-f0c4-41c9-8019-6b841d6cf242" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_81a8e5ee-814d-4a09-9f43-94845bd80522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ded4cb4e-f0c4-41c9-8019-6b841d6cf242" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_81a8e5ee-814d-4a09-9f43-94845bd80522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_81a8e5ee-814d-4a09-9f43-94845bd80522_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_81a8e5ee-814d-4a09-9f43-94845bd80522" xlink:to="loc_us-gaap_SegmentDomain_81a8e5ee-814d-4a09-9f43-94845bd80522_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fd2a7086-add5-42ae-bfd7-3538344b476b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_81a8e5ee-814d-4a09-9f43-94845bd80522" xlink:to="loc_us-gaap_SegmentDomain_fd2a7086-add5-42ae-bfd7-3538344b476b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SleepAndRespiratoryMember_3614e313-b540-4de0-80fc-d45cfd46bfe4" xlink:href="rmd-20220930.xsd#rmd_SleepAndRespiratoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fd2a7086-add5-42ae-bfd7-3538344b476b" xlink:to="loc_rmd_SleepAndRespiratoryMember_3614e313-b540-4de0-80fc-d45cfd46bfe4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SaasMember_d6d530fa-6626-46bd-91dc-93f9e8670989" xlink:href="rmd-20220930.xsd#rmd_SaasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fd2a7086-add5-42ae-bfd7-3538344b476b" xlink:to="loc_rmd_SaasMember_d6d530fa-6626-46bd-91dc-93f9e8670989" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#InvestmentsScheduleOfChangesInEquityInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails" xlink:type="extended" id="ifa3a259d3d6c4a63b68828411e3f6cd1_InvestmentsScheduleOfChangesInEquityInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_f25b9874-2db5-4973-b501-48710b4f4a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:href="rmd-20220930.xsd#rmd_DebtAndEquityInvestmentsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_f25b9874-2db5-4973-b501-48710b4f4a89" xlink:to="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_EquityInvestments_93cee6cf-e884-45a1-829c-8ff410fd6433" xlink:href="rmd-20220930.xsd#rmd_EquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:to="loc_rmd_EquityInvestments_93cee6cf-e884-45a1-829c-8ff410fd6433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_AdditionalEquityInvestments_c04106e8-e475-4567-a10a-90a9aeea1e5c" xlink:href="rmd-20220930.xsd#rmd_AdditionalEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:to="loc_rmd_AdditionalEquityInvestments_c04106e8-e475-4567-a10a-90a9aeea1e5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities_3502368a-2347-4e14-9f1b-78da4426973e" xlink:href="rmd-20220930.xsd#rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:to="loc_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities_3502368a-2347-4e14-9f1b-78da4426973e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_01c0c3ba-54a9-4f87-ba78-37c57ad63f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_01c0c3ba-54a9-4f87-ba78-37c57ad63f17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_8200c989-6918-42f7-b3a7-bf3b77815624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_8200c989-6918-42f7-b3a7-bf3b77815624" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a29f4281-3da3-4be9-8433-91c5247f1ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a29f4281-3da3-4be9-8433-91c5247f1ca6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_EquityInvestments_6338092a-13d0-4a99-bec7-76ce0c6054ec" xlink:href="rmd-20220930.xsd#rmd_EquityInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_29c777b4-5b37-4742-a921-2929ac77e6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_f25b9874-2db5-4973-b501-48710b4f4a89" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_29c777b4-5b37-4742-a921-2929ac77e6ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6a314284-c2c2-4b0e-96ad-eb58ebc65ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_29c777b4-5b37-4742-a921-2929ac77e6ff" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6a314284-c2c2-4b0e-96ad-eb58ebc65ee3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a314284-c2c2-4b0e-96ad-eb58ebc65ee3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6a314284-c2c2-4b0e-96ad-eb58ebc65ee3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a314284-c2c2-4b0e-96ad-eb58ebc65ee3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c36dbee7-e488-469b-ae77-088bd98a8b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6a314284-c2c2-4b0e-96ad-eb58ebc65ee3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c36dbee7-e488-469b-ae77-088bd98a8b1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_NonMarketableSecuritiesMember_f9e094f4-e53c-47b9-9dc0-fc9b3459a0d2" xlink:href="rmd-20220930.xsd#rmd_NonMarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c36dbee7-e488-469b-ae77-088bd98a8b1e" xlink:to="loc_rmd_NonMarketableSecuritiesMember_f9e094f4-e53c-47b9-9dc0-fc9b3459a0d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MarketableSecuritiesMember_a0148ad9-9039-4043-9677-6d988eb22828" xlink:href="rmd-20220930.xsd#rmd_MarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c36dbee7-e488-469b-ae77-088bd98a8b1e" xlink:to="loc_rmd_MarketableSecuritiesMember_a0148ad9-9039-4043-9677-6d988eb22828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsMember_cf3ad045-672a-4ec8-9cc9-6812ec4638a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c36dbee7-e488-469b-ae77-088bd98a8b1e" xlink:to="loc_us-gaap_EquityMethodInvestmentsMember_cf3ad045-672a-4ec8-9cc9-6812ec4638a4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://investor.resmed.com/role/IncomeTaxesDetails" xlink:type="extended" id="ib83402c861834af2bf42b6c588b61dca_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_1b14f7ed-b24f-4962-bc5b-cec86ed0027e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_IncomeTaxExaminationRemittedFinalPayment_9f6112f8-a0b6-4a88-9e7b-0117cfa1da9d" xlink:href="rmd-20220930.xsd#rmd_IncomeTaxExaminationRemittedFinalPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1b14f7ed-b24f-4962-bc5b-cec86ed0027e" xlink:to="loc_rmd_IncomeTaxExaminationRemittedFinalPayment_9f6112f8-a0b6-4a88-9e7b-0117cfa1da9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_IncomeTaxExaminationGrossSettlement_628531df-236f-4bec-8bc3-97b9306c6923" xlink:href="rmd-20220930.xsd#rmd_IncomeTaxExaminationGrossSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1b14f7ed-b24f-4962-bc5b-cec86ed0027e" xlink:to="loc_rmd_IncomeTaxExaminationGrossSettlement_628531df-236f-4bec-8bc3-97b9306c6923" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_IncomeTaxExaminationPriorRemittancePayments_cd310310-a73f-48ed-8a37-dc06a58bd4aa" xlink:href="rmd-20220930.xsd#rmd_IncomeTaxExaminationPriorRemittancePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1b14f7ed-b24f-4962-bc5b-cec86ed0027e" xlink:to="loc_rmd_IncomeTaxExaminationPriorRemittancePayments_cd310310-a73f-48ed-8a37-dc06a58bd4aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_15165cc2-5516-4d2c-9fa7-5235e919cb41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1b14f7ed-b24f-4962-bc5b-cec86ed0027e" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_15165cc2-5516-4d2c-9fa7-5235e919cb41" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_e27fdb91-e900-48b9-8657-499cb43fcb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_15165cc2-5516-4d2c-9fa7-5235e919cb41" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_e27fdb91-e900-48b9-8657-499cb43fcb4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_e27fdb91-e900-48b9-8657-499cb43fcb4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e27fdb91-e900-48b9-8657-499cb43fcb4f" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_e27fdb91-e900-48b9-8657-499cb43fcb4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_3f8ced5a-489c-4376-acc8-812b529537aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e27fdb91-e900-48b9-8657-499cb43fcb4f" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_3f8ced5a-489c-4376-acc8-812b529537aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_7510c232-8068-4a86-94fb-9a57864cd76d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3f8ced5a-489c-4376-acc8-812b529537aa" xlink:to="loc_us-gaap_DomesticCountryMember_7510c232-8068-4a86-94fb-9a57864cd76d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_3f8b4f10-b4ec-4f69-9249-992d574f756f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_15165cc2-5516-4d2c-9fa7-5235e919cb41" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_3f8b4f10-b4ec-4f69-9249-992d574f756f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_3f8b4f10-b4ec-4f69-9249-992d574f756f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_3f8b4f10-b4ec-4f69-9249-992d574f756f" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_3f8b4f10-b4ec-4f69-9249-992d574f756f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_7da7cff6-cd46-4dc1-b03d-0725370dcb62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_3f8b4f10-b4ec-4f69-9249-992d574f756f" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_7da7cff6-cd46-4dc1-b03d-0725370dcb62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AustralianTaxationOfficeMember_91ae7751-0904-4630-9ae5-0e816c2bbfec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AustralianTaxationOfficeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_7da7cff6-cd46-4dc1-b03d-0725370dcb62" xlink:to="loc_us-gaap_AustralianTaxationOfficeMember_91ae7751-0904-4630-9ae5-0e816c2bbfec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://investor.resmed.com/role/DebtNarrativeDetails" xlink:type="extended" id="ieefc6142e1094a1481669797d29082e3_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_350b44d7-bfdb-471a-9f20-3b3490f863e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_350b44d7-bfdb-471a-9f20-3b3490f863e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_UncommittedOptionToIncreaseCreditFacility_e6eac84c-2eb4-4e59-bb9b-c33b6571ba55" xlink:href="rmd-20220930.xsd#rmd_UncommittedOptionToIncreaseCreditFacility"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_rmd_UncommittedOptionToIncreaseCreditFacility_e6eac84c-2eb4-4e59-bb9b-c33b6571ba55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod_05f5a45a-bb99-4d31-8799-7d5ddf926ab9" xlink:href="rmd-20220930.xsd#rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod_05f5a45a-bb99-4d31-8799-7d5ddf926ab9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal_e20ac241-c796-4977-a71d-2ec6ecc5ae54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal_e20ac241-c796-4977-a71d-2ec6ecc5ae54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0b272357-636b-45bb-a3d7-55603e2ba06f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0b272357-636b-45bb-a3d7-55603e2ba06f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c1caae8a-f864-49a5-bcbf-2a186b88cf95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c1caae8a-f864-49a5-bcbf-2a186b88cf95" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_fcf8c230-6f75-44df-a47e-9a09ca96623e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_fcf8c230-6f75-44df-a47e-9a09ca96623e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_b428e521-6659-4984-9f49-31b438aa356b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_b428e521-6659-4984-9f49-31b438aa356b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_cfb43514-44a6-4eb2-83ae-798be4fd5d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_LongTermDebtFairValue_cfb43514-44a6-4eb2-83ae-798be4fd5d6c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ab6a3e43-7127-4406-8a01-a16eaf36b941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ab6a3e43-7127-4406-8a01-a16eaf36b941" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_beca4d50-a4ea-43b9-994c-e3d521db5b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_beca4d50-a4ea-43b9-994c-e3d521db5b4e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DebtToConsolidatedEbitdaRatio_626cc586-3fac-4a5f-84a0-c1fa5c212cf4" xlink:href="rmd-20220930.xsd#rmd_DebtToConsolidatedEbitdaRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_rmd_DebtToConsolidatedEbitdaRatio_626cc586-3fac-4a5f-84a0-c1fa5c212cf4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_LineOfCreditFacilityCollateralPercentageOfCompany_85998aef-11e0-4a93-ad2c-c8f32472201d" xlink:href="rmd-20220930.xsd#rmd_LineOfCreditFacilityCollateralPercentageOfCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_rmd_LineOfCreditFacilityCollateralPercentageOfCompany_85998aef-11e0-4a93-ad2c-c8f32472201d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_0dfb5673-081d-4607-bad0-9d9db8fbc459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_SeniorNotes_0dfb5673-081d-4607-bad0-9d9db8fbc459" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_16547033-92a3-4ddc-bf40-cbd65a10aa0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_16547033-92a3-4ddc-bf40-cbd65a10aa0a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_42a12fd4-3020-42e0-b7d8-b92a8a6c6f25" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:to="loc_dei_LegalEntityAxis_42a12fd4-3020-42e0-b7d8-b92a8a6c6f25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_42a12fd4-3020-42e0-b7d8-b92a8a6c6f25_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_42a12fd4-3020-42e0-b7d8-b92a8a6c6f25" xlink:to="loc_dei_EntityDomain_42a12fd4-3020-42e0-b7d8-b92a8a6c6f25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a35d186b-47ca-483e-837f-a51f0cf81179" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_42a12fd4-3020-42e0-b7d8-b92a8a6c6f25" xlink:to="loc_dei_EntityDomain_a35d186b-47ca-483e-837f-a51f0cf81179" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ResmedLimitedMember_eb5d127b-841e-49bc-957e-c05fa38e6a48" xlink:href="rmd-20220930.xsd#rmd_ResmedLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a35d186b-47ca-483e-837f-a51f0cf81179" xlink:to="loc_rmd_ResmedLimitedMember_eb5d127b-841e-49bc-957e-c05fa38e6a48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_307497e3-0a7b-4613-b86e-219c22cdbde2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:to="loc_us-gaap_CreditFacilityAxis_307497e3-0a7b-4613-b86e-219c22cdbde2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_307497e3-0a7b-4613-b86e-219c22cdbde2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_307497e3-0a7b-4613-b86e-219c22cdbde2" xlink:to="loc_us-gaap_CreditFacilityDomain_307497e3-0a7b-4613-b86e-219c22cdbde2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5327b8cf-8f8c-42e1-aa20-2ece7503d73b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_307497e3-0a7b-4613-b86e-219c22cdbde2" xlink:to="loc_us-gaap_CreditFacilityDomain_5327b8cf-8f8c-42e1-aa20-2ece7503d73b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember_cba5e8a7-40f3-4d17-9d1e-29178348e811" xlink:href="rmd-20220930.xsd#rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5327b8cf-8f8c-42e1-aa20-2ece7503d73b" xlink:to="loc_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember_cba5e8a7-40f3-4d17-9d1e-29178348e811" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_59f8c29d-6c60-4066-b3bb-bced498114d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember_cba5e8a7-40f3-4d17-9d1e-29178348e811" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_59f8c29d-6c60-4066-b3bb-bced498114d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_TermLoanCreditAgreementMember_8b77af9d-7368-42a1-b9e6-e96c685148f3" xlink:href="rmd-20220930.xsd#rmd_TermLoanCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember_cba5e8a7-40f3-4d17-9d1e-29178348e811" xlink:to="loc_rmd_TermLoanCreditAgreementMember_8b77af9d-7368-42a1-b9e6-e96c685148f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_0fa2cbd6-25ec-4154-94dc-41e6a56c6513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_0fa2cbd6-25ec-4154-94dc-41e6a56c6513" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_0fa2cbd6-25ec-4154-94dc-41e6a56c6513_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_0fa2cbd6-25ec-4154-94dc-41e6a56c6513" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_0fa2cbd6-25ec-4154-94dc-41e6a56c6513_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_dbc172d6-1e54-4af0-bdd1-70c419cf0e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_0fa2cbd6-25ec-4154-94dc-41e6a56c6513" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_dbc172d6-1e54-4af0-bdd1-70c419cf0e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MufgUnionBankNaAndWestpacBankingCorporationMember_5d74f86f-d58e-4a11-9594-db9b7d0ea687" xlink:href="rmd-20220930.xsd#rmd_MufgUnionBankNaAndWestpacBankingCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_dbc172d6-1e54-4af0-bdd1-70c419cf0e08" xlink:to="loc_rmd_MufgUnionBankNaAndWestpacBankingCorporationMember_5d74f86f-d58e-4a11-9594-db9b7d0ea687" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MufgUnionBankMember_da5ae9ae-9b2e-4c28-acb3-7f59cb2975c6" xlink:href="rmd-20220930.xsd#rmd_MufgUnionBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_dbc172d6-1e54-4af0-bdd1-70c419cf0e08" xlink:to="loc_rmd_MufgUnionBankMember_da5ae9ae-9b2e-4c28-acb3-7f59cb2975c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fc15b035-8e08-4ce0-848c-dbc831448948" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:to="loc_srt_RangeAxis_fc15b035-8e08-4ce0-848c-dbc831448948" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fc15b035-8e08-4ce0-848c-dbc831448948_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fc15b035-8e08-4ce0-848c-dbc831448948" xlink:to="loc_srt_RangeMember_fc15b035-8e08-4ce0-848c-dbc831448948_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6746bb17-ac51-4717-aa0d-28f7c46ab58b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fc15b035-8e08-4ce0-848c-dbc831448948" xlink:to="loc_srt_RangeMember_6746bb17-ac51-4717-aa0d-28f7c46ab58b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_44d31727-88ac-422c-bf46-de134032ec59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6746bb17-ac51-4717-aa0d-28f7c46ab58b" xlink:to="loc_srt_MinimumMember_44d31727-88ac-422c-bf46-de134032ec59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d679c736-e609-4e09-b248-1380a8045a58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6746bb17-ac51-4717-aa0d-28f7c46ab58b" xlink:to="loc_srt_MaximumMember_d679c736-e609-4e09-b248-1380a8045a58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e75cdefe-683f-4a29-982c-c341465a806a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:to="loc_us-gaap_VariableRateAxis_e75cdefe-683f-4a29-982c-c341465a806a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e75cdefe-683f-4a29-982c-c341465a806a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_e75cdefe-683f-4a29-982c-c341465a806a" xlink:to="loc_us-gaap_VariableRateDomain_e75cdefe-683f-4a29-982c-c341465a806a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d647a928-7d36-40fb-9ec9-62ee8d507568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_e75cdefe-683f-4a29-982c-c341465a806a" xlink:to="loc_us-gaap_VariableRateDomain_d647a928-7d36-40fb-9ec9-62ee8d507568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f3b4e5ad-e6bb-40a5-9fde-9bb5f8f0e27d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_d647a928-7d36-40fb-9ec9-62ee8d507568" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f3b4e5ad-e6bb-40a5-9fde-9bb5f8f0e27d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_362a5e7f-7097-42a5-b954-83629d35ac0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_d647a928-7d36-40fb-9ec9-62ee8d507568" xlink:to="loc_us-gaap_BaseRateMember_362a5e7f-7097-42a5-b954-83629d35ac0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_93354555-d135-47dd-a75b-bdeb133ff315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_93354555-d135-47dd-a75b-bdeb133ff315" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_93354555-d135-47dd-a75b-bdeb133ff315_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_93354555-d135-47dd-a75b-bdeb133ff315" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_93354555-d135-47dd-a75b-bdeb133ff315_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8330764f-2162-4bf4-8501-8f73b0ecb147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_93354555-d135-47dd-a75b-bdeb133ff315" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8330764f-2162-4bf4-8501-8f73b0ecb147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SeniorNotesOneMember_bf163139-b870-4230-a8c3-2c71e41056dc" xlink:href="rmd-20220930.xsd#rmd_SeniorNotesOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8330764f-2162-4bf4-8501-8f73b0ecb147" xlink:to="loc_rmd_SeniorNotesOneMember_bf163139-b870-4230-a8c3-2c71e41056dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SeniorNotesTwoMember_17189a17-1458-4b93-ad76-73ac9c26bb5b" xlink:href="rmd-20220930.xsd#rmd_SeniorNotesTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8330764f-2162-4bf4-8501-8f73b0ecb147" xlink:to="loc_rmd_SeniorNotesTwoMember_17189a17-1458-4b93-ad76-73ac9c26bb5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c9106c66-8494-4090-bb58-2ad50c08656b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8330764f-2162-4bf4-8501-8f73b0ecb147" xlink:to="loc_us-gaap_SeniorNotesMember_c9106c66-8494-4090-bb58-2ad50c08656b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember_8157982c-4e50-4484-8eff-d995cee53289" xlink:href="rmd-20220930.xsd#rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8330764f-2162-4bf4-8501-8f73b0ecb147" xlink:to="loc_rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember_8157982c-4e50-4484-8eff-d995cee53289" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>rmd-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:863cb569-faab-47da-ba4f-c2fd89e0377c,g:b569d9d4-e0e2-497b-a32d-7564d4bc33ab-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DeferredFinanceCostsCurrentNet_a8b9906f-c89c-452d-b069-818cfec03c1e_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsCurrentNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred borrowing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsCurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsCurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Current, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsCurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsCurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsCurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_327d389e-aaa5-486d-a484-eb3124c099fd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease revenue</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0953a3f0-45e2-4a8d-ba12-e44bbde9a811_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2aa00fca-7744-40de-a923-91b3f29f1d4a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_fc25da8c-96bc-4db7-a8a8-f6c5ffeffc20_netLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_0579c1b8-f892-47c0-99fa-cf3bffa55b43_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment, Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_0a207659-bea3-4bb3-8f7c-fe9ef62664d6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_967e0d71-1813-4571-9084-1c7c3ff2e00e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Changes In Liability For Warranty Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_cabfcff8-e37a-4ece-80e1-c5615a2ab809_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value per share (dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_d7e7cc82-f395-4abb-bb00-4344e66b1e44_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a6eeb94c-6c57-4f97-81b6-180e9422d47e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_6b7da0cd-bb27-424b-adc1-78335a0202c9_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional &#8206;Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_1e5feab6-117c-45c1-8d44-3b5710e7473a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_ab87fa81-ae91-4f67-b73d-d83875151da6_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_f691c8b5-c41a-4481-a81f-6302f94040d9_totalLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3ff91408-3d04-4406-a46c-9556ffbfadb5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted shares outstanding (000's) (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_02470eed-e8c4-4a26-a276-d9d5896cd05a_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_852a75a1-9813-4a78-91d7-38e94998f941_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2fc5ef9b-7d45-4d50-8154-0434149f754c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_8b85343d-5127-4798-a6d2-ba301ea06ca9_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d22019c3-601d-4c7f-87a8-d6fbe9d981ae_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_08a10976-c1c2-4850-8ad8-90e42ea0ae91_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_MufgUnionBankNaAndWestpacBankingCorporationMember_62d3595d-25ae-4474-9d91-e468de009e13_terseLabel_en-US" xlink:label="lab_rmd_MufgUnionBankNaAndWestpacBankingCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mufg Union Bank Na And Westpac Banking Corporation</link:label>
    <link:label id="lab_rmd_MufgUnionBankNaAndWestpacBankingCorporationMember_label_en-US" xlink:label="lab_rmd_MufgUnionBankNaAndWestpacBankingCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mufg Union Bank Na And Westpac Banking Corporation [Member]</link:label>
    <link:label id="lab_rmd_MufgUnionBankNaAndWestpacBankingCorporationMember_documentation_en-US" xlink:label="lab_rmd_MufgUnionBankNaAndWestpacBankingCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mufg Union Bank Na And Westpac Banking Corporation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MufgUnionBankNaAndWestpacBankingCorporationMember" xlink:href="rmd-20220930.xsd#rmd_MufgUnionBankNaAndWestpacBankingCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_MufgUnionBankNaAndWestpacBankingCorporationMember" xlink:to="lab_rmd_MufgUnionBankNaAndWestpacBankingCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_07f2c730-5ecc-4968-96f0-53183926a0bf_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal_25ba946a-eeb0-4f14-88ed-b5bbd2a35147_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payment</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_7132945a-f94a-4d31-836f-617c183515ae_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTextBlock_2c2e8ef7-d65a-48c7-bd22-84b4bfffcd8f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTextBlock" xlink:to="lab_us-gaap_InvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_AmortizationOfAcquiredIntangibleAssets1_89850409-63ce-4c34-9899-c62d085232bd_terseLabel_en-US" xlink:label="lab_rmd_AmortizationOfAcquiredIntangibleAssets1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_rmd_AmortizationOfAcquiredIntangibleAssets1_6ca7d217-4bde-4e1d-8381-5fc987ff5737_verboseLabel_en-US" xlink:label="lab_rmd_AmortizationOfAcquiredIntangibleAssets1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_rmd_AmortizationOfAcquiredIntangibleAssets1_label_en-US" xlink:label="lab_rmd_AmortizationOfAcquiredIntangibleAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets 1</link:label>
    <link:label id="lab_rmd_AmortizationOfAcquiredIntangibleAssets1_documentation_en-US" xlink:label="lab_rmd_AmortizationOfAcquiredIntangibleAssets1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate expense charged against earnings to allocate the cost of acquired intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_AmortizationOfAcquiredIntangibleAssets1" xlink:href="rmd-20220930.xsd#rmd_AmortizationOfAcquiredIntangibleAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_AmortizationOfAcquiredIntangibleAssets1" xlink:to="lab_rmd_AmortizationOfAcquiredIntangibleAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_d0ed01b0-567a-4b29-a360-b3b2dc436287_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty accruals for the period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_171533ad-25f4-4034-aadd-cf12a3b39b72_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_5ae8e7a0-e03a-4337-8657-7b789ca3a531_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_6487fd16-c04f-4858-a708-f0c8ea34ff2e_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility interest rate equal to reference rate plus</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_SummaryOfSignificantAccountingPoliciesLineItems_0e60be5d-56ff-4dc4-ba28-00db51fea37a_terseLabel_en-US" xlink:label="lab_rmd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_rmd_SummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_rmd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_rmd_SummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_rmd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="rmd-20220930.xsd#rmd_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_rmd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_SummaryOfSignificantAccountingPoliciesTable_83f8f7b5-2287-4e42-8a30-b406f09e47ac_terseLabel_en-US" xlink:label="lab_rmd_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_rmd_SummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_rmd_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_rmd_SummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_rmd_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SummaryOfSignificantAccountingPoliciesTable" xlink:href="rmd-20220930.xsd#rmd_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_rmd_SummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_ScheduleOfInvestmentsTableTextBlock_caa7de14-c2c0-4f3a-8af3-b22c068a43eb_terseLabel_en-US" xlink:label="lab_rmd_ScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Investments</link:label>
    <link:label id="lab_rmd_ScheduleOfInvestmentsTableTextBlock_label_en-US" xlink:label="lab_rmd_ScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Investments [Table Text Block]</link:label>
    <link:label id="lab_rmd_ScheduleOfInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_rmd_ScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ScheduleOfInvestmentsTableTextBlock" xlink:href="rmd-20220930.xsd#rmd_ScheduleOfInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_ScheduleOfInvestmentsTableTextBlock" xlink:to="lab_rmd_ScheduleOfInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_98362e9c-9438-4b03-89b3-213c21fd383b_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_790228d1-aa2b-4874-a14f-9489060e85cd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued on exercise of options (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_5e56b4d6-e452-4ca1-af83-404c0c4cb687_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued on vesting of restricted stock units, net of shares withheld for tax (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_420a2328-eff3-404a-a8ea-1e3aac83c8e6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_531e6d8e-4c4b-4c77-b0b1-96b8c48b395d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock_869a33f8-78fb-49cb-b543-87e859cc76f1_terseLabel_en-US" xlink:label="lab_rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Basis of Presentation</link:label>
    <link:label id="lab_rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock_label_en-US" xlink:label="lab_rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Basis Of Presentation, Policy [Policy Text Block]</link:label>
    <link:label id="lab_rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Basis Of Presentation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock" xlink:href="rmd-20220930.xsd#rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock" xlink:to="lab_rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_28c68ac4-c574-41d7-92a7-50408b7479d7_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:to="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_eaf43e37-aa9b-4c63-b45d-0199eee6f503_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_580b0953-8fc1-4b69-bdb0-c4db309984e4_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f5d3163a-0662-449d-ad8e-60686c40a188_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_deedabc6-0178-4c09-a342-c5a09cb50462_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9cffc058-4d61-40d4-8f2e-06340436484d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation (loss) gain adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_IncomeTaxExaminationPriorRemittancePayments_b8521859-4382-44b1-b223-4cc27c18e174_terseLabel_en-US" xlink:label="lab_rmd_IncomeTaxExaminationPriorRemittancePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax settlement, prior remittances</link:label>
    <link:label id="lab_rmd_IncomeTaxExaminationPriorRemittancePayments_label_en-US" xlink:label="lab_rmd_IncomeTaxExaminationPriorRemittancePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Prior Remittance Payments</link:label>
    <link:label id="lab_rmd_IncomeTaxExaminationPriorRemittancePayments_documentation_en-US" xlink:label="lab_rmd_IncomeTaxExaminationPriorRemittancePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Prior Remittance Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_IncomeTaxExaminationPriorRemittancePayments" xlink:href="rmd-20220930.xsd#rmd_IncomeTaxExaminationPriorRemittancePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_IncomeTaxExaminationPriorRemittancePayments" xlink:to="lab_rmd_IncomeTaxExaminationPriorRemittancePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_58b5c1a1-4956-4b7d-b4df-721670e864b0_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fdc3fab2-dbe1-4797-9372-20cebfb22c35_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Actions, Contingencies and Commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_1741cff8-afeb-4dbd-ae60-a75db83993b3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_91a3eb2b-c53a-40e6-88d1-6585f9f8d8ac_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings, net of borrowing costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_7319f8e0-fc0e-4e34-9431-c1c47eae8882_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_LineOfCreditFacilityCollateralPercentageOfCompany_50129f34-7fb3-41af-9482-21b36bb9ace1_verboseLabel_en-US" xlink:label="lab_rmd_LineOfCreditFacilityCollateralPercentageOfCompany" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility collateral, maximum percentage of ownership interests held in subsidiary</link:label>
    <link:label id="lab_rmd_LineOfCreditFacilityCollateralPercentageOfCompany_label_en-US" xlink:label="lab_rmd_LineOfCreditFacilityCollateralPercentageOfCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, collateral, percentage of the company</link:label>
    <link:label id="lab_rmd_LineOfCreditFacilityCollateralPercentageOfCompany_documentation_en-US" xlink:label="lab_rmd_LineOfCreditFacilityCollateralPercentageOfCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility collateral, percentage of the company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_LineOfCreditFacilityCollateralPercentageOfCompany" xlink:href="rmd-20220930.xsd#rmd_LineOfCreditFacilityCollateralPercentageOfCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_LineOfCreditFacilityCollateralPercentageOfCompany" xlink:to="lab_rmd_LineOfCreditFacilityCollateralPercentageOfCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_2279f075-ddfe-422c-b7da-68d76378fd50_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_2b27e7b6-14e1-4c41-8e2f-468e8a04aff2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_c383b820-cca9-4dcf-8392-b3aea78954ba_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_25da0e5d-3596-4122-8bd5-634a61f4836e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_5501e313-b38d-4ee8-9e49-97c17f6f86e9_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_113027ff-8622-45a6-9a79-3a2efe978a0e_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_fdb8f1ce-0a7b-4db4-b302-2b2cbdb188cf_negatedLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_acbb4606-ed94-47fd-be62-f199ed65c3da_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_fe836589-6478-486a-a639-9b7848a05581_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangibles</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_89a3063a-165b-40a2-bc36-62e10aebc648_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_e9f02ef7-08ad-4f70-89c8-1367b8ed214a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4fbfc8be-c87e-4241-b26b-19098e4484ca_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, estimated useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ea7bc99-b33a-4353-a487-a2a3d9dfd949_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_46354188-fd68-4a60-949e-1d3c07ce8807_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_e5242912-51d7-4d84-a87b-03407b3c8169_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f67b53f9-ef30-41b0-ad99-eb26419ac0fd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_fa1521b7-32b8-4457-958f-1cbee5c1d7d7_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_bb539a4c-955a-4258-b16c-42cda7ef025e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_a58d60d4-4b3a-414e-8cd3-ddb941a43e2f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum potential contingent liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_ee8fadcc-9a12-4fae-8fc6-7e4d1b2fcd88_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_ContractWithCustomerAssetAndLiabilityLineItems_3f9b1d2c-85e1-4420-b883-a143296f41bb_terseLabel_en-US" xlink:label="lab_rmd_ContractWithCustomerAssetAndLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Line Items]</link:label>
    <link:label id="lab_rmd_ContractWithCustomerAssetAndLiabilityLineItems_label_en-US" xlink:label="lab_rmd_ContractWithCustomerAssetAndLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Line Items]</link:label>
    <link:label id="lab_rmd_ContractWithCustomerAssetAndLiabilityLineItems_documentation_en-US" xlink:label="lab_rmd_ContractWithCustomerAssetAndLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ContractWithCustomerAssetAndLiabilityLineItems" xlink:href="rmd-20220930.xsd#rmd_ContractWithCustomerAssetAndLiabilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="lab_rmd_ContractWithCustomerAssetAndLiabilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6b23d703-706f-4dba-b5ad-f6005e8653ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Revenue By Segment and Reconciling Items</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_c68a7178-7f84-4197-9cf8-e6636e9bdbc6_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost, 41,836,234 shares at September&#160;30, 2022 and June&#160;30, 2022</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_4b530a29-0324-4d00-8300-ec533f81a9e1_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_de1a46de-6a90-4bcd-bf55-c6e36eccafab_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_IncomeTaxExaminationGrossSettlement_cfd2a93d-9b28-4254-806c-31381ed65395_terseLabel_en-US" xlink:label="lab_rmd_IncomeTaxExaminationGrossSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax settlement, gross amount</link:label>
    <link:label id="lab_rmd_IncomeTaxExaminationGrossSettlement_label_en-US" xlink:label="lab_rmd_IncomeTaxExaminationGrossSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Gross Settlement</link:label>
    <link:label id="lab_rmd_IncomeTaxExaminationGrossSettlement_documentation_en-US" xlink:label="lab_rmd_IncomeTaxExaminationGrossSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Gross Settlement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_IncomeTaxExaminationGrossSettlement" xlink:href="rmd-20220930.xsd#rmd_IncomeTaxExaminationGrossSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_IncomeTaxExaminationGrossSettlement" xlink:to="lab_rmd_IncomeTaxExaminationGrossSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_ccc22569-1eec-447a-a75b-816ea1fb741b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid taxes and other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_f8e27fcd-4fc6-40e9-8b5c-3b5310f47767_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_f19c0985-bbcb-4b45-8e7b-dfc71798ba41_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_56fd35a0-9c56-4f42-9f05-b9ba2e7d4b9f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization by segment</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_31e8a510-5ecb-4041-86fc-fb521871dd7b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_6246ffb2-8941-4bbe-a515-e60ed94569bb_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_06f8203f-575c-466a-88be-680924216167_negatedLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_MasksMember_4874e376-3fec-4382-a259-1c54675dbdbc_terseLabel_en-US" xlink:label="lab_rmd_MasksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Masks and other</link:label>
    <link:label id="lab_rmd_MasksMember_label_en-US" xlink:label="lab_rmd_MasksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Masks [Member]</link:label>
    <link:label id="lab_rmd_MasksMember_documentation_en-US" xlink:label="lab_rmd_MasksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Masks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MasksMember" xlink:href="rmd-20220930.xsd#rmd_MasksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_MasksMember" xlink:to="lab_rmd_MasksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_a43d30c6-2136-4f2d-94ff-5bf3b6a60950_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_ded74393-fdc4-4dda-9e20-1a4be91ced62_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_fcfcd9f0-5a2e-4858-ae8a-6f0d24681dda_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_61801a6e-87e5-4991-9aa5-563b1ebc2bd8_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.004 par value, 350,000,000 shares authorized; 188,295,266 issued and 146,459,032 outstanding at September&#160;30, 2022 and 188,246,955 issued and 146,410,721 outstanding at June&#160;30, 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6c2ff6f5-836e-4c75-a01f-158ec5a558c3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss_309c5f79-19b6-4ebf-b1e6-01808dee9876_terseLabel_en-US" xlink:label="lab_us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_SeniorNotesOneMember_3d1ef968-64d3-4990-9a5e-aa721e2b896e_terseLabel_en-US" xlink:label="lab_rmd_SeniorNotesOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.24% Senior Notes Due July 10, 2026</link:label>
    <link:label id="lab_rmd_SeniorNotesOneMember_label_en-US" xlink:label="lab_rmd_SeniorNotesOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes One [Member]</link:label>
    <link:label id="lab_rmd_SeniorNotesOneMember_documentation_en-US" xlink:label="lab_rmd_SeniorNotesOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SeniorNotesOneMember" xlink:href="rmd-20220930.xsd#rmd_SeniorNotesOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_SeniorNotesOneMember" xlink:to="lab_rmd_SeniorNotesOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_c79e9c6c-019d-4da8-9bf0-7aed46e6d130_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) / provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_ba8ef477-7fcf-4137-adc2-3679d454d331_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_5453b219-cc83-4646-a62f-d951fc7a6d40_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8f6c699d-7d12-4e05-842a-79c0a05be450_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_2e4c8541-fc41-4519-8424-079bdcf40f4a_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net (note 3)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_98a755d5-a5f9-4cd2-b229-e5bebb3841af_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_ea7e3fc7-33b4-4e04-b015-50708c6c0853_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_329f8618-ad1d-4c00-9961-1906eb01bd0e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_a52f8ef0-9a4b-431d-be43-a26db30f3bd0_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_68327c59-75f6-4c19-a018-9f1fc4379fa4_negatedLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_dcc3fc21-9d7c-47b9-a790-5ab3c063ab5c_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance for credit loss, current</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1aea2ee3-446c-4725-9b9e-883f0327ed3e_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued on exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_05d1aeaf-cfaf-4435-aeed-c11f50bd4bf4_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_155c9842-74da-435f-bbf4-f49b22e191e5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_20693d33-dd77-4ad1-b181-06ebb2d35db1_netLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_f4770526-6754-4c62-940e-2b2eb9671f36_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net (note 8)</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_6adcc85e-5da4-491e-8c4e-f39d4d8e2f75_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_53f3f1a5-c8ac-4df2-ba61-25d0fefd53d4_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_53ef18de-8ef1-4917-a9c6-8e98e83d7c48_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_503eb597-9c9b-4cc3-af13-3b5a3798dd6a_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_6f055415-5262-4feb-9060-0e7e901177a7_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable (note 6)</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_15b2f163-1c3e-4af9-bb96-cdc8a84020ef_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_37f2e73a-d76a-405e-abe3-f2e2daa0440c_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_f349c652-c777-4ab3-8a1a-76a2f505cf68_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_e7fe326c-4f22-43f4-ad0c-b6c5b7d44fa3_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ffc7aa92-bc25-48a4-9a52-676d88c58b93_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_490d418a-9117-47c4-9d31-aa69b038af0d_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_8ed8787f-71eb-4e77-b12c-d9e6218b3536_negatedLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty costs incurred for the period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_7fc9ebd8-741d-4a49-8f37-2c19384edea3_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_68e2bb70-9631-48fd-8baf-44717a62b332_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_78c46a8a-ad33-4225-84a8-b265d5bb2a5c_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_0b486609-be61-45bd-9592-b81995f68528_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on equity investments (note 5)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_4a3eecfc-eb83-4c60-9abb-7be0133037dc_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_e8fccfcb-2606-4a5d-8957-c1c9f7560e23_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components Of Property, Plant And Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_b14b2101-ecce-4835-9fd4-531e6d1e8906_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_b920fd7a-926d-4c52-882c-e151bcd892f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_a5a297b3-1761-463f-9f36-36aac7340b13_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_1800713f-2a27-4841-a352-2c411188465c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_SupplementalBalanceSheetInformationTextBlock_b6652350-3780-40b2-8402-0a4fa2a38b0c_terseLabel_en-US" xlink:label="lab_rmd_SupplementalBalanceSheetInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_rmd_SupplementalBalanceSheetInformationTextBlock_label_en-US" xlink:label="lab_rmd_SupplementalBalanceSheetInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Text Block]</link:label>
    <link:label id="lab_rmd_SupplementalBalanceSheetInformationTextBlock_documentation_en-US" xlink:label="lab_rmd_SupplementalBalanceSheetInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SupplementalBalanceSheetInformationTextBlock" xlink:href="rmd-20220930.xsd#rmd_SupplementalBalanceSheetInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_SupplementalBalanceSheetInformationTextBlock" xlink:to="lab_rmd_SupplementalBalanceSheetInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_eee7c13f-17eb-41b7-a1c4-ff6b202d8e77_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_f7c0970a-c441-47fd-abdf-2ddd1112a53c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Amounts Attributable to Parent, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:to="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_9e7ce4b4-de03-457d-8833-7548f63622ed_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_60b16ead-aa52-478a-8476-a633c7001140_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes, carrying amount</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_faad97c8-810c-4d09-85d7-d7130a0e13c2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend declared per share (dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_bb11a091-f7a3-4e09-bc9d-c3f72a076e34_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net (note 3)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_2ba1dcdc-c37c-483f-b94c-eade844a9f7a_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other intangibles, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_NonMarketableSecuritiesMember_0bd1fd9f-3e9f-4a06-a5cf-bee21955dd22_terseLabel_en-US" xlink:label="lab_rmd_NonMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-marketable securities</link:label>
    <link:label id="lab_rmd_NonMarketableSecuritiesMember_label_en-US" xlink:label="lab_rmd_NonMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Marketable Securities [Member]</link:label>
    <link:label id="lab_rmd_NonMarketableSecuritiesMember_documentation_en-US" xlink:label="lab_rmd_NonMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-marketable Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_NonMarketableSecuritiesMember" xlink:href="rmd-20220930.xsd#rmd_NonMarketableSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_NonMarketableSecuritiesMember" xlink:to="lab_rmd_NonMarketableSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bceeeff4-0bb5-4e43-9432-0ff15a52daa6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_5b331a1a-b2bc-4352-824a-b0435a2eddad_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_282b489d-76aa-41ca-8ec2-b76970297aa1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_a41961e2-48cf-40aa-ab58-7112c43b4a8d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_d835193a-a662-4c5d-8508-502ee5b28a06_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_f3a59d30-fc14-4638-a7a1-81c95c3f2294_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_SleepAndRespiratoryMember_13afa22c-5b3e-4095-b6eb-acc61d5ea180_terseLabel_en-US" xlink:label="lab_rmd_SleepAndRespiratoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Sleep and Respiratory Care</link:label>
    <link:label id="lab_rmd_SleepAndRespiratoryMember_label_en-US" xlink:label="lab_rmd_SleepAndRespiratoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sleep And Respiratory [Member]</link:label>
    <link:label id="lab_rmd_SleepAndRespiratoryMember_documentation_en-US" xlink:label="lab_rmd_SleepAndRespiratoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sleep And Respiratory [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SleepAndRespiratoryMember" xlink:href="rmd-20220930.xsd#rmd_SleepAndRespiratoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_SleepAndRespiratoryMember" xlink:to="lab_rmd_SleepAndRespiratoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_97149b2c-e07c-40c7-8a10-f7e1d124db03_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and Services [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_507c62aa-86cf-47b0-97f7-8ab73d8cac18_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_UnallocatedCorporateCosts_5fd971fb-1ee9-4513-8ef2-17b413cd7954_terseLabel_en-US" xlink:label="lab_rmd_UnallocatedCorporateCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate costs</link:label>
    <link:label id="lab_rmd_UnallocatedCorporateCosts_label_en-US" xlink:label="lab_rmd_UnallocatedCorporateCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated Corporate Costs</link:label>
    <link:label id="lab_rmd_UnallocatedCorporateCosts_documentation_en-US" xlink:label="lab_rmd_UnallocatedCorporateCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated corporate costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_UnallocatedCorporateCosts" xlink:href="rmd-20220930.xsd#rmd_UnallocatedCorporateCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_UnallocatedCorporateCosts" xlink:to="lab_rmd_UnallocatedCorporateCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_22b6aaaa-9ffc-42ea-bdb5-efa4c4ae6743_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_39647dc9-434b-4f46-903c-ad5f225891e7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_b6c1f5ce-fafe-48eb-b014-d0bdeedbebe5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt, net (note 8)</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_80dd01e7-43ea-4b63-9c9d-2b9d674cf9aa_totalLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt, net</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_57888ef6-aae3-41c3-9e2b-a7b4e4a59bb1_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_IncomeTaxExaminationRemittedFinalPayment_d1cb6e90-eaed-4b9e-88a7-ccea13380372_terseLabel_en-US" xlink:label="lab_rmd_IncomeTaxExaminationRemittedFinalPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax settlement, remitted final payment</link:label>
    <link:label id="lab_rmd_IncomeTaxExaminationRemittedFinalPayment_label_en-US" xlink:label="lab_rmd_IncomeTaxExaminationRemittedFinalPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Remitted Final Payment</link:label>
    <link:label id="lab_rmd_IncomeTaxExaminationRemittedFinalPayment_documentation_en-US" xlink:label="lab_rmd_IncomeTaxExaminationRemittedFinalPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Remitted Final Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_IncomeTaxExaminationRemittedFinalPayment" xlink:href="rmd-20220930.xsd#rmd_IncomeTaxExaminationRemittedFinalPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_IncomeTaxExaminationRemittedFinalPayment" xlink:to="lab_rmd_IncomeTaxExaminationRemittedFinalPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_4d45de5e-624d-4b65-b1a8-793bd707eaab_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_DebtToConsolidatedEbitdaRatio_7188cc05-911d-4547-95c6-a9f1fff49a0e_terseLabel_en-US" xlink:label="lab_rmd_DebtToConsolidatedEbitdaRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to consolidated EBITDA ratio</link:label>
    <link:label id="lab_rmd_DebtToConsolidatedEbitdaRatio_label_en-US" xlink:label="lab_rmd_DebtToConsolidatedEbitdaRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt To Consolidated EBITDA Ratio</link:label>
    <link:label id="lab_rmd_DebtToConsolidatedEbitdaRatio_documentation_en-US" xlink:label="lab_rmd_DebtToConsolidatedEbitdaRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt To Consolidated EBITDA Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DebtToConsolidatedEbitdaRatio" xlink:href="rmd-20220930.xsd#rmd_DebtToConsolidatedEbitdaRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_DebtToConsolidatedEbitdaRatio" xlink:to="lab_rmd_DebtToConsolidatedEbitdaRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d56782da-dc41-4386-aade-b6af157d808e_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Contract Balances</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_10918933-5033-406b-b9c2-9ecc010c66a9_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_7e4cd325-c676-449a-bd91-ed8c3ac5e767_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_ContractWithCustomerAssetAndLiabilityTable_246011bc-1948-4a7a-ae1c-f2606d33fe20_terseLabel_en-US" xlink:label="lab_rmd_ContractWithCustomerAssetAndLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Table]</link:label>
    <link:label id="lab_rmd_ContractWithCustomerAssetAndLiabilityTable_label_en-US" xlink:label="lab_rmd_ContractWithCustomerAssetAndLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Table]</link:label>
    <link:label id="lab_rmd_ContractWithCustomerAssetAndLiabilityTable_documentation_en-US" xlink:label="lab_rmd_ContractWithCustomerAssetAndLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ContractWithCustomerAssetAndLiabilityTable" xlink:href="rmd-20220930.xsd#rmd_ContractWithCustomerAssetAndLiabilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_ContractWithCustomerAssetAndLiabilityTable" xlink:to="lab_rmd_ContractWithCustomerAssetAndLiabilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_5246331c-5cd4-4672-86c2-8ffca865ed0f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_2511a2a2-4689-4133-bc3a-06a62e403103_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_30fc3bb7-4291-44ae-a12b-a67a59b2765b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_9db464fc-598e-451e-861a-95e291129d9c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_b5647efe-981f-4896-a3f7-2ea44680a4eb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease_8815b670-8a78-413d-9cdf-58175557b030_terseLabel_en-US" xlink:label="lab_rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill on acquisition</link:label>
    <link:label id="lab_rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease_label_en-US" xlink:label="lab_rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period, Increase (Decrease)</link:label>
    <link:label id="lab_rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease" xlink:href="rmd-20220930.xsd#rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease" xlink:to="lab_rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14f2351b-0ccf-4862-84d3-c3588723cbf4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_0848408c-703b-4cdc-b259-e430d025d158_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_d96ce9ff-c23c-4b1f-9536-b6a3b97bf9a4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent registration and acquisition costs</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetAbstract_cb80de1e-f27b-49b8-bc4f-b069c80420a5_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetAbstract" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_9a877fa0-0692-4494-a3fb-43f8a29940a8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) / provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_271d9abc-d86f-4f55-8d2e-6d0537b5d66d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_089f404d-71b3-4358-b42e-b711148e4e7b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_f4649644-53ac-4fac-9f6e-c7e2aa957ac5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_MarketableEquityInvestmentsFairValue_86169523-8ee7-46c3-8ef5-fc4e2fc49138_terseLabel_en-US" xlink:label="lab_rmd_MarketableEquityInvestmentsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_rmd_MarketableEquityInvestmentsFairValue_label_en-US" xlink:label="lab_rmd_MarketableEquityInvestmentsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Equity Investments, Fair Value</link:label>
    <link:label id="lab_rmd_MarketableEquityInvestmentsFairValue_documentation_en-US" xlink:label="lab_rmd_MarketableEquityInvestmentsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Equity Investments, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MarketableEquityInvestmentsFairValue" xlink:href="rmd-20220930.xsd#rmd_MarketableEquityInvestmentsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_MarketableEquityInvestmentsFairValue" xlink:to="lab_rmd_MarketableEquityInvestmentsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_a7c7ad7d-eea7-4a95-b3b1-57d8d50cded2_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories (note 3)</link:label>
    <link:label id="lab_us-gaap_InventoryNet_1c8f616c-3372-49cd-87d4-315acbb400e2_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_308e02cf-246d-4f92-a09a-1e7c314ef520_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities_639d20a0-2759-45fb-aba1-f79830861e15_terseLabel_en-US" xlink:label="lab_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Observable price adjustments on non-marketable equity securities</link:label>
    <link:label id="lab_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities_label_en-US" xlink:label="lab_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Observable price adjustments on non-marketable equity securities</link:label>
    <link:label id="lab_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities_documentation_en-US" xlink:label="lab_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Observable price adjustments on non-marketable equity securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities" xlink:href="rmd-20220930.xsd#rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities" xlink:to="lab_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d2d188cb-ed77-4c80-8e1e-96115853bc22_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_ReceivablesSoldWithLimitedRecourse_a5ae25ad-8282-4c4f-8e2d-c420b0d89d90_terseLabel_en-US" xlink:label="lab_rmd_ReceivablesSoldWithLimitedRecourse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables sold with limited recourse</link:label>
    <link:label id="lab_rmd_ReceivablesSoldWithLimitedRecourse_label_en-US" xlink:label="lab_rmd_ReceivablesSoldWithLimitedRecourse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables Sold With Limited Recourse</link:label>
    <link:label id="lab_rmd_ReceivablesSoldWithLimitedRecourse_documentation_en-US" xlink:label="lab_rmd_ReceivablesSoldWithLimitedRecourse" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables Sold With Limited Recourse</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ReceivablesSoldWithLimitedRecourse" xlink:href="rmd-20220930.xsd#rmd_ReceivablesSoldWithLimitedRecourse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_ReceivablesSoldWithLimitedRecourse" xlink:to="lab_rmd_ReceivablesSoldWithLimitedRecourse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_be9d6902-f083-41d0-8a10-9fa9ec594ee4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8c4a0802-e1e1-41f3-a3e1-d437fafe4660_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_9d7e0576-24e6-4c49-853f-0005fcd8d7cd_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_754c1f67-2d45-4efa-9ba0-3c02103be7e5_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets (note 3)</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2295779c-9558-4a0e-839b-090f47b52d7e_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_16eb56e5-79d9-41af-bbd7-69fe8d4b08a6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_489a0c28-f518-448c-aad5-0e5d675dfed0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_11200ab8-ab2d-45f3-b6b0-57a7ab321e2c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_AdditionalEquityInvestments_788e4e5c-7b93-4b19-8cfc-92dacc53c056_terseLabel_en-US" xlink:label="lab_rmd_AdditionalEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to investments</link:label>
    <link:label id="lab_rmd_AdditionalEquityInvestments_label_en-US" xlink:label="lab_rmd_AdditionalEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Equity Investments</link:label>
    <link:label id="lab_rmd_AdditionalEquityInvestments_documentation_en-US" xlink:label="lab_rmd_AdditionalEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_AdditionalEquityInvestments" xlink:href="rmd-20220930.xsd#rmd_AdditionalEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_AdditionalEquityInvestments" xlink:to="lab_rmd_AdditionalEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_c387e684-2c21-4012-9dc4-faa10a05f924_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember_00e21220-ea9a-4925-bd89-0b54f781ad31_terseLabel_en-US" xlink:label="lab_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Credit Agreement</link:label>
    <link:label id="lab_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember_label_en-US" xlink:label="lab_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan Credit Agreement [Member]</link:label>
    <link:label id="lab_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember_documentation_en-US" xlink:label="lab_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember" xlink:href="rmd-20220930.xsd#rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember" xlink:to="lab_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_7fc8d860-bccc-44ac-8dea-9ae64f86b8cc_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_48d9e82e-0833-42bb-a865-66934438678e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_840c4387-3cc1-4408-8d5e-1ccb039d40f5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic shares outstanding (000's) (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_13855d4f-48f1-42f1-893f-99a776678a0a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average common shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_ed4e1dc1-2d4b-495a-88c3-bdc6033afdc8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_df8bc144-73eb-4d93-ac2f-65caf313e631_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Payments) / proceeds on maturity of foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Derivative Instrument, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_0899bd96-2850-475c-98be-ba48fbdf48fa_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AustralianTaxationOfficeMember_d32eae7e-412c-449a-8181-e2e4eba3be5f_terseLabel_en-US" xlink:label="lab_us-gaap_AustralianTaxationOfficeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian Taxation Office</link:label>
    <link:label id="lab_us-gaap_AustralianTaxationOfficeMember_label_en-US" xlink:label="lab_us-gaap_AustralianTaxationOfficeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australian Taxation Office [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AustralianTaxationOfficeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AustralianTaxationOfficeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AustralianTaxationOfficeMember" xlink:to="lab_us-gaap_AustralianTaxationOfficeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_DeferredRevenueCurrentLiabilitiesMember_3db91744-27cd-4b02-860c-92bc7f29f5e8_terseLabel_en-US" xlink:label="lab_rmd_DeferredRevenueCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue (current liabilities)</link:label>
    <link:label id="lab_rmd_DeferredRevenueCurrentLiabilitiesMember_label_en-US" xlink:label="lab_rmd_DeferredRevenueCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue Current Liabilities [Member]</link:label>
    <link:label id="lab_rmd_DeferredRevenueCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_rmd_DeferredRevenueCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DeferredRevenueCurrentLiabilitiesMember" xlink:href="rmd-20220930.xsd#rmd_DeferredRevenueCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_DeferredRevenueCurrentLiabilitiesMember" xlink:to="lab_rmd_DeferredRevenueCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_321ffd50-1fcf-4c67-ba93-122797e85e00_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_56bc83b8-54c3-41d1-ab6d-21893ca76c49_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (note 10)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_621924a7-972a-4c53-91ef-c8f0f8ac0df5_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ed0be256-969e-4bfe-b036-1ccaf64d77ec_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_cab5eaf3-9e51-43f5-9173-53c65ea9d316_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_ef78c095-33bb-477f-9956-2f22d8c6c1ec_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_65928ba8-3bfd-4167-bdb2-8d8e021c6169_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciling items</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_8bbaeee5-5c90-4d94-b39f-a0f06d7a98de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_f569a872-e477-46d1-a9f4-dcf29d4d75d5_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_22d4f5c9-2ab3-4682-9e00-57dffae5a7e1_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_65cb2fe3-55e8-413c-a795-f9258c140236_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue by segment</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_GlobalMember_ca869714-9929-4c4c-9f18-37f635b00a69_terseLabel_en-US" xlink:label="lab_rmd_GlobalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global revenue</link:label>
    <link:label id="lab_rmd_GlobalMember_label_en-US" xlink:label="lab_rmd_GlobalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global [Member]</link:label>
    <link:label id="lab_rmd_GlobalMember_documentation_en-US" xlink:label="lab_rmd_GlobalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_GlobalMember" xlink:href="rmd-20220930.xsd#rmd_GlobalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_GlobalMember" xlink:to="lab_rmd_GlobalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_eb513e56-b034-4151-9483-3df6662b313b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_DevelopedOrCoreProductTechnologyMember_06fdf172-dbf6-4e2d-81e3-59dde76b0864_terseLabel_en-US" xlink:label="lab_rmd_DevelopedOrCoreProductTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed/core product technology</link:label>
    <link:label id="lab_rmd_DevelopedOrCoreProductTechnologyMember_label_en-US" xlink:label="lab_rmd_DevelopedOrCoreProductTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Or Core Product Technology [Member]</link:label>
    <link:label id="lab_rmd_DevelopedOrCoreProductTechnologyMember_documentation_en-US" xlink:label="lab_rmd_DevelopedOrCoreProductTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed/ Core Product Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DevelopedOrCoreProductTechnologyMember" xlink:href="rmd-20220930.xsd#rmd_DevelopedOrCoreProductTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_DevelopedOrCoreProductTechnologyMember" xlink:to="lab_rmd_DevelopedOrCoreProductTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_7d97cc8c-f701-420c-b90c-68c8aee24ace_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_87d2c550-d477-4bad-aea9-800d45997103_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_ee6ee787-c8eb-4ec0-8163-d5c5c52af048_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a3e2e49a-b95e-4860-b904-508baa912a19_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued on vesting of restricted stock units, net of shares withheld for tax</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_5caf4c68-9551-4625-b957-1493fece1986_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_82214560-308b-4343-accb-1e618747cebb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in progress</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_3436d70c-6674-429a-9cfe-9ff9b65b3e23_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_dac2d0cc-a085-4d6e-ae8d-97f843ae3bcd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_7bbedaf7-5e30-4343-aeb9-8c769fa86a5a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ad92959b-068e-491f-95ee-441de5a2e92d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_a4182707-c4e1-4eac-b1e4-156a088a16a9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value per share (dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_c40ff03a-d88b-48cf-a95e-f5c51248679f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligation_4d2ef0d5-97fa-47dd-af27-c18c3bf0ca3a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual obligation</link:label>
    <link:label id="lab_us-gaap_ContractualObligation_label_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligation" xlink:to="lab_us-gaap_ContractualObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2a101007-9230-4964-8680-f7ee19535246_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_ShortTermDebtGross_c4aac92d-d5e6-42d9-ba7d-0762b1c8e946_terseLabel_en-US" xlink:label="lab_rmd_ShortTermDebtGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_rmd_ShortTermDebtGross_label_en-US" xlink:label="lab_rmd_ShortTermDebtGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Gross</link:label>
    <link:label id="lab_rmd_ShortTermDebtGross_documentation_en-US" xlink:label="lab_rmd_ShortTermDebtGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ShortTermDebtGross" xlink:href="rmd-20220930.xsd#rmd_ShortTermDebtGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_ShortTermDebtGross" xlink:to="lab_rmd_ShortTermDebtGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_03d8af69-e11f-45b7-a96f-4ffdd1092a9c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_1693f40a-4e92-4292-8467-e5a5418ece91_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest (expense) income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_e2ce3afe-da9b-4737-831c-2ace09af7955_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent provision</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_60ab2a51-90fc-4712-8419-2cd0d7518c35_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_58dd1736-c306-4a67-80d7-b469df57693a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d82ca32f-7832-442b-ae54-12feb69cf796_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_34abadd5-ac53-4613-8ce8-0d94312d8878_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_2e94057b-6e5e-46ea-9759-f929c728bcc6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_3af2edb5-e7ae-4e0d-8055-537426ae3722_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, common, beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_af612d90-66d3-4794-b845-3f918000ebaa_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, common, ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_9ce37508-ddd1-4ae4-9927-f60f2bf47dd7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_ccdaad37-1f5f-44c9-abcd-086bd566529d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock_05b1ce2f-cb24-475c-8788-eb3ac1123c1e_terseLabel_en-US" xlink:label="lab_rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Changes In Equity Investments</link:label>
    <link:label id="lab_rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock_label_en-US" xlink:label="lab_rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Changes In Equity Investments [Table Text Block]</link:label>
    <link:label id="lab_rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Changes In Equity Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock" xlink:href="rmd-20220930.xsd#rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock" xlink:to="lab_rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_ad47639b-d776-4dab-987b-30fcbd01502f_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_e94cc4dc-d5fa-44b5-b91d-f3667c816309_negatedLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, non-current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_02c28447-9dd8-4793-9c08-3341d9b5e379_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_2b77084a-dd4f-4871-b286-2cb480b7cbf9_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision For Warranty</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_UncommittedOptionToIncreaseCreditFacility_8ba0de4c-e3be-4e0d-a95d-c854d5f71c7e_terseLabel_en-US" xlink:label="lab_rmd_UncommittedOptionToIncreaseCreditFacility" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted option to increase credit facility</link:label>
    <link:label id="lab_rmd_UncommittedOptionToIncreaseCreditFacility_label_en-US" xlink:label="lab_rmd_UncommittedOptionToIncreaseCreditFacility" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted option to increase credit facility</link:label>
    <link:label id="lab_rmd_UncommittedOptionToIncreaseCreditFacility_documentation_en-US" xlink:label="lab_rmd_UncommittedOptionToIncreaseCreditFacility" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted option to increase credit facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_UncommittedOptionToIncreaseCreditFacility" xlink:href="rmd-20220930.xsd#rmd_UncommittedOptionToIncreaseCreditFacility"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_UncommittedOptionToIncreaseCreditFacility" xlink:to="lab_rmd_UncommittedOptionToIncreaseCreditFacility" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember_ed0c1fd8-bbae-46ca-9127-4f155493a47e_terseLabel_en-US" xlink:label="lab_rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreement, Term Credit Agreement, And Senior Notes</link:label>
    <link:label id="lab_rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember_label_en-US" xlink:label="lab_rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreement Term Credit Agreement And Senior Notes [Member]</link:label>
    <link:label id="lab_rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember_documentation_en-US" xlink:label="lab_rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreement, Term Credit Agreement, And Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember" xlink:href="rmd-20220930.xsd#rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember" xlink:to="lab_rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_dce5911f-b41d-4993-acc4-362667c31ccb_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_DeferredPaymentObligationsForAcquisitions_c649b7de-6fd6-46c6-bd76-74eba013d458_negatedTerseLabel_en-US" xlink:label="lab_rmd_DeferredPaymentObligationsForAcquisitions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred payments</link:label>
    <link:label id="lab_rmd_DeferredPaymentObligationsForAcquisitions_label_en-US" xlink:label="lab_rmd_DeferredPaymentObligationsForAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Payment Obligations For Acquisitions</link:label>
    <link:label id="lab_rmd_DeferredPaymentObligationsForAcquisitions_documentation_en-US" xlink:label="lab_rmd_DeferredPaymentObligationsForAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Payment Obligations For Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DeferredPaymentObligationsForAcquisitions" xlink:href="rmd-20220930.xsd#rmd_DeferredPaymentObligationsForAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_DeferredPaymentObligationsForAcquisitions" xlink:to="lab_rmd_DeferredPaymentObligationsForAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsMember_6201062d-4eb7-4a34-a77d-1091a41790e7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsMember" xlink:to="lab_us-gaap_EquityMethodInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_DevicesMember_d661bb16-3a1a-438b-80ed-6407c3218b46_terseLabel_en-US" xlink:label="lab_rmd_DevicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Devices</link:label>
    <link:label id="lab_rmd_DevicesMember_label_en-US" xlink:label="lab_rmd_DevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Devices [Member]</link:label>
    <link:label id="lab_rmd_DevicesMember_documentation_en-US" xlink:label="lab_rmd_DevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Devices [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DevicesMember" xlink:href="rmd-20220930.xsd#rmd_DevicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_DevicesMember" xlink:to="lab_rmd_DevicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_c2102c04-9763-425f-80ad-846e9f84aac4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments (note 5)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_SoftwareAsServiceMember_91628477-8b49-43bf-9239-9dd482bd2052_terseLabel_en-US" xlink:label="lab_rmd_SoftwareAsServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software as a Service</link:label>
    <link:label id="lab_rmd_SoftwareAsServiceMember_label_en-US" xlink:label="lab_rmd_SoftwareAsServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software As Service [Member]</link:label>
    <link:label id="lab_rmd_SoftwareAsServiceMember_documentation_en-US" xlink:label="lab_rmd_SoftwareAsServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software As A Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SoftwareAsServiceMember" xlink:href="rmd-20220930.xsd#rmd_SoftwareAsServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_SoftwareAsServiceMember" xlink:to="lab_rmd_SoftwareAsServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_75cce433-2320-4fb1-a310-28c21386f616_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_TermOfContractUnderRevenueRecognition_aa472b13-c591-454c-a7db-23ada43cae22_verboseLabel_en-US" xlink:label="lab_rmd_TermOfContractUnderRevenueRecognition" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue recognized, term</link:label>
    <link:label id="lab_rmd_TermOfContractUnderRevenueRecognition_label_en-US" xlink:label="lab_rmd_TermOfContractUnderRevenueRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Of Contract Under Revenue Recognition</link:label>
    <link:label id="lab_rmd_TermOfContractUnderRevenueRecognition_documentation_en-US" xlink:label="lab_rmd_TermOfContractUnderRevenueRecognition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Of Contract Under Revenue Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_TermOfContractUnderRevenueRecognition" xlink:href="rmd-20220930.xsd#rmd_TermOfContractUnderRevenueRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_TermOfContractUnderRevenueRecognition" xlink:to="lab_rmd_TermOfContractUnderRevenueRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_53956b89-ecd3-49a1-8772-7d23776df8a8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_581e97d1-939b-4e2f-8f83-956201fe57b8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_6a1e74ef-d1d7-452e-93df-6db825026131_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share (dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_9cb8e469-3407-4dfa-9c66-864c4e86ca98_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_6762703b-fef6-4860-9bc5-0c1716b8eba6_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_53b04052-603a-4c95-893d-e24616ea7d86_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_e3e76f0c-22c9-44ab-a1f9-584f2c4d7f5c_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1830876b-4029-4f48-a91a-ed354c0e0d69_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_MarketableSecuritiesMember_6dc05156-e15f-4b03-8a9c-afa2783eb9e2_terseLabel_en-US" xlink:label="lab_rmd_MarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_rmd_MarketableSecuritiesMember_label_en-US" xlink:label="lab_rmd_MarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Member]</link:label>
    <link:label id="lab_rmd_MarketableSecuritiesMember_documentation_en-US" xlink:label="lab_rmd_MarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MarketableSecuritiesMember" xlink:href="rmd-20220930.xsd#rmd_MarketableSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_MarketableSecuritiesMember" xlink:to="lab_rmd_MarketableSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_SaasMember_0c349a9e-aef4-4c55-97d7-3559a1048d38_terseLabel_en-US" xlink:label="lab_rmd_SaasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SaaS</link:label>
    <link:label id="lab_rmd_SaasMember_label_en-US" xlink:label="lab_rmd_SaasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Saas [Member]</link:label>
    <link:label id="lab_rmd_SaasMember_documentation_en-US" xlink:label="lab_rmd_SaasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Saas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SaasMember" xlink:href="rmd-20220930.xsd#rmd_SaasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_SaasMember" xlink:to="lab_rmd_SaasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_84c890f5-1cc7-428a-9b62-4586f1e17b02_periodStartLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_bb6a177f-a252-4745-9c71-b3db9eb28755_periodEndLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual" xlink:to="lab_us-gaap_ProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_c15bbe4f-84b5-4e58-aedf-fd0a6a2983dc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other prepaid expenses and current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_568fc762-617b-48a1-9ee2-2636fb02e905_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses, income taxes payable and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_90c1eeaa-d507-496d-a97a-1741703f243f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_b722f87f-c79f-4ffe-9369-030a77d6e962_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_2d7a1f68-565f-45da-821a-432672d3e1ac_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term income taxes payable (note 6)</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_31da8717-2d1f-4610-8947-5e03fe343395_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_7ea0836e-21e9-4d0f-b2d6-dafe330ea425_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_fe2cf8ce-4518-4309-b69b-1939ae001917_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_5f5dc12b-db11-46ad-8024-58dde33b6928_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_fd37fbcd-990b-4cce-85d3-2f1d33a910a5_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Changes In Carrying Amount Of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_085fa555-583d-43ee-89cc-6c3b81c1c14b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8f7c8792-7c3f-448e-b276-7587153866b6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share (dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_ddca1aa2-abff-4457-bdb9-d3ecbead62fa_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fees percentage rate on unused portion of credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_8ffad741-99e2-4e17-b222-93e90c75f2e5_totalLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_26026307-db0d-4c05-821c-404784c21d54_terseLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding debt</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-Term and Short-Term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_1f268ee9-fdfa-4eea-827f-42d786c45069_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (loss), net:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_435e02ff-6d06-4225-8f20-4c4b6307c96b_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, net unrealized gain (loss)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_6d3c912c-146e-4950-9c17-5cc70a561ffa_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Costs</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_4720a274-f547-482a-a6d0-dc055e706e25_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_d9502d66-2f3b-439e-a8b2-6cde2a560e5f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_EquityInvestments_c2983a19-a486-4e59-be86-7ef8cd02008a_periodStartLabel_en-US" xlink:label="lab_rmd_EquityInvestments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period</link:label>
    <link:label id="lab_rmd_EquityInvestments_26ca5299-5961-4254-b6ff-d78cfef6ae1d_periodEndLabel_en-US" xlink:label="lab_rmd_EquityInvestments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value at the end of the period</link:label>
    <link:label id="lab_rmd_EquityInvestments_label_en-US" xlink:label="lab_rmd_EquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments</link:label>
    <link:label id="lab_rmd_EquityInvestments_documentation_en-US" xlink:label="lab_rmd_EquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_EquityInvestments" xlink:href="rmd-20220930.xsd#rmd_EquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_EquityInvestments" xlink:to="lab_rmd_EquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_UsCanadaAndLatinAmericaMember_d9cf2a65-9677-4ae8-95a1-0a99d657d88b_terseLabel_en-US" xlink:label="lab_rmd_UsCanadaAndLatinAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S., Canada and Latin America</link:label>
    <link:label id="lab_rmd_UsCanadaAndLatinAmericaMember_label_en-US" xlink:label="lab_rmd_UsCanadaAndLatinAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Us Canada And Latin America [Member]</link:label>
    <link:label id="lab_rmd_UsCanadaAndLatinAmericaMember_documentation_en-US" xlink:label="lab_rmd_UsCanadaAndLatinAmericaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Canada And Latin America [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_UsCanadaAndLatinAmericaMember" xlink:href="rmd-20220930.xsd#rmd_UsCanadaAndLatinAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_UsCanadaAndLatinAmericaMember" xlink:to="lab_rmd_UsCanadaAndLatinAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_a90cf8cd-5daa-4a24-816b-a076b7abd3b9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_95ff5b9f-8b35-49e5-b252-ce63dbf04ccb_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_55e79eb7-7b22-4457-b388-2c5f6d1866fd_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_cd4f44c0-e1ff-4a67-97aa-63dfc81b92dd_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_3735fa2d-bc9c-4b47-82f5-3d5bc8c9be75_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_5c678bd8-7842-43d5-b899-c02114aecfe2_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense (income), net</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_6862b4f0-73c9-40f5-b1f5-8d704cb25325_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7945b60b-7919-41f8-9356-ba075a5147ba_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_1f885e97-3004-44aa-8cd2-698ef4ab43b3_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_EquityInvestmentsTotalByMeasurementCategory_39434b45-3a61-4576-9b46-91c25b6d013a_totalLabel_en-US" xlink:label="lab_rmd_EquityInvestmentsTotalByMeasurementCategory" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_rmd_EquityInvestmentsTotalByMeasurementCategory_label_en-US" xlink:label="lab_rmd_EquityInvestmentsTotalByMeasurementCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments, Total by Measurement Category</link:label>
    <link:label id="lab_rmd_EquityInvestmentsTotalByMeasurementCategory_documentation_en-US" xlink:label="lab_rmd_EquityInvestmentsTotalByMeasurementCategory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments, Total by Measurement Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_EquityInvestmentsTotalByMeasurementCategory" xlink:href="rmd-20220930.xsd#rmd_EquityInvestmentsTotalByMeasurementCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_EquityInvestmentsTotalByMeasurementCategory" xlink:to="lab_rmd_EquityInvestmentsTotalByMeasurementCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_12879a35-b998-4eb2-91fc-8192116f5fda_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fd8d059f-2209-4222-993e-660b77faf543_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_c1ee27bf-f252-4320-802c-2a505d201411_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on marketable equity securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_PrepaidInventory_7f456c2b-3b54-4a18-a533-8188794ec66b_terseLabel_en-US" xlink:label="lab_rmd_PrepaidInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid inventories</link:label>
    <link:label id="lab_rmd_PrepaidInventory_label_en-US" xlink:label="lab_rmd_PrepaidInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Inventory</link:label>
    <link:label id="lab_rmd_PrepaidInventory_documentation_en-US" xlink:label="lab_rmd_PrepaidInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_PrepaidInventory" xlink:href="rmd-20220930.xsd#rmd_PrepaidInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_PrepaidInventory" xlink:to="lab_rmd_PrepaidInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_bd2d464f-1373-40a8-ac0c-15c768f4dc64_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f9f00f5e-b6d7-45dc-bfe1-02d47b5b9c8a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_a6d68ea6-1d83-4f27-9d23-37e5ca1f0405_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_95483887-c66a-471a-9a18-c13eb57b384a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_4461b270-6078-4ff2-a5f4-63b074b57e36_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_17a63fce-3ee9-4484-9fbb-6ce6fad3853f_negatedLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_251661cd-7527-48a1-aa8b-e0b5b3a5771d_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_LeaseRevenuePolicyTextBlock_558ea105-0755-4b46-8d92-529f44b0a44f_terseLabel_en-US" xlink:label="lab_rmd_LeaseRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue</link:label>
    <link:label id="lab_rmd_LeaseRevenuePolicyTextBlock_label_en-US" xlink:label="lab_rmd_LeaseRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue [Policy Text Block]</link:label>
    <link:label id="lab_rmd_LeaseRevenuePolicyTextBlock_documentation_en-US" xlink:label="lab_rmd_LeaseRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_LeaseRevenuePolicyTextBlock" xlink:href="rmd-20220930.xsd#rmd_LeaseRevenuePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_LeaseRevenuePolicyTextBlock" xlink:to="lab_rmd_LeaseRevenuePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_55d545f0-ab0a-43c7-b111-00d66421db94_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_3b286d47-2b2e-437d-8514-328af1942e82_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_f62401a7-bcf5-4898-a09e-6e7a68f4327c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_7a27502e-3f28-4dab-8983-d8b60168eb52_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Net Revenue Disaggregated By Product And Region</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f867bc55-053a-4ee0-8db7-5110ee4d6089_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on outstanding principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability_af36870c-f1bb-40aa-a546-4cbf329377f2_negatedLabel_en-US" xlink:label="lab_rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent consideration</link:label>
    <link:label id="lab_rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability_label_en-US" xlink:label="lab_rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration, Recognized Liability</link:label>
    <link:label id="lab_rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability_documentation_en-US" xlink:label="lab_rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration, Recognized Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability" xlink:href="rmd-20220930.xsd#rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability" xlink:to="lab_rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_5b6708e5-0cef-490c-ae0c-c9ab3d9b84cf_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled revenue, current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_a5ab9e41-331c-4d73-be69-921c1f44e5b7_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_SeniorNotesTwoMember_c3b43401-c4f5-4e16-96cb-b100b42a7e39_terseLabel_en-US" xlink:label="lab_rmd_SeniorNotesTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.45% Senior Notes Due July 10, 2029</link:label>
    <link:label id="lab_rmd_SeniorNotesTwoMember_label_en-US" xlink:label="lab_rmd_SeniorNotesTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two [Member]</link:label>
    <link:label id="lab_rmd_SeniorNotesTwoMember_documentation_en-US" xlink:label="lab_rmd_SeniorNotesTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SeniorNotesTwoMember" xlink:href="rmd-20220930.xsd#rmd_SeniorNotesTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_SeniorNotesTwoMember" xlink:to="lab_rmd_SeniorNotesTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_7ee40e00-7524-44d5-9f78-6d7725c605ed_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_abb5816a-47d6-4b3c-944b-efccd1b974f6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantiesDisclosuresAbstract_4c74e273-a941-4900-ae1c-59b978d4fa6a_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ProductWarrantiesDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:to="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_DeferredRevenueNonCurrentLiabilitiesMember_87ccd3b7-c0f6-4d84-b151-f10d31ba8615_terseLabel_en-US" xlink:label="lab_rmd_DeferredRevenueNonCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue (non-current liabilities)</link:label>
    <link:label id="lab_rmd_DeferredRevenueNonCurrentLiabilitiesMember_label_en-US" xlink:label="lab_rmd_DeferredRevenueNonCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue Non Current Liabilities [Member]</link:label>
    <link:label id="lab_rmd_DeferredRevenueNonCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_rmd_DeferredRevenueNonCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue Non Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DeferredRevenueNonCurrentLiabilitiesMember" xlink:href="rmd-20220930.xsd#rmd_DeferredRevenueNonCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_DeferredRevenueNonCurrentLiabilitiesMember" xlink:to="lab_rmd_DeferredRevenueNonCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_908cd2d7-e746-4430-8352-6e2e6435e45a_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6e20eb95-9bcb-4248-9fd9-f8a83ab55a7c_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_dae8828f-12b9-45b7-81ff-ffa6503902f1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_8b55e3b6-82a5-468f-bc40-b0ced202f101_netLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and restricted stock units (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_4a4bde91-75d8-416f-832c-e4c5725d5dac_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled revenue, non-current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_88018d9d-fb8c-4a09-8ac2-ca705b7f1762_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_8cef4ca8-f0b4-4809-bc3b-d91ccfb39653_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances of $23,867 and $23,259 at September&#160;30, 2022 and June&#160;30, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_c205029c-c645-4f7b-8217-a85fdc142f5c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_82629950-10f4-49e4-8a34-899755680719_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_82bdebd5-e180-4c39-ad4a-2d62a4b282b6_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_479dff01-d343-4bb7-ab50-bd403d5a43a8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5f69d404-66dd-46f2-8bb3-43d23fa23f49_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_AccountsReceivableNetMember_2e4b6bc1-a076-4de4-9b91-f8370a74c0b6_terseLabel_en-US" xlink:label="lab_rmd_AccountsReceivableNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_rmd_AccountsReceivableNetMember_label_en-US" xlink:label="lab_rmd_AccountsReceivableNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Net [Member]</link:label>
    <link:label id="lab_rmd_AccountsReceivableNetMember_documentation_en-US" xlink:label="lab_rmd_AccountsReceivableNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_AccountsReceivableNetMember" xlink:href="rmd-20220930.xsd#rmd_AccountsReceivableNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_AccountsReceivableNetMember" xlink:to="lab_rmd_AccountsReceivableNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember_1da82047-679c-42ba-8000-07dd9180254b_terseLabel_en-US" xlink:label="lab_rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid taxes and other non-current assets</link:label>
    <link:label id="lab_rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember_label_en-US" xlink:label="lab_rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes And Other Non Current Assets [Member]</link:label>
    <link:label id="lab_rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember_documentation_en-US" xlink:label="lab_rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes And Other Non Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember" xlink:href="rmd-20220930.xsd#rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember" xlink:to="lab_rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_TermLoanCreditAgreementMember_2ee0757a-ceb4-4f68-908e-5d7d068d2475_terseLabel_en-US" xlink:label="lab_rmd_TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Credit Agreement</link:label>
    <link:label id="lab_rmd_TermLoanCreditAgreementMember_label_en-US" xlink:label="lab_rmd_TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Credit Agreement [Member]</link:label>
    <link:label id="lab_rmd_TermLoanCreditAgreementMember_documentation_en-US" xlink:label="lab_rmd_TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_TermLoanCreditAgreementMember" xlink:href="rmd-20220930.xsd#rmd_TermLoanCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_TermLoanCreditAgreementMember" xlink:to="lab_rmd_TermLoanCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_0f9029dc-85f6-4689-a5e8-74f8ff08caef_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_6c5d2d02-f509-4cde-8e18-d7188a8a08b8_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_3a5b8f36-d76a-4548-9f4d-670dd72f82c2_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales (exclusive of amortization shown separately below)</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_64f1cdc0-d7a5-42d8-a903-ae01e93b2b55_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_2b8af301-577c-46d5-abd3-b625b853832c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ada9985e-7df8-41e2-838b-86b404515397_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_313906d1-ac97-4e61-bae2-f8c9c387e781_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_74f7f6df-c8c5-4df7-a062-60b04ad14a51_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred borrowing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_d53d19aa-67cb-428f-8046-0319d1c56cb3_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_9246ff41-6e6c-494e-a612-c102037776ff_negatedNetLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on equity investments (note 5)</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_813d4528-14de-4285-84ab-a2d665b68498_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on equity investments</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_743d57c3-e443-4cad-9944-85f33330325c_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (loss), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_38e2d800-46cf-422d-bf20-494a046ea5f4_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_CombinedEuropeAsiaAndOtherMarketsMember_d20e39fd-96ab-4fd4-b02f-11d3c2bbb725_terseLabel_en-US" xlink:label="lab_rmd_CombinedEuropeAsiaAndOtherMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined Europe, Asia and other markets</link:label>
    <link:label id="lab_rmd_CombinedEuropeAsiaAndOtherMarketsMember_label_en-US" xlink:label="lab_rmd_CombinedEuropeAsiaAndOtherMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined Europe Asia And Other Markets [Member]</link:label>
    <link:label id="lab_rmd_CombinedEuropeAsiaAndOtherMarketsMember_documentation_en-US" xlink:label="lab_rmd_CombinedEuropeAsiaAndOtherMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined Europe Asia And Other Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_CombinedEuropeAsiaAndOtherMarketsMember" xlink:href="rmd-20220930.xsd#rmd_CombinedEuropeAsiaAndOtherMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_CombinedEuropeAsiaAndOtherMarketsMember" xlink:to="lab_rmd_CombinedEuropeAsiaAndOtherMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_SupplementalBalanceSheetInformationAbstract_6e383ce8-23d3-4054-acb6-736d0d98129b_terseLabel_en-US" xlink:label="lab_rmd_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Abstract]</link:label>
    <link:label id="lab_rmd_SupplementalBalanceSheetInformationAbstract_label_en-US" xlink:label="lab_rmd_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Abstract]</link:label>
    <link:label id="lab_rmd_SupplementalBalanceSheetInformationAbstract_documentation_en-US" xlink:label="lab_rmd_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SupplementalBalanceSheetInformationAbstract" xlink:href="rmd-20220930.xsd#rmd_SupplementalBalanceSheetInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract" xlink:to="lab_rmd_SupplementalBalanceSheetInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_3063facd-7242-4350-9535-0bc337eb200d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_f94a3653-fe6a-41a8-b878-59ed5854708b_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangibles, gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_ba8a112c-0fa5-4894-a789-3948d8c682b5_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_b7c4ed7a-607e-48fc-9008-da1c75a3ee25_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9da4684a-651f-4a8d-97da-5409cef87b53_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_9a8e16a4-4d1a-4956-a25f-c14a75819202_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5f15d053-5f54-444c-8ac6-083bd5401075_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated &#8206;Other &#8206;Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod_7edd16d4-c764-435b-9e80-ce7e7609bd8b_terseLabel_en-US" xlink:label="lab_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EBITDA multiple of trailing twelve-month measurement period</link:label>
    <link:label id="lab_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod_label_en-US" xlink:label="lab_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, EBITDA Multiple of Trailing Twelve-Month Measurement Period</link:label>
    <link:label id="lab_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod_documentation_en-US" xlink:label="lab_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, EBITDA Multiple of Trailing Twelve-Month Measurement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod" xlink:href="rmd-20220930.xsd#rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod" xlink:to="lab_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_c98abc4b-e194-4ded-8261-5315c94d4aff_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_18f1d9dc-d39a-419b-998f-8f8312ee7051_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation costs</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_4d19b865-7793-46f3-919a-57103ba5810e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6df50b3f-c33b-4eb3-8650-6b2cd4b3db44_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_16be91ce-9965-40ac-b7dd-4c1d6695fbb2_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss attributable to equity method investments (note 5)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_2255db4e-df72-45ff-9bff-d00c4a51bfa7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss attributable to equity method investments (note 5)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_085d9afe-7ebd-479d-9deb-b3e0ec98f9fb_negatedNetLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss attributable to equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_442b4148-91cf-4422-973d-f136c6d5eecd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss attributable to equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_ed117ea7-a3da-408b-a9f7-3c3b2e35000b_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_db79c6a6-b82f-42b9-9297-35533d560986_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_DebtAndEquityInvestmentsRollForward_30eaf9e3-5789-4513-ac66-a594c250794b_terseLabel_en-US" xlink:label="lab_rmd_DebtAndEquityInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Investments [Roll Forward]</link:label>
    <link:label id="lab_rmd_DebtAndEquityInvestmentsRollForward_label_en-US" xlink:label="lab_rmd_DebtAndEquityInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Investments [Roll Forward]</link:label>
    <link:label id="lab_rmd_DebtAndEquityInvestmentsRollForward_documentation_en-US" xlink:label="lab_rmd_DebtAndEquityInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DebtAndEquityInvestmentsRollForward" xlink:href="rmd-20220930.xsd#rmd_DebtAndEquityInvestmentsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward" xlink:to="lab_rmd_DebtAndEquityInvestmentsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_95e5ff1c-e34d-4c2a-88fe-d7ab06b96d2f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c9cbf73a-b491-45df-b6b1-b8973341e8da_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_44f458f6-b35a-482a-9ce6-163fd8b9837f_netLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating profit by segment</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_ResmedLimitedMember_7bea6176-2c2d-485c-8200-ffc4cf79749a_terseLabel_en-US" xlink:label="lab_rmd_ResmedLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ResMed Limited</link:label>
    <link:label id="lab_rmd_ResmedLimitedMember_label_en-US" xlink:label="lab_rmd_ResmedLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Resmed Limited [Member]</link:label>
    <link:label id="lab_rmd_ResmedLimitedMember_documentation_en-US" xlink:label="lab_rmd_ResmedLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ResMed Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ResmedLimitedMember" xlink:href="rmd-20220930.xsd#rmd_ResmedLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_ResmedLimitedMember" xlink:to="lab_rmd_ResmedLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_8ff1974a-41c9-4b73-a85c-6157a7709baf_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_d009a5dd-9c49-4c61-867c-41453d852a7a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0e224c83-43d3-4a70-97bd-152b0208af8b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Basic And Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_8686b00f-223d-4a79-b360-889667c9a249_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for draw</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c5a75e95-15f5-44e2-b02f-45c064641159_netLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement alternative</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b2b8c760-e10d-41e5-8669-c4365bd31509_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses, net deferred income taxes and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired_a28eb19a-a13d-4ac4-8900-f2fa911003d3_terseLabel_en-US" xlink:label="lab_rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired, excluding cash</link:label>
    <link:label id="lab_rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired_label_en-US" xlink:label="lab_rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Part Of Acquisition, Fair Value of Assets Acquired</link:label>
    <link:label id="lab_rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired_documentation_en-US" xlink:label="lab_rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The fair value of an asset or business acquired in a noncash acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired" xlink:href="rmd-20220930.xsd#rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired" xlink:to="lab_rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_612e21b1-837a-48eb-bfd5-f9dd0cc112fe_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6b5a5261-68b0-4fb1-8f78-dcf86153b961_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding, beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_1baae039-13e7-4767-8b0f-14ffb5b4d25e_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding, ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_f2ef37c7-d7af-44bd-b7e8-39e7204f1d47_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (note 4)</link:label>
    <link:label id="lab_us-gaap_Goodwill_9ad1a033-f416-41ab-97b2-bbcc6b9b7143_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_Goodwill_75a6a3f2-ac76-488b-8248-0a5fd92a4db3_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of the period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_5b7ba3b9-459e-49c7-9166-0afc8c0669da_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_56ea4d42-df52-41e4-be7e-369247e42e15_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_rmd_MufgUnionBankMember_d6f025b1-36f4-4d9e-b708-e7b4dfd76e89_terseLabel_en-US" xlink:label="lab_rmd_MufgUnionBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mufg Union Bank</link:label>
    <link:label id="lab_rmd_MufgUnionBankMember_label_en-US" xlink:label="lab_rmd_MufgUnionBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mufg Union Bank [Member]</link:label>
    <link:label id="lab_rmd_MufgUnionBankMember_documentation_en-US" xlink:label="lab_rmd_MufgUnionBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mufg Union Bank</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MufgUnionBankMember" xlink:href="rmd-20220930.xsd#rmd_MufgUnionBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rmd_MufgUnionBankMember" xlink:to="lab_rmd_MufgUnionBankMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>rmd-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:863cb569-faab-47da-ba4f-c2fd89e0377c,g:b569d9d4-e0e2-497b-a32d-7564d4bc33ab-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://investor.resmed.com/role/Cover" xlink:type="simple" xlink:href="rmd-20220930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7f490ca3-c351-41d0-857d-e89348dc03fe" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_DocumentType_7f490ca3-c351-41d0-857d-e89348dc03fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_ae0200e9-2e67-4971-950e-77f272ca5d42" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_DocumentQuarterlyReport_ae0200e9-2e67-4971-950e-77f272ca5d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c389c0c7-ef44-45e7-9e2f-714f6f133276" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_DocumentPeriodEndDate_c389c0c7-ef44-45e7-9e2f-714f6f133276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_f21657a1-6834-4c79-aa18-f4bc91016a64" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_DocumentTransitionReport_f21657a1-6834-4c79-aa18-f4bc91016a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2d246d51-1f11-4aef-8b47-ddbec0b8a99d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityFileNumber_2d246d51-1f11-4aef-8b47-ddbec0b8a99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b7a0bad5-d4bf-4bf6-a94d-5160a43ba22d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityRegistrantName_b7a0bad5-d4bf-4bf6-a94d-5160a43ba22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3f263704-089f-4594-97eb-8b733bb43234" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3f263704-089f-4594-97eb-8b733bb43234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_346a520a-4f96-40ff-891c-73bd94fd1fd4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityTaxIdentificationNumber_346a520a-4f96-40ff-891c-73bd94fd1fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_003513ef-28e5-4355-b488-12c74a055fb3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityAddressAddressLine1_003513ef-28e5-4355-b488-12c74a055fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_65bc72c3-e6ed-430d-a4e0-0861db40cfe4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityAddressCityOrTown_65bc72c3-e6ed-430d-a4e0-0861db40cfe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_af1cde4e-d142-44a1-856d-f709052d48ec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityAddressStateOrProvince_af1cde4e-d142-44a1-856d-f709052d48ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3193efc9-257b-4320-8609-8e2af08c1101" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityAddressPostalZipCode_3193efc9-257b-4320-8609-8e2af08c1101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_acb15a08-ffcd-45ca-a812-ec9e83cb6ed5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityAddressCountry_acb15a08-ffcd-45ca-a812-ec9e83cb6ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d36c2337-79da-495c-82f1-cbcc01ec1ccf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_CityAreaCode_d36c2337-79da-495c-82f1-cbcc01ec1ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_367c78c9-6ca2-4552-9036-5acef1a4d58c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_LocalPhoneNumber_367c78c9-6ca2-4552-9036-5acef1a4d58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e83d09e0-933a-45e4-9449-372f4d3f36ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_Security12bTitle_e83d09e0-933a-45e4-9449-372f4d3f36ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_6329bcd9-f989-4aba-ae64-9684df9391d4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_TradingSymbol_6329bcd9-f989-4aba-ae64-9684df9391d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_90df94b9-e6d8-44d0-ba2e-f2b034f33c5f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_SecurityExchangeName_90df94b9-e6d8-44d0-ba2e-f2b034f33c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_f321c9f4-0a1b-4122-9858-1f749b4589fd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityCurrentReportingStatus_f321c9f4-0a1b-4122-9858-1f749b4589fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_256011f8-f7f0-44d3-8420-10ffa8708cb9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityInteractiveDataCurrent_256011f8-f7f0-44d3-8420-10ffa8708cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_29076535-72fd-4549-bc8d-bc041662ba77" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityFilerCategory_29076535-72fd-4549-bc8d-bc041662ba77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_8f43e5ac-54fa-41db-b7f1-6985a1b3265d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntitySmallBusiness_8f43e5ac-54fa-41db-b7f1-6985a1b3265d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_0ce5e74b-7263-4158-a3fb-18a862a10f2d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityEmergingGrowthCompany_0ce5e74b-7263-4158-a3fb-18a862a10f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_44f026c2-174a-43b5-af22-6b790adcbaeb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityShellCompany_44f026c2-174a-43b5-af22-6b790adcbaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_eb8da976-1369-4b9d-bd72-424f8b0c3cd6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_eb8da976-1369-4b9d-bd72-424f8b0c3cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1b0398da-b772-4883-b9fa-256eec6d4ee6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_AmendmentFlag_1b0398da-b772-4883-b9fa-256eec6d4ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_72812ea4-e5e9-4369-8da9-e164ce9ea205" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_DocumentFiscalYearFocus_72812ea4-e5e9-4369-8da9-e164ce9ea205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_0417a590-1cd9-42d2-8635-6d21ce0ecd6f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_DocumentFiscalPeriodFocus_0417a590-1cd9-42d2-8635-6d21ce0ecd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_ba895197-167d-4848-b5a8-be0751dbe9c1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_CurrentFiscalYearEndDate_ba895197-167d-4848-b5a8-be0751dbe9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_71552d9a-9dc9-45ca-b038-0aa19582262f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2e938793-5e99-4d4e-82ce-5028d7f1ae06" xlink:to="loc_dei_EntityCentralIndexKey_71552d9a-9dc9-45ca-b038-0aa19582262f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="rmd-20220930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_afce7545-58d0-4b05-af86-4a6e5c0cdfee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4dcd0508-7536-4c7d-9f5a-c60a23229e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_afce7545-58d0-4b05-af86-4a6e5c0cdfee" xlink:to="loc_us-gaap_AssetsAbstract_4dcd0508-7536-4c7d-9f5a-c60a23229e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_6c17bdee-186f-48f3-bb28-ae1749fe01f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4dcd0508-7536-4c7d-9f5a-c60a23229e75" xlink:to="loc_us-gaap_AssetsCurrentAbstract_6c17bdee-186f-48f3-bb28-ae1749fe01f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9d226777-2c8a-492e-96e4-cf13913a0d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6c17bdee-186f-48f3-bb28-ae1749fe01f0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9d226777-2c8a-492e-96e4-cf13913a0d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_245fb717-b55d-49e5-9eb4-2814d6d095b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6c17bdee-186f-48f3-bb28-ae1749fe01f0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_245fb717-b55d-49e5-9eb4-2814d6d095b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_782b226a-7e2e-482f-bf0e-3907ba7c1553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6c17bdee-186f-48f3-bb28-ae1749fe01f0" xlink:to="loc_us-gaap_InventoryNet_782b226a-7e2e-482f-bf0e-3907ba7c1553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_aed78790-278c-4a24-9ccf-40f3c0615c66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6c17bdee-186f-48f3-bb28-ae1749fe01f0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_aed78790-278c-4a24-9ccf-40f3c0615c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d659f419-fa54-44c7-acba-991319e783bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6c17bdee-186f-48f3-bb28-ae1749fe01f0" xlink:to="loc_us-gaap_AssetsCurrent_d659f419-fa54-44c7-acba-991319e783bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_7d555070-96bc-45d9-8c09-b151c1efad64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4dcd0508-7536-4c7d-9f5a-c60a23229e75" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_7d555070-96bc-45d9-8c09-b151c1efad64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2dce710e-8800-426e-b9cf-8571321e4928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7d555070-96bc-45d9-8c09-b151c1efad64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2dce710e-8800-426e-b9cf-8571321e4928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_692cec2e-8427-4a7e-8f41-0e4fb0006121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7d555070-96bc-45d9-8c09-b151c1efad64" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_692cec2e-8427-4a7e-8f41-0e4fb0006121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dd683d47-c6ac-4bb5-a733-639fef241df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7d555070-96bc-45d9-8c09-b151c1efad64" xlink:to="loc_us-gaap_Goodwill_dd683d47-c6ac-4bb5-a733-639fef241df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9630ebd2-806a-4660-be94-1d0b806fee82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7d555070-96bc-45d9-8c09-b151c1efad64" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9630ebd2-806a-4660-be94-1d0b806fee82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_1cee639e-653e-4634-baca-a36784090e16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7d555070-96bc-45d9-8c09-b151c1efad64" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_1cee639e-653e-4634-baca-a36784090e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f86d6802-d933-4b4e-a79f-c6ec4a347477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7d555070-96bc-45d9-8c09-b151c1efad64" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f86d6802-d933-4b4e-a79f-c6ec4a347477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_b56c4815-45de-4b54-81e3-38620b1ce1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7d555070-96bc-45d9-8c09-b151c1efad64" xlink:to="loc_us-gaap_AssetsNoncurrent_b56c4815-45de-4b54-81e3-38620b1ce1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6a525d47-9b50-4049-8348-b781c2a3b98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4dcd0508-7536-4c7d-9f5a-c60a23229e75" xlink:to="loc_us-gaap_Assets_6a525d47-9b50-4049-8348-b781c2a3b98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5937e34f-9735-4a70-9dfb-7a8c36550f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_afce7545-58d0-4b05-af86-4a6e5c0cdfee" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5937e34f-9735-4a70-9dfb-7a8c36550f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_01bf00bb-ddf0-4af5-94d7-e51e5e726a28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5937e34f-9735-4a70-9dfb-7a8c36550f5b" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_01bf00bb-ddf0-4af5-94d7-e51e5e726a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ca408f96-10c5-47f7-83ef-fd5d54699a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_01bf00bb-ddf0-4af5-94d7-e51e5e726a28" xlink:to="loc_us-gaap_AccountsPayableCurrent_ca408f96-10c5-47f7-83ef-fd5d54699a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4b50babd-5f74-4046-9ef8-d62c0671e4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_01bf00bb-ddf0-4af5-94d7-e51e5e726a28" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4b50babd-5f74-4046-9ef8-d62c0671e4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3b6566d8-8e25-4051-99be-421e089933ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_01bf00bb-ddf0-4af5-94d7-e51e5e726a28" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3b6566d8-8e25-4051-99be-421e089933ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_279a4110-dc0f-40f8-8c75-36e524b57dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_01bf00bb-ddf0-4af5-94d7-e51e5e726a28" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_279a4110-dc0f-40f8-8c75-36e524b57dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_21251c45-c7d1-4dcd-8896-d6c4be1d4a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_01bf00bb-ddf0-4af5-94d7-e51e5e726a28" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_21251c45-c7d1-4dcd-8896-d6c4be1d4a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_b95f9087-312f-4ec4-964a-5bad1e5bfa76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_01bf00bb-ddf0-4af5-94d7-e51e5e726a28" xlink:to="loc_us-gaap_ShortTermBorrowings_b95f9087-312f-4ec4-964a-5bad1e5bfa76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_21ef5cc0-53a7-42f0-9d16-80425513a107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_01bf00bb-ddf0-4af5-94d7-e51e5e726a28" xlink:to="loc_us-gaap_LiabilitiesCurrent_21ef5cc0-53a7-42f0-9d16-80425513a107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_c4fe6544-3e38-4365-886c-c0f34b6971eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5937e34f-9735-4a70-9dfb-7a8c36550f5b" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_c4fe6544-3e38-4365-886c-c0f34b6971eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_8d62e72e-91fd-4bb0-81d0-0a6aedb2df8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_c4fe6544-3e38-4365-886c-c0f34b6971eb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_8d62e72e-91fd-4bb0-81d0-0a6aedb2df8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_2d280225-de00-465d-94ee-9fb1080daf96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_c4fe6544-3e38-4365-886c-c0f34b6971eb" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_2d280225-de00-465d-94ee-9fb1080daf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_38dc4973-7669-46da-a515-86c4a44ee789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_c4fe6544-3e38-4365-886c-c0f34b6971eb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_38dc4973-7669-46da-a515-86c4a44ee789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_fd1c0ccc-6754-463a-a983-031bc6e6bf29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_c4fe6544-3e38-4365-886c-c0f34b6971eb" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_fd1c0ccc-6754-463a-a983-031bc6e6bf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7dd1d2b1-cabc-469d-945e-61aa095f3491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_c4fe6544-3e38-4365-886c-c0f34b6971eb" xlink:to="loc_us-gaap_LongTermDebt_7dd1d2b1-cabc-469d-945e-61aa095f3491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a89344b1-c97d-4b52-8fdf-f5873e7afd8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_c4fe6544-3e38-4365-886c-c0f34b6971eb" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_a89344b1-c97d-4b52-8fdf-f5873e7afd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_92b79ffa-8b81-4f9d-a099-1361d6aee66e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_c4fe6544-3e38-4365-886c-c0f34b6971eb" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_92b79ffa-8b81-4f9d-a099-1361d6aee66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_59825314-d90f-4fd0-ba9a-e80755504e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5937e34f-9735-4a70-9dfb-7a8c36550f5b" xlink:to="loc_us-gaap_Liabilities_59825314-d90f-4fd0-ba9a-e80755504e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_fc742240-4acd-4a95-a200-8a0926817af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5937e34f-9735-4a70-9dfb-7a8c36550f5b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_fc742240-4acd-4a95-a200-8a0926817af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_67c4ff94-d3a2-4c18-b619-0efde2598a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5937e34f-9735-4a70-9dfb-7a8c36550f5b" xlink:to="loc_us-gaap_StockholdersEquityAbstract_67c4ff94-d3a2-4c18-b619-0efde2598a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_fa5260a5-c6a4-4a8b-b17e-8352fb0a40c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_67c4ff94-d3a2-4c18-b619-0efde2598a69" xlink:to="loc_us-gaap_PreferredStockValue_fa5260a5-c6a4-4a8b-b17e-8352fb0a40c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_05efb9bc-2198-4c1e-b9b2-01ffd0eb85ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_67c4ff94-d3a2-4c18-b619-0efde2598a69" xlink:to="loc_us-gaap_CommonStockValueOutstanding_05efb9bc-2198-4c1e-b9b2-01ffd0eb85ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ba9e217f-6d06-4478-9d5e-bf049077407f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_67c4ff94-d3a2-4c18-b619-0efde2598a69" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ba9e217f-6d06-4478-9d5e-bf049077407f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d02c450d-3e2d-4f54-b576-22cc8d148695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_67c4ff94-d3a2-4c18-b619-0efde2598a69" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d02c450d-3e2d-4f54-b576-22cc8d148695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_87a3cf99-a0d6-465f-8bc8-b814b6a2c4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_67c4ff94-d3a2-4c18-b619-0efde2598a69" xlink:to="loc_us-gaap_TreasuryStockCommonValue_87a3cf99-a0d6-465f-8bc8-b814b6a2c4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bad27e0f-4818-45a7-9447-fdfa6b986330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_67c4ff94-d3a2-4c18-b619-0efde2598a69" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bad27e0f-4818-45a7-9447-fdfa6b986330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cbe24810-49b2-4e26-bba7-11015213b3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_67c4ff94-d3a2-4c18-b619-0efde2598a69" xlink:to="loc_us-gaap_StockholdersEquity_cbe24810-49b2-4e26-bba7-11015213b3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_18a878c3-c85f-4864-bdfe-abdcb2858980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5937e34f-9735-4a70-9dfb-7a8c36550f5b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_18a878c3-c85f-4864-bdfe-abdcb2858980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="rmd-20220930.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_78fa3486-d846-405d-987f-95bb0a63e316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_97df36da-67c7-4a2e-b4f9-3b81ff9f8ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78fa3486-d846-405d-987f-95bb0a63e316" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_97df36da-67c7-4a2e-b4f9-3b81ff9f8ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_53753a6c-56f4-45d6-ab03-3cde46174149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78fa3486-d846-405d-987f-95bb0a63e316" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_53753a6c-56f4-45d6-ab03-3cde46174149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_3c70aa78-8523-4c5b-a1bd-fb59a32e2260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78fa3486-d846-405d-987f-95bb0a63e316" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_3c70aa78-8523-4c5b-a1bd-fb59a32e2260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_5f4ef5e0-170b-4b96-a3cd-ddecb6a508cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78fa3486-d846-405d-987f-95bb0a63e316" xlink:to="loc_us-gaap_PreferredStockSharesIssued_5f4ef5e0-170b-4b96-a3cd-ddecb6a508cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_023d72b9-b57e-44d0-afa7-afd2bdb7e100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78fa3486-d846-405d-987f-95bb0a63e316" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_023d72b9-b57e-44d0-afa7-afd2bdb7e100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_22d8b9fc-5e58-4923-baef-7f081ff9a2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78fa3486-d846-405d-987f-95bb0a63e316" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_22d8b9fc-5e58-4923-baef-7f081ff9a2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_0592d0d6-569c-4684-a1ac-5255dc2306d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78fa3486-d846-405d-987f-95bb0a63e316" xlink:to="loc_us-gaap_CommonStockSharesIssued_0592d0d6-569c-4684-a1ac-5255dc2306d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_109c3702-2343-4e5c-a765-a5f386690782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78fa3486-d846-405d-987f-95bb0a63e316" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_109c3702-2343-4e5c-a765-a5f386690782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_02fbbd39-b23e-425f-96e7-4b58c66b38fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_78fa3486-d846-405d-987f-95bb0a63e316" xlink:to="loc_us-gaap_TreasuryStockCommonShares_02fbbd39-b23e-425f-96e7-4b58c66b38fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="rmd-20220930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_5a0851e5-909b-43f8-8a58-25bc386fe492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8729695a-b61c-4849-84c3-06a2bae78426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5a0851e5-909b-43f8-8a58-25bc386fe492" xlink:to="loc_us-gaap_StatementTable_8729695a-b61c-4849-84c3-06a2bae78426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ad40b605-3c57-4781-bfbe-471adb48cd55" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8729695a-b61c-4849-84c3-06a2bae78426" xlink:to="loc_srt_ProductOrServiceAxis_ad40b605-3c57-4781-bfbe-471adb48cd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1273eedf-f03d-41bb-a7a0-688af19c7500" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ad40b605-3c57-4781-bfbe-471adb48cd55" xlink:to="loc_srt_ProductsAndServicesDomain_1273eedf-f03d-41bb-a7a0-688af19c7500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SleepAndRespiratoryMember_01e27c10-4ffb-4a72-8169-4501d73a9ec5" xlink:href="rmd-20220930.xsd#rmd_SleepAndRespiratoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1273eedf-f03d-41bb-a7a0-688af19c7500" xlink:to="loc_rmd_SleepAndRespiratoryMember_01e27c10-4ffb-4a72-8169-4501d73a9ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SoftwareAsServiceMember_b19a5ce8-b56c-4ed8-ad81-3ef3648f645a" xlink:href="rmd-20220930.xsd#rmd_SoftwareAsServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1273eedf-f03d-41bb-a7a0-688af19c7500" xlink:to="loc_rmd_SoftwareAsServiceMember_b19a5ce8-b56c-4ed8-ad81-3ef3648f645a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8729695a-b61c-4849-84c3-06a2bae78426" xlink:to="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26113334-2855-4492-9530-102ea18e4019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26113334-2855-4492-9530-102ea18e4019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_e3c29ff4-f848-417d-9a34-ac76b588f9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_e3c29ff4-f848-417d-9a34-ac76b588f9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_fbbb50b6-1d98-4cc4-845a-b1b99f14a444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_fbbb50b6-1d98-4cc4-845a-b1b99f14a444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_09bcaf1a-a810-4967-b135-d31e5a410a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_09bcaf1a-a810-4967-b135-d31e5a410a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2e3a57dd-eb1c-47ef-977d-1c076926fa56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_GrossProfit_2e3a57dd-eb1c-47ef-977d-1c076926fa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_add2c4d0-51eb-49ed-9512-a88ccbf324c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_OperatingExpensesAbstract_add2c4d0-51eb-49ed-9512-a88ccbf324c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8acac313-828b-4e70-939d-7f893499c11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_add2c4d0-51eb-49ed-9512-a88ccbf324c9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8acac313-828b-4e70-939d-7f893499c11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_91e82485-d9b8-4d46-9751-20f68df91f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_add2c4d0-51eb-49ed-9512-a88ccbf324c9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_91e82485-d9b8-4d46-9751-20f68df91f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_AmortizationOfAcquiredIntangibleAssets1_cc6ab7f6-2669-40d3-84c1-20eb4fdf310e" xlink:href="rmd-20220930.xsd#rmd_AmortizationOfAcquiredIntangibleAssets1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_add2c4d0-51eb-49ed-9512-a88ccbf324c9" xlink:to="loc_rmd_AmortizationOfAcquiredIntangibleAssets1_cc6ab7f6-2669-40d3-84c1-20eb4fdf310e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_23413b24-2202-4c14-b703-6a62c29ee290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_add2c4d0-51eb-49ed-9512-a88ccbf324c9" xlink:to="loc_us-gaap_OperatingExpenses_23413b24-2202-4c14-b703-6a62c29ee290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b3b18761-928e-48c7-b4bb-6df9cfafc0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_OperatingIncomeLoss_b3b18761-928e-48c7-b4bb-6df9cfafc0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_671e361b-240f-41a4-81cf-b69f98dd3093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_671e361b-240f-41a4-81cf-b69f98dd3093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1af51019-6287-4317-9ba8-f312c9868812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1af51019-6287-4317-9ba8-f312c9868812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_68527f5a-460a-4935-ae3c-c42a2bd319fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_68527f5a-460a-4935-ae3c-c42a2bd319fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_42807491-8226-415c-8d60-380c6cbdeae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_42807491-8226-415c-8d60-380c6cbdeae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f749ccf1-197c-4cf7-92ca-3a879fdf98c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_be3a5f03-4181-4139-aee5-4a5396213b22" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f749ccf1-197c-4cf7-92ca-3a879fdf98c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1168d7a7-9251-4ccd-b418-31d1b4389d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1168d7a7-9251-4ccd-b418-31d1b4389d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d83136b8-e53a-4b8c-8880-7945dc0d990d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d83136b8-e53a-4b8c-8880-7945dc0d990d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_677c80a3-8fa0-48ff-b96a-e60139d50eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_NetIncomeLoss_677c80a3-8fa0-48ff-b96a-e60139d50eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9cdba3b5-0516-413e-a63c-1afd3638e6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_EarningsPerShareBasic_9cdba3b5-0516-413e-a63c-1afd3638e6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_567a4d29-b6d4-4935-afc3-bfc8dec0e13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_EarningsPerShareDiluted_567a4d29-b6d4-4935-afc3-bfc8dec0e13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_18c3cb42-0cff-49e2-b654-6092437d1230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_18c3cb42-0cff-49e2-b654-6092437d1230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_322bce69-0dbf-4e34-bc25-e1ecdf2e348c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_322bce69-0dbf-4e34-bc25-e1ecdf2e348c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6e466d98-2775-4cb9-aed5-a8dfadc75ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_70e6d3ef-96db-41a8-b792-606634d42d44" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6e466d98-2775-4cb9-aed5-a8dfadc75ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="rmd-20220930.xsd#CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_3bacc6c3-98d3-4721-9837-a09f7b77f975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_26c82fb4-3e98-45be-8a26-433e2ef54ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_3bacc6c3-98d3-4721-9837-a09f7b77f975" xlink:to="loc_us-gaap_NetIncomeLoss_26c82fb4-3e98-45be-8a26-433e2ef54ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_2dbd4347-3147-4fb8-9b41-6f3c902d8081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_3bacc6c3-98d3-4721-9837-a09f7b77f975" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_2dbd4347-3147-4fb8-9b41-6f3c902d8081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_81a2ccc1-0925-4d14-953b-c6c62810a039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_2dbd4347-3147-4fb8-9b41-6f3c902d8081" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_81a2ccc1-0925-4d14-953b-c6c62810a039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b90739d-2962-43a9-bc2b-2d25ebde12f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_3bacc6c3-98d3-4721-9837-a09f7b77f975" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b90739d-2962-43a9-bc2b-2d25ebde12f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited" xlink:type="simple" xlink:href="rmd-20220930.xsd#CondensedConsolidatedStatementsOfChangesInEquityUnaudited"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_5a1637d5-ee8e-4cb1-9c93-93610afcf816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1ed9e59f-08e0-419e-8ea4-7c60fa83724d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_5a1637d5-ee8e-4cb1-9c93-93610afcf816" xlink:to="loc_us-gaap_StatementTable_1ed9e59f-08e0-419e-8ea4-7c60fa83724d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_07c0bc87-469d-4daf-928f-b4e5f235a751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1ed9e59f-08e0-419e-8ea4-7c60fa83724d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_07c0bc87-469d-4daf-928f-b4e5f235a751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_07c0bc87-469d-4daf-928f-b4e5f235a751" xlink:to="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bf9c38fd-a204-49ce-bee4-5859acd985ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:to="loc_us-gaap_CommonStockMember_bf9c38fd-a204-49ce-bee4-5859acd985ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_658b6021-198d-4819-8074-fa271d3d3d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_658b6021-198d-4819-8074-fa271d3d3d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_6b21d9a8-2889-4d74-97c6-791965dd2089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:to="loc_us-gaap_TreasuryStockMember_6b21d9a8-2889-4d74-97c6-791965dd2089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f2e27af5-0eb6-49a6-93a4-9a47f4f51595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:to="loc_us-gaap_RetainedEarningsMember_f2e27af5-0eb6-49a6-93a4-9a47f4f51595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_febb303c-1453-4617-8843-55c2e21ca22f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c47efeb6-a43d-4de2-803c-b7c3a65e891b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_febb303c-1453-4617-8843-55c2e21ca22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b1b34137-36a2-4113-82ee-aea05932effa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1ed9e59f-08e0-419e-8ea4-7c60fa83724d" xlink:to="loc_us-gaap_StatementLineItems_b1b34137-36a2-4113-82ee-aea05932effa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b1b34137-36a2-4113-82ee-aea05932effa" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c4bc74fe-4075-4c38-be9c-799d6e25468c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c4bc74fe-4075-4c38-be9c-799d6e25468c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6f9d5e0e-37d5-474f-a23b-feeed2ea304a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_StockholdersEquity_6f9d5e0e-37d5-474f-a23b-feeed2ea304a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_367fbc1f-b674-4cc2-8248-d1a34adc507e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_TreasuryStockCommonShares_367fbc1f-b674-4cc2-8248-d1a34adc507e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_674ce11f-2d1f-4790-ad02-c84f3ae6db6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_674ce11f-2d1f-4790-ad02-c84f3ae6db6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e957d37e-0933-4135-8b08-328cb7e5bb35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e957d37e-0933-4135-8b08-328cb7e5bb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3ff5a29c-577f-4e9e-9616-4128a86a1c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3ff5a29c-577f-4e9e-9616-4128a86a1c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a3b993f7-2e4f-4cba-9d11-b7c09dcedc90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a3b993f7-2e4f-4cba-9d11-b7c09dcedc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_326bebe6-aaba-4f8d-a764-8ee515434bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_326bebe6-aaba-4f8d-a764-8ee515434bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c2f9ff3a-2189-4c08-a3ff-bac0fd04cd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c2f9ff3a-2189-4c08-a3ff-bac0fd04cd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a79d8e04-1723-4741-be5e-be8585b6f1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_NetIncomeLoss_a79d8e04-1723-4741-be5e-be8585b6f1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_ca9ce96e-6d1c-4ea8-b204-0638dc84d46b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_Dividends_ca9ce96e-6d1c-4ea8-b204-0638dc84d46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9c645fa7-dca2-4ce2-940b-ff0a6a9d76cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9c645fa7-dca2-4ce2-940b-ff0a6a9d76cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5fd67d1c-5f74-4fb6-b10b-cce755e0bfef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_StockholdersEquity_5fd67d1c-5f74-4fb6-b10b-cce755e0bfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_448e8b14-1075-48cb-886c-17c4e9d7e704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_aaddd680-a968-4913-9c9d-3600c84e387c" xlink:to="loc_us-gaap_TreasuryStockCommonShares_448e8b14-1075-48cb-886c-17c4e9d7e704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnauditedParenthetical" xlink:type="simple" xlink:href="rmd-20220930.xsd#CondensedConsolidatedStatementsOfChangesInEquityUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_18bbaff8-4164-447b-a3cb-a0833a425589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_26fee80b-7a71-473f-95b1-23bce6b07b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_18bbaff8-4164-447b-a3cb-a0833a425589" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_26fee80b-7a71-473f-95b1-23bce6b07b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" xlink:href="rmd-20220930.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_f5fbdc5b-fba8-4e71-b02f-945f573de4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_87b491d5-adfe-4f9b-b03a-281702217ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f5fbdc5b-fba8-4e71-b02f-945f573de4ea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_87b491d5-adfe-4f9b-b03a-281702217ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fd784873-ef78-4110-882c-6cabb4277a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_87b491d5-adfe-4f9b-b03a-281702217ad9" xlink:to="loc_us-gaap_NetIncomeLoss_fd784873-ef78-4110-882c-6cabb4277a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd2a6603-0277-491c-81d9-6f59876fc106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_87b491d5-adfe-4f9b-b03a-281702217ad9" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd2a6603-0277-491c-81d9-6f59876fc106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_335cb249-93a4-4535-a232-f644395e2fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd2a6603-0277-491c-81d9-6f59876fc106" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_335cb249-93a4-4535-a232-f644395e2fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_5315767f-70a3-4abd-9530-70b751d644d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd2a6603-0277-491c-81d9-6f59876fc106" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_5315767f-70a3-4abd-9530-70b751d644d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2c625c98-8bea-46b2-8356-07179ec66a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd2a6603-0277-491c-81d9-6f59876fc106" xlink:to="loc_us-gaap_ShareBasedCompensation_2c625c98-8bea-46b2-8356-07179ec66a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_29a35646-cf36-4d40-a21f-c41851641970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd2a6603-0277-491c-81d9-6f59876fc106" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_29a35646-cf36-4d40-a21f-c41851641970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_efb24580-57fe-4715-a767-1f7267f7e2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dd2a6603-0277-491c-81d9-6f59876fc106" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_efb24580-57fe-4715-a767-1f7267f7e2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20367138-10dc-4e5d-bf3a-a5063218a93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_87b491d5-adfe-4f9b-b03a-281702217ad9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20367138-10dc-4e5d-bf3a-a5063218a93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_26c500a2-27c3-48f9-9927-b708fdbdf371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20367138-10dc-4e5d-bf3a-a5063218a93f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_26c500a2-27c3-48f9-9927-b708fdbdf371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_849338a8-b7be-4a22-9709-399990dfbf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20367138-10dc-4e5d-bf3a-a5063218a93f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_849338a8-b7be-4a22-9709-399990dfbf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6f48ee73-39e6-4f25-833a-678e07ee0cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20367138-10dc-4e5d-bf3a-a5063218a93f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6f48ee73-39e6-4f25-833a-678e07ee0cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8e56848e-b1fa-4211-919e-82a306fbed00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_20367138-10dc-4e5d-bf3a-a5063218a93f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8e56848e-b1fa-4211-919e-82a306fbed00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f79c98f5-71d4-43be-bb3b-dc0c8ec30ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_87b491d5-adfe-4f9b-b03a-281702217ad9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f79c98f5-71d4-43be-bb3b-dc0c8ec30ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ce19541a-959e-4ec2-8b41-c6b6ed259f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f5fbdc5b-fba8-4e71-b02f-945f573de4ea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ce19541a-959e-4ec2-8b41-c6b6ed259f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_962291d1-7c5a-495f-90a5-784e7b344962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ce19541a-959e-4ec2-8b41-c6b6ed259f1b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_962291d1-7c5a-495f-90a5-784e7b344962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_23838302-a171-4c9c-b492-54592bfe4f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ce19541a-959e-4ec2-8b41-c6b6ed259f1b" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_23838302-a171-4c9c-b492-54592bfe4f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_facb4086-2bff-4ffd-8f35-3028fe51789b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ce19541a-959e-4ec2-8b41-c6b6ed259f1b" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_facb4086-2bff-4ffd-8f35-3028fe51789b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_c61f200b-c1f0-4769-932f-b75c7e1442d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ce19541a-959e-4ec2-8b41-c6b6ed259f1b" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_c61f200b-c1f0-4769-932f-b75c7e1442d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_8ba5e9d1-d884-4707-a936-fa165f7fb84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ce19541a-959e-4ec2-8b41-c6b6ed259f1b" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities_8ba5e9d1-d884-4707-a936-fa165f7fb84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_338073c3-6991-4f48-ba96-5caab1dbdd9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ce19541a-959e-4ec2-8b41-c6b6ed259f1b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_338073c3-6991-4f48-ba96-5caab1dbdd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c35f59a-6b06-4a9d-a631-a251d4b0d57c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f5fbdc5b-fba8-4e71-b02f-945f573de4ea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c35f59a-6b06-4a9d-a631-a251d4b0d57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_498ca75d-8594-4c8a-9fac-c19d572f9612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c35f59a-6b06-4a9d-a631-a251d4b0d57c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_498ca75d-8594-4c8a-9fac-c19d572f9612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_15299d04-510c-4256-8bc6-9a841faa508e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c35f59a-6b06-4a9d-a631-a251d4b0d57c" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_15299d04-510c-4256-8bc6-9a841faa508e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_95642fab-663a-464c-ae35-6b3f54da2268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c35f59a-6b06-4a9d-a631-a251d4b0d57c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_95642fab-663a-464c-ae35-6b3f54da2268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a7cc519a-e41a-4d7e-8b4a-cd7df7e42051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c35f59a-6b06-4a9d-a631-a251d4b0d57c" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a7cc519a-e41a-4d7e-8b4a-cd7df7e42051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_12683a23-0fbf-4412-850c-72b5a7a35685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c35f59a-6b06-4a9d-a631-a251d4b0d57c" xlink:to="loc_us-gaap_PaymentsOfDividends_12683a23-0fbf-4412-850c-72b5a7a35685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0fa873cd-47b2-4e2e-90a7-664e12947641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3c35f59a-6b06-4a9d-a631-a251d4b0d57c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0fa873cd-47b2-4e2e-90a7-664e12947641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cf81c1e7-7dad-40c0-9049-8f0fd104f8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f5fbdc5b-fba8-4e71-b02f-945f573de4ea" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cf81c1e7-7dad-40c0-9049-8f0fd104f8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd1889c8-6325-4197-9b3b-52d8a2a73244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f5fbdc5b-fba8-4e71-b02f-945f573de4ea" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd1889c8-6325-4197-9b3b-52d8a2a73244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3a4005a8-0a94-4ed0-a72c-39ac76deb22d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f5fbdc5b-fba8-4e71-b02f-945f573de4ea" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3a4005a8-0a94-4ed0-a72c-39ac76deb22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_80c004a7-0e7d-4f83-92dc-da34d061049b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f5fbdc5b-fba8-4e71-b02f-945f573de4ea" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_80c004a7-0e7d-4f83-92dc-da34d061049b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_916e38ba-2186-4b62-94d9-38a7db20925c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f5fbdc5b-fba8-4e71-b02f-945f573de4ea" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_916e38ba-2186-4b62-94d9-38a7db20925c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_61e40b09-3adc-4e9d-a368-9d116ec93e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_916e38ba-2186-4b62-94d9-38a7db20925c" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_61e40b09-3adc-4e9d-a368-9d116ec93e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_4e5d9d4c-1682-4dac-8779-a3ade3afd727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_916e38ba-2186-4b62-94d9-38a7db20925c" xlink:to="loc_us-gaap_InterestPaidNet_4e5d9d4c-1682-4dac-8779-a3ade3afd727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired_47892e61-3ae5-48b2-8016-bf20245b918c" xlink:href="rmd-20220930.xsd#rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_916e38ba-2186-4b62-94d9-38a7db20925c" xlink:to="loc_rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired_47892e61-3ae5-48b2-8016-bf20245b918c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_10c86de6-b006-461c-8e04-a1cff2830ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_916e38ba-2186-4b62-94d9-38a7db20925c" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_10c86de6-b006-461c-8e04-a1cff2830ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease_d5791c05-3b0b-4202-9dec-1b3dd2d0b6ef" xlink:href="rmd-20220930.xsd#rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_916e38ba-2186-4b62-94d9-38a7db20925c" xlink:to="loc_rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease_d5791c05-3b0b-4202-9dec-1b3dd2d0b6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DeferredPaymentObligationsForAcquisitions_49d1880b-6ff4-4cc9-a8d9-0e79d449b540" xlink:href="rmd-20220930.xsd#rmd_DeferredPaymentObligationsForAcquisitions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_916e38ba-2186-4b62-94d9-38a7db20925c" xlink:to="loc_rmd_DeferredPaymentObligationsForAcquisitions_49d1880b-6ff4-4cc9-a8d9-0e79d449b540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability_e6f31170-204d-453d-b998-5109ade9af61" xlink:href="rmd-20220930.xsd#rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_916e38ba-2186-4b62-94d9-38a7db20925c" xlink:to="loc_rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability_e6f31170-204d-453d-b998-5109ade9af61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_7531ce4e-ee00-4224-96c9-4cb108a0b7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_916e38ba-2186-4b62-94d9-38a7db20925c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_7531ce4e-ee00-4224-96c9-4cb108a0b7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="rmd-20220930.xsd#SummaryOfSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_24741b6d-4946-4ffc-9dd0-a9002e931671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_41bb5e39-d5a9-4fea-a0f1-a874d7f242f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24741b6d-4946-4ffc-9dd0-a9002e931671" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_41bb5e39-d5a9-4fea-a0f1-a874d7f242f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SegmentInformation" xlink:type="simple" xlink:href="rmd-20220930.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a5ec1399-6085-4cb0-8bc5-6a18d6cb7920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_d76b4b78-35f2-4884-9d0c-98e9935f3251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a5ec1399-6085-4cb0-8bc5-6a18d6cb7920" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_d76b4b78-35f2-4884-9d0c-98e9935f3251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformation" xlink:type="simple" xlink:href="rmd-20220930.xsd#SupplementalBalanceSheetInformation"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SupplementalBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SupplementalBalanceSheetInformationAbstract_f77e371e-76f4-4588-93f1-2d2141ec3b12" xlink:href="rmd-20220930.xsd#rmd_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SupplementalBalanceSheetInformationTextBlock_a31aa488-60ea-4f77-a5f7-f1c91ed29444" xlink:href="rmd-20220930.xsd#rmd_SupplementalBalanceSheetInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_f77e371e-76f4-4588-93f1-2d2141ec3b12" xlink:to="loc_rmd_SupplementalBalanceSheetInformationTextBlock_a31aa488-60ea-4f77-a5f7-f1c91ed29444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/Goodwill" xlink:type="simple" xlink:href="rmd-20220930.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f1bbcd4-b324-4708-b448-833b6ade31c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_3b7b80f8-62e8-4d3d-808c-edd34fedc121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f1bbcd4-b324-4708-b448-833b6ade31c9" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_3b7b80f8-62e8-4d3d-808c-edd34fedc121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/Investments" xlink:type="simple" xlink:href="rmd-20220930.xsd#Investments"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c39aad08-9d05-434a-8947-6ee73e0243ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock_9ee21bdb-b535-4686-8cb5-ba681d83d848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c39aad08-9d05-434a-8947-6ee73e0243ae" xlink:to="loc_us-gaap_InvestmentTextBlock_9ee21bdb-b535-4686-8cb5-ba681d83d848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/IncomeTaxes" xlink:type="simple" xlink:href="rmd-20220930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8e074b09-4a4d-4224-8019-18817c72a7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f6b79090-bdd9-415a-bc89-6e5b099fc6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8e074b09-4a4d-4224-8019-18817c72a7c0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f6b79090-bdd9-415a-bc89-6e5b099fc6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/ProductWarranties" xlink:type="simple" xlink:href="rmd-20220930.xsd#ProductWarranties"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/ProductWarranties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_e764f022-b80c-4fff-93ba-e08b6bc548eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock_bd12429e-e79b-408d-9e51-71cb9461398a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_e764f022-b80c-4fff-93ba-e08b6bc548eb" xlink:to="loc_us-gaap_ProductWarrantyDisclosureTextBlock_bd12429e-e79b-408d-9e51-71cb9461398a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/Debt" xlink:type="simple" xlink:href="rmd-20220930.xsd#Debt"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_82d74248-ca4f-44d0-8c0e-d3e346060f57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_b6f53127-5cc0-4e50-b95f-57c4d7cf453f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_82d74248-ca4f-44d0-8c0e-d3e346060f57" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_b6f53127-5cc0-4e50-b95f-57c4d7cf453f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/EarningsPerShare" xlink:type="simple" xlink:href="rmd-20220930.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_31e73122-1f30-4ffe-9c6d-e6a91c1febb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_3ede5cf1-096a-4ccb-8233-4e80a68cb1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_31e73122-1f30-4ffe-9c6d-e6a91c1febb2" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_3ede5cf1-096a-4ccb-8233-4e80a68cb1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/LegalActionsContingenciesandCommitments" xlink:type="simple" xlink:href="rmd-20220930.xsd#LegalActionsContingenciesandCommitments"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/LegalActionsContingenciesandCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_02f74874-81ed-45c1-8bfa-72dc939508ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_676128e3-6ee4-402c-82b1-923b4e76df0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_02f74874-81ed-45c1-8bfa-72dc939508ff" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_676128e3-6ee4-402c-82b1-923b4e76df0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="rmd-20220930.xsd#SummaryOfSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_92ab0ba3-d60e-48e2-ad57-128a71027a22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock_d260f755-e7b0-48ad-b46b-ae84b4f7a8a7" xlink:href="rmd-20220930.xsd#rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_92ab0ba3-d60e-48e2-ad57-128a71027a22" xlink:to="loc_rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock_d260f755-e7b0-48ad-b46b-ae84b4f7a8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_3d9fa33a-71e5-48c9-8531-39bec46dc663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_92ab0ba3-d60e-48e2-ad57-128a71027a22" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_3d9fa33a-71e5-48c9-8531-39bec46dc663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_LeaseRevenuePolicyTextBlock_3c5a810b-2360-4f0a-b1b0-f0aa33142cbe" xlink:href="rmd-20220930.xsd#rmd_LeaseRevenuePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_92ab0ba3-d60e-48e2-ad57-128a71027a22" xlink:to="loc_rmd_LeaseRevenuePolicyTextBlock_3c5a810b-2360-4f0a-b1b0-f0aa33142cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_3ab9dcdb-f990-4ef8-b254-0c28126f0792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_92ab0ba3-d60e-48e2-ad57-128a71027a22" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_3ab9dcdb-f990-4ef8-b254-0c28126f0792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="rmd-20220930.xsd#SummaryOfSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a562bc08-fa11-4efb-b184-ae704244e917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_2d5b5383-c0b2-4b6b-a824-04a7eadc4994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a562bc08-fa11-4efb-b184-ae704244e917" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_2d5b5383-c0b2-4b6b-a824-04a7eadc4994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0305f921-09b9-4faa-abd1-961be09f77e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a562bc08-fa11-4efb-b184-ae704244e917" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0305f921-09b9-4faa-abd1-961be09f77e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="rmd-20220930.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a4c83aee-b069-43b6-863b-533ac67a2284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_95a2df78-db11-4bc3-a125-114968718c66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a4c83aee-b069-43b6-863b-533ac67a2284" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_95a2df78-db11-4bc3-a125-114968718c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationTables" xlink:type="simple" xlink:href="rmd-20220930.xsd#SupplementalBalanceSheetInformationTables"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SupplementalBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SupplementalBalanceSheetInformationAbstract_9cc9c196-1655-45ed-ae39-f377b52af7cb" xlink:href="rmd-20220930.xsd#rmd_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b3cd30aa-4785-4620-a0ef-8a91afe2e19e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_9cc9c196-1655-45ed-ae39-f377b52af7cb" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b3cd30aa-4785-4620-a0ef-8a91afe2e19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_2f14a255-0a31-4f37-8562-70a251e94274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_9cc9c196-1655-45ed-ae39-f377b52af7cb" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_2f14a255-0a31-4f37-8562-70a251e94274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ae28357e-f485-4de9-bf62-ec5e1d571ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_9cc9c196-1655-45ed-ae39-f377b52af7cb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ae28357e-f485-4de9-bf62-ec5e1d571ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_65af0e27-8dac-451a-9c17-16475f7131db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_9cc9c196-1655-45ed-ae39-f377b52af7cb" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_65af0e27-8dac-451a-9c17-16475f7131db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/GoodwillTables" xlink:type="simple" xlink:href="rmd-20220930.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5a3f5d17-ebe5-450d-b607-4a3d8d2cce94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_d0613018-be7c-4adf-87ba-9c9467b73515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5a3f5d17-ebe5-450d-b607-4a3d8d2cce94" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_d0613018-be7c-4adf-87ba-9c9467b73515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/InvestmentsTables" xlink:type="simple" xlink:href="rmd-20220930.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_155647ec-f960-4900-bf0f-605a3987bf73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ScheduleOfInvestmentsTableTextBlock_a6a36a81-cbaf-4e0f-9f03-dd6cdf1f19d5" xlink:href="rmd-20220930.xsd#rmd_ScheduleOfInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_155647ec-f960-4900-bf0f-605a3987bf73" xlink:to="loc_rmd_ScheduleOfInvestmentsTableTextBlock_a6a36a81-cbaf-4e0f-9f03-dd6cdf1f19d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock_9177db8e-77c9-4724-b0a6-1f62aae1df9c" xlink:href="rmd-20220930.xsd#rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_155647ec-f960-4900-bf0f-605a3987bf73" xlink:to="loc_rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock_9177db8e-77c9-4724-b0a6-1f62aae1df9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/ProductWarrantiesTables" xlink:type="simple" xlink:href="rmd-20220930.xsd#ProductWarrantiesTables"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/ProductWarrantiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_03ae0bdb-00c8-4caf-89f8-ea2e740bc298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_15fb3222-cb1e-48b2-a66a-1a0a3366e262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_03ae0bdb-00c8-4caf-89f8-ea2e740bc298" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_15fb3222-cb1e-48b2-a66a-1a0a3366e262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/DebtTables" xlink:type="simple" xlink:href="rmd-20220930.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ee87603e-1fd2-4d64-872c-f8b586f6acda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_913e8070-ce8e-49cc-a3d2-d036acc300b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ee87603e-1fd2-4d64-872c-f8b586f6acda" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_913e8070-ce8e-49cc-a3d2-d036acc300b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="rmd-20220930.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a2728314-d5df-4295-97f0-c25645a984ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3fcb1baa-eb5a-4992-bb74-33748d053b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a2728314-d5df-4295-97f0-c25645a984ac" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3fcb1baa-eb5a-4992-bb74-33748d053b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SummaryOfSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_35220fda-e742-45a9-8d2d-a0e6808c0b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SummaryOfSignificantAccountingPoliciesTable_db71e46b-1bcb-4101-96db-9715cfbe5fec" xlink:href="rmd-20220930.xsd#rmd_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_35220fda-e742-45a9-8d2d-a0e6808c0b0a" xlink:to="loc_rmd_SummaryOfSignificantAccountingPoliciesTable_db71e46b-1bcb-4101-96db-9715cfbe5fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5dd30977-c23b-46d7-9714-cf39c5707597" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SummaryOfSignificantAccountingPoliciesTable_db71e46b-1bcb-4101-96db-9715cfbe5fec" xlink:to="loc_srt_RangeAxis_5dd30977-c23b-46d7-9714-cf39c5707597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a3c3264a-f8f7-464c-bdfd-708e46b49639" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5dd30977-c23b-46d7-9714-cf39c5707597" xlink:to="loc_srt_RangeMember_a3c3264a-f8f7-464c-bdfd-708e46b49639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b0147196-b328-46b8-ba71-3208895dc92e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a3c3264a-f8f7-464c-bdfd-708e46b49639" xlink:to="loc_srt_MinimumMember_b0147196-b328-46b8-ba71-3208895dc92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a4766c60-0cb3-423b-8ad2-6930b2991f93" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a3c3264a-f8f7-464c-bdfd-708e46b49639" xlink:to="loc_srt_MaximumMember_a4766c60-0cb3-423b-8ad2-6930b2991f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SummaryOfSignificantAccountingPoliciesLineItems_a2c83da4-e2d3-4256-bec4-5d9c87dacbab" xlink:href="rmd-20220930.xsd#rmd_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SummaryOfSignificantAccountingPoliciesTable_db71e46b-1bcb-4101-96db-9715cfbe5fec" xlink:to="loc_rmd_SummaryOfSignificantAccountingPoliciesLineItems_a2c83da4-e2d3-4256-bec4-5d9c87dacbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_b62bd159-0ac9-4d31-8ecc-4d8cc1fab63e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SummaryOfSignificantAccountingPoliciesLineItems_a2c83da4-e2d3-4256-bec4-5d9c87dacbab" xlink:to="loc_us-gaap_NumberOfOperatingSegments_b62bd159-0ac9-4d31-8ecc-4d8cc1fab63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_TermOfContractUnderRevenueRecognition_0385c991-7da3-4694-9224-349b07734935" xlink:href="rmd-20220930.xsd#rmd_TermOfContractUnderRevenueRecognition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SummaryOfSignificantAccountingPoliciesLineItems_a2c83da4-e2d3-4256-bec4-5d9c87dacbab" xlink:to="loc_rmd_TermOfContractUnderRevenueRecognition_0385c991-7da3-4694-9224-349b07734935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_3af61473-1bfb-4850-bce2-0acdbb1947a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SummaryOfSignificantAccountingPoliciesLineItems_a2c83da4-e2d3-4256-bec4-5d9c87dacbab" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_3af61473-1bfb-4850-bce2-0acdbb1947a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c9b6393a-4d21-4785-a231-e34923447d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c5c16cf1-2bf5-4ae1-ae73-3d18e09b12a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c9b6393a-4d21-4785-a231-e34923447d42" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c5c16cf1-2bf5-4ae1-ae73-3d18e09b12a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0e5079fd-fc1e-40b6-93d7-ef7de7f53702" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c5c16cf1-2bf5-4ae1-ae73-3d18e09b12a5" xlink:to="loc_srt_StatementGeographicalAxis_0e5079fd-fc1e-40b6-93d7-ef7de7f53702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e1c96f3e-8a27-4c52-b14e-e59e8262e15c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0e5079fd-fc1e-40b6-93d7-ef7de7f53702" xlink:to="loc_srt_SegmentGeographicalDomain_e1c96f3e-8a27-4c52-b14e-e59e8262e15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_UsCanadaAndLatinAmericaMember_70175b48-0adf-4126-af43-3d782c4fb37c" xlink:href="rmd-20220930.xsd#rmd_UsCanadaAndLatinAmericaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e1c96f3e-8a27-4c52-b14e-e59e8262e15c" xlink:to="loc_rmd_UsCanadaAndLatinAmericaMember_70175b48-0adf-4126-af43-3d782c4fb37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_CombinedEuropeAsiaAndOtherMarketsMember_cb9f87be-d33d-4bba-a3d7-fbfc852d6547" xlink:href="rmd-20220930.xsd#rmd_CombinedEuropeAsiaAndOtherMarketsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e1c96f3e-8a27-4c52-b14e-e59e8262e15c" xlink:to="loc_rmd_CombinedEuropeAsiaAndOtherMarketsMember_cb9f87be-d33d-4bba-a3d7-fbfc852d6547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_GlobalMember_68916e03-0c6a-4b6b-9a70-0607f7ae90b1" xlink:href="rmd-20220930.xsd#rmd_GlobalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e1c96f3e-8a27-4c52-b14e-e59e8262e15c" xlink:to="loc_rmd_GlobalMember_68916e03-0c6a-4b6b-9a70-0607f7ae90b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_938b79c0-81c7-4ac4-a7bb-a7d86cc7c17b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c5c16cf1-2bf5-4ae1-ae73-3d18e09b12a5" xlink:to="loc_srt_ProductOrServiceAxis_938b79c0-81c7-4ac4-a7bb-a7d86cc7c17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ad170275-9b53-4bbe-aca3-c657b100158e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_938b79c0-81c7-4ac4-a7bb-a7d86cc7c17b" xlink:to="loc_srt_ProductsAndServicesDomain_ad170275-9b53-4bbe-aca3-c657b100158e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DevicesMember_2ceb1325-0d7b-4035-b89b-ec79eedcdbcf" xlink:href="rmd-20220930.xsd#rmd_DevicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ad170275-9b53-4bbe-aca3-c657b100158e" xlink:to="loc_rmd_DevicesMember_2ceb1325-0d7b-4035-b89b-ec79eedcdbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MasksMember_9c7fbccd-5762-4521-9893-59d23c8f77c6" xlink:href="rmd-20220930.xsd#rmd_MasksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ad170275-9b53-4bbe-aca3-c657b100158e" xlink:to="loc_rmd_MasksMember_9c7fbccd-5762-4521-9893-59d23c8f77c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SleepAndRespiratoryMember_e9edc602-7745-4fc5-b989-7a960a4db15d" xlink:href="rmd-20220930.xsd#rmd_SleepAndRespiratoryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ad170275-9b53-4bbe-aca3-c657b100158e" xlink:to="loc_rmd_SleepAndRespiratoryMember_e9edc602-7745-4fc5-b989-7a960a4db15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SoftwareAsServiceMember_ce8a5ea2-0a34-45af-bc24-e695d075e2b7" xlink:href="rmd-20220930.xsd#rmd_SoftwareAsServiceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ad170275-9b53-4bbe-aca3-c657b100158e" xlink:to="loc_rmd_SoftwareAsServiceMember_ce8a5ea2-0a34-45af-bc24-e695d075e2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_46730dc7-8bf2-49e9-ac6f-057116e9ab98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c5c16cf1-2bf5-4ae1-ae73-3d18e09b12a5" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_46730dc7-8bf2-49e9-ac6f-057116e9ab98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_327ddf0f-2793-4f51-ad32-a3446b1389f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_46730dc7-8bf2-49e9-ac6f-057116e9ab98" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_327ddf0f-2793-4f51-ad32-a3446b1389f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e2e88ce6-0a89-45c6-82a9-8177630212e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ContractWithCustomerAssetAndLiabilityTable_cd72ef2d-18fe-4f82-9817-cdc0964101be" xlink:href="rmd-20220930.xsd#rmd_ContractWithCustomerAssetAndLiabilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2e88ce6-0a89-45c6-82a9-8177630212e4" xlink:to="loc_rmd_ContractWithCustomerAssetAndLiabilityTable_cd72ef2d-18fe-4f82-9817-cdc0964101be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_47a37c28-a2ef-4403-8471-fa5cd7ec3436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_ContractWithCustomerAssetAndLiabilityTable_cd72ef2d-18fe-4f82-9817-cdc0964101be" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_47a37c28-a2ef-4403-8471-fa5cd7ec3436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_47a37c28-a2ef-4403-8471-fa5cd7ec3436" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_AccountsReceivableNetMember_27d6767b-93dc-4f94-9e39-24a953475d5f" xlink:href="rmd-20220930.xsd#rmd_AccountsReceivableNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:to="loc_rmd_AccountsReceivableNetMember_27d6767b-93dc-4f94-9e39-24a953475d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ce142926-afc1-4c3c-ad47-3543cb6e5e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ce142926-afc1-4c3c-ad47-3543cb6e5e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember_24c25123-ccdf-482d-abcc-bc5dd5303d5d" xlink:href="rmd-20220930.xsd#rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:to="loc_rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember_24c25123-ccdf-482d-abcc-bc5dd5303d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DeferredRevenueCurrentLiabilitiesMember_3655eccf-59eb-4863-9d37-2ebb4d6547df" xlink:href="rmd-20220930.xsd#rmd_DeferredRevenueCurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:to="loc_rmd_DeferredRevenueCurrentLiabilitiesMember_3655eccf-59eb-4863-9d37-2ebb4d6547df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DeferredRevenueNonCurrentLiabilitiesMember_300d7172-721f-494e-958f-f55893f424c7" xlink:href="rmd-20220930.xsd#rmd_DeferredRevenueNonCurrentLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2a47bda9-f6e2-4c7f-82b4-639ebcaf0f6a" xlink:to="loc_rmd_DeferredRevenueNonCurrentLiabilitiesMember_300d7172-721f-494e-958f-f55893f424c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ContractWithCustomerAssetAndLiabilityLineItems_e10c3f57-8aaa-4686-a296-905b8e09a759" xlink:href="rmd-20220930.xsd#rmd_ContractWithCustomerAssetAndLiabilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_ContractWithCustomerAssetAndLiabilityTable_cd72ef2d-18fe-4f82-9817-cdc0964101be" xlink:to="loc_rmd_ContractWithCustomerAssetAndLiabilityLineItems_e10c3f57-8aaa-4686-a296-905b8e09a759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetAbstract_f61fe4c4-2c1e-4ccb-88f0-f8b73abd9a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_ContractWithCustomerAssetAndLiabilityLineItems_e10c3f57-8aaa-4686-a296-905b8e09a759" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetAbstract_f61fe4c4-2c1e-4ccb-88f0-f8b73abd9a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1e86bd9c-930b-4b6b-bfde-9a4117851ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetAbstract_f61fe4c4-2c1e-4ccb-88f0-f8b73abd9a47" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1e86bd9c-930b-4b6b-bfde-9a4117851ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_f90a555e-2822-429e-8865-afb624fb42f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetAbstract_f61fe4c4-2c1e-4ccb-88f0-f8b73abd9a47" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_f90a555e-2822-429e-8865-afb624fb42f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_ff265bf1-a0b8-40c3-a451-525e3cb85bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetAbstract_f61fe4c4-2c1e-4ccb-88f0-f8b73abd9a47" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_ff265bf1-a0b8-40c3-a451-525e3cb85bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract_ee18ddd6-0e18-4157-8495-abe424caeefb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_ContractWithCustomerAssetAndLiabilityLineItems_e10c3f57-8aaa-4686-a296-905b8e09a759" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityAbstract_ee18ddd6-0e18-4157-8495-abe424caeefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_852b6545-2102-473a-ab10-05ec9bf528e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_ee18ddd6-0e18-4157-8495-abe424caeefb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_852b6545-2102-473a-ab10-05ec9bf528e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_d33e3ba5-39cb-48c0-aab1-c00b6e463021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_ee18ddd6-0e18-4157-8495-abe424caeefb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_d33e3ba5-39cb-48c0-aab1-c00b6e463021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e4ce1775-3d14-4c43-927f-d9945e7a7c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_e4b376c0-d507-4a64-948e-043efd19e79c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e4ce1775-3d14-4c43-927f-d9945e7a7c27" xlink:to="loc_us-gaap_NumberOfOperatingSegments_e4b376c0-d507-4a64-948e-043efd19e79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c4fe0030-bdf2-424e-888b-147239b6178e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3b1b94e-7fc4-40d6-a365-618b1e16a526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c4fe0030-bdf2-424e-888b-147239b6178e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3b1b94e-7fc4-40d6-a365-618b1e16a526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ce485317-a1ad-4f3f-8e4b-ee6e42e7b1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3b1b94e-7fc4-40d6-a365-618b1e16a526" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ce485317-a1ad-4f3f-8e4b-ee6e42e7b1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b099dc7d-5720-47c3-8358-e039121ed5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ce485317-a1ad-4f3f-8e4b-ee6e42e7b1cd" xlink:to="loc_us-gaap_SegmentDomain_b099dc7d-5720-47c3-8358-e039121ed5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SleepAndRespiratoryMember_52522e8f-4111-459a-b893-39bf1b876f47" xlink:href="rmd-20220930.xsd#rmd_SleepAndRespiratoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b099dc7d-5720-47c3-8358-e039121ed5d2" xlink:to="loc_rmd_SleepAndRespiratoryMember_52522e8f-4111-459a-b893-39bf1b876f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SoftwareAsServiceMember_93cf72fc-5233-483d-81cf-5ac7dc216ce4" xlink:href="rmd-20220930.xsd#rmd_SoftwareAsServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b099dc7d-5720-47c3-8358-e039121ed5d2" xlink:to="loc_rmd_SoftwareAsServiceMember_93cf72fc-5233-483d-81cf-5ac7dc216ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a6072e25-0247-4873-8976-8f02366568f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3b1b94e-7fc4-40d6-a365-618b1e16a526" xlink:to="loc_srt_ConsolidationItemsAxis_a6072e25-0247-4873-8976-8f02366568f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_1d8e59a0-43e5-48b8-bb11-0bfc2d97a164" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_a6072e25-0247-4873-8976-8f02366568f0" xlink:to="loc_srt_ConsolidationItemsDomain_1d8e59a0-43e5-48b8-bb11-0bfc2d97a164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_5bdec908-bdb6-436d-a1e3-1291c270618e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_1d8e59a0-43e5-48b8-bb11-0bfc2d97a164" xlink:to="loc_us-gaap_OperatingSegmentsMember_5bdec908-bdb6-436d-a1e3-1291c270618e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c447e2f2-c295-48ef-afbd-c2c28bde2f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_1d8e59a0-43e5-48b8-bb11-0bfc2d97a164" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c447e2f2-c295-48ef-afbd-c2c28bde2f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_ce9a6c61-5d17-4183-a58b-87033788ebbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_1d8e59a0-43e5-48b8-bb11-0bfc2d97a164" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_ce9a6c61-5d17-4183-a58b-87033788ebbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3b1b94e-7fc4-40d6-a365-618b1e16a526" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_35df8dbb-56ab-44d8-9dfb-b30915522aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_35df8dbb-56ab-44d8-9dfb-b30915522aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_509a73d7-61b2-4d20-b022-5ca9a2fef283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_509a73d7-61b2-4d20-b022-5ca9a2fef283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9caf4fe1-398b-4a98-a60b-08c7477ae112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_OperatingIncomeLoss_9caf4fe1-398b-4a98-a60b-08c7477ae112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_UnallocatedCorporateCosts_c9adf584-1503-4844-8a46-853ab82887fb" xlink:href="rmd-20220930.xsd#rmd_UnallocatedCorporateCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_rmd_UnallocatedCorporateCosts_c9adf584-1503-4844-8a46-853ab82887fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_AmortizationOfAcquiredIntangibleAssets1_fe3f087f-93fd-429c-b8cb-fdf0ff2835ef" xlink:href="rmd-20220930.xsd#rmd_AmortizationOfAcquiredIntangibleAssets1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_rmd_AmortizationOfAcquiredIntangibleAssets1_fe3f087f-93fd-429c-b8cb-fdf0ff2835ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_26f1a987-39d2-4a93-894d-acdc889bc498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_InterestExpense_26f1a987-39d2-4a93-894d-acdc889bc498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9523f1e3-54de-4e9f-a284-61c99e7b3656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9523f1e3-54de-4e9f-a284-61c99e7b3656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_83ed00c7-4077-4b73-ba24-dc8d4eff6400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_83ed00c7-4077-4b73-ba24-dc8d4eff6400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6d560520-76b1-4f30-bd1c-b5fc6e7274e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6d560520-76b1-4f30-bd1c-b5fc6e7274e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_37a5a9bd-a973-486e-ab98-9e313b3e61fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99f47a66-4319-4e1a-83f4-390adcb34e0a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_37a5a9bd-a973-486e-ab98-9e313b3e61fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SupplementalBalanceSheetInformationScheduleOfInventoriesDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SupplementalBalanceSheetInformationAbstract_44f3bf11-3148-4026-a570-b306afadda83" xlink:href="rmd-20220930.xsd#rmd_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d8b10e9f-3cfc-45e3-9e19-60c2190932c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_44f3bf11-3148-4026-a570-b306afadda83" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d8b10e9f-3cfc-45e3-9e19-60c2190932c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_bea2c104-d080-477c-9634-9307ad463858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_44f3bf11-3148-4026-a570-b306afadda83" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_bea2c104-d080-477c-9634-9307ad463858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_88671480-6822-46a7-b835-e5e509a37a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_44f3bf11-3148-4026-a570-b306afadda83" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_88671480-6822-46a7-b835-e5e509a37a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d38f1dee-e453-4b61-83f0-1f57b9f39633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_44f3bf11-3148-4026-a570-b306afadda83" xlink:to="loc_us-gaap_InventoryNet_d38f1dee-e453-4b61-83f0-1f57b9f39633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SupplementalBalanceSheetInformationAbstract_cd2fc29a-b3a3-4531-b8b1-ba7969045615" xlink:href="rmd-20220930.xsd#rmd_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c82191f5-6404-49f4-bc4a-1c38a022f3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_cd2fc29a-b3a3-4531-b8b1-ba7969045615" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c82191f5-6404-49f4-bc4a-1c38a022f3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_db0727bd-0363-4eb1-8f1d-aeb83d811353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c82191f5-6404-49f4-bc4a-1c38a022f3eb" xlink:to="loc_us-gaap_PrepaidTaxes_db0727bd-0363-4eb1-8f1d-aeb83d811353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_PrepaidInventory_8f1c179f-89c7-4eaf-8fb5-c7926709c511" xlink:href="rmd-20220930.xsd#rmd_PrepaidInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c82191f5-6404-49f4-bc4a-1c38a022f3eb" xlink:to="loc_rmd_PrepaidInventory_8f1c179f-89c7-4eaf-8fb5-c7926709c511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_ed330c55-036e-402a-a914-a16bc9ce5c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c82191f5-6404-49f4-bc4a-1c38a022f3eb" xlink:to="loc_us-gaap_OtherAssetsCurrent_ed330c55-036e-402a-a914-a16bc9ce5c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c86ffb8f-7da1-4e47-b381-93bee437fd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_c82191f5-6404-49f4-bc4a-1c38a022f3eb" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c86ffb8f-7da1-4e47-b381-93bee437fd7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SupplementalBalanceSheetInformationAbstract_096125a4-b229-488e-a2d5-e8a5585157fa" xlink:href="rmd-20220930.xsd#rmd_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a35571ba-844e-41bf-ad25-c1ff23ae4963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_096125a4-b229-488e-a2d5-e8a5585157fa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a35571ba-844e-41bf-ad25-c1ff23ae4963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_de754be2-ee83-472b-99d6-dc3d66db57ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_096125a4-b229-488e-a2d5-e8a5585157fa" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_de754be2-ee83-472b-99d6-dc3d66db57ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_74acf942-a7ac-4c65-98e0-03bd738b11db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_096125a4-b229-488e-a2d5-e8a5585157fa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_74acf942-a7ac-4c65-98e0-03bd738b11db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SupplementalBalanceSheetInformationAbstract_13bdff22-645c-4481-bfe3-c5a440cc043d" xlink:href="rmd-20220930.xsd#rmd_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_48a93a88-60a1-4710-b3e0-424c460ed080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_SupplementalBalanceSheetInformationAbstract_13bdff22-645c-4481-bfe3-c5a440cc043d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_48a93a88-60a1-4710-b3e0-424c460ed080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1e7483a0-812d-45fb-949c-5b8aeef2d899" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_48a93a88-60a1-4710-b3e0-424c460ed080" xlink:to="loc_srt_RangeAxis_1e7483a0-812d-45fb-949c-5b8aeef2d899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a04cf0e2-1f90-461e-af7a-dc32d1c398de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1e7483a0-812d-45fb-949c-5b8aeef2d899" xlink:to="loc_srt_RangeMember_a04cf0e2-1f90-461e-af7a-dc32d1c398de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ea900896-0b07-41ef-95ee-d989640a0858" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a04cf0e2-1f90-461e-af7a-dc32d1c398de" xlink:to="loc_srt_MinimumMember_ea900896-0b07-41ef-95ee-d989640a0858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ce9c4558-c68f-4c40-a989-6a9ae6ea1e6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a04cf0e2-1f90-461e-af7a-dc32d1c398de" xlink:to="loc_srt_MaximumMember_ce9c4558-c68f-4c40-a989-6a9ae6ea1e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cac986e-96d3-48b3-8c10-6b4be11f1186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_48a93a88-60a1-4710-b3e0-424c460ed080" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cac986e-96d3-48b3-8c10-6b4be11f1186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f25f8bc-f328-4cf5-8b2c-701e86ab8a41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6cac986e-96d3-48b3-8c10-6b4be11f1186" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f25f8bc-f328-4cf5-8b2c-701e86ab8a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DevelopedOrCoreProductTechnologyMember_209df9f1-0593-4cc5-82a8-80c1dbe1bced" xlink:href="rmd-20220930.xsd#rmd_DevelopedOrCoreProductTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f25f8bc-f328-4cf5-8b2c-701e86ab8a41" xlink:to="loc_rmd_DevelopedOrCoreProductTechnologyMember_209df9f1-0593-4cc5-82a8-80c1dbe1bced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_28e4fdc6-e89a-4075-87a4-76bf2cec7e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f25f8bc-f328-4cf5-8b2c-701e86ab8a41" xlink:to="loc_us-gaap_CustomerRelationshipsMember_28e4fdc6-e89a-4075-87a4-76bf2cec7e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_b37c15de-1f3e-487e-8535-aedf736a8cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2f25f8bc-f328-4cf5-8b2c-701e86ab8a41" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_b37c15de-1f3e-487e-8535-aedf736a8cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3df0dacf-1e13-4d9d-b2d6-0df52d54e7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_48a93a88-60a1-4710-b3e0-424c460ed080" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3df0dacf-1e13-4d9d-b2d6-0df52d54e7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8a6aa239-3d48-45f6-b5ef-4ec3691efedf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3df0dacf-1e13-4d9d-b2d6-0df52d54e7d3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8a6aa239-3d48-45f6-b5ef-4ec3691efedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ff64c65b-2305-48b5-a582-38a88b1abc1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3df0dacf-1e13-4d9d-b2d6-0df52d54e7d3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ff64c65b-2305-48b5-a582-38a88b1abc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_856c2b11-35c2-4baa-b3d1-a73739835ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3df0dacf-1e13-4d9d-b2d6-0df52d54e7d3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_856c2b11-35c2-4baa-b3d1-a73739835ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_17f5e244-6aea-44ac-aa0a-1db88ce69f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3df0dacf-1e13-4d9d-b2d6-0df52d54e7d3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_17f5e244-6aea-44ac-aa0a-1db88ce69f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5be70183-1670-4837-a0e0-4233fdb2b1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ded4cb4e-f0c4-41c9-8019-6b841d6cf242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5be70183-1670-4837-a0e0-4233fdb2b1f5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ded4cb4e-f0c4-41c9-8019-6b841d6cf242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_81a8e5ee-814d-4a09-9f43-94845bd80522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ded4cb4e-f0c4-41c9-8019-6b841d6cf242" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_81a8e5ee-814d-4a09-9f43-94845bd80522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fd2a7086-add5-42ae-bfd7-3538344b476b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_81a8e5ee-814d-4a09-9f43-94845bd80522" xlink:to="loc_us-gaap_SegmentDomain_fd2a7086-add5-42ae-bfd7-3538344b476b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SleepAndRespiratoryMember_3614e313-b540-4de0-80fc-d45cfd46bfe4" xlink:href="rmd-20220930.xsd#rmd_SleepAndRespiratoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fd2a7086-add5-42ae-bfd7-3538344b476b" xlink:to="loc_rmd_SleepAndRespiratoryMember_3614e313-b540-4de0-80fc-d45cfd46bfe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SaasMember_d6d530fa-6626-46bd-91dc-93f9e8670989" xlink:href="rmd-20220930.xsd#rmd_SaasMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fd2a7086-add5-42ae-bfd7-3538344b476b" xlink:to="loc_rmd_SaasMember_d6d530fa-6626-46bd-91dc-93f9e8670989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_6a4cb5e3-5fec-4c76-bfa4-1aea6eef7f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ded4cb4e-f0c4-41c9-8019-6b841d6cf242" xlink:to="loc_us-gaap_GoodwillLineItems_6a4cb5e3-5fec-4c76-bfa4-1aea6eef7f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_4aa0d9bf-8c58-481e-9996-e418447e771a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_6a4cb5e3-5fec-4c76-bfa4-1aea6eef7f51" xlink:to="loc_us-gaap_GoodwillRollForward_4aa0d9bf-8c58-481e-9996-e418447e771a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6aff3ccb-1f32-4ddb-b21d-9caf24fdccc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4aa0d9bf-8c58-481e-9996-e418447e771a" xlink:to="loc_us-gaap_Goodwill_6aff3ccb-1f32-4ddb-b21d-9caf24fdccc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8d16f995-5216-44d0-801c-cda33d496e66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4aa0d9bf-8c58-481e-9996-e418447e771a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8d16f995-5216-44d0-801c-cda33d496e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3aa07c1e-7b2f-4724-99ee-c9af332d9591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4aa0d9bf-8c58-481e-9996-e418447e771a" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3aa07c1e-7b2f-4724-99ee-c9af332d9591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b965d661-84b0-4847-9484-29cfe549f9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_4aa0d9bf-8c58-481e-9996-e418447e771a" xlink:to="loc_us-gaap_Goodwill_b965d661-84b0-4847-9484-29cfe549f9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#InvestmentsScheduleOfInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_724798de-907a-4188-8e71-145c512221db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MarketableEquityInvestmentsFairValue_b41b5efe-80a9-4c07-9125-e215ec075d3b" xlink:href="rmd-20220930.xsd#rmd_MarketableEquityInvestmentsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_724798de-907a-4188-8e71-145c512221db" xlink:to="loc_rmd_MarketableEquityInvestmentsFairValue_b41b5efe-80a9-4c07-9125-e215ec075d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_ee812ee4-6aac-4f83-aeb8-0426d1a42a34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_724798de-907a-4188-8e71-145c512221db" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_ee812ee4-6aac-4f83-aeb8-0426d1a42a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_89ad0b26-b66b-43de-9649-d0fd9db4993b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_724798de-907a-4188-8e71-145c512221db" xlink:to="loc_us-gaap_EquityMethodInvestments_89ad0b26-b66b-43de-9649-d0fd9db4993b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_EquityInvestmentsTotalByMeasurementCategory_e702694f-dbdc-4ec7-96e6-a8acd0e954e1" xlink:href="rmd-20220930.xsd#rmd_EquityInvestmentsTotalByMeasurementCategory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_724798de-907a-4188-8e71-145c512221db" xlink:to="loc_rmd_EquityInvestmentsTotalByMeasurementCategory_e702694f-dbdc-4ec7-96e6-a8acd0e954e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#InvestmentsScheduleOfChangesInEquityInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_ab1a28e0-896b-4824-8818-b2ed409061f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_29c777b4-5b37-4742-a921-2929ac77e6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_ab1a28e0-896b-4824-8818-b2ed409061f7" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_29c777b4-5b37-4742-a921-2929ac77e6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6a314284-c2c2-4b0e-96ad-eb58ebc65ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_29c777b4-5b37-4742-a921-2929ac77e6ff" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6a314284-c2c2-4b0e-96ad-eb58ebc65ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c36dbee7-e488-469b-ae77-088bd98a8b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6a314284-c2c2-4b0e-96ad-eb58ebc65ee3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c36dbee7-e488-469b-ae77-088bd98a8b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_NonMarketableSecuritiesMember_f9e094f4-e53c-47b9-9dc0-fc9b3459a0d2" xlink:href="rmd-20220930.xsd#rmd_NonMarketableSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c36dbee7-e488-469b-ae77-088bd98a8b1e" xlink:to="loc_rmd_NonMarketableSecuritiesMember_f9e094f4-e53c-47b9-9dc0-fc9b3459a0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MarketableSecuritiesMember_a0148ad9-9039-4043-9677-6d988eb22828" xlink:href="rmd-20220930.xsd#rmd_MarketableSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c36dbee7-e488-469b-ae77-088bd98a8b1e" xlink:to="loc_rmd_MarketableSecuritiesMember_a0148ad9-9039-4043-9677-6d988eb22828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsMember_cf3ad045-672a-4ec8-9cc9-6812ec4638a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c36dbee7-e488-469b-ae77-088bd98a8b1e" xlink:to="loc_us-gaap_EquityMethodInvestmentsMember_cf3ad045-672a-4ec8-9cc9-6812ec4638a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_f25b9874-2db5-4973-b501-48710b4f4a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_29c777b4-5b37-4742-a921-2929ac77e6ff" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_f25b9874-2db5-4973-b501-48710b4f4a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:href="rmd-20220930.xsd#rmd_DebtAndEquityInvestmentsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_f25b9874-2db5-4973-b501-48710b4f4a89" xlink:to="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_EquityInvestments_93cee6cf-e884-45a1-829c-8ff410fd6433" xlink:href="rmd-20220930.xsd#rmd_EquityInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:to="loc_rmd_EquityInvestments_93cee6cf-e884-45a1-829c-8ff410fd6433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_AdditionalEquityInvestments_c04106e8-e475-4567-a10a-90a9aeea1e5c" xlink:href="rmd-20220930.xsd#rmd_AdditionalEquityInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:to="loc_rmd_AdditionalEquityInvestments_c04106e8-e475-4567-a10a-90a9aeea1e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities_3502368a-2347-4e14-9f1b-78da4426973e" xlink:href="rmd-20220930.xsd#rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:to="loc_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities_3502368a-2347-4e14-9f1b-78da4426973e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_01c0c3ba-54a9-4f87-ba78-37c57ad63f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_01c0c3ba-54a9-4f87-ba78-37c57ad63f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_8200c989-6918-42f7-b3a7-bf3b77815624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_8200c989-6918-42f7-b3a7-bf3b77815624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a29f4281-3da3-4be9-8433-91c5247f1ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a29f4281-3da3-4be9-8433-91c5247f1ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_EquityInvestments_6338092a-13d0-4a99-bec7-76ce0c6054ec" xlink:href="rmd-20220930.xsd#rmd_EquityInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_DebtAndEquityInvestmentsRollForward_b8d3dcb1-347b-4a85-bdd6-3d1d466912e1" xlink:to="loc_rmd_EquityInvestments_6338092a-13d0-4a99-bec7-76ce0c6054ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_b52074c2-4a72-4964-88db-43a37d8b78d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_6293c3e6-6dfc-41f8-913b-ca3b4fbbea7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_b52074c2-4a72-4964-88db-43a37d8b78d6" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_6293c3e6-6dfc-41f8-913b-ca3b4fbbea7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e20b79d0-9a3e-47c5-a406-9ce5989a6c44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_15165cc2-5516-4d2c-9fa7-5235e919cb41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e20b79d0-9a3e-47c5-a406-9ce5989a6c44" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_15165cc2-5516-4d2c-9fa7-5235e919cb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_e27fdb91-e900-48b9-8657-499cb43fcb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_15165cc2-5516-4d2c-9fa7-5235e919cb41" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_e27fdb91-e900-48b9-8657-499cb43fcb4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_3f8ced5a-489c-4376-acc8-812b529537aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_e27fdb91-e900-48b9-8657-499cb43fcb4f" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_3f8ced5a-489c-4376-acc8-812b529537aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_7510c232-8068-4a86-94fb-9a57864cd76d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3f8ced5a-489c-4376-acc8-812b529537aa" xlink:to="loc_us-gaap_DomesticCountryMember_7510c232-8068-4a86-94fb-9a57864cd76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_3f8b4f10-b4ec-4f69-9249-992d574f756f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_15165cc2-5516-4d2c-9fa7-5235e919cb41" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_3f8b4f10-b4ec-4f69-9249-992d574f756f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_7da7cff6-cd46-4dc1-b03d-0725370dcb62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_3f8b4f10-b4ec-4f69-9249-992d574f756f" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_7da7cff6-cd46-4dc1-b03d-0725370dcb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AustralianTaxationOfficeMember_91ae7751-0904-4630-9ae5-0e816c2bbfec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AustralianTaxationOfficeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_7da7cff6-cd46-4dc1-b03d-0725370dcb62" xlink:to="loc_us-gaap_AustralianTaxationOfficeMember_91ae7751-0904-4630-9ae5-0e816c2bbfec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_1b14f7ed-b24f-4962-bc5b-cec86ed0027e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_15165cc2-5516-4d2c-9fa7-5235e919cb41" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_1b14f7ed-b24f-4962-bc5b-cec86ed0027e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_IncomeTaxExaminationRemittedFinalPayment_9f6112f8-a0b6-4a88-9e7b-0117cfa1da9d" xlink:href="rmd-20220930.xsd#rmd_IncomeTaxExaminationRemittedFinalPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1b14f7ed-b24f-4962-bc5b-cec86ed0027e" xlink:to="loc_rmd_IncomeTaxExaminationRemittedFinalPayment_9f6112f8-a0b6-4a88-9e7b-0117cfa1da9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_IncomeTaxExaminationGrossSettlement_628531df-236f-4bec-8bc3-97b9306c6923" xlink:href="rmd-20220930.xsd#rmd_IncomeTaxExaminationGrossSettlement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1b14f7ed-b24f-4962-bc5b-cec86ed0027e" xlink:to="loc_rmd_IncomeTaxExaminationGrossSettlement_628531df-236f-4bec-8bc3-97b9306c6923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_IncomeTaxExaminationPriorRemittancePayments_cd310310-a73f-48ed-8a37-dc06a58bd4aa" xlink:href="rmd-20220930.xsd#rmd_IncomeTaxExaminationPriorRemittancePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1b14f7ed-b24f-4962-bc5b-cec86ed0027e" xlink:to="loc_rmd_IncomeTaxExaminationPriorRemittancePayments_cd310310-a73f-48ed-8a37-dc06a58bd4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/ProductWarrantiesScheduleOfChangesInLiabilityForWarrantyCostsDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#ProductWarrantiesScheduleOfChangesInLiabilityForWarrantyCostsDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/ProductWarrantiesScheduleOfChangesInLiabilityForWarrantyCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_94d48be1-7dfe-43b0-ad45-4dd12e7b144c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_29eca7af-e388-451b-8cbb-e121c6c498a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_94d48be1-7dfe-43b0-ad45-4dd12e7b144c" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_29eca7af-e388-451b-8cbb-e121c6c498a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_8591e1c9-2458-42b6-baf8-fcc22f190911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_29eca7af-e388-451b-8cbb-e121c6c498a9" xlink:to="loc_us-gaap_ProductWarrantyAccrual_8591e1c9-2458-42b6-baf8-fcc22f190911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_51419b36-1893-4507-9233-dc281c02eaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_29eca7af-e388-451b-8cbb-e121c6c498a9" xlink:to="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_51419b36-1893-4507-9233-dc281c02eaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_b3e9ed5b-e26e-4738-bdc6-017e8c5235fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_29eca7af-e388-451b-8cbb-e121c6c498a9" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_b3e9ed5b-e26e-4738-bdc6-017e8c5235fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss_a080fab6-0f00-4c0d-a6c1-055d5efb87b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_29eca7af-e388-451b-8cbb-e121c6c498a9" xlink:to="loc_us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss_a080fab6-0f00-4c0d-a6c1-055d5efb87b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_26ceb315-e23d-4778-a7af-b19371b1ddea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_29eca7af-e388-451b-8cbb-e121c6c498a9" xlink:to="loc_us-gaap_ProductWarrantyAccrual_26ceb315-e23d-4778-a7af-b19371b1ddea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#DebtScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/DebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_db9e774e-94b6-4fd1-a114-dd89b08905d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ShortTermDebtGross_244e7699-a36f-4fdf-ba4a-274619832f4b" xlink:href="rmd-20220930.xsd#rmd_ShortTermDebtGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_db9e774e-94b6-4fd1-a114-dd89b08905d4" xlink:to="loc_rmd_ShortTermDebtGross_244e7699-a36f-4fdf-ba4a-274619832f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet_6d8d2431-71d6-42fd-ab4a-c404adca49c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsCurrentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_db9e774e-94b6-4fd1-a114-dd89b08905d4" xlink:to="loc_us-gaap_DeferredFinanceCostsCurrentNet_6d8d2431-71d6-42fd-ab4a-c404adca49c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_53586ac5-a290-4fe7-9e17-f45fb6ca8664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_db9e774e-94b6-4fd1-a114-dd89b08905d4" xlink:to="loc_us-gaap_ShortTermBorrowings_53586ac5-a290-4fe7-9e17-f45fb6ca8664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_bbac6ce0-583b-45da-8e83-51d466adc5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_db9e774e-94b6-4fd1-a114-dd89b08905d4" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_bbac6ce0-583b-45da-8e83-51d466adc5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_80a3e325-a684-4554-bf23-7387766d3e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_db9e774e-94b6-4fd1-a114-dd89b08905d4" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_80a3e325-a684-4554-bf23-7387766d3e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_552c270f-4285-42be-988a-58980db96f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_db9e774e-94b6-4fd1-a114-dd89b08905d4" xlink:to="loc_us-gaap_LongTermDebt_552c270f-4285-42be-988a-58980db96f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_e564af95-16da-48eb-8359-76356d479465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_db9e774e-94b6-4fd1-a114-dd89b08905d4" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_e564af95-16da-48eb-8359-76356d479465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ff07f22f-45d5-4b44-832e-cb0412d06344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ff07f22f-45d5-4b44-832e-cb0412d06344" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_42a12fd4-3020-42e0-b7d8-b92a8a6c6f25" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:to="loc_dei_LegalEntityAxis_42a12fd4-3020-42e0-b7d8-b92a8a6c6f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a35d186b-47ca-483e-837f-a51f0cf81179" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_42a12fd4-3020-42e0-b7d8-b92a8a6c6f25" xlink:to="loc_dei_EntityDomain_a35d186b-47ca-483e-837f-a51f0cf81179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ResmedLimitedMember_eb5d127b-841e-49bc-957e-c05fa38e6a48" xlink:href="rmd-20220930.xsd#rmd_ResmedLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a35d186b-47ca-483e-837f-a51f0cf81179" xlink:to="loc_rmd_ResmedLimitedMember_eb5d127b-841e-49bc-957e-c05fa38e6a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_307497e3-0a7b-4613-b86e-219c22cdbde2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:to="loc_us-gaap_CreditFacilityAxis_307497e3-0a7b-4613-b86e-219c22cdbde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5327b8cf-8f8c-42e1-aa20-2ece7503d73b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_307497e3-0a7b-4613-b86e-219c22cdbde2" xlink:to="loc_us-gaap_CreditFacilityDomain_5327b8cf-8f8c-42e1-aa20-2ece7503d73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember_cba5e8a7-40f3-4d17-9d1e-29178348e811" xlink:href="rmd-20220930.xsd#rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5327b8cf-8f8c-42e1-aa20-2ece7503d73b" xlink:to="loc_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember_cba5e8a7-40f3-4d17-9d1e-29178348e811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_59f8c29d-6c60-4066-b3bb-bced498114d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember_cba5e8a7-40f3-4d17-9d1e-29178348e811" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_59f8c29d-6c60-4066-b3bb-bced498114d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_TermLoanCreditAgreementMember_8b77af9d-7368-42a1-b9e6-e96c685148f3" xlink:href="rmd-20220930.xsd#rmd_TermLoanCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember_cba5e8a7-40f3-4d17-9d1e-29178348e811" xlink:to="loc_rmd_TermLoanCreditAgreementMember_8b77af9d-7368-42a1-b9e6-e96c685148f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_0fa2cbd6-25ec-4154-94dc-41e6a56c6513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_0fa2cbd6-25ec-4154-94dc-41e6a56c6513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_dbc172d6-1e54-4af0-bdd1-70c419cf0e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_0fa2cbd6-25ec-4154-94dc-41e6a56c6513" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_dbc172d6-1e54-4af0-bdd1-70c419cf0e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MufgUnionBankNaAndWestpacBankingCorporationMember_5d74f86f-d58e-4a11-9594-db9b7d0ea687" xlink:href="rmd-20220930.xsd#rmd_MufgUnionBankNaAndWestpacBankingCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_dbc172d6-1e54-4af0-bdd1-70c419cf0e08" xlink:to="loc_rmd_MufgUnionBankNaAndWestpacBankingCorporationMember_5d74f86f-d58e-4a11-9594-db9b7d0ea687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_MufgUnionBankMember_da5ae9ae-9b2e-4c28-acb3-7f59cb2975c6" xlink:href="rmd-20220930.xsd#rmd_MufgUnionBankMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_dbc172d6-1e54-4af0-bdd1-70c419cf0e08" xlink:to="loc_rmd_MufgUnionBankMember_da5ae9ae-9b2e-4c28-acb3-7f59cb2975c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fc15b035-8e08-4ce0-848c-dbc831448948" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:to="loc_srt_RangeAxis_fc15b035-8e08-4ce0-848c-dbc831448948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6746bb17-ac51-4717-aa0d-28f7c46ab58b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fc15b035-8e08-4ce0-848c-dbc831448948" xlink:to="loc_srt_RangeMember_6746bb17-ac51-4717-aa0d-28f7c46ab58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_44d31727-88ac-422c-bf46-de134032ec59" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6746bb17-ac51-4717-aa0d-28f7c46ab58b" xlink:to="loc_srt_MinimumMember_44d31727-88ac-422c-bf46-de134032ec59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d679c736-e609-4e09-b248-1380a8045a58" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6746bb17-ac51-4717-aa0d-28f7c46ab58b" xlink:to="loc_srt_MaximumMember_d679c736-e609-4e09-b248-1380a8045a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e75cdefe-683f-4a29-982c-c341465a806a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:to="loc_us-gaap_VariableRateAxis_e75cdefe-683f-4a29-982c-c341465a806a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d647a928-7d36-40fb-9ec9-62ee8d507568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_e75cdefe-683f-4a29-982c-c341465a806a" xlink:to="loc_us-gaap_VariableRateDomain_d647a928-7d36-40fb-9ec9-62ee8d507568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f3b4e5ad-e6bb-40a5-9fde-9bb5f8f0e27d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_d647a928-7d36-40fb-9ec9-62ee8d507568" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f3b4e5ad-e6bb-40a5-9fde-9bb5f8f0e27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_362a5e7f-7097-42a5-b954-83629d35ac0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_d647a928-7d36-40fb-9ec9-62ee8d507568" xlink:to="loc_us-gaap_BaseRateMember_362a5e7f-7097-42a5-b954-83629d35ac0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_93354555-d135-47dd-a75b-bdeb133ff315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_93354555-d135-47dd-a75b-bdeb133ff315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8330764f-2162-4bf4-8501-8f73b0ecb147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_93354555-d135-47dd-a75b-bdeb133ff315" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8330764f-2162-4bf4-8501-8f73b0ecb147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SeniorNotesOneMember_bf163139-b870-4230-a8c3-2c71e41056dc" xlink:href="rmd-20220930.xsd#rmd_SeniorNotesOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8330764f-2162-4bf4-8501-8f73b0ecb147" xlink:to="loc_rmd_SeniorNotesOneMember_bf163139-b870-4230-a8c3-2c71e41056dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_SeniorNotesTwoMember_17189a17-1458-4b93-ad76-73ac9c26bb5b" xlink:href="rmd-20220930.xsd#rmd_SeniorNotesTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8330764f-2162-4bf4-8501-8f73b0ecb147" xlink:to="loc_rmd_SeniorNotesTwoMember_17189a17-1458-4b93-ad76-73ac9c26bb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c9106c66-8494-4090-bb58-2ad50c08656b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8330764f-2162-4bf4-8501-8f73b0ecb147" xlink:to="loc_us-gaap_SeniorNotesMember_c9106c66-8494-4090-bb58-2ad50c08656b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember_8157982c-4e50-4484-8eff-d995cee53289" xlink:href="rmd-20220930.xsd#rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8330764f-2162-4bf4-8501-8f73b0ecb147" xlink:to="loc_rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember_8157982c-4e50-4484-8eff-d995cee53289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e488fed4-f0a3-454a-bea6-59a31891828b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_350b44d7-bfdb-471a-9f20-3b3490f863e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_350b44d7-bfdb-471a-9f20-3b3490f863e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_UncommittedOptionToIncreaseCreditFacility_e6eac84c-2eb4-4e59-bb9b-c33b6571ba55" xlink:href="rmd-20220930.xsd#rmd_UncommittedOptionToIncreaseCreditFacility"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_rmd_UncommittedOptionToIncreaseCreditFacility_e6eac84c-2eb4-4e59-bb9b-c33b6571ba55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod_05f5a45a-bb99-4d31-8799-7d5ddf926ab9" xlink:href="rmd-20220930.xsd#rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod_05f5a45a-bb99-4d31-8799-7d5ddf926ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal_e20ac241-c796-4977-a71d-2ec6ecc5ae54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal_e20ac241-c796-4977-a71d-2ec6ecc5ae54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0b272357-636b-45bb-a3d7-55603e2ba06f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0b272357-636b-45bb-a3d7-55603e2ba06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c1caae8a-f864-49a5-bcbf-2a186b88cf95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_c1caae8a-f864-49a5-bcbf-2a186b88cf95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_fcf8c230-6f75-44df-a47e-9a09ca96623e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_fcf8c230-6f75-44df-a47e-9a09ca96623e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_b428e521-6659-4984-9f49-31b438aa356b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_b428e521-6659-4984-9f49-31b438aa356b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_cfb43514-44a6-4eb2-83ae-798be4fd5d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_LongTermDebtFairValue_cfb43514-44a6-4eb2-83ae-798be4fd5d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ab6a3e43-7127-4406-8a01-a16eaf36b941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ab6a3e43-7127-4406-8a01-a16eaf36b941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_beca4d50-a4ea-43b9-994c-e3d521db5b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_beca4d50-a4ea-43b9-994c-e3d521db5b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_DebtToConsolidatedEbitdaRatio_626cc586-3fac-4a5f-84a0-c1fa5c212cf4" xlink:href="rmd-20220930.xsd#rmd_DebtToConsolidatedEbitdaRatio"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_rmd_DebtToConsolidatedEbitdaRatio_626cc586-3fac-4a5f-84a0-c1fa5c212cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_LineOfCreditFacilityCollateralPercentageOfCompany_85998aef-11e0-4a93-ad2c-c8f32472201d" xlink:href="rmd-20220930.xsd#rmd_LineOfCreditFacilityCollateralPercentageOfCompany"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_rmd_LineOfCreditFacilityCollateralPercentageOfCompany_85998aef-11e0-4a93-ad2c-c8f32472201d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_0dfb5673-081d-4607-bad0-9d9db8fbc459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_SeniorNotes_0dfb5673-081d-4607-bad0-9d9db8fbc459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_16547033-92a3-4ddc-bf40-cbd65a10aa0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5a806d0c-09de-4233-94dc-9d6b74ed7753" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_16547033-92a3-4ddc-bf40-cbd65a10aa0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/EarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#EarningsPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/EarningsPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3818cb92-3754-404d-9499-323689c95311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0d484b63-97b5-4061-9af6-0c578cc6ee1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3818cb92-3754-404d-9499-323689c95311" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0d484b63-97b5-4061-9af6-0c578cc6ee1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7a840020-c531-4ef6-86c5-0f60d824ec6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_2258457e-3031-46bd-ba76-9c88851f69a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a840020-c531-4ef6-86c5-0f60d824ec6b" xlink:to="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_2258457e-3031-46bd-ba76-9c88851f69a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4a2767d0-eb7c-49ee-8472-da521c00f630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_2258457e-3031-46bd-ba76-9c88851f69a8" xlink:to="loc_us-gaap_NetIncomeLoss_4a2767d0-eb7c-49ee-8472-da521c00f630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_60336313-01b2-4138-8dac-ca5061f8594a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a840020-c531-4ef6-86c5-0f60d824ec6b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_60336313-01b2-4138-8dac-ca5061f8594a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_030e290e-104c-4a15-a4ee-c0138a0da3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_60336313-01b2-4138-8dac-ca5061f8594a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_030e290e-104c-4a15-a4ee-c0138a0da3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_c0cfcbb6-ee5c-48dd-a244-25c3fae5c78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_60336313-01b2-4138-8dac-ca5061f8594a" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_c0cfcbb6-ee5c-48dd-a244-25c3fae5c78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_13269315-8942-47d1-8993-2fa620048756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_c0cfcbb6-ee5c-48dd-a244-25c3fae5c78d" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_13269315-8942-47d1-8993-2fa620048756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_de0f0495-ccf5-4bfd-93bd-596daa427698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_c0cfcbb6-ee5c-48dd-a244-25c3fae5c78d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_de0f0495-ccf5-4bfd-93bd-596daa427698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_276dd8f1-9314-408d-86e8-a6283cb28c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_60336313-01b2-4138-8dac-ca5061f8594a" xlink:to="loc_us-gaap_EarningsPerShareBasic_276dd8f1-9314-408d-86e8-a6283cb28c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_ede078c1-8334-4e55-aafe-915c0fb0c009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_60336313-01b2-4138-8dac-ca5061f8594a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_ede078c1-8334-4e55-aafe-915c0fb0c009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://investor.resmed.com/role/LegalActionsContingenciesandCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="rmd-20220930.xsd#LegalActionsContingenciesandCommitmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://investor.resmed.com/role/LegalActionsContingenciesandCommitmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fa4411e8-4bca-40dd-8e62-038e8902d6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rmd_ReceivablesSoldWithLimitedRecourse_0bb75637-34ec-4418-be36-e9bbe1a0e3dc" xlink:href="rmd-20220930.xsd#rmd_ReceivablesSoldWithLimitedRecourse"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fa4411e8-4bca-40dd-8e62-038e8902d6ac" xlink:to="loc_rmd_ReceivablesSoldWithLimitedRecourse_0bb75637-34ec-4418-be36-e9bbe1a0e3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_0a694237-4e91-48b9-a08a-0d1e0a1fe99d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fa4411e8-4bca-40dd-8e62-038e8902d6ac" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_0a694237-4e91-48b9-a08a-0d1e0a1fe99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_a8a926cd-8f5d-42f7-af7c-f015c8bc244b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fa4411e8-4bca-40dd-8e62-038e8902d6ac" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_a8a926cd-8f5d-42f7-af7c-f015c8bc244b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_20e80577-c2bb-4239-8fb0-5a4853927d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fa4411e8-4bca-40dd-8e62-038e8902d6ac" xlink:to="loc_us-gaap_ContractualObligation_20e80577-c2bb-4239-8fb0-5a4853927d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554107641504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ResMed Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0152841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9001 Spectrum Center Blvd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">US<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">836-5000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.004 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RMD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,483,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000943819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554106707056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 207,163<span></span>
</td>
<td class="nump">$ 273,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $23,867 and $23,259 at September&#160;30, 2022 and June&#160;30, 2022, respectively</a></td>
<td class="nump">620,483<span></span>
</td>
<td class="nump">575,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories (note 3)</a></td>
<td class="nump">864,852<span></span>
</td>
<td class="nump">743,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets (note 3)</a></td>
<td class="nump">341,199<span></span>
</td>
<td class="nump">337,908<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,033,697<span></span>
</td>
<td class="nump">1,931,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net (note 3)</a></td>
<td class="nump">487,376<span></span>
</td>
<td class="nump">498,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">125,319<span></span>
</td>
<td class="nump">132,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill (note 4)</a></td>
<td class="nump">1,938,843<span></span>
</td>
<td class="nump">1,936,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net (note 3)</a></td>
<td class="nump">338,151<span></span>
</td>
<td class="nump">345,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent', window );">Deferred income taxes</a></td>
<td class="nump">80,745<span></span>
</td>
<td class="nump">79,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Prepaid taxes and other non-current assets</a></td>
<td class="nump">173,429<span></span>
</td>
<td class="nump">171,748<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">3,143,863<span></span>
</td>
<td class="nump">3,164,375<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">5,177,560<span></span>
</td>
<td class="nump">5,095,853<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">181,485<span></span>
</td>
<td class="nump">159,245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">324,055<span></span>
</td>
<td class="nump">344,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">21,076<span></span>
</td>
<td class="nump">21,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">108,195<span></span>
</td>
<td class="nump">108,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable (note 6)</a></td>
<td class="nump">47,942<span></span>
</td>
<td class="nump">44,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt, net (note 8)</a></td>
<td class="nump">9,906<span></span>
</td>
<td class="nump">9,916<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">692,659<span></span>
</td>
<td class="nump">689,299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue</a></td>
<td class="nump">97,620<span></span>
</td>
<td class="nump">95,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent', window );">Deferred income taxes</a></td>
<td class="nump">11,830<span></span>
</td>
<td class="nump">9,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">114,214<span></span>
</td>
<td class="nump">120,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">5,838<span></span>
</td>
<td class="nump">5,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net (note 8)</a></td>
<td class="nump">785,436<span></span>
</td>
<td class="nump">765,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Long-term income taxes payable (note 6)</a></td>
<td class="nump">37,076<span></span>
</td>
<td class="nump">48,882<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">1,052,014<span></span>
</td>
<td class="nump">1,045,803<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,744,673<span></span>
</td>
<td class="nump">1,735,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.004 par value, 350,000,000 shares authorized; 188,295,266 issued and 146,459,032 outstanding at September&#160;30, 2022 and 188,246,955 issued and 146,410,721 outstanding at June&#160;30, 2022</a></td>
<td class="nump">586<span></span>
</td>
<td class="nump">586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,701,902<span></span>
</td>
<td class="nump">1,682,432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">3,759,783<span></span>
</td>
<td class="nump">3,613,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 41,836,234 shares at September&#160;30, 2022 and June&#160;30, 2022</a></td>
<td class="num">(1,623,256)<span></span>
</td>
<td class="num">(1,623,256)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(406,128)<span></span>
</td>
<td class="num">(312,747)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">3,432,887<span></span>
</td>
<td class="nump">3,360,751<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 5,177,560<span></span>
</td>
<td class="nump">$ 5,095,853<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554105487008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for credit loss, current</a></td>
<td class="nump">$ 23,867<span></span>
</td>
<td class="nump">$ 23,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share (dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share (dollars per share)</a></td>
<td class="nump">$ 0.004<span></span>
</td>
<td class="nump">$ 0.004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (shares)</a></td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (shares)</a></td>
<td class="nump">188,295,266<span></span>
</td>
<td class="nump">188,246,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (shares)</a></td>
<td class="nump">146,459,032<span></span>
</td>
<td class="nump">146,410,721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (shares)</a></td>
<td class="nump">41,836,234<span></span>
</td>
<td class="nump">41,836,234<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554107732752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 950,294<span></span>
</td>
<td class="nump">$ 904,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of sales (exclusive of amortization shown separately below)</a></td>
<td class="nump">403,110<span></span>
</td>
<td class="nump">386,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">6,374<span></span>
</td>
<td class="nump">11,059<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of sales</a></td>
<td class="nump">409,484<span></span>
</td>
<td class="nump">397,726<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">540,810<span></span>
</td>
<td class="nump">506,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative</a></td>
<td class="nump">193,933<span></span>
</td>
<td class="nump">176,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">63,188<span></span>
</td>
<td class="nump">59,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_AmortizationOfAcquiredIntangibleAssets1', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">7,950<span></span>
</td>
<td class="nump">7,707<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">265,071<span></span>
</td>
<td class="nump">244,376<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">275,739<span></span>
</td>
<td class="nump">261,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (loss), net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest (expense) income, net</a></td>
<td class="num">(7,134)<span></span>
</td>
<td class="num">(5,360)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss attributable to equity method investments (note 5)</a></td>
<td class="num">(2,028)<span></span>
</td>
<td class="num">(1,386)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Gain (loss) on equity investments (note 5)</a></td>
<td class="num">(3,280)<span></span>
</td>
<td class="nump">5,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(1,504)<span></span>
</td>
<td class="num">(1,991)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (loss), net</a></td>
<td class="num">(13,946)<span></span>
</td>
<td class="num">(3,125)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">261,793<span></span>
</td>
<td class="nump">258,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">51,315<span></span>
</td>
<td class="nump">55,175<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 210,478<span></span>
</td>
<td class="nump">$ 203,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (dollars per share)</a></td>
<td class="nump">$ 1.44<span></span>
</td>
<td class="nump">$ 1.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (dollars per share)</a></td>
<td class="nump">1.43<span></span>
</td>
<td class="nump">1.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend declared per share (dollars per share)</a></td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic shares outstanding (000's) (in shares)</a></td>
<td class="nump">146,431<span></span>
</td>
<td class="nump">145,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted shares outstanding (000's) (in shares)</a></td>
<td class="nump">147,134<span></span>
</td>
<td class="nump">146,860<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rmd_SleepAndRespiratoryMember', window );">Total Sleep and Respiratory Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 844,443<span></span>
</td>
<td class="nump">$ 806,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of sales (exclusive of amortization shown separately below)</a></td>
<td class="nump">363,844<span></span>
</td>
<td class="nump">349,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">1,228<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rmd_SoftwareAsServiceMember', window );">Software as a Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">105,851<span></span>
</td>
<td class="nump">97,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of sales (exclusive of amortization shown separately below)</a></td>
<td class="nump">39,266<span></span>
</td>
<td class="nump">36,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">$ 5,146<span></span>
</td>
<td class="nump">$ 10,159<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_AmortizationOfAcquiredIntangibleAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of acquired intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_AmortizationOfAcquiredIntangibleAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rmd_SleepAndRespiratoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rmd_SleepAndRespiratoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rmd_SoftwareAsServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rmd_SoftwareAsServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554107578560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements Of Comprehensive Income (Loss) (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 210,478<span></span>
</td>
<td class="nump">$ 203,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation (loss) gain adjustments</a></td>
<td class="num">(93,381)<span></span>
</td>
<td class="num">(23,516)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 117,097<span></span>
</td>
<td class="nump">$ 180,097<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554102845792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements Of Changes In Equity (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional &#8206;Paid-in Capital</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated &#8206;Other &#8206;Comprehensive Income (Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding, beginning balance (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,485,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="nump">$ 2,885,679<span></span>
</td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">$ 1,622,199<span></span>
</td>
<td class="num">$ (1,623,256)<span></span>
</td>
<td class="nump">$ 3,079,640<span></span>
</td>
<td class="num">$ (193,487)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, beginning balance (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,836,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued on exercise of options (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued on exercise of options</a></td>
<td class="nump">4,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued on vesting of restricted stock units, net of shares withheld for tax (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued on vesting of restricted stock units, net of shares withheld for tax</a></td>
<td class="num">(195)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(195)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation costs</a></td>
<td class="nump">17,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(23,516)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,516)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">203,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(61,189)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61,189)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding, ending balance (shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,547,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 3,026,049<span></span>
</td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">1,643,661<span></span>
</td>
<td class="num">$ (1,623,256)<span></span>
</td>
<td class="nump">3,222,064<span></span>
</td>
<td class="num">(217,003)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, ending balance (shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,836,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding, beginning balance (shares) at Jun. 30, 2022</a></td>
<td class="nump">146,410,721<span></span>
</td>
<td class="nump">188,247,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2022</a></td>
<td class="nump">$ 3,360,751<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">1,682,432<span></span>
</td>
<td class="num">$ (1,623,256)<span></span>
</td>
<td class="nump">3,613,736<span></span>
</td>
<td class="num">(312,747)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, beginning balance (shares) at Jun. 30, 2022</a></td>
<td class="num">(41,836,234)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,836,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued on exercise of options (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued on exercise of options</a></td>
<td class="nump">$ 2,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued on vesting of restricted stock units, net of shares withheld for tax (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued on vesting of restricted stock units, net of shares withheld for tax</a></td>
<td class="num">(59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation costs</a></td>
<td class="nump">16,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(93,381)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93,381)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">210,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">$ (64,431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64,431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding, ending balance (shares) at Sep. 30, 2022</a></td>
<td class="nump">146,459,032<span></span>
</td>
<td class="nump">188,295,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 3,432,887<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">$ 1,701,902<span></span>
</td>
<td class="num">$ (1,623,256)<span></span>
</td>
<td class="nump">$ 3,759,783<span></span>
</td>
<td class="num">$ (406,128)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, ending balance (shares) at Sep. 30, 2022</a></td>
<td class="num">(41,836,234)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,836,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554105701440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements Of Changes In Equity (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend declared per share (dollars per share)</a></td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554105446384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 210,478<span></span>
</td>
<td class="nump">$ 203,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustment to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">36,273<span></span>
</td>
<td class="nump">39,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets</a></td>
<td class="nump">7,761<span></span>
</td>
<td class="nump">8,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation costs</a></td>
<td class="nump">16,919<span></span>
</td>
<td class="nump">17,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss attributable to equity method investments (note 5)</a></td>
<td class="nump">2,028<span></span>
</td>
<td class="nump">1,386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss', window );">(Gain) loss on equity investments (note 5)</a></td>
<td class="nump">3,280<span></span>
</td>
<td class="num">(5,612)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(56,238)<span></span>
</td>
<td class="nump">33,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(147,096)<span></span>
</td>
<td class="num">(55,976)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses, net deferred income taxes and other current assets</a></td>
<td class="num">(36,784)<span></span>
</td>
<td class="num">(14,391)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses, income taxes payable and other</a></td>
<td class="nump">8,041<span></span>
</td>
<td class="num">(293,303)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) / provided by operating activities</a></td>
<td class="nump">44,662<span></span>
</td>
<td class="num">(65,657)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(29,056)<span></span>
</td>
<td class="num">(27,340)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Patent registration and acquisition costs</a></td>
<td class="num">(3,317)<span></span>
</td>
<td class="num">(4,453)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="num">(19,100)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments (note 5)</a></td>
<td class="num">(4,291)<span></span>
</td>
<td class="num">(6,600)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities', window );">(Payments) / proceeds on maturity of foreign currency contracts</a></td>
<td class="num">(3,042)<span></span>
</td>
<td class="num">(3,481)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(58,806)<span></span>
</td>
<td class="num">(41,874)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net</a></td>
<td class="nump">2,610<span></span>
</td>
<td class="nump">4,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(195)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from borrowings, net of borrowing costs</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of borrowings</a></td>
<td class="num">(30,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(64,431)<span></span>
</td>
<td class="num">(61,189)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) / provided by financing activities</a></td>
<td class="num">(41,880)<span></span>
</td>
<td class="nump">92,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(10,523)<span></span>
</td>
<td class="num">(4,568)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="num">(66,547)<span></span>
</td>
<td class="num">(19,129)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">273,710<span></span>
</td>
<td class="nump">295,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">207,163<span></span>
</td>
<td class="nump">276,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid, net of refunds</a></td>
<td class="nump">53,437<span></span>
</td>
<td class="nump">345,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">7,134<span></span>
</td>
<td class="nump">5,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired', window );">Fair value of assets acquired, excluding cash</a></td>
<td class="nump">9,506<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1', window );">Liabilities assumed</a></td>
<td class="num">(3,975)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease', window );">Goodwill on acquisition</a></td>
<td class="nump">19,281<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_DeferredPaymentObligationsForAcquisitions', window );">Deferred payments</a></td>
<td class="num">(2,856)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability', window );">Fair value of contingent consideration</a></td>
<td class="num">(2,856)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisitions</a></td>
<td class="nump">$ 19,100<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Consideration, Recognized Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_DeferredPaymentObligationsForAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Payment Obligations For Acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_DeferredPaymentObligationsForAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Acquired During Period, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of an asset or business acquired in a noncash acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of [all] liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554111300224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary Of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary Of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ResMed Inc. (referred to herein as &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221;) is a Delaware corporation formed in March 1994 as a holding company for the ResMed Group. Through our subsidiaries, we design, manufacture and market equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea. Our manufacturing operations are located in Australia, Singapore, Malaysia, France, China and the United States. Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, China, Finland, Norway and Sweden. We also operate a Software as a Service (&#8220;SaaS&#8221;) business in the United States that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and the rules of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the fiscal year ending June&#160;30, 2023. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements for the three months ended September&#160;30, 2022 and September&#160;30, 2021 are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K (our &#8220;Form 10-K&#8221;) for the year ended June&#160;30, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Accounting Standard Codification (&#8220;ASC&#8221;) Topic 606, &#8220;Revenue from Contracts with Customers&#8221;, we account for a contract with a customer when there is a legally enforceable contract, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We have determined that we have two operating segments, which are the sleep and respiratory disorders sector of the medical device industry (&#8220;Sleep and Respiratory Care&#8221;) and the supply of business management software as a service to out-of-hospital health providers (&#8220;SaaS&#8221;). Our Sleep and Respiratory Care revenue relates primarily to the sale of our products that are therapy-based equipment. Some contracts include additional performance obligations such as the provision of extended warranties and provision of data for patient monitoring. Our SaaS revenue relates to the provision of software access with ongoing support and maintenance services as well as professional services such as training and consulting. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disaggregation of revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):  </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S., Canada and Latin America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">339,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">238,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">578,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">491,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">683,956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">588,554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Combined Europe, Asia and other markets </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">218,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">315,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Global revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">517,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">494,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">326,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">844,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">806,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950,294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">904,015&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance obligations and contract balances</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied; generally, this occurs with the transfer of risk and/or control of our products at a point in time. For products in our Sleep and Respiratory Care business, we transfer control and recognize a sale when products are shipped to the customer in accordance with the contractual shipping terms. For our SaaS business, revenue associated with professional services are recognized as they are provided. We defer the recognition of a portion of the consideration received when performance obligations are not yet satisfied. Consideration received from customers in advance of revenue recognition is classified as deferred revenue. Performance obligations resulting in deferred revenue in our Sleep and Respiratory Care business relate primarily to extended warranties on our devices and the provision of data for patient monitoring. Performance obligations resulting in deferred revenue in our SaaS business relate primarily to the provision of software access with maintenance and support over an agreed term and material rights associated with future discounts upon renewal of some SaaS contracts. Generally, deferred revenue will be recognized over a period of one year to five years. Our contracts do not contain significant financing components.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract balances (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.114%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance sheet caption</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">620,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">575,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unbilled revenue, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unbilled revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid taxes and other non-current assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108,195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108,667)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue (current liabilities)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(97,620)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(95,455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue (non-current liabilities)</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transaction price determination</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. In our Sleep and Respiratory Care segment, the amount of consideration received and revenue recognized varies </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with changes in marketing incentives (e.g. rebates, discounts, free goods) and returns offered to our customers and their customers. When we give customers the right to return eligible products and receive credit, returns are estimated based on an analysis of historical experience. However, returns of products, excluding warranty-related returns, are infrequent and insignificant. We adjust the estimate of revenue at the earlier of when the most likely amount of consideration can be estimated, the amount expected to be received changes, or when the consideration becomes fixed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer our Sleep and Respiratory Care customers cash or product rebates based on volume or sales targets measured over quarterly or annual periods. We estimate rebates based on each customer&#8217;s expected achievement of its targets. In accounting for these rebate programs, we reduce revenue ratably as sales occur over the rebate period by the expected value of the rebates to be returned to the customer. Rebates measured over a quarterly period are updated based on actual sales results and, therefore, no estimation is required to determine the reduction to revenue. For rebates measured over annual periods, we update our estimates on a quarterly basis based on actual sales results and updated forecasts for the remaining rebate periods. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in programs where we issue credits to our Sleep and Respiratory Care distributors when they are required to sell our products below negotiated list prices if we have preexisting contracts with the distributors' customers. We reduce revenue for future credits at the time of sale to the distributor, which we estimate based on historical experience using the expected value method. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer discounts to both our Sleep and Respiratory Care as well as our SaaS customers as part of normal business practice and these are deducted from revenue when the sale occurs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When Sleep and Respiratory Care or SaaS contracts have multiple performance obligations, we generally use an observable price to determine the stand-alone selling price by reference to pricing and discounting practices for the specific product or service when sold separately to similar customers. Revenue is then allocated proportionately, based on the determined stand-alone selling price, to each performance obligation. An allocation is not required for many of our Sleep and Respiratory Care contracts that have a single performance obligation, which is the shipment of our therapy-based equipment.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting and practical expedient elections</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected to account for shipping and handling activities associated with our Sleep and Respiratory Care segment as a fulfillment cost within cost of sales, and record shipping and handling costs collected from customers in net revenue. We have also elected for all taxes assessed by government authorities that are imposed on and concurrent with revenue-producing transactions, such as sales and value added taxes, to be excluded from revenue and presented on a net basis. We have elected two practical expedients including the &#8220;right to invoice&#8221; practical expedient, which is relevant for some of our SaaS contracts as it allows us to recognize revenue in the amount of the invoice when it corresponds directly with the value of performance completed to date. The second practical expedient adopted permits relief from considering a significant financing component when the payment for the good or service is expected to be one year or less.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease Sleep and Respiratory Care medical devices to customers primarily as a means to comply with local health insurer requirements in certain foreign geographies. Device rental contracts include operating leases, and contract terms vary by customer and include options to terminate or extend the contract. When lease contracts also include the sale of masks and accessories, we allocate contract consideration to those items on a relative standalone price basis and recognize revenue when control transfers to the customer. Operating lease revenue was $23.7 million for the three months ended September 30, 2022 and $25.2 million for the three months ended September 30, 2021.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provision for Warranty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for the estimated cost of product warranties on our Sleep and Respiratory Care products at the time the related revenue is recognized. We determine the amount of this provision by using a financial model, which takes into consideration actual historical expenses and potential risks associated with our different products. We use this financial model to calculate the future probable expenses related to warranty and the required level of the warranty provision. Although we engage in product improvement programs and processes, our warranty obligation is affected by product failure rates and costs incurred to correct those product failures. Should actual product failure rates or estimated costs to repair those product failures differ from our estimates, we would be required to revise our estimated warranty provision.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554108022880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have quantitatively and qualitatively determined that we operate in two operating segments, which are the Sleep and Respiratory Care segment and the SaaS segment. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate the performance of our segments based on net revenues and income from operations. The accounting policies of the segments are the same as those described in note 2 of our consolidated financial statements included in our Form 10-K for the year ended June&#160;30, 2022. Segment net revenues and segment income from operations do not include inter-segment profits and revenue is allocated to a geographic area based on where the products are shipped to or where the services are performed. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate headquarters costs, stock-based compensation, amortization expense from acquired intangibles, net interest expense (income), loss attributable to equity method investments, gains and losses on equity investments, and other, net. We neither discretely allocate assets to our operating segments, nor does our Chief Operating Decision Maker evaluate the operating segments using discrete asset information.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, effective in the first quarter of fiscal year 2023, we updated the extent of allocation and method of attribution of certain shared costs that are principally managed at the corporate level as part of our evaluation of segment operating performance. As a result, certain shared administrative costs, including shared IT, legal and other administrative functions, which were previously included in segment operating results, are now reported in Corporate costs within our reconciliation of segment operating profit to income before income taxes. The financial information presented herein reflects the impact of the preceding reporting change for all periods presented.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents a reconciliation of net revenues and net operating profit by reportable segments (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net revenue by segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">844,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">806,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">904,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Depreciation and amortization by segment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sleep and Respiratory Care</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets and corporate assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net operating profit by segment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sleep and Respiratory Care</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">352,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">336,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">377,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">358,903&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reconciling items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss attributable to equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain) loss on equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,612)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258,788&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554108383840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_SupplementalBalanceSheetInformationTextBlock', window );">Supplemental Balance Sheet Information</a></td>
<td class="text">Supplemental Balance Sheet Information<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the condensed consolidated balance sheets consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">398,520&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">355,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">461,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">385,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">864,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">743,910&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other prepaid expenses and current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">341,199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">337,908&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property, Plant and Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,107,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,131,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(620,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(633,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">498,181&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Intangible Assets </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed/core product technology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">354,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">350,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(244,255)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(239,647)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed/core product technology, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110,515&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">111,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258,312&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,034&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(97,143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(91,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">161,169&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other intangibles</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">194,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204,580&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(128,503)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(134,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other intangibles, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,617&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other intangibles, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">338,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">345,944&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of developed/core product technology, trade names, non-compete agreements, customer relationships, and patents, which we amortize over the estimated useful life of the assets, generally between two years to fifteen years. There are no expected residual values related to these intangible assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_SupplementalBalanceSheetInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_SupplementalBalanceSheetInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554111423520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of changes in our goodwill by reportable segment is as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sleep and <br/>Respiratory Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SaaS</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">641,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,294,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,936,442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16,880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16,880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">644,125&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,294,718&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,938,843&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554111445840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have equity investments in privately and publicly held companies that are unconsolidated entities. The following discusses our investments in marketable equity securities, non-marketable equity securities, and investments accounted for under the equity method.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketable equity securities are publicly traded stocks measured at fair value and classified within Level 1 in the fair value hierarchy because we use quoted prices for identical assets in active markets. Marketable equity securities are recorded in prepaid expenses and other current assets on the condensed consolidated balance sheets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values and are recorded in prepaid taxes and other non-current assets on the condensed consolidated balance sheets. Non-marketable equity securities are reported at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. We assess non-marketable equity securities at least quarterly for impairment and consider qualitative and quantitative factors including the investee's financial metrics, product and commercial outlook and cash usage. All gains and losses on marketable and non-marketable equity securities, realized and unrealized, are recognized in gain (loss) on equity investments as a component of other income (loss), net on the condensed consolidated statements of operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments whereby we have significant influence, but not control over the investee and are not the primary beneficiary of the investee&#8217;s activities, are accounted for under the equity method. Under this method, we record our share of gains or losses attributable to equity method investments as a component of other income (loss), net on the condensed consolidated statements of operations. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments by measurement category were as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement category</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Measurement alternative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,358&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58,375&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show a reconciliation of the changes in our equity investments (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.809%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-marketable securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marketable securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions to investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized losses on marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss attributable to equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying value at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,581&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,890&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-marketable securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marketable securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions to investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Observable price adjustments on non-marketable equity securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gains on marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of investments</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss attributable to equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying value at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,160&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,138&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,768&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80,066&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net unrealized losses recognized for equity investments in non-marketable and marketable securities held as of September&#160;30, 2022 for the three months ended September&#160;30, 2022 were $3.3 million. Net unrealized gains recognized for equity investments in non-marketable and marketable securities held as of September&#160;30, 2021 for the three months ended September&#160;30, 2021 were $5.6 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI https://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI https://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554216270528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, each interim reporting period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 19, 2021, we concluded the settlement agreement with the Australian Taxation Office (&#8220;ATO&#8221;) in relation to the previously disclosed transfer pricing dispute for the tax years 2009 through 2018 (&#8220;ATO settlement&#8221;). The ATO settlement fully resolved the dispute for all prior years, with no admission of liability and provides clarity in relation to certain future taxation principles.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;28, 2021, we remitted final payment to the ATO of $284.8 million, consisting of the agreed settlement amount of $381.7 million less prior remittances made to the ATO of $96.9 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554108169536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantiesDisclosuresAbstract', window );"><strong>Product Warranties Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">Product Warranties</a></td>
<td class="text">Product Warranties<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the liability for warranty costs, which is included in accrued expenses in our condensed consolidated balance sheets, are as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warranty accruals for the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warranty costs incurred for the period </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,612)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,972)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,093&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,960&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantiesDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantiesDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI https://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554108169536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consisted of the following (in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term debt </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred borrowing costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,916&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">790,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">770,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred borrowing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,675)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">785,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">765,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">795,342&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">775,241&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facility</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;29, 2022, we entered into a second amended and restated credit agreement (the &#8220;Revolving Credit Agreement&#8221;), as borrower, with lenders MUFG Union Bank, N.A., as administrative agent, joint lead arranger, sole book runner, swing line lender and letter of credit issuer, Westpac Banking Corporation, as syndication agent and joint lead arranger, HSBC Bank USA, National Association, as syndication agent and joint lead arranger, and Wells Fargo Bank, National Association, as documentation agent. The Revolving Credit Agreement, among other things, provided a senior unsecured revolving credit facility of $1,500.0 million, with an uncommitted option to increase the revolving credit facility by an additional amount equal to the greater of $1,000.0 million and 1.00 times the EBITDA (as defined in the Revolving Credit Agreement) for the trailing twelve-month measurement period. The Revolving Credit Agreement amends and restates that certain Amended and Restated Credit Agreement, dated as of April 17, 2018, among ResMed, MUFG Union Bank, N.A., Westpac Banking Corporation and the lenders party thereto.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on June&#160;29, 2022, ResMed Pty Limited entered into a Second Amendment to the Syndicated Facility Agreement and First Amendment to Unconditional Guaranty Agreement (the &#8220;Term Credit Agreement&#8221;), as borrower, with lenders MUFG Union Bank, N.A., as administrative agent, joint lead arranger and joint book runner, and Westpac Banking Corporation, as syndication agent, joint lead arranger and joint book runner, which amends that certain Syndicated Facility Agreement dated as of April 17, 2018. The Term Credit Agreement, among other things, provides ResMed Pty a senior unsecured term credit facility of $200.0 million. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Revolving Credit Agreement are guaranteed by certain of our direct and indirect U.S. subsidiaries, and ResMed Pty Limited&#8217;s obligations under the Term Credit Agreement are guaranteed by us and certain of our direct and indirect U.S. subsidiaries. The Revolving Credit Agreement and Term Credit Agreement contain customary covenants, including, in each case, a financial covenant that requires that we maintain a maximum leverage ratio of funded debt to EBITDA (as defined in the Revolving Credit Agreement and Term Credit Agreement, as applicable). The entire principal amounts of the revolving credit facility and term credit facility, and, in each case, any accrued but unpaid interest may be declared immediately due and payable if an event of default occurs, as defined in the Revolving Credit Agreement and the Term Credit Agreement, as applicable. Events of default under the Revolving Credit Agreement and the Term Credit Agreement include, in each case, failure to make payments when due, the occurrence of a default in the performance of any covenants in the respective agreements or related documents, or certain changes of control of us, or the respective guarantors of the obligations borrowed under the Revolving Credit Agreement and Term Credit Agreement. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Agreement and Term Credit Agreement each terminate on June&#160;29, 2027, when all unpaid principal and interest under the loans must be repaid. Amounts borrowed under the Term Credit Agreement will also amortize on a semi-annual basis, with a $5.0 million principal payment required on each such semi-annual amortization date. The outstanding principal amounts will bear interest at a rate equal to the Adjusted Term SOFR (as defined in the Revolving Credit Facility) plus 0.75% to 1.50% (depending on the then-applicable leverage ratio) or the Base Rate (as defined in the Revolving Credit Agreement and the Term Credit Agreement, as applicable) plus 0.0% to 0.50% (depending on the then-applicable leverage ratio). At September&#160;30, 2022, the interest rate that was being charged on the outstanding principal amounts was 3.5%. An applicable commitment fee of 0.075% to 0.150% (depending on the then-applicable leverage ratio) applies on the unused portion of the revolving credit facility. As of September&#160;30, 2022, we had $1.4 billion available for draw down under the revolving credit facility.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. As the Revolving Credit and Term Credit Agreements&#8217; interest rate is calculated as Adjusted Term SOFR plus the spreads described above, its carrying amount is equivalent to its fair value as at September&#160;30, 2022 and June&#160;30, 2022, which was $300.0 million and $280.0 million, respectively. Quoted market prices in active markets for similar liabilities based inputs (Level 2) were used to estimate fair value.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 10, 2019, we entered into a Note Purchase Agreement with the purchasers to that agreement, in connection with the issuance and sale of $250.0 million principal amount of our 3.24% senior notes due July&#160;10, 2026, and $250.0 million principal amount of our 3.45% senior notes due July&#160;10, 2029 (collectively referred to as the &#8220;Senior Notes&#8221;). Our obligations under the Note Purchase Agreement and the Senior Notes are unconditionally and irrevocably guaranteed by certain of our direct and indirect U.S. subsidiaries. The net proceeds from this transaction were used to pay down borrowings on our Revolving Credit Agreement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Note Purchase Agreement, we agreed to customary covenants including with respect to our corporate existence, transactions with affiliates, and mergers and other extraordinary transactions. We also agreed that, subject to limited exceptions, we will maintain a ratio of consolidated funded debt to consolidated EBITDA (as defined in the Note Purchase Agreement) of no more than 3.50 to 1.00 as of the last day of any fiscal quarter, and will not at any time permit the amount of all priority secured and unsecured debt of us and our subsidiaries to exceed 10% of our consolidated tangible assets, determined as of the end of our most recently ended fiscal quarter. This ratio is calculated at the end of each reporting period for which the Note Purchase Agreement requires us to deliver financial statements, using the results of the 12 consecutive month period ending with such reporting period.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. As of September&#160;30, 2022 and June&#160;30, 2022, the Senior Notes had a carrying amount of $500.0 million, excluding deferred borrowing costs, and an estimated fair value of $455.7 million and $477.7 million, respectively. Quoted market prices in active markets for similar liabilities based inputs (Level 2) were used to estimate fair value.</span></div>At September&#160;30, 2022, we were in compliance with our debt covenants and there was $800.0 million outstanding under the Revolving Credit Agreement, Term Credit Agreement and Senior Notes.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554108031280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing the net income available to common stockholders by the weighted average number of shares of common stock outstanding. For purposes of calculating diluted earnings per share, the denominator includes both the weighted average number of shares of common stock outstanding and the number of dilutive common stock equivalents such as stock options and restricted stock units. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average number of outstanding stock options and restricted stock units not included in the computation of diluted earnings per share were 113,167 and 1,322 for the three months ended September&#160;30, 2022 and 2021, respectively, as the effect would have been anti-dilutive.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings per share are calculated as follows (in thousands except per share data):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">210,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">146,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock options and restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted weighted average shares </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147,134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">146,860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.44&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.43&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554111445840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal Actions, Contingencies and Commitments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Legal Actions, Contingencies and Commitments</a></td>
<td class="text">Legal Actions, Contingencies and Commitments<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are subject to routine litigation incidental to our business. While the results of this litigation cannot be predicted with certainty, we believe that their final outcome will not, individually or in aggregate, have a material adverse effect on our consolidated financial statements taken as a whole.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2021, New York University ("NYU") filed a complaint for patent infringement in the United States District Court, District of Delaware against ResMed Inc., case no. 1:21-cv-00813 (JPM). The complaint alleges that the AutoSet or AutoRamp features of ResMed&#8217;s AirSense 10 AutoSet flow generators infringe one or more claims of various NYU patents, including U.S. Patent Nos. 6,988,994; 9,108,009; 9,168,344; 9,427,539; 9,533,115; 9,867,955; and 10,384,024. According to the complaint, the NYU patents are directed to systems and methods for diagnosis and treating sleeping disorders during different sleep states. The complaint seeks monetary damages and attorneys&#8217; fees. We answered the complaint on September 30, 2021 and filed a motion to dismiss the complaint on the basis that the patents are invalid because the subject matter of the patents is not patentable under the Supreme Court and Federal Circuit precedent. The motion to dismiss was granted in part and denied in part. We have also requested that the court dismiss the case based on NYU&#8217;s license of the patents to Fisher &amp; Paykel and Fisher &amp; Paykel&#8217;s prior settlement with us. The matter is proceeding to discovery while the court considers our request. We have also filed petitions for inter partes review with the Patent Trial and Appeal Board (&#8220;PTAB&#8221;) of the United States Patent and Trademark Office seeking to invalidate the asserted claims of the patents-in-suit. A determination by the PTAB whether to institute the petitions is expected by early December 2022. If the petitions are instituted by the PTAB, a final written decision determining the invalidity of the challenged claims is expected by December 2023. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 27, 2021, the International Trade Commission ("ITC") instituted In Re Certain UMTS and LTE Cellular Communications Modules and Products Containing the Same, Investigation No. 337-TA-1240, by complainants Philips RS North America, LLC and Koninklijke Philips N.V. (collectively &#8220;Philips&#8221;) against Quectel Wireless Solutions Co., Ltd; Thales DIS AIS USA, LLC, Thales DIS AIS Deutschland GmbH; Telit Wireless Solutions, Inc., Telit Communications PLC, CalAmp. Corp., Xirgo Technologies, LLC, and Laird Connectivity, Inc. (collectively &#8220;respondents&#8221;). In the ITC investigation, Philips seeks an order excluding communications modules, and products that contain them, from importation into the United States based on alleged infringement of 3G and 4G standard essential patents held by Philips. On October 6-14, 2021, the administrative law judge held a hearing on the merits. The administrative law judge issued an initial determination on April 1, 2022, finding no violation of any of the Philips' patents asserted in the ITC. Philips sought review by the full ITC. On July 6, 2022, the Commission affirmed the administrative law judge&#8217;s determination that there was no violation of asserted Philips' patents. The Commission terminated the ITC proceedings. Philips did not appeal the ITC&#8217;s decision. On December 17, 2020, Philips filed companion cases for patent infringement against the same defendants in the United States District Court for the District of Delaware, case nos. 1:20-cv-01707, 01708, 01709, 01710, 01711, and 01713 (CFC) seeking damages, an injunction, and a declaration from the court on the amount of a fair reasonable and non-discriminatory license rate for the standard essential patents it is asserting against the communications module defendants. The district court cases have been stayed pending the resolution of the ITC proceedings. Philips has not yet moved to lift </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the stay following the termination of the ITC Investigation. We are not a party to the ITC investigation or the district court cases, but we sell products that incorporate some of the communications modules at issue in the cases. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2022, Cleveland Medical Devices Inc. ("Cleveland Medical") filed suit for patent infringement against ResMed Inc. in the United States District Court for the District of Delaware, case no. 1:22-cv-00794. Cleveland Medical asserts that numerous ResMed connected devices, when combined with certain ResMed data platforms and/or software, including AirView and ResScan, infringe one or more of eight Cleveland Medical patents, including U.S. Patent Nos. 10,076,269; 10,426,399; 10,925,535; 11,064,937; 10,028,698; 10,478,118; 11,202,603; and 11,234,637. We have moved to dismiss the action because Cleveland Medical sued the wrong ResMed entity. We have also moved to dismiss all claims based on U.S. Patent No. 10,076,269, as well as indirect and willful infringement allegations as to the remaining patents asserted against ResMed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on currently available information, we are unable to make a reasonable estimate of loss or range of losses, if any, arising from matters that remain open.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Obligations Under Recourse Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use independent financing institutions to offer some of our customers financing for the purchase of some of our products. Under these arrangements, if the customer qualifies under the financing institutions&#8217; credit criteria and finances the transaction, the customers repay the financing institution on a fixed payment plan. For some of these arrangements, the customer&#8217;s receivable balance is with limited recourse whereby we are responsible for repaying the financing company should the customer default. We record a contingent provision, which is estimated based on historical default rates. This is applied to receivables sold with recourse and is recorded in accrued expenses.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2022 and September&#160;30, 2021, receivables sold with limited recourse were $39.9 million and $49.5 million, respectively. As of September&#160;30, 2022, the maximum exposure on outstanding receivables sold with recourse and contingent provision were $22.4 million and $1.2 million, respectively. As of June&#160;30, 2022, the maximum exposure on outstanding receivables sold with recourse and contingent provision were $24.2 million and $2.1 million, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments</span></div>In June 2022 we signed a definitive agreement to acquire MEDIFOX DAN which is expected to close during our fiscal year 2023. The MEDIFOX DAN acquisition remains subject to regulatory clearances and other customary closing conditions. Upon closing, acquisition consideration of EUR 950&#160;million will be paid, in part, with funds available for draw under our Revolving Credit Agreement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554107595504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary Of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock', window );">Organization and Basis of Presentation</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ResMed Inc. (referred to herein as &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221;) is a Delaware corporation formed in March 1994 as a holding company for the ResMed Group. Through our subsidiaries, we design, manufacture and market equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea. Our manufacturing operations are located in Australia, Singapore, Malaysia, France, China and the United States. Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, China, Finland, Norway and Sweden. We also operate a Software as a Service (&#8220;SaaS&#8221;) business in the United States that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and the rules of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the fiscal year ending June&#160;30, 2023. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements for the three months ended September&#160;30, 2022 and September&#160;30, 2021 are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K (our &#8220;Form 10-K&#8221;) for the year ended June&#160;30, 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Accounting Standard Codification (&#8220;ASC&#8221;) Topic 606, &#8220;Revenue from Contracts with Customers&#8221;, we account for a contract with a customer when there is a legally enforceable contract, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We have determined that we have two operating segments, which are the sleep and respiratory disorders sector of the medical device industry (&#8220;Sleep and Respiratory Care&#8221;) and the supply of business management software as a service to out-of-hospital health providers (&#8220;SaaS&#8221;). Our Sleep and Respiratory Care revenue relates primarily to the sale of our products that are therapy-based equipment. Some contracts include additional performance obligations such as the provision of extended warranties and provision of data for patient monitoring. Our SaaS revenue relates to the provision of software access with ongoing support and maintenance services as well as professional services such as training and consulting. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disaggregation of revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):  </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S., Canada and Latin America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">339,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">238,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">578,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">491,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">683,956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">588,554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Combined Europe, Asia and other markets </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">218,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">315,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Global revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">517,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">494,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">326,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">844,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">806,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950,294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">904,015&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance obligations and contract balances</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied; generally, this occurs with the transfer of risk and/or control of our products at a point in time. For products in our Sleep and Respiratory Care business, we transfer control and recognize a sale when products are shipped to the customer in accordance with the contractual shipping terms. For our SaaS business, revenue associated with professional services are recognized as they are provided. We defer the recognition of a portion of the consideration received when performance obligations are not yet satisfied. Consideration received from customers in advance of revenue recognition is classified as deferred revenue. Performance obligations resulting in deferred revenue in our Sleep and Respiratory Care business relate primarily to extended warranties on our devices and the provision of data for patient monitoring. Performance obligations resulting in deferred revenue in our SaaS business relate primarily to the provision of software access with maintenance and support over an agreed term and material rights associated with future discounts upon renewal of some SaaS contracts. Generally, deferred revenue will be recognized over a period of one year to five years. Our contracts do not contain significant financing components.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract balances (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.114%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance sheet caption</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">620,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">575,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unbilled revenue, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unbilled revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid taxes and other non-current assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108,195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108,667)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue (current liabilities)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(97,620)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(95,455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue (non-current liabilities)</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transaction price determination</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. In our Sleep and Respiratory Care segment, the amount of consideration received and revenue recognized varies </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with changes in marketing incentives (e.g. rebates, discounts, free goods) and returns offered to our customers and their customers. When we give customers the right to return eligible products and receive credit, returns are estimated based on an analysis of historical experience. However, returns of products, excluding warranty-related returns, are infrequent and insignificant. We adjust the estimate of revenue at the earlier of when the most likely amount of consideration can be estimated, the amount expected to be received changes, or when the consideration becomes fixed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer our Sleep and Respiratory Care customers cash or product rebates based on volume or sales targets measured over quarterly or annual periods. We estimate rebates based on each customer&#8217;s expected achievement of its targets. In accounting for these rebate programs, we reduce revenue ratably as sales occur over the rebate period by the expected value of the rebates to be returned to the customer. Rebates measured over a quarterly period are updated based on actual sales results and, therefore, no estimation is required to determine the reduction to revenue. For rebates measured over annual periods, we update our estimates on a quarterly basis based on actual sales results and updated forecasts for the remaining rebate periods. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in programs where we issue credits to our Sleep and Respiratory Care distributors when they are required to sell our products below negotiated list prices if we have preexisting contracts with the distributors' customers. We reduce revenue for future credits at the time of sale to the distributor, which we estimate based on historical experience using the expected value method. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer discounts to both our Sleep and Respiratory Care as well as our SaaS customers as part of normal business practice and these are deducted from revenue when the sale occurs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When Sleep and Respiratory Care or SaaS contracts have multiple performance obligations, we generally use an observable price to determine the stand-alone selling price by reference to pricing and discounting practices for the specific product or service when sold separately to similar customers. Revenue is then allocated proportionately, based on the determined stand-alone selling price, to each performance obligation. An allocation is not required for many of our Sleep and Respiratory Care contracts that have a single performance obligation, which is the shipment of our therapy-based equipment.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting and practical expedient elections</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected to account for shipping and handling activities associated with our Sleep and Respiratory Care segment as a fulfillment cost within cost of sales, and record shipping and handling costs collected from customers in net revenue. We have also elected for all taxes assessed by government authorities that are imposed on and concurrent with revenue-producing transactions, such as sales and value added taxes, to be excluded from revenue and presented on a net basis. We have elected two practical expedients including the &#8220;right to invoice&#8221; practical expedient, which is relevant for some of our SaaS contracts as it allows us to recognize revenue in the amount of the invoice when it corresponds directly with the value of performance completed to date. The second practical expedient adopted permits relief from considering a significant financing component when the payment for the good or service is expected to be one year or less.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_LeaseRevenuePolicyTextBlock', window );">Lease Revenue</a></td>
<td class="text">Lease RevenueWe lease Sleep and Respiratory Care medical devices to customers primarily as a means to comply with local health insurer requirements in certain foreign geographies. Device rental contracts include operating leases, and contract terms vary by customer and include options to terminate or extend the contract. When lease contracts also include the sale of masks and accessories, we allocate contract consideration to those items on a relative standalone price basis and recognize revenue when control transfers to the customer.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Provision For Warranty</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provision for Warranty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for the estimated cost of product warranties on our Sleep and Respiratory Care products at the time the related revenue is recognized. We determine the amount of this provision by using a financial model, which takes into consideration actual historical expenses and potential risks associated with our different products. We use this financial model to calculate the future probable expenses related to warranty and the required level of the warranty provision. Although we engage in product improvement programs and processes, our warranty obligation is affected by product failure rates and costs incurred to correct those product failures. Should actual product failure rates or estimated costs to repair those product failures differ from our estimates, we would be required to revise our estimated warranty provision.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_LeaseRevenuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Revenue [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_LeaseRevenuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization And Basis Of Presentation, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554107906480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary Of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Summary Of Net Revenue Disaggregated By Product And Region</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):  </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S., Canada and Latin America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">339,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">238,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">578,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">491,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">683,956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">588,554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Combined Europe, Asia and other markets </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">218,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">315,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Global revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Devices</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">517,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">494,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Masks and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">326,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">844,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">806,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950,294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">904,015&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary Of Contract Balances</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract balances (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.114%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance sheet caption</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">620,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">575,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unbilled revenue, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unbilled revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid taxes and other non-current assets</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contract liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108,195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(108,667)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue (current liabilities)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(97,620)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(95,455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue (non-current liabilities)</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554110053040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Revenue By Segment and Reconciling Items</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents a reconciliation of net revenues and net operating profit by reportable segments (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net revenue by segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Sleep and Respiratory Care</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">844,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">806,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">904,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Depreciation and amortization by segment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sleep and Respiratory Care</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets and corporate assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net operating profit by segment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sleep and Respiratory Care</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">352,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">336,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software as a Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">377,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">358,903&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reconciling items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss attributable to equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain) loss on equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,612)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258,788&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554108372288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule Of Inventories</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the condensed consolidated balance sheets consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">398,520&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">355,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">461,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">385,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">864,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">743,910&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other prepaid expenses and current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">341,199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">337,908&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Components Of Property, Plant And Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Property, Plant and Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,107,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,131,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(620,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(633,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">498,181&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule Of Other Intangible Assets, Net</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Intangible Assets </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed/core product technology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">354,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">350,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(244,255)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(239,647)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed/core product technology, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110,515&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">111,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258,312&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,034&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(97,143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(91,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">161,169&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other intangibles</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">194,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204,580&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(128,503)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(134,963)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other intangibles, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,617&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other intangibles, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">338,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">345,944&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554105844272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule Of Changes In Carrying Amount Of Goodwill</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of changes in our goodwill by reportable segment is as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sleep and <br/>Respiratory Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SaaS</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">641,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,294,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,936,442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16,880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16,880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">644,125&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,294,718&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,938,843&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554107918832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_ScheduleOfInvestmentsTableTextBlock', window );">Schedule Of Investments</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments by measurement category were as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement category</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Measurement alternative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity method</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,358&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58,375&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock', window );">Schedule Of Changes In Equity Investments</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show a reconciliation of the changes in our equity investments (in thousands):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.809%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-marketable securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marketable securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions to investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized losses on marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss attributable to equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying value at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,581&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,890&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-marketable securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marketable securities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additions to investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Observable price adjustments on non-marketable equity securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gains on marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of investments</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss attributable to equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying value at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,160&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,138&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,768&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80,066&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Changes In Equity Investments [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_ScheduleOfInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Investments [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_ScheduleOfInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554108067264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantiesDisclosuresAbstract', window );"><strong>Product Warranties Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule Of Changes In Liability For Warranty Costs</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the liability for warranty costs, which is included in accrued expenses in our condensed consolidated balance sheets, are as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warranty accruals for the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warranty costs incurred for the period </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,612)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,972)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,093&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,960&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantiesDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantiesDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554110013360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consisted of the following (in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term debt </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred borrowing costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,916&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">790,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">770,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred borrowing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,675)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">785,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">765,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">795,342&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">775,241&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554106685392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule Of Basic And Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings per share are calculated as follows (in thousands except per share data):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">210,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">146,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock options and restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted weighted average shares </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147,134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">146,860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.44&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.43&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554107678512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary Of Significant Accounting Policies (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Operating lease revenue | $</a></td>
<td class="nump">$ 23.7<span></span>
</td>
<td class="nump">$ 25.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_TermOfContractUnderRevenueRecognition', window );">Deferred revenue recognized, term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_TermOfContractUnderRevenueRecognition', window );">Deferred revenue recognized, term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_TermOfContractUnderRevenueRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term Of Contract Under Revenue Recognition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_TermOfContractUnderRevenueRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554102680224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary Of Significant Accounting Policies (Summary Of Net Revenue Disaggregated By Product And Region) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">$ 950,294<span></span>
</td>
<td class="nump">$ 904,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rmd_SleepAndRespiratoryMember', window );">Total Sleep and Respiratory Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">844,443<span></span>
</td>
<td class="nump">806,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rmd_SoftwareAsServiceMember', window );">Software as a Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">105,851<span></span>
</td>
<td class="nump">97,516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rmd_UsCanadaAndLatinAmericaMember', window );">U.S., Canada and Latin America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">683,956<span></span>
</td>
<td class="nump">588,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rmd_UsCanadaAndLatinAmericaMember', window );">U.S., Canada and Latin America | Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">339,545<span></span>
</td>
<td class="nump">275,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rmd_UsCanadaAndLatinAmericaMember', window );">U.S., Canada and Latin America | Masks and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">238,560<span></span>
</td>
<td class="nump">215,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rmd_UsCanadaAndLatinAmericaMember', window );">U.S., Canada and Latin America | Total Sleep and Respiratory Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">578,105<span></span>
</td>
<td class="nump">491,038<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rmd_UsCanadaAndLatinAmericaMember', window );">U.S., Canada and Latin America | Software as a Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">105,851<span></span>
</td>
<td class="nump">97,516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rmd_CombinedEuropeAsiaAndOtherMarketsMember', window );">Combined Europe, Asia and other markets | Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">178,032<span></span>
</td>
<td class="nump">218,226<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rmd_CombinedEuropeAsiaAndOtherMarketsMember', window );">Combined Europe, Asia and other markets | Masks and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">88,306<span></span>
</td>
<td class="nump">97,235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rmd_CombinedEuropeAsiaAndOtherMarketsMember', window );">Combined Europe, Asia and other markets | Total Sleep and Respiratory Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">266,338<span></span>
</td>
<td class="nump">315,461<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rmd_GlobalMember', window );">Global revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">950,294<span></span>
</td>
<td class="nump">904,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rmd_GlobalMember', window );">Global revenue | Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">517,577<span></span>
</td>
<td class="nump">494,158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rmd_GlobalMember', window );">Global revenue | Masks and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">326,866<span></span>
</td>
<td class="nump">312,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rmd_GlobalMember', window );">Global revenue | Total Sleep and Respiratory Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">844,443<span></span>
</td>
<td class="nump">806,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rmd_GlobalMember', window );">Global revenue | Software as a Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">$ 105,851<span></span>
</td>
<td class="nump">$ 97,516<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rmd_SleepAndRespiratoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rmd_SleepAndRespiratoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rmd_SoftwareAsServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rmd_SoftwareAsServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=rmd_UsCanadaAndLatinAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=rmd_UsCanadaAndLatinAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rmd_DevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rmd_DevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rmd_MasksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rmd_MasksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=rmd_CombinedEuropeAsiaAndOtherMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=rmd_CombinedEuropeAsiaAndOtherMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=rmd_GlobalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=rmd_GlobalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554102504592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary Of Significant Accounting Policies (Summary Of Contract Balances) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetAbstract', window );"><strong>Contract assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">$ 620,483<span></span>
</td>
<td class="nump">$ 575,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Contract liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current</a></td>
<td class="num">(108,195)<span></span>
</td>
<td class="num">(108,667)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, non-current</a></td>
<td class="num">(97,620)<span></span>
</td>
<td class="num">(95,455)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=rmd_AccountsReceivableNetMember', window );">Accounts receivable, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetAbstract', window );"><strong>Contract assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">620,483<span></span>
</td>
<td class="nump">575,950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetAbstract', window );"><strong>Contract assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Unbilled revenue, current</a></td>
<td class="nump">23,615<span></span>
</td>
<td class="nump">25,692<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember', window );">Prepaid taxes and other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetAbstract', window );"><strong>Contract assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetNoncurrent', window );">Unbilled revenue, non-current</a></td>
<td class="nump">8,106<span></span>
</td>
<td class="nump">8,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=rmd_DeferredRevenueCurrentLiabilitiesMember', window );">Deferred revenue (current liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Contract liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current</a></td>
<td class="num">(108,195)<span></span>
</td>
<td class="num">(108,667)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=rmd_DeferredRevenueNonCurrentLiabilitiesMember', window );">Deferred revenue (non-current liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Contract liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, non-current</a></td>
<td class="num">$ (97,620)<span></span>
</td>
<td class="num">$ (95,455)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=rmd_AccountsReceivableNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=rmd_AccountsReceivableNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=rmd_DeferredRevenueCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=rmd_DeferredRevenueCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=rmd_DeferredRevenueNonCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=rmd_DeferredRevenueNonCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554107677744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554102950928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Summary Of Revenue By Segment And Reconciling Items) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">$ 950,294<span></span>
</td>
<td class="nump">$ 904,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization by segment</a></td>
<td class="nump">36,273<span></span>
</td>
<td class="nump">39,102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Net operating profit by segment</a></td>
<td class="nump">275,739<span></span>
</td>
<td class="nump">261,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_AmortizationOfAcquiredIntangibleAssets1', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">7,950<span></span>
</td>
<td class="nump">7,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss attributable to equity method investments</a></td>
<td class="nump">2,028<span></span>
</td>
<td class="nump">1,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss', window );">(Gain) loss on equity investments</a></td>
<td class="nump">3,280<span></span>
</td>
<td class="num">(5,612)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(1,504)<span></span>
</td>
<td class="num">(1,991)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">261,793<span></span>
</td>
<td class="nump">258,788<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Net operating profit by segment</a></td>
<td class="nump">377,001<span></span>
</td>
<td class="nump">358,903<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization by segment</a></td>
<td class="nump">14,593<span></span>
</td>
<td class="nump">19,384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Reconciling items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_UnallocatedCorporateCosts', window );">Corporate costs</a></td>
<td class="nump">86,938<span></span>
</td>
<td class="nump">78,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_AmortizationOfAcquiredIntangibleAssets1', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">14,324<span></span>
</td>
<td class="nump">18,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense (income), net</a></td>
<td class="nump">7,134<span></span>
</td>
<td class="nump">5,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss attributable to equity method investments</a></td>
<td class="nump">2,028<span></span>
</td>
<td class="nump">1,386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss', window );">(Gain) loss on equity investments</a></td>
<td class="nump">3,280<span></span>
</td>
<td class="num">(5,612)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="nump">1,504<span></span>
</td>
<td class="nump">1,991<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">261,793<span></span>
</td>
<td class="nump">258,788<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rmd_SleepAndRespiratoryMember', window );">Total Sleep and Respiratory Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">844,443<span></span>
</td>
<td class="nump">806,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rmd_SleepAndRespiratoryMember', window );">Total Sleep and Respiratory Care | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization by segment</a></td>
<td class="nump">19,767<span></span>
</td>
<td class="nump">18,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Net operating profit by segment</a></td>
<td class="nump">352,560<span></span>
</td>
<td class="nump">336,996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rmd_SoftwareAsServiceMember', window );">Software as a Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue by segment</a></td>
<td class="nump">105,851<span></span>
</td>
<td class="nump">97,516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rmd_SoftwareAsServiceMember', window );">Software as a Service | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization by segment</a></td>
<td class="nump">1,913<span></span>
</td>
<td class="nump">1,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Net operating profit by segment</a></td>
<td class="nump">$ 24,441<span></span>
</td>
<td class="nump">$ 21,907<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_AmortizationOfAcquiredIntangibleAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of acquired intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_AmortizationOfAcquiredIntangibleAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_UnallocatedCorporateCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unallocated corporate costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_UnallocatedCorporateCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rmd_SleepAndRespiratoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rmd_SleepAndRespiratoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rmd_SoftwareAsServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rmd_SoftwareAsServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554102799712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Schedule Of Inventories) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 398,520<span></span>
</td>
<td class="nump">$ 355,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in progress</a></td>
<td class="nump">4,491<span></span>
</td>
<td class="nump">3,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">461,841<span></span>
</td>
<td class="nump">385,608<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 864,852<span></span>
</td>
<td class="nump">$ 743,910<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554106659888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Schedule Of Prepaid Expenses and Other Current Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid expenses and other current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">$ 92,226<span></span>
</td>
<td class="nump">$ 99,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_PrepaidInventory', window );">Prepaid inventories</a></td>
<td class="nump">122,839<span></span>
</td>
<td class="nump">107,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other prepaid expenses and current assets</a></td>
<td class="nump">126,134<span></span>
</td>
<td class="nump">131,265<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other current assets</a></td>
<td class="nump">$ 341,199<span></span>
</td>
<td class="nump">$ 337,908<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_PrepaidInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_PrepaidInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554105841344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Components Of Property, Plant And Equipment) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 1,107,564<span></span>
</td>
<td class="nump">$ 1,131,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(620,188)<span></span>
</td>
<td class="num">(633,114)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 487,376<span></span>
</td>
<td class="nump">$ 498,181<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554102893456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Schedule Of Other Intangible Assets, Net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total other intangibles, net</a></td>
<td class="nump">$ 338,151<span></span>
</td>
<td class="nump">$ 345,944<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rmd_DevelopedOrCoreProductTechnologyMember', window );">Developed/core product technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangibles, gross</a></td>
<td class="nump">354,770<span></span>
</td>
<td class="nump">350,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(244,255)<span></span>
</td>
<td class="num">(239,647)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total other intangibles, net</a></td>
<td class="nump">110,515<span></span>
</td>
<td class="nump">111,024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangibles, gross</a></td>
<td class="nump">258,312<span></span>
</td>
<td class="nump">257,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(97,143)<span></span>
</td>
<td class="num">(91,731)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total other intangibles, net</a></td>
<td class="nump">161,169<span></span>
</td>
<td class="nump">165,303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangibles, gross</a></td>
<td class="nump">194,970<span></span>
</td>
<td class="nump">204,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(128,503)<span></span>
</td>
<td class="num">(134,963)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total other intangibles, net</a></td>
<td class="nump">$ 66,467<span></span>
</td>
<td class="nump">$ 69,617<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, estimated useful life</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, estimated useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rmd_DevelopedOrCoreProductTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rmd_DevelopedOrCoreProductTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554105885152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Schedule Of Changes In Carrying Amount Of Goodwill) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at the beginning of the period</a></td>
<td class="nump">$ 1,936,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business acquisitions</a></td>
<td class="nump">19,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="num">(16,880)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at the end of the period</a></td>
<td class="nump">1,938,843<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rmd_SleepAndRespiratoryMember', window );">Total Sleep and Respiratory Care</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at the beginning of the period</a></td>
<td class="nump">641,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business acquisitions</a></td>
<td class="nump">19,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="num">(16,880)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at the end of the period</a></td>
<td class="nump">644,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rmd_SaasMember', window );">SaaS</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at the beginning of the period</a></td>
<td class="nump">1,294,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Business acquisitions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at the end of the period</a></td>
<td class="nump">$ 1,294,718<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rmd_SleepAndRespiratoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rmd_SleepAndRespiratoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rmd_SaasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rmd_SaasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554106655008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Schedule Of Investments) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_MarketableEquityInvestmentsFairValue', window );">Fair value</a></td>
<td class="nump">$ 5,887<span></span>
</td>
<td class="nump">$ 9,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Measurement alternative</a></td>
<td class="nump">43,581<span></span>
</td>
<td class="nump">39,290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method</a></td>
<td class="nump">7,890<span></span>
</td>
<td class="nump">9,918<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_EquityInvestmentsTotalByMeasurementCategory', window );">Total</a></td>
<td class="nump">$ 57,358<span></span>
</td>
<td class="nump">$ 58,375<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_EquityInvestmentsTotalByMeasurementCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Investments, Total by Measurement Category</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_EquityInvestmentsTotalByMeasurementCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_MarketableEquityInvestmentsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable Equity Investments, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_MarketableEquityInvestmentsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554106483952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Schedule Of Changes In Equity Investments) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_DebtAndEquityInvestmentsRollForward', window );"><strong>Debt and Equity Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_EquityInvestments', window );">Balance at the beginning of the period</a></td>
<td class="nump">$ 58,375<span></span>
</td>
<td class="nump">$ 69,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_AdditionalEquityInvestments', window );">Additions to investments</a></td>
<td class="nump">4,291<span></span>
</td>
<td class="nump">6,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities', window );">Observable price adjustments on non-marketable equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gains (losses) on marketable equity securities</a></td>
<td class="num">(3,280)<span></span>
</td>
<td class="nump">454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss attributable to equity method investments</a></td>
<td class="num">(2,028)<span></span>
</td>
<td class="num">(1,386)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_EquityInvestments', window );">Carrying value at the end of the period</a></td>
<td class="nump">57,358<span></span>
</td>
<td class="nump">80,066<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=rmd_NonMarketableSecuritiesMember', window );">Non-marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_DebtAndEquityInvestmentsRollForward', window );"><strong>Debt and Equity Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_EquityInvestments', window );">Balance at the beginning of the period</a></td>
<td class="nump">39,290<span></span>
</td>
<td class="nump">23,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_AdditionalEquityInvestments', window );">Additions to investments</a></td>
<td class="nump">4,291<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities', window );">Observable price adjustments on non-marketable equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_EquityInvestments', window );">Carrying value at the end of the period</a></td>
<td class="nump">43,581<span></span>
</td>
<td class="nump">31,160<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=rmd_MarketableSecuritiesMember', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_DebtAndEquityInvestmentsRollForward', window );"><strong>Debt and Equity Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_EquityInvestments', window );">Balance at the beginning of the period</a></td>
<td class="nump">9,167<span></span>
</td>
<td class="nump">29,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_AdditionalEquityInvestments', window );">Additions to investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gains (losses) on marketable equity securities</a></td>
<td class="num">(3,280)<span></span>
</td>
<td class="nump">454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_EquityInvestments', window );">Carrying value at the end of the period</a></td>
<td class="nump">5,887<span></span>
</td>
<td class="nump">33,138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquityMethodInvestmentsMember', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_DebtAndEquityInvestmentsRollForward', window );"><strong>Debt and Equity Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_EquityInvestments', window );">Balance at the beginning of the period</a></td>
<td class="nump">9,918<span></span>
</td>
<td class="nump">17,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss attributable to equity method investments</a></td>
<td class="num">(2,028)<span></span>
</td>
<td class="num">(1,386)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_EquityInvestments', window );">Carrying value at the end of the period</a></td>
<td class="nump">$ 7,890<span></span>
</td>
<td class="nump">$ 15,768<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_AdditionalEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Equity Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_AdditionalEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_DebtAndEquityInvestmentsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt and Equity Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_DebtAndEquityInvestmentsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_EquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_EquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Observable price adjustments on non-marketable equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI https://asc.fasb.org/extlink&amp;oid=126903467&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=rmd_NonMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=rmd_NonMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=rmd_MarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=rmd_MarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquityMethodInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquityMethodInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554107847616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Equity securities, net unrealized gain (loss)</a></td>
<td class="num">$ (3.3)<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554106623232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details) - Domestic Tax Authority - Australian Taxation Office<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 28, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_IncomeTaxExaminationRemittedFinalPayment', window );">Tax settlement, remitted final payment</a></td>
<td class="nump">$ 284.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_IncomeTaxExaminationGrossSettlement', window );">Tax settlement, gross amount</a></td>
<td class="nump">381.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_IncomeTaxExaminationPriorRemittancePayments', window );">Tax settlement, prior remittances</a></td>
<td class="nump">$ 96.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_IncomeTaxExaminationGrossSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Gross Settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_IncomeTaxExaminationGrossSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_IncomeTaxExaminationPriorRemittancePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Prior Remittance Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_IncomeTaxExaminationPriorRemittancePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_IncomeTaxExaminationRemittedFinalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Remitted Final Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_IncomeTaxExaminationRemittedFinalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_AustralianTaxationOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_AustralianTaxationOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554109939328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties (Schedule Of Changes In Liability For Warranty Costs) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance at the beginning of the period</a></td>
<td class="nump">$ 25,889<span></span>
</td>
<td class="nump">$ 22,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued', window );">Warranty accruals for the period</a></td>
<td class="nump">2,088<span></span>
</td>
<td class="nump">5,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Warranty costs incurred for the period</a></td>
<td class="num">(2,612)<span></span>
</td>
<td class="num">(3,972)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="num">(1,272)<span></span>
</td>
<td class="num">(513)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance at the end of the period</a></td>
<td class="nump">$ 24,093<span></span>
</td>
<td class="nump">$ 22,960<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from warranties issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the standard and extended product warranty accrual.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554102698896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Schedule of Debt) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_ShortTermDebtGross', window );">Short-term debt</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsCurrentNet', window );">Deferred borrowing costs</a></td>
<td class="num">(94)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt, net</a></td>
<td class="nump">9,906<span></span>
</td>
<td class="nump">9,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">790,000<span></span>
</td>
<td class="nump">770,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Deferred borrowing costs</a></td>
<td class="num">(4,564)<span></span>
</td>
<td class="num">(4,675)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net</a></td>
<td class="nump">785,436<span></span>
</td>
<td class="nump">765,325<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total debt</a></td>
<td class="nump">$ 795,342<span></span>
</td>
<td class="nump">$ 775,241<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_ShortTermDebtGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-Term Debt, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_ShortTermDebtGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsCurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsCurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554102036640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 10, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_DebtToConsolidatedEbitdaRatio', window );">Debt to consolidated EBITDA ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_LineOfCreditFacilityCollateralPercentageOfCompany', window );">Line of credit facility collateral, maximum percentage of ownership interests held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes, carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Outstanding debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">795,342,000<span></span>
</td>
<td class="nump">775,241,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rmd_SeniorNotesOneMember', window );">3.24% Senior Notes Due July 10, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.24%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rmd_SeniorNotesTwoMember', window );">3.45% Senior Notes Due July 10, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.45%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">455,700,000<span></span>
</td>
<td class="nump">477,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember', window );">Revolving Credit Agreement, Term Credit Agreement, And Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Outstanding debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember', window );">Revolving Credit Facility And Term Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="nump">$ 280,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember', window );">Revolving Credit Facility And Term Credit Agreement | Mufg Union Bank Na And Westpac Banking Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest rate on outstanding principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Available for draw</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Mufg Union Bank Na And Westpac Banking Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_UncommittedOptionToIncreaseCreditFacility', window );">Uncommitted option to increase credit facility</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod', window );">EBITDA multiple of trailing twelve-month measurement period</a></td>
<td class="nump">1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Mufg Union Bank Na And Westpac Banking Corporation | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fees percentage rate on unused portion of credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.075%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Mufg Union Bank Na And Westpac Banking Corporation | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fees percentage rate on unused portion of credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=rmd_TermLoanCreditAgreementMember', window );">Term Loan Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal', window );">Principal payment</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=rmd_TermLoanCreditAgreementMember', window );">Term Loan Credit Agreement | Minimum | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility interest rate equal to reference rate plus</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=rmd_TermLoanCreditAgreementMember', window );">Term Loan Credit Agreement | Minimum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility interest rate equal to reference rate plus</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=rmd_TermLoanCreditAgreementMember', window );">Term Loan Credit Agreement | Maximum | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility interest rate equal to reference rate plus</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=rmd_TermLoanCreditAgreementMember', window );">Term Loan Credit Agreement | Maximum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility interest rate equal to reference rate plus</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rmd_ResmedLimitedMember', window );">ResMed Limited | Revolving Credit Facility | Mufg Union Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, EBITDA Multiple of Trailing Twelve-Month Measurement Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_DebtToConsolidatedEbitdaRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt To Consolidated EBITDA Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_DebtToConsolidatedEbitdaRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_LineOfCreditFacilityCollateralPercentageOfCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility collateral, percentage of the company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_LineOfCreditFacilityCollateralPercentageOfCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_UncommittedOptionToIncreaseCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Uncommitted option to increase credit facility</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_UncommittedOptionToIncreaseCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payment applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rmd_SeniorNotesOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rmd_SeniorNotesOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rmd_SeniorNotesTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rmd_SeniorNotesTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rmd_MufgUnionBankNaAndWestpacBankingCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rmd_MufgUnionBankNaAndWestpacBankingCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=rmd_TermLoanCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=rmd_TermLoanCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rmd_ResmedLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rmd_ResmedLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rmd_MufgUnionBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rmd_MufgUnionBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554106638464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Narrative) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount</a></td>
<td class="nump">113,167<span></span>
</td>
<td class="nump">1,322<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554107430000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 210,478<span></span>
</td>
<td class="nump">$ 203,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average common shares outstanding (shares)</a></td>
<td class="nump">146,431<span></span>
</td>
<td class="nump">145,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Stock options and restricted stock units (shares)</a></td>
<td class="nump">703<span></span>
</td>
<td class="nump">1,180<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares (shares)</a></td>
<td class="nump">147,134<span></span>
</td>
<td class="nump">146,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (dollars per share)</a></td>
<td class="nump">$ 1.44<span></span>
</td>
<td class="nump">$ 1.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (dollars per share)</a></td>
<td class="nump">$ 1.43<span></span>
</td>
<td class="nump">$ 1.39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140554109938288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal Actions, Contingencies and Commitments (Narrative) (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rmd_ReceivablesSoldWithLimitedRecourse', window );">Receivables sold with limited recourse</a></td>
<td class="nump">$ 39.9<span></span>
</td>
<td class="nump">$ 49.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Maximum potential contingent liability</a></td>
<td class="nump">22.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Contingent provision</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Contractual obligation | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 950<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rmd_ReceivablesSoldWithLimitedRecourse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables Sold With Limited Recourse</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rmd_ReceivablesSoldWithLimitedRecourse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>rmd-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rmd="http://investor.resmed.com/20220930"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rmd-20220930.xsd" xlink:type="simple"/>
    <context id="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i29c92ffe566544d486d203907c01034b_I20221024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
        </entity>
        <period>
            <instant>2022-10-24</instant>
        </period>
    </context>
    <context id="ief4927d3a2364a12bd6b170de6d43c70_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icae7390e292248aea5680eee7705a952_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1c309ac73e7e4954ac2e526a95941779_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie5e4bee0df6d465bb76a7a14d683ed9e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8ec5cd27d9fc4cd1a6b87aaa117fa062_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iced71fbf9d854f909b168ae0c5dc6d3d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if39dcb9003eb460791aab51dde509ee3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i661416e60db0471f9d33a485c88000b8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic75938a78dd84e31a55814a504baa727_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2e425ee5a1764ebd9c10b93f28121cc9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i07bf4ea60e5c4a4ba7835c9c6b099652_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iebae534f8f214c65956df85450291a21_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i51a67b36abb34b5db4ef0af0016dec20_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2360ae9649ff48d281a132f80281a277_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic0bed1de6d224a628823074853f5cc02_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ided8696a9071487f85d658c6f7894111_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iaff681621a6a47ddb2e69a84b657d563_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib0edd8bdae674d5cba3df7e0bdab0a13_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if39d380d692046bfac4dd7d9da85fd9e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i82486906991d41c1bb227364f4e66f47_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifaceb858b79144bdb1473e507f59ebc8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib9a3ed59012748f68b30ed7614b16350_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if62ca46e58ff4e1ab852ba34c6e8125d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if778f54978bb489ab25d9277813650fd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id4c1bec761d343199bfb5656845fee5a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7d6e74c5fb8447bd9b144f2ba9b48825_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie68cba427884448a91f3ab762c19133d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2353812c8d374d0a99adb123069a8c45_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i39ae840cff9d4541883d39909be26bdb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2d609f79239f44f6b1a7c7d6b7b1bff4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic5c16a9474794461b2f4f520cab49c3f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i798ee6146fe04ee0a38f656f451210d4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i82b83a0ce15f4487baf7464a93daa021_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie3f1b5aa49a4420192a8beece7104061_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iee72006a6fb24b64994718e79dad7dfe_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i15ed4af6e542498aae586bf6f9ef5374_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:DevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia7cbf2f1f9774adaa9291a924a186b8e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:DevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2c97b22f44884dc591a2167585ba6e8d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:MasksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifa6d64210dc448b9a17c35d3c897c556_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:MasksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3e62e9945cad4965bcf36433023bfa68_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1eb5f7403b904bc9aab323b65ef846d5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i82ea3d05492e4ac98479d3e2ac49f908_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idc52733e9d564165bf93a97dacfc17f0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i98d3fc3d460b4652ad6b75c8adc858c4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3db47d0b4bae4fcfbccf115899c75152_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:UsCanadaAndLatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i02ae09329eef4efb848e53487594187f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:DevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:CombinedEuropeAsiaAndOtherMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2426e6fcaf654da9bb98fe543e2db047_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:DevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:CombinedEuropeAsiaAndOtherMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie9911d26ac214b2a8b97be040bea08d3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:MasksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:CombinedEuropeAsiaAndOtherMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4b207b56bf2b41e8bebae3064d374c7a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:MasksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:CombinedEuropeAsiaAndOtherMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6da4ff69d9ec4d9abbe4b31ba6f9e9cd_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:CombinedEuropeAsiaAndOtherMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic782a1e47cae42b893165007b949eb54_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:CombinedEuropeAsiaAndOtherMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibf87dfd1f7d7454cbbb3fdbfed511f9a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:DevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaa348c66adf44ac79c2e1d968c1e940d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:DevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i690f74a8d9e04be4a7acfb5c2e3e6fed_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:MasksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if2893d2234624bd1bcd6209e5bd0e3c5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:MasksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ice4bd47dac83461983f5e1caf7313368_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i599afb89a0f94887b16e08b956a275a3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if6ce4de0cebf48adbeadffe538eee9fd_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9688c0dafa244d73b3ea05467409af36_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i687eebe94bad4f46bc7e06b4c56dc88e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie5dc82ad0f3d42b68b84f9f7beb91b53_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rmd:GlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i64b8ab9a3e3045bdae18cd12d207e6f3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if328dc4c5e254ff8962ff04237432117_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibc375d0ba418427f8b2b60d529de7690_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:AccountsReceivableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib3bae8b8d6404de1893a39a0a2fb73d5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:AccountsReceivableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie987664fe8794b05be297c50f780e4df_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0705b4a48526488d8f80b81d4da788e9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5018235ea25d4087971080bf06c36785_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:PrepaidTaxesAndOtherNonCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8a609ca3d66545e89aa80e54d5cbf456_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:PrepaidTaxesAndOtherNonCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i396aafec23c5497f9a9a0124dd672b37_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:DeferredRevenueCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i84379be5bb434df49678f14cabe16d60_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:DeferredRevenueCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i77c2ddab74374037b8dfa317884bcb87_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:DeferredRevenueNonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie2a02b6469384b2fa69e00189cde926f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">rmd:DeferredRevenueNonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib78c1fac3c4347a38db050a74046fbb0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic8c22fc714d74cffb6b2a777dedeb592_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9c3bb7515a714bb0922f36fa159ea208_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5b9cb77e265a44399ae4e1c4466f9da9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie76543872e91484aae4ea6e093ade66c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i94a674e4585d44dfae6658ddd3dfe6fc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i640cd8511e9741ad923b981271756f3a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id4b603503f594377ba49d4d341fc0c76_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SoftwareAsServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iff46fa3403a545618690423df187e3f2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8c07d72c891a46a795fddf79d7928217_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9147d5a65f12434291bdbb355c876cb4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3822bb4d001f4343bad4507eaf24339d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i759637b4e24642d0af3b47249b185359_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i69e86a0970d447abaac8ad86f67160f7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rmd:DevelopedOrCoreProductTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i84b7e50d4346433e95666fb6afc046da_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rmd:DevelopedOrCoreProductTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1159ad451e6e4aeb9d34a0012448665f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if69726299ae44abb98de417d5a419afa_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0408bf19028f4072a1d8dd44df5a9ea3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i72f4980bc58d49c2966d8c1aa7bc905d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i14ad6e094e8c4c7a80ada79f330a56c5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i92f6ff0f41fd4e56a622577a92df8168_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SaasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3cb35257bd8b437e92849ecc0592453e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SaasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i15dc957f85fb4fe890100775f942c978_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SleepAndRespiratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8e9f732c1100497b8985d47b059e8339_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rmd:SaasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i70a87039741047098a43d0ed149675b0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:NonMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i754cf4a776a241f191b33f0081cd2afe_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:MarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5e7b9f80be8c4d2394bb2681a276056a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idc6e99edaebb4a609919407282c99506_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:NonMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i40e4bbc8f424443797674f57dc109757_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:MarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i670bbe1c2cb64cd2b590c0fadd7844ec_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ieadf15b970044d0a838558a15de8430f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:NonMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia4eb3627d8824fc0afceae4d64ab2a10_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:MarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i40bb05a82f774f53aabc2ee8e712ed5d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifadb68bbd9524af8a7d16266b166a2cf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:NonMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if4d7015735be42eb89bbf6e16b348801_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:MarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4f2c400950d04ed1912934bd2c201d82_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i398d34a58e00477c83fa76e1309cbf0c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:NonMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i790d1b42ed1c4ff3bb9c53be9acff926_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:MarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id077d5ad4d284fe9b8c598b153545a40_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia4567248f80c40ab88a38b16d19ad029_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:NonMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie62277cf19044d9fa1cd841612748260_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rmd:MarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i212dd8da8d734d648e06f65c84619472_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5f0fabb698be42fb98ac32d821f1a373_D20210928-20210928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="i5b783cdf50e346eaa8a19a835c62bd94_I20220629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rmd:MufgUnionBankNaAndWestpacBankingCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-29</instant>
        </period>
    </context>
    <context id="if40a26ace8cb428880b197363318cec6_D20220629-20220629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rmd:MufgUnionBankNaAndWestpacBankingCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-29</startDate>
            <endDate>2022-06-29</endDate>
        </period>
    </context>
    <context id="if612b91bc22e4ac586b695411b41fcc0_I20220629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rmd:MufgUnionBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rmd:ResmedLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-29</instant>
        </period>
    </context>
    <context id="i3e7585e7a6994d2f9e4c76acb9f9385c_D20220629-20220629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:TermLoanCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-29</startDate>
            <endDate>2022-06-29</endDate>
        </period>
    </context>
    <context id="i5f41dcaf8ccd46709b5faa04c5fea871_D20220629-20220629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-29</startDate>
            <endDate>2022-06-29</endDate>
        </period>
    </context>
    <context id="i9f70c29ca1d548b5ae6f93b716b75536_D20220629-20220629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-29</startDate>
            <endDate>2022-06-29</endDate>
        </period>
    </context>
    <context id="i22e4bb0fad4d40c5af0492d1dc204cbc_D20220629-20220629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-29</startDate>
            <endDate>2022-06-29</endDate>
        </period>
    </context>
    <context id="i34f25e5e32fb41b9b7fb9e569b16cbdc_D20220629-20220629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-29</startDate>
            <endDate>2022-06-29</endDate>
        </period>
    </context>
    <context id="i1297f32638a142a0ba72932abf60d77d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:RevolvingCreditFacilityAndTermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rmd:MufgUnionBankNaAndWestpacBankingCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8a573e957f98484584a0734afd58d57f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rmd:MufgUnionBankNaAndWestpacBankingCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i52939f1db3354c2c83c55393bca89e73_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rmd:MufgUnionBankNaAndWestpacBankingCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib7d3d056a48b41ffafd0825a2500cd15_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iaf532dad3c0a4d5cb85816567efdfe50_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:RevolvingCreditFacilityAndTermLoanCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0a79621ce364424f8da12a47723d1717_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">rmd:RevolvingCreditFacilityAndTermLoanCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i48ec36cab3dc49749081f5531f83adae_I20190710">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rmd:SeniorNotesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-10</instant>
        </period>
    </context>
    <context id="i3220e912ac0c4ec792285781acd932a8_I20190710">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rmd:SeniorNotesTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-10</instant>
        </period>
    </context>
    <context id="i1345482cbeee4a25a7bde5fd11f5d59f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia97609d461e84c708a6451bc44ca5926_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i52c4dfffd15a49a6932fb065ffdb3d23_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rmd:RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i543df4c733354c07b6ce1628c05bd511_D20210701-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000943819</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>rmd:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180L2ZyYWc6NWE3MGM4MzQxMjFjNDVhNmFmYjM3MDk2ZDkwYWNjZTkvdGFibGU6NDU4MzQ4ODA3MzkyNGRhZmE5N2NhZWRmZjljNjVkZTUvdGFibGVyYW5nZTo0NTgzNDg4MDczOTI0ZGFmYTk3Y2FlZGZmOWM2NWRlNV8zLTEtMS0xLTYyMTE5_c63115bf-cd2c-4a46-b283-f69e93770a05">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180L2ZyYWc6NWE3MGM4MzQxMjFjNDVhNmFmYjM3MDk2ZDkwYWNjZTkvdGFibGU6NDU4MzQ4ODA3MzkyNGRhZmE5N2NhZWRmZjljNjVkZTUvdGFibGVyYW5nZTo0NTgzNDg4MDczOTI0ZGFmYTk3Y2FlZGZmOWM2NWRlNV80LTEtMS0xLTYyMTE5_ea07a97f-3851-4b65-abb3-f245b36b8a4d">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180L2ZyYWc6NWE3MGM4MzQxMjFjNDVhNmFmYjM3MDk2ZDkwYWNjZTkvdGFibGU6NDU4MzQ4ODA3MzkyNGRhZmE5N2NhZWRmZjljNjVkZTUvdGFibGVyYW5nZTo0NTgzNDg4MDczOTI0ZGFmYTk3Y2FlZGZmOWM2NWRlNV81LTEtMS0xLTYyMTE5_1066f961-85a5-4e20-937b-5ea3552e9bb6">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180L2ZyYWc6NWE3MGM4MzQxMjFjNDVhNmFmYjM3MDk2ZDkwYWNjZTkvdGFibGU6NDU4MzQ4ODA3MzkyNGRhZmE5N2NhZWRmZjljNjVkZTUvdGFibGVyYW5nZTo0NTgzNDg4MDczOTI0ZGFmYTk3Y2FlZGZmOWM2NWRlNV82LTEtMS0xLTYyMTE5_df98688d-da63-42df-9481-89cf7771ff61">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180L2ZyYWc6NWE3MGM4MzQxMjFjNDVhNmFmYjM3MDk2ZDkwYWNjZTkvdGFibGU6NDU4MzQ4ODA3MzkyNGRhZmE5N2NhZWRmZjljNjVkZTUvdGFibGVyYW5nZTo0NTgzNDg4MDczOTI0ZGFmYTk3Y2FlZGZmOWM2NWRlNV83LTEtMS0xLTYyMTE5_0c03ac2a-cd56-4dc5-818c-d1033cccfc1e">0000943819</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNzA1_b1a8b5cd-4f3b-4884-97ee-0882420f883c">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6MGI5MTJiMGRhYmZhNDIyZDhkNjQyYjI2NGQ3YTQ1YjYvdGFibGVyYW5nZTowYjkxMmIwZGFiZmE0MjJkOGQ2NDJiMjY0ZDdhNDViNl8wLTAtMS0xLTYyMTE5_79d9e034-332a-4454-98de-a774839748b4">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yMTk5MDIzMjU4MzQ1_5bff343f-9a81-4478-beb3-d309535d60e7">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6NjA3NjU2MzYwZWU1NDhiMTllNTllZmExMzU5MGZmMTcvdGFibGVyYW5nZTo2MDc2NTYzNjBlZTU0OGIxOWU1OWVmYTEzNTkwZmYxN18wLTAtMS0xLTYyMTE5_2b45e24a-04cf-494c-93bf-a6a8143ef6fa">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNzAw_7bd12893-7c17-47a1-b173-afaa0dece12f">001-15317</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNzA2_41d43520-6a42-4f78-b57d-ceae80d97041">ResMed Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNjk2_400a4fcc-ce51-4828-9b17-4424f2869f72">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNzAx_7fcb02e4-25a6-47fe-9c61-4cf9c957bea4">98-0152841</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF83ODg_0d0dcd13-e650-4d1a-ac5b-5fd43daced84">9001 Spectrum Center Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF83OTE_8a1dede5-0441-4575-a296-7c288dfa77cf">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF83OTU_889fb7ec-0f46-48e8-afd0-e8174d5a612a">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF83OTg_9883fcd1-de85-4dcc-a1e6-2b0b57ac6d4d">92123</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNjk0_be1a1a0f-9291-4071-a1ee-a633bbaaf5d5">US</dei:EntityAddressCountry>
    <dei:CityAreaCode
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNzA3_0919a0d5-f600-4990-b006-6bcc73813cc8">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNzAy_edbf3687-9209-4a38-aeb7-ba033e30e921">836-5000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6ZDUzZmE1MDUyZDI1NDdmMWEzMjU4MTAzNjA2YzRiMzYvdGFibGVyYW5nZTpkNTNmYTUwNTJkMjU0N2YxYTMyNTgxMDM2MDZjNGIzNl8xLTAtMS0xLTYyMTE5_3c4bbe8b-df9f-44b3-bfac-5acc1221b234">Common Stock, par value $0.004 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6ZDUzZmE1MDUyZDI1NDdmMWEzMjU4MTAzNjA2YzRiMzYvdGFibGVyYW5nZTpkNTNmYTUwNTJkMjU0N2YxYTMyNTgxMDM2MDZjNGIzNl8xLTItMS0xLTYyMTE5_39851989-8141-401e-8ca4-7a2ecfb52283">RMD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6ZDUzZmE1MDUyZDI1NDdmMWEzMjU4MTAzNjA2YzRiMzYvdGFibGVyYW5nZTpkNTNmYTUwNTJkMjU0N2YxYTMyNTgxMDM2MDZjNGIzNl8xLTQtMS0xLTYyMTE5_e57e3a0c-1876-47e1-9289-15b552d29eff">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNjk3_88c92c98-e37d-48f1-9a89-b07e8173ad73">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNjk4_3c59b255-b1b1-4046-b344-8d9554b94bf1">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6YTM3YjM3ZmExNzFiNDI1MDgwYzdmMmMwNDI4NDc4ZjYvdGFibGVyYW5nZTphMzdiMzdmYTE3MWI0MjUwODBjN2YyYzA0Mjg0NzhmNl8wLTAtMS0xLTYyMTE5_919748fc-981d-4ef8-869b-ab3de9052301">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6YTM3YjM3ZmExNzFiNDI1MDgwYzdmMmMwNDI4NDc4ZjYvdGFibGVyYW5nZTphMzdiMzdmYTE3MWI0MjUwODBjN2YyYzA0Mjg0NzhmNl8xLTQtMS0xLTYyMTE5_ee1880d6-7a3e-4771-93f4-6d65feb634eb">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGFibGU6YTM3YjM3ZmExNzFiNDI1MDgwYzdmMmMwNDI4NDc4ZjYvdGFibGVyYW5nZTphMzdiMzdmYTE3MWI0MjUwODBjN2YyYzA0Mjg0NzhmNl8yLTEtMS0xLTYyMTE5_64ea848e-8dcc-45b1-91c6-adda00cf7321">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF8yNjk1_b1d8d9d0-321e-44e0-95c7-e10487eaed9d">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i29c92ffe566544d486d203907c01034b_I20221024"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xL2ZyYWc6MzNlM2VmN2U1ZmNkNDhiMjg3MDhhZDYxNzUzNTNmMjgvdGV4dHJlZ2lvbjozM2UzZWY3ZTVmY2Q0OGIyODcwOGFkNjE3NTM1M2YyOF84MjQ2MzM3MjExMDM1_8c90c871-8f6e-41d6-afce-de84055f43d6"
      unitRef="shares">146483650</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMy0xLTEtMS02MjExOQ_07543377-2b01-4e19-954f-51dc39cf904e"
      unitRef="usd">207163000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMy0zLTEtMS02MjExOQ_c721f6c8-5fda-4be5-9030-954bc9c3e97d"
      unitRef="usd">273710000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNC0wLTEtMS02MjExOS90ZXh0cmVnaW9uOmY3YjY2NWU1ZmY5YjQ0ZWJhMDMwYTIyNWQ1MGRkYjI5XzQ2_6b52006d-a9d0-4907-84a7-17c1ce07ba78"
      unitRef="usd">23867000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNC0wLTEtMS02MjExOS90ZXh0cmVnaW9uOmY3YjY2NWU1ZmY5YjQ0ZWJhMDMwYTIyNWQ1MGRkYjI5XzUz_c4c7a304-8ef8-46a1-aec3-e8db4e6ab25d"
      unitRef="usd">23259000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNC0xLTEtMS02MjExOQ_26debdca-ee69-4777-abb6-298d8cb17ba9"
      unitRef="usd">620483000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNC0zLTEtMS02MjExOQ_53fa2b1e-304e-4403-96fa-523b316c569f"
      unitRef="usd">575950000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNS0xLTEtMS02MjExOQ_701c4e0f-ea7c-4d73-90c3-272be2aed0da"
      unitRef="usd">864852000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNS0zLTEtMS02MjExOQ_1c9a1132-85dd-41ca-a6b6-7cc114b2d50e"
      unitRef="usd">743910000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNi0xLTEtMS02MjExOQ_ef03939e-642d-4f5d-9e4e-9fe11955bde9"
      unitRef="usd">341199000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNi0zLTEtMS02MjExOQ_989b93f4-51f7-4950-be8d-f84ea1ad4706"
      unitRef="usd">337908000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNy0xLTEtMS02MjExOQ_922f52da-246a-4f91-8427-0d223c7d1755"
      unitRef="usd">2033697000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNy0zLTEtMS02MjExOQ_57751311-9e0c-47bb-a96e-e33f99802247"
      unitRef="usd">1931478000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfOS0xLTEtMS02MjExOQ_b8db1d7b-98a4-48a6-a32a-ef96a011e01e"
      unitRef="usd">487376000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfOS0zLTEtMS02MjExOQ_c6160885-5435-465d-8104-6d4331dbba59"
      unitRef="usd">498181000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTAtMS0xLTEtNjIxMTk_c0da16e5-dcaf-4ed3-bf86-2884e953686c"
      unitRef="usd">125319000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTAtMy0xLTEtNjIxMTk_4d779341-ec98-441d-8e68-1ed5d341bd8a"
      unitRef="usd">132314000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTEtMS0xLTEtNjIxMTk_fdf88ed4-67e3-431b-bcf8-f42a9c251b1e"
      unitRef="usd">1938843000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTEtMy0xLTEtNjIxMTk_a9fc1ace-3b01-4895-8a48-762170842f2e"
      unitRef="usd">1936442000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTItMS0xLTEtNjIxMTk_1340381e-b7d4-4cab-8786-356721ac3a40"
      unitRef="usd">338151000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTItMy0xLTEtNjIxMTk_34671d62-2ebe-4042-83ca-46fe5f320fe3"
      unitRef="usd">345944000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTMtMS0xLTEtNjIxMTk_300cdb2a-85e6-492d-9756-c5a412be6893"
      unitRef="usd">80745000</us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTMtMy0xLTEtNjIxMTk_2784e4a7-c70f-47f9-a965-2e1bd07e4770"
      unitRef="usd">79746000</us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTQtMS0xLTEtNjIxMTk_f953e6a4-e5f1-4583-a38f-e09781e059f7"
      unitRef="usd">173429000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTQtMy0xLTEtNjIxMTk_aaddf185-97b7-4930-91b5-4096ce3c68f7"
      unitRef="usd">171748000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTUtMS0xLTEtNjIxMTk_921d1c22-26be-4253-81fe-c86cb4e5ac66"
      unitRef="usd">3143863000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTUtMy0xLTEtNjIxMTk_5203c8d0-6605-4d0d-b448-03027c9682f7"
      unitRef="usd">3164375000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTYtMS0xLTEtNjIxMTk_71921a93-3f11-42b7-b1c0-6b499d6e030a"
      unitRef="usd">5177560000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTYtMy0xLTEtNjIxMTk_efbb09e5-5d28-44ae-bccc-835fdfc8ee7e"
      unitRef="usd">5095853000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTktMS0xLTEtNjIxMTk_5ef65c8a-a356-4208-bd72-7b1ad3f89425"
      unitRef="usd">181485000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMTktMy0xLTEtNjIxMTk_a50b37b2-93c0-4b0d-b8e8-18eafdb3c488"
      unitRef="usd">159245000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjAtMS0xLTEtNjIxMTk_3aeca099-2154-4576-aa7a-5727c9cd8555"
      unitRef="usd">324055000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjAtMy0xLTEtNjIxMTk_fd78704f-b442-4217-97f0-17fe2167197b"
      unitRef="usd">344722000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjEtMS0xLTEtNjIxMTk_cbaaeb61-41e7-4b0e-93ac-050b844248a1"
      unitRef="usd">21076000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjEtMy0xLTEtNjIxMTk_e2d37f60-6f25-44c5-a3aa-4c34954a698c"
      unitRef="usd">21856000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjItMS0xLTEtNjIxMTk_d33b49bd-56ab-4427-b705-75e1ac8d7f4b"
      unitRef="usd">108195000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjItMy0xLTEtNjIxMTk_9091347e-58cf-4611-97f3-ac09cbe7271c"
      unitRef="usd">108667000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjMtMS0xLTEtNjIxMTk_6d0e6cfe-f55c-40cf-acae-4ca43ac57330"
      unitRef="usd">47942000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjMtMy0xLTEtNjIxMTk_91b3d4b9-53f3-4f2f-821f-294ad585fb10"
      unitRef="usd">44893000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjQtMS0xLTEtNjIxMTk_f0cd7e7e-9934-4964-b058-07401b1a30d3"
      unitRef="usd">9906000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjQtMy0xLTEtNjIxMTk_cc606cbe-5e04-4a67-ad4f-521b75ac7b8d"
      unitRef="usd">9916000</us-gaap:ShortTermBorrowings>
    <us-gaap:LiabilitiesCurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjUtMS0xLTEtNjIxMTk_1a2f1634-1dc5-4b4c-b413-7d730dc381fb"
      unitRef="usd">692659000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjUtMy0xLTEtNjIxMTk_9e440391-3f2d-489e-88c1-389f1feda9a8"
      unitRef="usd">689299000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjctMS0xLTEtNjIxMTk_84e9f2f2-9e46-49e7-b433-938c1a088e56"
      unitRef="usd">97620000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjctMy0xLTEtNjIxMTk_70810028-e0e3-4087-913a-baefa1e310ed"
      unitRef="usd">95455000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjgtMS0xLTEtNjIxMTk_71deaea5-d110-4b07-8e2f-2c7a7b2f489a"
      unitRef="usd">11830000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjgtMy0xLTEtNjIxMTk_0ec4df2a-f283-45a1-b034-49fa95d07776"
      unitRef="usd">9714000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjktMS0xLTEtNjIxMTk_3f825c61-33b0-4985-8e6d-883eb9e8e64c"
      unitRef="usd">114214000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMjktMy0xLTEtNjIxMTk_49247881-b0aa-48b3-bce0-dc0c0f8ef6ce"
      unitRef="usd">120453000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzAtMS0xLTEtNjIxMTk_da081197-ff65-40fa-9930-d2ac28cb1f7b"
      unitRef="usd">5838000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzAtMy0xLTEtNjIxMTk_624cb6e6-5ff4-419d-82cb-ae8c4f58f091"
      unitRef="usd">5974000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzEtMS0xLTEtNjIxMTk_1646a496-5a6c-423a-8551-39d48447137d"
      unitRef="usd">785436000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzEtMy0xLTEtNjIxMTk_14bae321-21f6-4d81-b79a-456734f56a12"
      unitRef="usd">765325000</us-gaap:LongTermDebt>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzItMS0xLTEtNjIxMTk_822d4c52-8cb6-4124-85c0-4b81b4676b92"
      unitRef="usd">37076000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzItMy0xLTEtNjIxMTk_8192f9e0-ac0c-4f60-98b1-cf9269e564b9"
      unitRef="usd">48882000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzMtMS0xLTEtNjIxMTk_e29b6d71-dc93-4a3e-a517-c59ed8c84e77"
      unitRef="usd">1052014000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzMtMy0xLTEtNjIxMTk_a2ee0930-ab2b-42e5-8dfe-b82e16e7f910"
      unitRef="usd">1045803000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzQtMS0xLTEtNjIxMTk_1572bd19-417a-4a73-88d2-85c291481a7d"
      unitRef="usd">1744673000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzQtMy0xLTEtNjIxMTk_970cc1db-6801-430d-b535-c9ef7d94568f"
      unitRef="usd">1735102000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzUtMS0xLTEtNjIxMTk_f0984456-d8be-4d6a-be53-8705d925db24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzUtMy0xLTEtNjIxMTk_8de1248a-9a63-4919-acb3-ca7eef44b77e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo2YzFlYWQ3YTYwZmU0MGRmOWVjMjIxY2JjZWQ5NmRmN18yMQ_3886725d-c1b6-48b4-a89e-47f193340fff"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo2YzFlYWQ3YTYwZmU0MGRmOWVjMjIxY2JjZWQ5NmRmN18yMQ_5fba0dcb-acb3-49f1-82a5-d45695776279"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo2YzFlYWQ3YTYwZmU0MGRmOWVjMjIxY2JjZWQ5NmRmN18zNQ_ab7700eb-5264-4d0c-9768-5945f696e048"
      unitRef="shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo2YzFlYWQ3YTYwZmU0MGRmOWVjMjIxY2JjZWQ5NmRmN18zNQ_b9b199c1-459e-412e-a5c9-2f2dfbe09538"
      unitRef="shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo2YzFlYWQ3YTYwZmU0MGRmOWVjMjIxY2JjZWQ5NmRmN181Nw_1685cf6d-720f-45cd-9647-aa5337eedcdf"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo2YzFlYWQ3YTYwZmU0MGRmOWVjMjIxY2JjZWQ5NmRmN181Nw_d6c62e87-a817-4f93-8d12-6b39bfd5c6d0"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMS0xLTEtNjIxMTk_501dfc35-bdf7-4cd5-b5b5-e3b75ef9f465"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzctMy0xLTEtNjIxMTk_74cd39c0-6b2f-4477-9a13-7096c0c41a39"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl8xOA_b0556cb0-19e3-438c-bc0d-66038ac9f2e6"
      unitRef="usdPerShare">0.004</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl8xOA_b533dee2-d01c-47b1-86e8-da0ad6805e03"
      unitRef="usdPerShare">0.004</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl8zMg_45b216e8-7340-4ffc-9777-5c326ba953a3"
      unitRef="shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl8zMg_c24e52b5-2a1d-4819-b790-1096ef00da8b"
      unitRef="shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl81NA_b80fc947-5223-4012-8f20-00475d65f429"
      unitRef="shares">188295266</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl82OA_46de5c58-ea15-4231-b583-df8b4c7ffd37"
      unitRef="shares">146459032</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl85Mw_fdb13184-d7f6-4df2-8ab2-ef735c51f2d0"
      unitRef="shares">188246955</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjo4OGQ0Y2VlMzczNGI0NDgzOTI1NTdmMDM2YmVjNTViMl8xMDc_b0d1d6b8-b160-4efb-9987-88d6f0ce1b09"
      unitRef="shares">146410721</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMS0xLTEtNjIxMTk_e4bbe9b3-df3f-4bc3-9455-8c6145f33f87"
      unitRef="usd">586000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzgtMy0xLTEtNjIxMTk_8dbba734-24e9-4474-a110-01e3ec847da7"
      unitRef="usd">586000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzktMS0xLTEtNjIxMTk_cf4dd467-2b56-468b-8782-c1cba98c5108"
      unitRef="usd">1701902000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfMzktMy0xLTEtNjIxMTk_8d982605-4be0-46e6-9342-f7ba23b30d11"
      unitRef="usd">1682432000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDAtMS0xLTEtNjIxMTk_f182b8a1-5d64-4523-8f67-b135f8f87d3f"
      unitRef="usd">3759783000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDAtMy0xLTEtNjIxMTk_874fcd0b-7e36-45eb-843c-1f1b8d194b9f"
      unitRef="usd">3613736000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDEtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjplYzk3NzE2NjkwMWQ0M2U1OTBjNjM1NjZmNzZlODkxMF8yOQ_6919ee21-be8a-47fc-a93a-7a5de688cbcc"
      unitRef="shares">41836234</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDEtMC0xLTEtNjIxMTkvdGV4dHJlZ2lvbjplYzk3NzE2NjkwMWQ0M2U1OTBjNjM1NjZmNzZlODkxMF8yOQ_d5035632-3b77-44ec-ba9d-ca3e1d02b744"
      unitRef="shares">41836234</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDEtMS0xLTEtNjIxMTk_e69dc60f-33ed-46d8-a0df-7bc6ee604ee5"
      unitRef="usd">1623256000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDEtMy0xLTEtNjIxMTk_25372cfe-4877-405f-ab1a-7a6fe65aafa5"
      unitRef="usd">1623256000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDItMS0xLTEtNjIxMTk_5e1f741c-f836-47c4-91ec-52d80473c186"
      unitRef="usd">-406128000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDItMy0xLTEtNjIxMTk_64a6ebda-9b6d-4a6a-be37-6fdb54f3fdba"
      unitRef="usd">-312747000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDMtMS0xLTEtNjIxMTk_c6de7844-781f-45f2-8a08-efe0d9a78747"
      unitRef="usd">3432887000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDMtMy0xLTEtNjIxMTk_08b19057-6f96-40ae-9633-b8347ec65efd"
      unitRef="usd">3360751000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDQtMS0xLTEtNjIxMTk_7c08b4bf-3e8d-4b57-adfa-ed34d13c53d6"
      unitRef="usd">5177560000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMC9mcmFnOjk5NWVmYzBjNWY4MTQ1Y2ZhZWUwYzdiYTRlMzI1YzdiL3RhYmxlOmU3MDYyYjA1ODIxZTQ0OTRhMTQ0OWIzMGNlNGZiNmY2L3RhYmxlcmFuZ2U6ZTcwNjJiMDU4MjFlNDQ5NGExNDQ5YjMwY2U0ZmI2ZjZfNDQtMy0xLTEtNjIxMTk_b6212ffc-9abd-45f9-a3ed-22807e6726e3"
      unitRef="usd">5095853000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icae7390e292248aea5680eee7705a952_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMi0xLTEtMS02MjExOQ_391ba7ec-4254-4d60-9921-3d48df17044e"
      unitRef="usd">844443000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c309ac73e7e4954ac2e526a95941779_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMi0zLTEtMS02MjExOQ_7b90802f-b816-4e7a-b647-afda0f42a0c3"
      unitRef="usd">806499000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5e4bee0df6d465bb76a7a14d683ed9e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMy0xLTEtMS02MjExOQ_23a5e5f7-e61c-4477-8a12-c02b2767ed11"
      unitRef="usd">105851000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ec5cd27d9fc4cd1a6b87aaa117fa062_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMy0zLTEtMS02MjExOQ_f5747bf3-aca7-408c-81f7-d34ada2c8dec"
      unitRef="usd">97516000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfNC0xLTEtMS02MjExOQ_d44414fb-3510-4468-a007-bc6f4e0b3e0f"
      unitRef="usd">950294000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfNC0zLTEtMS02MjExOQ_798812d2-470a-46a0-9e88-079704a3acb3"
      unitRef="usd">904015000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="icae7390e292248aea5680eee7705a952_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfNi0xLTEtMS02MjExOQ_d7a624d0-5fb7-402f-ba20-bdde74e5fd7d"
      unitRef="usd">363844000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i1c309ac73e7e4954ac2e526a95941779_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfNi0zLTEtMS02MjExOQ_d5364478-dc61-4508-acf6-b68b9400d328"
      unitRef="usd">349681000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="ie5e4bee0df6d465bb76a7a14d683ed9e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfNy0xLTEtMS02MjExOQ_f74c0dcf-d69a-4672-8346-1bfbe3d517c9"
      unitRef="usd">39266000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i8ec5cd27d9fc4cd1a6b87aaa117fa062_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfNy0zLTEtMS02MjExOQ_d3b83281-7954-467f-8023-a171eb5538b4"
      unitRef="usd">36986000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfOC0xLTEtMS02MjExOQ_98b34e43-47a3-47f1-824e-e9d6cdb0910e"
      unitRef="usd">403110000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfOC0zLTEtMS02MjExOQ_7143df33-bb00-41df-9973-859e6bf22dc3"
      unitRef="usd">386667000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="icae7390e292248aea5680eee7705a952_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTAtMS0xLTEtNjIxMTk_48b3e7b3-2406-4377-b881-bac27b28d4cc"
      unitRef="usd">1228000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1c309ac73e7e4954ac2e526a95941779_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTAtMy0xLTEtNjIxMTk_c7261766-dd16-4970-97b5-a601f3ef2b1d"
      unitRef="usd">900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie5e4bee0df6d465bb76a7a14d683ed9e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTEtMS0xLTEtNjIxMTk_cef14a78-a81e-47a4-9899-eaf4a5a0a104"
      unitRef="usd">5146000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8ec5cd27d9fc4cd1a6b87aaa117fa062_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTEtMy0xLTEtNjIxMTk_4b8d547a-9be3-4237-b888-87988ceef67f"
      unitRef="usd">10159000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTItMS0xLTEtNjIxMTk_36edc17f-51c5-4941-aca4-908de547bdec"
      unitRef="usd">6374000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTItMy0xLTEtNjIxMTk_5cd14597-d94e-49d7-b6fa-ae7bd21e54ba"
      unitRef="usd">11059000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTMtMS0xLTEtNjIxMTk_0f53b146-dcb5-4b40-9900-2e9978e2433b"
      unitRef="usd">409484000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTMtMy0xLTEtNjIxMTk_a063d00f-1697-4106-8e27-469a875a3830"
      unitRef="usd">397726000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTQtMS0xLTEtNjIxMTk_2514d04d-09c0-4d53-9979-d03993d6982d"
      unitRef="usd">540810000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTQtMy0xLTEtNjIxMTk_33e9c8c3-8d45-46f3-b19d-aa90f3f0ce90"
      unitRef="usd">506289000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTYtMS0xLTEtNjIxMTk_9d34a9d5-3193-4ce3-a892-f2d537a32856"
      unitRef="usd">193933000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTYtMy0xLTEtNjIxMTk_33e2a271-cf55-40df-8ab5-5d64cdeeb62e"
      unitRef="usd">176719000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTctMS0xLTEtNjIxMTk_95d900b6-68b8-4f72-9eb1-131d74d0ccf4"
      unitRef="usd">63188000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTctMy0xLTEtNjIxMTk_1f3935a4-c51c-407f-a117-3fca537a03f3"
      unitRef="usd">59950000</us-gaap:ResearchAndDevelopmentExpense>
    <rmd:AmortizationOfAcquiredIntangibleAssets1
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTgtMS0xLTEtNjIxMTk_a61d5c9b-4310-45e4-bfdc-908ac50285a5"
      unitRef="usd">7950000</rmd:AmortizationOfAcquiredIntangibleAssets1>
    <rmd:AmortizationOfAcquiredIntangibleAssets1
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMTgtMy0xLTEtNjIxMTk_6a79fc9d-8c8d-4266-a3c9-3b007803c1e1"
      unitRef="usd">7707000</rmd:AmortizationOfAcquiredIntangibleAssets1>
    <us-gaap:OperatingExpenses
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjAtMS0xLTEtNjIxMTk_c519b67b-4b42-4f2e-92cb-94bcf1314b1b"
      unitRef="usd">265071000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjAtMy0xLTEtNjIxMTk_c014de6e-ec49-4ceb-9abf-089e604d6085"
      unitRef="usd">244376000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjEtMS0xLTEtNjIxMTk_01a8044e-3ce2-44e1-83b4-74d9c0921308"
      unitRef="usd">275739000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjEtMy0xLTEtNjIxMTk_a3350148-f38b-46c4-8a9f-ee68fb8d4004"
      unitRef="usd">261913000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjMtMS0xLTEtNjIxMTk_1402e3b3-65df-4d4f-bc79-27d3f3c4ef80"
      unitRef="usd">-7134000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjMtMy0xLTEtNjIxMTk_a65807fd-ddfe-49fb-8a9d-99997766bf09"
      unitRef="usd">-5360000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjQtMS0xLTEtNjIxMTk_e52b34b8-bd37-4c92-85e4-eaf0ac60d963"
      unitRef="usd">-2028000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjQtMy0xLTEtNjIxMTk_a17699c5-48f6-45b0-afd2-b321b858df33"
      unitRef="usd">-1386000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjUtMS0xLTEtNjIxMTk_af5c750d-935b-4dce-b9ab-e4b0ae22164d"
      unitRef="usd">-3280000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjUtMy0xLTEtNjIxMTk_ccc6b302-647d-4646-9a76-9f8f913a0577"
      unitRef="usd">5612000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjYtMS0xLTEtNjIxMTk_eb4016c1-dc42-4552-8720-8042120aa19d"
      unitRef="usd">-1504000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjYtMy0xLTEtNjIxMTk_13d4d488-fdf4-4226-9efc-846a8d9cb018"
      unitRef="usd">-1991000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjctMS0xLTEtNjIxMTk_fbdf62e5-d94b-4bd6-8867-0e3393cd32e9"
      unitRef="usd">-13946000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjctMy0xLTEtNjIxMTk_3603176c-d9f7-454e-9b52-11d1cc2196f3"
      unitRef="usd">-3125000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjgtMS0xLTEtNjIxMTk_95214eb9-e51b-4055-b0f4-7bd58c42e0b2"
      unitRef="usd">261793000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjgtMy0xLTEtNjIxMTk_eb6f7309-ba7a-47a3-94e0-0a54633c8f67"
      unitRef="usd">258788000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjktMS0xLTEtNjIxMTk_f0d65410-4225-4e8a-a83d-705d915c8f1e"
      unitRef="usd">51315000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMjktMy0xLTEtNjIxMTk_3a882123-72ed-49b1-95dc-e155cdc6b525"
      unitRef="usd">55175000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzAtMS0xLTEtNjIxMTk_8af084a1-6ae5-4d2e-9125-36a8a2ceb241"
      unitRef="usd">210478000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzAtMy0xLTEtNjIxMTk_dd4f59ca-6728-4ba6-b75a-af28f84306a9"
      unitRef="usd">203613000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzEtMS0xLTEtNjIxMTk_84ba5c12-192c-41dd-b396-e5de50bbbe45"
      unitRef="usdPerShare">1.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzEtMy0xLTEtNjIxMTk_e9a9947d-22cf-4edc-b8f5-5fdf2732568a"
      unitRef="usdPerShare">1.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzItMS0xLTEtNjIxMTk_7538aa0e-29b6-497b-a75a-806d347be309"
      unitRef="usdPerShare">1.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzItMy0xLTEtNjIxMTk_0bb31733-df15-4ded-946b-9b1727a25821"
      unitRef="usdPerShare">1.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzMtMS0xLTEtNjIxMTk_c7063cd8-a81e-4ed7-b844-144f1f9d3b9e"
      unitRef="usdPerShare">0.44</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzMtMy0xLTEtNjIxMTk_bb7a0856-9689-44bc-ab0d-b21d81db8c01"
      unitRef="usdPerShare">0.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzQtMS0xLTEtNjIxMTk_ac02c50d-2dd0-4f01-ad79-52c425e06eea"
      unitRef="shares">146431000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzQtMy0xLTEtNjIxMTk_64cdbf49-398b-418b-9bc3-c74b7f4af0b6"
      unitRef="shares">145680000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzUtMS0xLTEtNjIxMTk_74bfc1f8-261e-40f3-8f32-9430757a8789"
      unitRef="shares">147134000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xMy9mcmFnOjY0MjI4Yzc3MWJjNDQ0ZThhYjU0ZDdkMjg5M2UwNzhjL3RhYmxlOmI3YTg3NTk3ZmU3NDQ0NjliZDA5YmM5OWM2ODMxZWE1L3RhYmxlcmFuZ2U6YjdhODc1OTdmZTc0NDQ2OWJkMDliYzk5YzY4MzFlYTVfMzUtMy0xLTEtNjIxMTk_f05c91c5-71d7-4e4a-89c8-55eff0e72897"
      unitRef="shares">146860000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xNi9mcmFnOjI3NzU2MTRmN2ZhYzQyMzdhMzU5Y2I4MmNmZGEyMDBiL3RhYmxlOmEzYjA1OGEwYzNjMDRmMmQ4NDRlOTRiMTNlZGJhYTdkL3RhYmxlcmFuZ2U6YTNiMDU4YTBjM2MwNGYyZDg0NGU5NGIxM2VkYmFhN2RfMi0xLTEtMS02MjExOQ_26e600d7-fa70-4eec-b4e9-2d1447a9b462"
      unitRef="usd">210478000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xNi9mcmFnOjI3NzU2MTRmN2ZhYzQyMzdhMzU5Y2I4MmNmZGEyMDBiL3RhYmxlOmEzYjA1OGEwYzNjMDRmMmQ4NDRlOTRiMTNlZGJhYTdkL3RhYmxlcmFuZ2U6YTNiMDU4YTBjM2MwNGYyZDg0NGU5NGIxM2VkYmFhN2RfMi0zLTEtMS02MjExOQ_86b8f1ce-d406-4c21-a4b4-93c3f4215a9e"
      unitRef="usd">203613000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xNi9mcmFnOjI3NzU2MTRmN2ZhYzQyMzdhMzU5Y2I4MmNmZGEyMDBiL3RhYmxlOmEzYjA1OGEwYzNjMDRmMmQ4NDRlOTRiMTNlZGJhYTdkL3RhYmxlcmFuZ2U6YTNiMDU4YTBjM2MwNGYyZDg0NGU5NGIxM2VkYmFhN2RfNC0xLTEtMS02MjExOQ_129f1843-47f7-4b36-9c5d-9c49269f26d6"
      unitRef="usd">-93381000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xNi9mcmFnOjI3NzU2MTRmN2ZhYzQyMzdhMzU5Y2I4MmNmZGEyMDBiL3RhYmxlOmEzYjA1OGEwYzNjMDRmMmQ4NDRlOTRiMTNlZGJhYTdkL3RhYmxlcmFuZ2U6YTNiMDU4YTBjM2MwNGYyZDg0NGU5NGIxM2VkYmFhN2RfNC0zLTEtMS02MjExOQ_d0db5ac5-83f4-4324-be43-7751d883fd55"
      unitRef="usd">-23516000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xNi9mcmFnOjI3NzU2MTRmN2ZhYzQyMzdhMzU5Y2I4MmNmZGEyMDBiL3RhYmxlOmEzYjA1OGEwYzNjMDRmMmQ4NDRlOTRiMTNlZGJhYTdkL3RhYmxlcmFuZ2U6YTNiMDU4YTBjM2MwNGYyZDg0NGU5NGIxM2VkYmFhN2RfNS0xLTEtMS02MjExOQ_5a1cbb06-224a-4e88-8a77-95dfc21fffe3"
      unitRef="usd">117097000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xNi9mcmFnOjI3NzU2MTRmN2ZhYzQyMzdhMzU5Y2I4MmNmZGEyMDBiL3RhYmxlOmEzYjA1OGEwYzNjMDRmMmQ4NDRlOTRiMTNlZGJhYTdkL3RhYmxlcmFuZ2U6YTNiMDU4YTBjM2MwNGYyZDg0NGU5NGIxM2VkYmFhN2RfNS0zLTEtMS02MjExOQ_e09fa823-a651-49c2-a1bf-36e18cbbfc4d"
      unitRef="usd">180097000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iced71fbf9d854f909b168ae0c5dc6d3d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi0xLTEtMS02MjExOQ_52855efa-33e0-41d8-ad23-6e24422b52d0"
      unitRef="shares">188247000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iced71fbf9d854f909b168ae0c5dc6d3d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi0yLTEtMS02MjExOQ_11d09724-88af-4ee1-864d-f69a6e4c5322"
      unitRef="usd">586000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if39dcb9003eb460791aab51dde509ee3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi0zLTEtMS02MjExOQ_90434afb-5d80-49a5-beaf-63cb5c1987f4"
      unitRef="usd">1682432000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i661416e60db0471f9d33a485c88000b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi00LTEtMS02MjExOQ_fee64bb4-6c59-4fb2-8397-ec97646e3065"
      unitRef="shares">41836000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="i661416e60db0471f9d33a485c88000b8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi01LTEtMS02MjExOQ_aa8da63a-da01-44fe-8781-c584903bff2e"
      unitRef="usd">-1623256000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic75938a78dd84e31a55814a504baa727_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi02LTEtMS02MjExOQ_811410fe-e654-408c-a688-7d3ca9366a9b"
      unitRef="usd">3613736000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2e425ee5a1764ebd9c10b93f28121cc9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi03LTEtMS02MjExOQ_2c53fcea-0f93-4374-a251-c40171f4c2f1"
      unitRef="usd">-312747000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMi04LTEtMS02MjExOQ_8700bb24-1c65-4e0d-9a75-c111e4f1992d"
      unitRef="usd">3360751000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i07bf4ea60e5c4a4ba7835c9c6b099652_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMy0xLTEtMS02MjExOQ_d0bc6f1c-07d0-4b05-b19a-a5a9580a6888"
      unitRef="shares">45000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iebae534f8f214c65956df85450291a21_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMy0zLTEtMS02MjExOQ_ebe2aafe-685a-4a36-8f32-f456de4b36f3"
      unitRef="usd">2610000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfMy04LTEtMS02MjExOQ_f7a661f6-2d7a-4be8-a0e6-c763f58509a0"
      unitRef="usd">2610000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i07bf4ea60e5c4a4ba7835c9c6b099652_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNC0xLTEtMS02MjExOQ_0e172cec-ac08-4ed2-9a21-ebcf680b9cb5"
      unitRef="shares">3000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="iebae534f8f214c65956df85450291a21_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNC0zLTEtMS02MjExOQ_8f9b5893-a88e-4681-aa43-6982d341859d"
      unitRef="usd">-59000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNC04LTEtMS02MjExOQ_52b6350e-cc4a-4fb5-9369-814c39302299"
      unitRef="usd">-59000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iebae534f8f214c65956df85450291a21_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNS0zLTEtMS02MjExOQ_640d7d24-384f-49c6-87dc-d27bf49b3bbf"
      unitRef="usd">16919000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNS04LTEtMS02MjExOQ_4e9cdb74-f656-433d-90eb-eb219ad33787"
      unitRef="usd">16919000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i51a67b36abb34b5db4ef0af0016dec20_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNi03LTEtMS02MjExOQ_ffe2d27e-7e63-4d58-8f93-98bda2a20d6a"
      unitRef="usd">-93381000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNi04LTEtMS02MjExOQ_a9bf2382-ec8c-4458-bf7c-353782208008"
      unitRef="usd">-93381000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i2360ae9649ff48d281a132f80281a277_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNy02LTEtMS02MjExOQ_0d7f9a8e-af26-4429-a21b-a09e7de3ab89"
      unitRef="usd">210478000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfNy04LTEtMS02MjExOQ_c47315d6-5009-4c39-9503-7e715f71b2e6"
      unitRef="usd">210478000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOC0wLTEtMS02MjExOS90ZXh0cmVnaW9uOjg0ZTZlNDM4MzQzYjRiNTliYmJhMmVjM2E0NzBhMDA5XzI0_58cf339b-712e-4a8b-81d0-1a3e1c8b5926"
      unitRef="usdPerShare">0.44</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="i2360ae9649ff48d281a132f80281a277_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOC02LTEtMS02MjExOQ_23fbebe9-99f9-4b8d-b415-9b08df7d792d"
      unitRef="usd">64431000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOC04LTEtMS02MjExOQ_9b42eb4d-8afe-4bd4-9ed8-dda9a0e8217a"
      unitRef="usd">64431000</us-gaap:Dividends>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic0bed1de6d224a628823074853f5cc02_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS0xLTEtMS02MjExOQ_b5591a60-acf4-48c9-bd2d-1af289da32a9"
      unitRef="shares">188295000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic0bed1de6d224a628823074853f5cc02_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS0yLTEtMS02MjExOQ_44d9cf7a-8194-4353-ad3e-3e041cb4c6be"
      unitRef="usd">586000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ided8696a9071487f85d658c6f7894111_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS0zLTEtMS02MjExOQ_d6693e2f-d3ba-4802-bbb1-4ff1edc7cbbd"
      unitRef="usd">1701902000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="iaff681621a6a47ddb2e69a84b657d563_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS00LTEtMS02MjExOQ_896ccc1f-22d0-48e5-a688-7171fa851688"
      unitRef="shares">41836000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="iaff681621a6a47ddb2e69a84b657d563_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS01LTEtMS02MjExOQ_ccc994bf-ad87-4164-89c5-dab150ecf186"
      unitRef="usd">-1623256000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib0edd8bdae674d5cba3df7e0bdab0a13_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS02LTEtMS02MjExOQ_04d27859-1a22-416b-b320-971fa98d3652"
      unitRef="usd">3759783000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if39d380d692046bfac4dd7d9da85fd9e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS03LTEtMS02MjExOQ_4ffab28d-4db3-49f4-92a4-415124cb912a"
      unitRef="usd">-406128000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOjEwZTMyM2I5ZDJhYjQ2YjNiNWJkYTYwZjI5OGEzMTljL3RhYmxlcmFuZ2U6MTBlMzIzYjlkMmFiNDZiM2I1YmRhNjBmMjk4YTMxOWNfOS04LTEtMS02MjExOQ_00617a88-1289-449d-b909-04faceea9306"
      unitRef="usd">3432887000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i82486906991d41c1bb227364f4e66f47_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi0xLTEtMS02MjExOQ_add2cd02-b824-4e4b-9c2a-84eb95ef8d22"
      unitRef="shares">187485000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i82486906991d41c1bb227364f4e66f47_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi0yLTEtMS02MjExOQ_e58031f8-e44e-4ee4-9538-8220dc3fc3a4"
      unitRef="usd">583000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifaceb858b79144bdb1473e507f59ebc8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi0zLTEtMS02MjExOQ_46529ec2-f2e8-409a-81c5-8e85c4de0f38"
      unitRef="usd">1622199000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ib9a3ed59012748f68b30ed7614b16350_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi00LTEtMS02MjExOQ_65d80bd6-2044-47d5-b5fc-1643ab13a6a8"
      unitRef="shares">41836000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="ib9a3ed59012748f68b30ed7614b16350_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi01LTEtMS02MjExOQ_2f2b7fde-47cc-4cf1-b9d8-a5ab776aece3"
      unitRef="usd">-1623256000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if62ca46e58ff4e1ab852ba34c6e8125d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi02LTEtMS02MjExOQ_59b45feb-fd42-4a6c-9395-827fb554b45d"
      unitRef="usd">3079640000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if778f54978bb489ab25d9277813650fd_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi03LTEtMS02MjExOQ_8b96b2dc-d64b-420c-b760-36d3f59cdf0f"
      unitRef="usd">-193487000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id4c1bec761d343199bfb5656845fee5a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMi04LTEtMS02MjExOQ_4c203260-c726-48d8-acd0-6e87e05e96a4"
      unitRef="usd">2885679000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7d6e74c5fb8447bd9b144f2ba9b48825_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMy0xLTEtMS02MjExOQ_125b236a-6692-42c8-8ee2-307cfac00cb3"
      unitRef="shares">61000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie68cba427884448a91f3ab762c19133d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMy0zLTEtMS02MjExOQ_6c19e23c-e86e-4f06-8b97-3318023b57ef"
      unitRef="usd">4354000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMy04LTEtMS02MjExOQ_575b6010-52da-403b-b69d-6f7abfd9e49c"
      unitRef="usd">4354000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i7d6e74c5fb8447bd9b144f2ba9b48825_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNC0xLTEtMS02MjExOQ_c939c7f4-ff6e-4c28-8ed7-10d64d1463f4"
      unitRef="shares">1000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ie68cba427884448a91f3ab762c19133d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNC0zLTEtMS02MjExOQ_6ae9d484-be8b-4de7-979d-b96939fc4917"
      unitRef="usd">-195000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNC04LTEtMS02MjExOQ_9776c9b5-d04b-459a-82d2-f7d1419a6b40"
      unitRef="usd">-195000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie68cba427884448a91f3ab762c19133d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNS0zLTEtMS02MjExOQ_742fbcce-979f-47a0-a3e7-908530845268"
      unitRef="usd">17303000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNS04LTEtMS02MjExOQ_62a3e394-1453-47d1-bdc5-dcd0353bca66"
      unitRef="usd">17303000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2353812c8d374d0a99adb123069a8c45_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNi03LTEtMS02MjExOQ_49cf4bc5-07ff-4985-be8b-3337c5017c44"
      unitRef="usd">-23516000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfNi04LTEtMS02MjExOQ_18c758bb-11d1-4480-8754-453468fc9314"
      unitRef="usd">-23516000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i39ae840cff9d4541883d39909be26bdb_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfOC02LTEtMS02MjExOQ_742972bc-5fe1-4726-9784-6fa5166f0084"
      unitRef="usd">203613000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfOC04LTEtMS02MjExOQ_042d168e-1f45-4e0c-9c06-756217d3ce31"
      unitRef="usd">203613000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfOS0wLTEtMS02MjExOS90ZXh0cmVnaW9uOjI0ZDY0MzQwYTNhZjQyNDc5MmI4NTYzMTM5ODUwMzBhXzI0_7be367d5-c08b-4170-8fe0-1397b366bf0b"
      unitRef="usdPerShare">0.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="i39ae840cff9d4541883d39909be26bdb_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfOS02LTEtMS02MjExOQ_6d296d2b-a645-4f51-a6a7-fc47f7498fe5"
      unitRef="usd">61189000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfOS04LTEtMS02MjExOQ_137629ea-e7aa-47da-ad10-e9fc3cfa6a71"
      unitRef="usd">61189000</us-gaap:Dividends>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2d609f79239f44f6b1a7c7d6b7b1bff4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtMS0xLTEtNjIxMTk_b3d1bd81-5ff7-42be-a83b-8c815679072f"
      unitRef="shares">187547000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i2d609f79239f44f6b1a7c7d6b7b1bff4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtMi0xLTEtNjIxMTk_185a8d44-2896-4ce2-87fd-cc1b49bb4577"
      unitRef="usd">583000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic5c16a9474794461b2f4f520cab49c3f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtMy0xLTEtNjIxMTk_fb3eb526-5685-4834-972d-df8aeddb0614"
      unitRef="usd">1643661000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i798ee6146fe04ee0a38f656f451210d4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtNC0xLTEtNjIxMTk_1cad90bb-448b-464c-9e19-2281a11fb41a"
      unitRef="shares">41836000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity
      contextRef="i798ee6146fe04ee0a38f656f451210d4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtNS0xLTEtNjIxMTk_f6ab60f6-f559-44cc-ae32-a9863d4b7e55"
      unitRef="usd">-1623256000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i82b83a0ce15f4487baf7464a93daa021_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtNi0xLTEtNjIxMTk_33887d92-25c9-46cd-85ec-750051a14881"
      unitRef="usd">3222064000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie3f1b5aa49a4420192a8beece7104061_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtNy0xLTEtNjIxMTk_c204bfe3-d792-441d-9d55-7d9291ff14f9"
      unitRef="usd">-217003000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iee72006a6fb24b64994718e79dad7dfe_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18xOS9mcmFnOjZlODcwNjc4YmVmZDRlNDQ4MmE1OWVmOGVkNTdmOTNhL3RhYmxlOmNjNGVhYjMxNDNiMTQzMWRhNjA2N2M2N2M2N2VjOWQyL3RhYmxlcmFuZ2U6Y2M0ZWFiMzE0M2IxNDMxZGE2MDY3YzY3YzY3ZWM5ZDJfMTAtOC0xLTEtNjIxMTk_40fb7db2-e33a-48ac-9840-3996ba7a01f4"
      unitRef="usd">3026049000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMy0xLTEtMS02MjExOQ_19414fe4-9c97-4518-8f47-0594b01ab6a4"
      unitRef="usd">210478000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMy0zLTEtMS02MjExOQ_936a6aa1-4f19-42e8-b54c-bd2f0a29ef5b"
      unitRef="usd">203613000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNS0xLTEtMS02MjExOQ_84d2a9be-3c7d-489b-904f-b19dc3dc48f5"
      unitRef="usd">36273000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNS0zLTEtMS02MjExOQ_12b02e25-5615-445d-8f53-d39dc56653f0"
      unitRef="usd">39102000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNi0xLTEtMS02MjExOQ_d7f21d69-7c1d-4c02-a2db-bfdd61d9a4ae"
      unitRef="usd">7761000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNi0zLTEtMS02MjExOQ_e68c997f-8292-4269-a06b-e66d9f68f60f"
      unitRef="usd">8517000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNy0xLTEtMS02MjExOQ_77945f68-1cbe-479c-ac7c-ad3fa32ff546"
      unitRef="usd">16919000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNy0zLTEtMS02MjExOQ_84bbc0c1-eea7-4249-bcb2-751616a64c61"
      unitRef="usd">17303000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfOC0xLTEtMS02MjExOQ_bd5eb568-da9d-4d9c-9174-fd7e0fbd87d2"
      unitRef="usd">-2028000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfOC0zLTEtMS02MjExOQ_fb3334c0-4cbc-4766-aee6-4877ab4f062f"
      unitRef="usd">-1386000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfOS0xLTEtMS02MjExOQ_ddbda6f9-cfc2-4089-9b7e-815fb40e3349"
      unitRef="usd">-3280000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfOS0zLTEtMS02MjExOQ_664b50b2-656c-42fb-bcdc-cd0710d291b7"
      unitRef="usd">5612000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTItMS0xLTEtNjIxMTk_bea5a9e5-0118-4d2d-9874-a8c985640eb0"
      unitRef="usd">56238000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTItMy0xLTEtNjIxMTk_d04aaea2-5aa4-4a10-8031-01a1398419b9"
      unitRef="usd">-33704000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTMtMS0xLTEtNjIxMTk_70d4ca77-934a-447a-b758-24cb9c29e80f"
      unitRef="usd">147096000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTMtMy0xLTEtNjIxMTk_40aaad1c-4b75-49cf-b08f-61919780e429"
      unitRef="usd">55976000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTQtMS0xLTEtNjIxMTk_25401ee5-2f10-488a-ac0e-69cc43b16290"
      unitRef="usd">36784000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTQtMy0xLTEtNjIxMTk_7763dfbe-92d3-4ddf-a479-efec8f1502bd"
      unitRef="usd">14391000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTUtMS0xLTEtNjIxMTk_cbdb0870-a8f4-4ecd-9381-819fb8355539"
      unitRef="usd">8041000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTUtMy0xLTEtNjIxMTk_7ce0cc34-cee3-4c85-9ce8-02f37843ccf3"
      unitRef="usd">-293303000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTYtMS0xLTEtNjIxMTk_cd2458df-41c3-476d-8cc2-84c497b4278b"
      unitRef="usd">44662000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTYtMy0xLTEtNjIxMTk_f98d84cd-1d05-4e8c-af7e-a228900a2a7b"
      unitRef="usd">-65657000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTgtMS0xLTEtNjIxMTk_1f019f22-4f0e-4d17-a649-d19fd4c6977d"
      unitRef="usd">29056000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTgtMy0xLTEtNjIxMTk_c8fcb613-98ee-4222-ba35-42230e884c23"
      unitRef="usd">27340000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTktMS0xLTEtNjIxMTk_7d6007a5-95b2-470b-a7b8-31e35d6558e2"
      unitRef="usd">3317000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMTktMy0xLTEtNjIxMTk_695e590d-29bd-4f7a-b2e5-221314151fbc"
      unitRef="usd">4453000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjAtMS0xLTEtNjIxMTk_585e4dc9-96b0-4d58-91f2-2d67a8d0bca5"
      unitRef="usd">19100000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjAtMy0xLTEtNjIxMTk_c0a904f0-d27c-4668-af47-dc8525582e27"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjEtMS0xLTEtNjIxMTk_b11e31f8-dd6e-4a96-a262-e845730d7e18"
      unitRef="usd">4291000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjEtMy0xLTEtNjIxMTk_4c745291-11f1-4d23-bccf-2b51f364958b"
      unitRef="usd">6600000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjMtMS0xLTEtNjIxMTk_1c01ddb7-f5cf-4a21-b02a-ec7d633b6b02"
      unitRef="usd">3042000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjMtMy0xLTEtNjIxMTk_401a6fed-71e2-489b-a4fc-455c998897ad"
      unitRef="usd">3481000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjQtMS0xLTEtNjIxMTk_cde5ce3c-5adc-48a6-9393-57dc347aa718"
      unitRef="usd">-58806000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjQtMy0xLTEtNjIxMTk_82bf3a51-4627-4b40-824a-faf15b2a09d2"
      unitRef="usd">-41874000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjYtMS0xLTEtNjIxMTk_7ccfe779-3af9-4548-ba05-438556039903"
      unitRef="usd">2610000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjYtMy0xLTEtNjIxMTk_da03d920-5d7a-4902-8036-bf765536f3cd"
      unitRef="usd">4354000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjctMS0xLTEtNjIxMTk_c78d96cf-e77c-4bff-a59d-17a904c4bd8a"
      unitRef="usd">59000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjctMy0xLTEtNjIxMTk_21f3c3c5-240c-4223-9d17-8dac88e925c7"
      unitRef="usd">195000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjktMS0xLTEtNjIxMTk_cf3658d3-1ace-42ca-a4c9-adfc604373ac"
      unitRef="usd">50000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMjktMy0xLTEtNjIxMTk_0483f054-f359-4ffc-b010-873c38396f8e"
      unitRef="usd">150000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzAtMS0xLTEtNjIxMTk_5a1f7b15-596a-4d42-b13b-a26197a35688"
      unitRef="usd">30000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzAtMy0xLTEtNjIxMTk_e74cd735-909d-435f-9a58-8a6a3dfb3119"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDividends
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzEtMS0xLTEtNjIxMTk_4803a698-ce74-4b5c-bc78-e463c1fb3b8f"
      unitRef="usd">64431000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzEtMy0xLTEtNjIxMTk_0f10aa06-a21c-4e3d-96d2-0ee751f96f3d"
      unitRef="usd">61189000</us-gaap:PaymentsOfDividends>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzItMS0xLTEtNjIxMTk_578e907e-731b-4efc-bcba-e2daacc59020"
      unitRef="usd">-41880000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzItMy0xLTEtNjIxMTk_8157c4b6-f062-42cd-8b10-331e19ab2b15"
      unitRef="usd">92970000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzMtMS0xLTEtNjIxMTk_eb868d01-d7de-43af-92ed-2f2c13bf58c6"
      unitRef="usd">-10523000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzMtMy0xLTEtNjIxMTk_aec28888-864a-47e5-91f6-9ca98f60fb64"
      unitRef="usd">-4568000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzQtMS0xLTEtNjIxMTk_4dbe1d3e-90a3-45cd-bdc2-49cf3379961c"
      unitRef="usd">-66547000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzQtMy0xLTEtNjIxMTk_57022f8a-4f56-4f31-a6c8-7dc8005f6b6d"
      unitRef="usd">-19129000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzUtMS0xLTEtNjIxMTk_d5e1f014-96d2-4576-9299-9e4b278324dc"
      unitRef="usd">273710000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id4c1bec761d343199bfb5656845fee5a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzUtMy0xLTEtNjIxMTk_d2f8bc86-c70f-437f-80cd-b5e78a5d83ad"
      unitRef="usd">295278000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzYtMS0xLTEtNjIxMTk_d44c87ef-0908-4778-b7d0-bc9cf64f3781"
      unitRef="usd">207163000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iee72006a6fb24b64994718e79dad7dfe_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzYtMy0xLTEtNjIxMTk_9e02ec63-c8ad-4c56-b745-8a706a6ce0d7"
      unitRef="usd">276149000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzgtMS0xLTEtNjIxMTk_6bbc119f-8089-49b3-93b8-a7fd32a9a7c9"
      unitRef="usd">53437000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzgtMy0xLTEtNjIxMTk_c623cb77-fe03-4f49-9fbe-df6f2725f3a1"
      unitRef="usd">345909000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzktMS0xLTEtNjIxMTk_f52c4bf6-8cd7-4a2f-9426-04f5767281e9"
      unitRef="usd">7134000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfMzktMy0xLTEtNjIxMTk_cf4b365c-34ee-4b32-bffb-212e7c40d370"
      unitRef="usd">5360000</us-gaap:InterestPaidNet>
    <rmd:NoncashPartOfAcquisitionFairValueOfAssetsAcquired
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDAtMS0xLTEtNjIxMTk_4a2fc96e-3da8-464a-98ac-d47d4776a406"
      unitRef="usd">9506000</rmd:NoncashPartOfAcquisitionFairValueOfAssetsAcquired>
    <rmd:NoncashPartOfAcquisitionFairValueOfAssetsAcquired
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDAtMy0xLTEtNjIxMTk_6ecd18c9-30cf-4d78-88c5-f8d5003a07a6"
      unitRef="usd">0</rmd:NoncashPartOfAcquisitionFairValueOfAssetsAcquired>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDEtMS0xLTEtNjIxMTk_4151943e-9d4e-4c29-88b5-a125fae439cd"
      unitRef="usd">3975000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDEtMy0xLTEtNjIxMTk_f5237f64-71ec-4ef0-93e0-ea256157b3bb"
      unitRef="usd">0</us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1>
    <rmd:GoodwillAcquiredDuringPeriodIncreaseDecrease
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDItMS0xLTEtNjIxMTk_37fa4e35-bad4-42c1-9efe-fc83c44a7ceb"
      unitRef="usd">19281000</rmd:GoodwillAcquiredDuringPeriodIncreaseDecrease>
    <rmd:GoodwillAcquiredDuringPeriodIncreaseDecrease
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDItMy0xLTEtNjIxMTk_1a0a0228-c13b-4797-8265-80259371a661"
      unitRef="usd">0</rmd:GoodwillAcquiredDuringPeriodIncreaseDecrease>
    <rmd:DeferredPaymentObligationsForAcquisitions
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDQtMS0xLTEtNjIxMTk_95866e52-06b0-4d93-8722-7e3965860868"
      unitRef="usd">2856000</rmd:DeferredPaymentObligationsForAcquisitions>
    <rmd:DeferredPaymentObligationsForAcquisitions
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDQtMy0xLTEtNjIxMTk_70a02583-6be6-4f6e-9615-0ad8f9d0bd41"
      unitRef="usd">0</rmd:DeferredPaymentObligationsForAcquisitions>
    <rmd:BusinessAcquisitionContingentConsiderationRecognizedLiability
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDYtMS0xLTEtNjc1NzE_6437112d-afb4-42df-9738-e26da9dc04c4"
      unitRef="usd">2856000</rmd:BusinessAcquisitionContingentConsiderationRecognizedLiability>
    <rmd:BusinessAcquisitionContingentConsiderationRecognizedLiability
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDYtMy0xLTEtNjc1NzE_511f0a88-3fc3-43f4-b309-dcfdbec4c099"
      unitRef="usd">0</rmd:BusinessAcquisitionContingentConsiderationRecognizedLiability>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDUtMS0xLTEtNjIxMTk_4b1641f1-a831-436d-a26f-d9adae727bdc"
      unitRef="usd">19100000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yMi9mcmFnOjljYjBiNGUyMTExODRkMTc4OTFiNzEzNmMwZmE0ZTcxL3RhYmxlOjAyNzVhNmU3MzY5MzQyNjI5OGY3MjQ1NWE2NTlhMTUxL3RhYmxlcmFuZ2U6MDI3NWE2ZTczNjkzNDI2Mjk4ZjcyNDU1YTY1OWExNTFfNDUtMy0xLTEtNjIxMTk_612acb74-d149-4847-97e6-8901961b0fc8"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMDk_20e7a72a-6ceb-4e04-96c1-cdec4decdbdd">Summary of Significant Accounting Policies&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Organization and Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ResMed Inc. (referred to herein as &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d; or the &#x201c;Company&#x201d;) is a Delaware corporation formed in March 1994 as a holding company for the ResMed Group. Through our subsidiaries, we design, manufacture and market equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea. Our manufacturing operations are located in Australia, Singapore, Malaysia, France, China and the United States. Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, China, Finland, Norway and Sweden. We also operate a Software as a Service (&#x201c;SaaS&#x201d;) business in the United States that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) for interim financial information and with the instructions to Form 10-Q and the rules of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the fiscal year ending June&#160;30, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements for the three months ended September&#160;30, 2022 and September&#160;30, 2021 are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K (our &#x201c;Form 10-K&#x201d;) for the year ended June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with Accounting Standard Codification (&#x201c;ASC&#x201d;) Topic 606, &#x201c;Revenue from Contracts with Customers&#x201d;, we account for a contract with a customer when there is a legally enforceable contract, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We have determined that we have two operating segments, which are the sleep and respiratory disorders sector of the medical device industry (&#x201c;Sleep and Respiratory Care&#x201d;) and the supply of business management software as a service to out-of-hospital health providers (&#x201c;SaaS&#x201d;). Our Sleep and Respiratory Care revenue relates primarily to the sale of our products that are therapy-based equipment. Some contracts include additional performance obligations such as the provision of extended warranties and provision of data for patient monitoring. Our SaaS revenue relates to the provision of software access with ongoing support and maintenance services as well as professional services such as training and consulting. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Disaggregation of revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S., Canada and Latin America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Devices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;339,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;275,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Masks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;238,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;215,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;578,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;491,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software as a Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;683,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;588,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Combined Europe, Asia and other markets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Devices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;218,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Masks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;266,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;315,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Global revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Devices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;517,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;494,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Masks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;326,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;844,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;806,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software as a Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;950,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;904,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Performance obligations and contract balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied; generally, this occurs with the transfer of risk and/or control of our products at a point in time. For products in our Sleep and Respiratory Care business, we transfer control and recognize a sale when products are shipped to the customer in accordance with the contractual shipping terms. For our SaaS business, revenue associated with professional services are recognized as they are provided. We defer the recognition of a portion of the consideration received when performance obligations are not yet satisfied. Consideration received from customers in advance of revenue recognition is classified as deferred revenue. Performance obligations resulting in deferred revenue in our Sleep and Respiratory Care business relate primarily to extended warranties on our devices and the provision of data for patient monitoring. Performance obligations resulting in deferred revenue in our SaaS business relate primarily to the provision of software access with maintenance and support over an agreed term and material rights associated with future discounts upon renewal of some SaaS contracts. Generally, deferred revenue will be recognized over a period of one year to five years. Our contracts do not contain significant financing components.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract balances (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance sheet caption&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;620,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;575,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unbilled revenue, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unbilled revenue, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prepaid taxes and other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(108,195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(108,667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue (current liabilities)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(97,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(95,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue (non-current liabilities)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Transaction price determination&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. In our Sleep and Respiratory Care segment, the amount of consideration received and revenue recognized varies &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;with changes in marketing incentives (e.g. rebates, discounts, free goods) and returns offered to our customers and their customers. When we give customers the right to return eligible products and receive credit, returns are estimated based on an analysis of historical experience. However, returns of products, excluding warranty-related returns, are infrequent and insignificant. We adjust the estimate of revenue at the earlier of when the most likely amount of consideration can be estimated, the amount expected to be received changes, or when the consideration becomes fixed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We offer our Sleep and Respiratory Care customers cash or product rebates based on volume or sales targets measured over quarterly or annual periods. We estimate rebates based on each customer&#x2019;s expected achievement of its targets. In accounting for these rebate programs, we reduce revenue ratably as sales occur over the rebate period by the expected value of the rebates to be returned to the customer. Rebates measured over a quarterly period are updated based on actual sales results and, therefore, no estimation is required to determine the reduction to revenue. For rebates measured over annual periods, we update our estimates on a quarterly basis based on actual sales results and updated forecasts for the remaining rebate periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We participate in programs where we issue credits to our Sleep and Respiratory Care distributors when they are required to sell our products below negotiated list prices if we have preexisting contracts with the distributors' customers. We reduce revenue for future credits at the time of sale to the distributor, which we estimate based on historical experience using the expected value method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also offer discounts to both our Sleep and Respiratory Care as well as our SaaS customers as part of normal business practice and these are deducted from revenue when the sale occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When Sleep and Respiratory Care or SaaS contracts have multiple performance obligations, we generally use an observable price to determine the stand-alone selling price by reference to pricing and discounting practices for the specific product or service when sold separately to similar customers. Revenue is then allocated proportionately, based on the determined stand-alone selling price, to each performance obligation. An allocation is not required for many of our Sleep and Respiratory Care contracts that have a single performance obligation, which is the shipment of our therapy-based equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting and practical expedient elections&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have elected to account for shipping and handling activities associated with our Sleep and Respiratory Care segment as a fulfillment cost within cost of sales, and record shipping and handling costs collected from customers in net revenue. We have also elected for all taxes assessed by government authorities that are imposed on and concurrent with revenue-producing transactions, such as sales and value added taxes, to be excluded from revenue and presented on a net basis. We have elected two practical expedients including the &#x201c;right to invoice&#x201d; practical expedient, which is relevant for some of our SaaS contracts as it allows us to recognize revenue in the amount of the invoice when it corresponds directly with the value of performance completed to date. The second practical expedient adopted permits relief from considering a significant financing component when the payment for the good or service is expected to be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease Sleep and Respiratory Care medical devices to customers primarily as a means to comply with local health insurer requirements in certain foreign geographies. Device rental contracts include operating leases, and contract terms vary by customer and include options to terminate or extend the contract. When lease contracts also include the sale of masks and accessories, we allocate contract consideration to those items on a relative standalone price basis and recognize revenue when control transfers to the customer. Operating lease revenue was $23.7 million for the three months ended September 30, 2022 and $25.2 million for the three months ended September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Provision for Warranty&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide for the estimated cost of product warranties on our Sleep and Respiratory Care products at the time the related revenue is recognized. We determine the amount of this provision by using a financial model, which takes into consideration actual historical expenses and potential risks associated with our different products. We use this financial model to calculate the future probable expenses related to warranty and the required level of the warranty provision. Although we engage in product improvement programs and processes, our warranty obligation is affected by product failure rates and costs incurred to correct those product failures. Should actual product failure rates or estimated costs to repair those product failures differ from our estimates, we would be required to revise our estimated warranty provision.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <rmd:OrganizationAndBasisOfPresentationPolicyPolicyTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMTA_7f410af2-2e40-4b69-991c-14b9b682f24b">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Organization and Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ResMed Inc. (referred to herein as &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d; or the &#x201c;Company&#x201d;) is a Delaware corporation formed in March 1994 as a holding company for the ResMed Group. Through our subsidiaries, we design, manufacture and market equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea. Our manufacturing operations are located in Australia, Singapore, Malaysia, France, China and the United States. Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, China, Finland, Norway and Sweden. We also operate a Software as a Service (&#x201c;SaaS&#x201d;) business in the United States that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) for interim financial information and with the instructions to Form 10-Q and the rules of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the fiscal year ending June&#160;30, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements for the three months ended September&#160;30, 2022 and September&#160;30, 2021 are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K (our &#x201c;Form 10-K&#x201d;) for the year ended June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;</rmd:OrganizationAndBasisOfPresentationPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMDQ_99b16c8f-7e4b-414e-8761-4df4b5715d90">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with Accounting Standard Codification (&#x201c;ASC&#x201d;) Topic 606, &#x201c;Revenue from Contracts with Customers&#x201d;, we account for a contract with a customer when there is a legally enforceable contract, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We have determined that we have two operating segments, which are the sleep and respiratory disorders sector of the medical device industry (&#x201c;Sleep and Respiratory Care&#x201d;) and the supply of business management software as a service to out-of-hospital health providers (&#x201c;SaaS&#x201d;). Our Sleep and Respiratory Care revenue relates primarily to the sale of our products that are therapy-based equipment. Some contracts include additional performance obligations such as the provision of extended warranties and provision of data for patient monitoring. Our SaaS revenue relates to the provision of software access with ongoing support and maintenance services as well as professional services such as training and consulting. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Disaggregation of revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S., Canada and Latin America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Devices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;339,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;275,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Masks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;238,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;215,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;578,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;491,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software as a Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;683,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;588,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Combined Europe, Asia and other markets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Devices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;218,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Masks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;266,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;315,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Global revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Devices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;517,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;494,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Masks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;326,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;844,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;806,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software as a Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;950,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;904,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Performance obligations and contract balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied; generally, this occurs with the transfer of risk and/or control of our products at a point in time. For products in our Sleep and Respiratory Care business, we transfer control and recognize a sale when products are shipped to the customer in accordance with the contractual shipping terms. For our SaaS business, revenue associated with professional services are recognized as they are provided. We defer the recognition of a portion of the consideration received when performance obligations are not yet satisfied. Consideration received from customers in advance of revenue recognition is classified as deferred revenue. Performance obligations resulting in deferred revenue in our Sleep and Respiratory Care business relate primarily to extended warranties on our devices and the provision of data for patient monitoring. Performance obligations resulting in deferred revenue in our SaaS business relate primarily to the provision of software access with maintenance and support over an agreed term and material rights associated with future discounts upon renewal of some SaaS contracts. Generally, deferred revenue will be recognized over a period of one year to five years. Our contracts do not contain significant financing components.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract balances (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance sheet caption&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;620,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;575,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unbilled revenue, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unbilled revenue, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prepaid taxes and other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(108,195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(108,667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue (current liabilities)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(97,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(95,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue (non-current liabilities)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Transaction price determination&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. In our Sleep and Respiratory Care segment, the amount of consideration received and revenue recognized varies &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;with changes in marketing incentives (e.g. rebates, discounts, free goods) and returns offered to our customers and their customers. When we give customers the right to return eligible products and receive credit, returns are estimated based on an analysis of historical experience. However, returns of products, excluding warranty-related returns, are infrequent and insignificant. We adjust the estimate of revenue at the earlier of when the most likely amount of consideration can be estimated, the amount expected to be received changes, or when the consideration becomes fixed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We offer our Sleep and Respiratory Care customers cash or product rebates based on volume or sales targets measured over quarterly or annual periods. We estimate rebates based on each customer&#x2019;s expected achievement of its targets. In accounting for these rebate programs, we reduce revenue ratably as sales occur over the rebate period by the expected value of the rebates to be returned to the customer. Rebates measured over a quarterly period are updated based on actual sales results and, therefore, no estimation is required to determine the reduction to revenue. For rebates measured over annual periods, we update our estimates on a quarterly basis based on actual sales results and updated forecasts for the remaining rebate periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We participate in programs where we issue credits to our Sleep and Respiratory Care distributors when they are required to sell our products below negotiated list prices if we have preexisting contracts with the distributors' customers. We reduce revenue for future credits at the time of sale to the distributor, which we estimate based on historical experience using the expected value method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also offer discounts to both our Sleep and Respiratory Care as well as our SaaS customers as part of normal business practice and these are deducted from revenue when the sale occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When Sleep and Respiratory Care or SaaS contracts have multiple performance obligations, we generally use an observable price to determine the stand-alone selling price by reference to pricing and discounting practices for the specific product or service when sold separately to similar customers. Revenue is then allocated proportionately, based on the determined stand-alone selling price, to each performance obligation. An allocation is not required for many of our Sleep and Respiratory Care contracts that have a single performance obligation, which is the shipment of our therapy-based equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting and practical expedient elections&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have elected to account for shipping and handling activities associated with our Sleep and Respiratory Care segment as a fulfillment cost within cost of sales, and record shipping and handling costs collected from customers in net revenue. We have also elected for all taxes assessed by government authorities that are imposed on and concurrent with revenue-producing transactions, such as sales and value added taxes, to be excluded from revenue and presented on a net basis. We have elected two practical expedients including the &#x201c;right to invoice&#x201d; practical expedient, which is relevant for some of our SaaS contracts as it allows us to recognize revenue in the amount of the invoice when it corresponds directly with the value of performance completed to date. The second practical expedient adopted permits relief from considering a significant financing component when the payment for the good or service is expected to be one year or less.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMjQ4MQ_8494bd4f-bd74-4708-989b-45093098dc0a"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMTE_2277a48a-d0d5-4fd8-be58-b29762d30274">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S., Canada and Latin America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Devices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;339,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;275,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Masks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;238,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;215,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;578,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;491,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software as a Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;683,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;588,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Combined Europe, Asia and other markets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Devices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;218,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Masks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;266,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;315,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Global revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Devices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;517,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;494,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Masks and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;326,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;844,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;806,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software as a Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;950,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;904,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15ed4af6e542498aae586bf6f9ef5374_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMy0xLTEtMS02MjExOQ_9c099182-e12a-4682-a4ce-ae4a0110407e"
      unitRef="usd">339545000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7cbf2f1f9774adaa9291a924a186b8e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMy0zLTEtMS02MjExOQ_f4c0084e-4dcd-4769-bb65-1156bbc4a54e"
      unitRef="usd">275932000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c97b22f44884dc591a2167585ba6e8d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNC0xLTEtMS02MjExOQ_938b5074-9de4-4ae8-9ec2-f48003e071f5"
      unitRef="usd">238560000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa6d64210dc448b9a17c35d3c897c556_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNC0zLTEtMS02MjExOQ_9eefacc0-8c33-48fc-80e3-762d50fab34f"
      unitRef="usd">215106000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e62e9945cad4965bcf36433023bfa68_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNS0xLTEtMS02MjExOQ_b43fd429-5ba9-453a-bf42-ee5d3625630a"
      unitRef="usd">578105000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1eb5f7403b904bc9aab323b65ef846d5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNS0zLTEtMS02MjExOQ_0321b9e3-2d45-40a5-ac3a-2d5f3dc87135"
      unitRef="usd">491038000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82ea3d05492e4ac98479d3e2ac49f908_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNi0xLTEtMS02MjExOQ_a5026575-8aab-4a91-b0b5-3d50cacbb4df"
      unitRef="usd">105851000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc52733e9d564165bf93a97dacfc17f0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNi0zLTEtMS02MjExOQ_6acdd006-e7f1-4a8b-abfd-29ba8540d59b"
      unitRef="usd">97516000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98d3fc3d460b4652ad6b75c8adc858c4_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNy0xLTEtMS02MjExOQ_779dfab2-66b5-4b16-ba9d-9244e055e893"
      unitRef="usd">683956000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3db47d0b4bae4fcfbccf115899c75152_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfNy0zLTEtMS02MjExOQ_626855f5-18b8-4c7c-9fa3-1387e8df044d"
      unitRef="usd">588554000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02ae09329eef4efb848e53487594187f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfOS0xLTEtMS02MjExOQ_1152fb12-9dce-43b4-9339-a589df472777"
      unitRef="usd">178032000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2426e6fcaf654da9bb98fe543e2db047_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfOS0zLTEtMS02MjExOQ_d4bd1aa5-d142-42d7-b0b3-a0fcdc0207cc"
      unitRef="usd">218226000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9911d26ac214b2a8b97be040bea08d3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTAtMS0xLTEtNjIxMTk_b958a7df-0f89-46a8-b183-b6488cb5a9b6"
      unitRef="usd">88306000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b207b56bf2b41e8bebae3064d374c7a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTAtMy0xLTEtNjIxMTk_602d67ad-0664-45a6-8f4b-e295024bbab7"
      unitRef="usd">97235000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6da4ff69d9ec4d9abbe4b31ba6f9e9cd_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTEtMS0xLTEtNjIxMTk_d3887143-fb55-4739-a951-9fcba954f45d"
      unitRef="usd">266338000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic782a1e47cae42b893165007b949eb54_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTEtMy0xLTEtNjIxMTk_aeee60ef-c091-4140-9d68-95e0cf21d9bf"
      unitRef="usd">315461000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf87dfd1f7d7454cbbb3fdbfed511f9a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTMtMS0xLTEtNjIxMTk_8522a1ed-9930-4f80-b9dc-d76bdaa20855"
      unitRef="usd">517577000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa348c66adf44ac79c2e1d968c1e940d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTMtMy0xLTEtNjIxMTk_363a8f75-8fcb-41ce-9132-321a1616b841"
      unitRef="usd">494158000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i690f74a8d9e04be4a7acfb5c2e3e6fed_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTQtMS0xLTEtNjIxMTk_6b535e93-3228-4cd2-813d-8bf11f8d4587"
      unitRef="usd">326866000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2893d2234624bd1bcd6209e5bd0e3c5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTQtMy0xLTEtNjIxMTk_f14fee9d-897d-4700-9205-e3769a18072e"
      unitRef="usd">312341000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice4bd47dac83461983f5e1caf7313368_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTUtMS0xLTEtNjIxMTk_b6d2112e-01ea-4d27-a983-df9c875157c9"
      unitRef="usd">844443000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i599afb89a0f94887b16e08b956a275a3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTUtMy0xLTEtNjIxMTk_54bfc39f-050b-4f89-ab7f-13b4c004cf94"
      unitRef="usd">806499000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if6ce4de0cebf48adbeadffe538eee9fd_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTYtMS0xLTEtNjIxMTk_b67f1af8-6855-4124-aec5-168005bf84ae"
      unitRef="usd">105851000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9688c0dafa244d73b3ea05467409af36_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTYtMy0xLTEtNjIxMTk_d6b6a75a-6c8c-42c1-ac2e-36a2e49ede1b"
      unitRef="usd">97516000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i687eebe94bad4f46bc7e06b4c56dc88e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTctMS0xLTEtNjIxMTk_d2f8ffae-051e-44a2-83ed-62a69773f5b9"
      unitRef="usd">950294000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5dc82ad0f3d42b68b84f9f7beb91b53_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmQ5OTc1NTVmOTdhYzQ5MWZhOWViZWQwNmVmYjMwMTUyL3RhYmxlcmFuZ2U6ZDk5NzU1NWY5N2FjNDkxZmE5ZWJlZDA2ZWZiMzAxNTJfMTctMy0xLTEtNjIxMTk_e4bd0575-4e6e-4473-ad08-dd6f78112b2d"
      unitRef="usd">904015000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <rmd:TermOfContractUnderRevenueRecognition
      contextRef="i64b8ab9a3e3045bdae18cd12d207e6f3_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfNDYyMA_1e313f14-1614-4d29-a689-aabe31d204cf">P1Y</rmd:TermOfContractUnderRevenueRecognition>
    <rmd:TermOfContractUnderRevenueRecognition
      contextRef="if328dc4c5e254ff8962ff04237432117_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfNDYyNg_ed533e86-e1b9-4670-9d0c-398f895ffab0">P5Y</rmd:TermOfContractUnderRevenueRecognition>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMDU_6b23d92a-68ff-4a97-a260-585058fd1f79">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract balances (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance sheet caption&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;620,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;575,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unbilled revenue, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unbilled revenue, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prepaid taxes and other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(108,195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(108,667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue (current liabilities)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(97,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(95,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue (non-current liabilities)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ibc375d0ba418427f8b2b60d529de7690_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfMi0xLTEtMS02MjExOQ_6c392028-8fb3-4bd3-a027-5a54be0a4fbb"
      unitRef="usd">620483000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib3bae8b8d6404de1893a39a0a2fb73d5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfMi0zLTEtMS02MjExOQ_03e6d4a4-08ee-42e7-8822-2eb5cf0180de"
      unitRef="usd">575950000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ie987664fe8794b05be297c50f780e4df_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfMy0xLTEtMS02MjExOQ_5a0fc4fe-9a72-4e23-9c72-cebe0bedfac5"
      unitRef="usd">23615000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i0705b4a48526488d8f80b81d4da788e9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfMy0zLTEtMS02MjExOQ_6bbe3f9f-3abf-480c-b07e-92505852065d"
      unitRef="usd">25692000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent
      contextRef="i5018235ea25d4087971080bf06c36785_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfNC0xLTEtMS02MjExOQ_e9854966-c59a-49b0-a3bf-73c3af25bbc7"
      unitRef="usd">8106000</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent
      contextRef="i8a609ca3d66545e89aa80e54d5cbf456_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfNC0zLTEtMS02MjExOQ_c6a16dec-4ded-46d5-b990-bd1de7cffb4a"
      unitRef="usd">8840000</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i396aafec23c5497f9a9a0124dd672b37_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfNy0xLTEtMS02MjExOQ_348ef6a0-f2f9-423d-acb0-298f458063b5"
      unitRef="usd">108195000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i84379be5bb434df49678f14cabe16d60_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfNy0zLTEtMS02MjExOQ_7cd67e06-747d-45df-8a35-8af0c6d6b5a6"
      unitRef="usd">108667000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i77c2ddab74374037b8dfa317884bcb87_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfOC0xLTEtMS02MjExOQ_c718242c-260b-4b07-a76b-febbdd966ac9"
      unitRef="usd">97620000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ie2a02b6469384b2fa69e00189cde926f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RhYmxlOmZhMGE0YWFiZDVmNDQ0OTRhNGZmNDViNzBkNmYyNTgyL3RhYmxlcmFuZ2U6ZmEwYTRhYWJkNWY0NDQ5NGE0ZmY0NWI3MGQ2ZjI1ODJfOC0zLTEtMS02MjExOQ_0873ced3-f178-4baa-bf61-a8922dd03659"
      unitRef="usd">95455000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <rmd:LeaseRevenuePolicyTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMDY_83116f76-a7f5-468a-a8a7-f6ae9341dae9">Lease RevenueWe lease Sleep and Respiratory Care medical devices to customers primarily as a means to comply with local health insurer requirements in certain foreign geographies. Device rental contracts include operating leases, and contract terms vary by customer and include options to terminate or extend the contract. When lease contracts also include the sale of masks and accessories, we allocate contract consideration to those items on a relative standalone price basis and recognize revenue when control transfers to the customer.</rmd:LeaseRevenuePolicyTextBlock>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfNTQ5NzU1ODI2MTY1_b0a5e2a6-d4ff-40cc-8398-5180819d6f1d"
      unitRef="usd">23700000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfNTQ5NzU1ODI2MTkx_f73db5de-72ad-460d-8011-889ee10936c7"
      unitRef="usd">25200000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:StandardProductWarrantyPolicy
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18yOC9mcmFnOjdkMGMyYzQyNzAyMDQ5MDJiOWQ2ZTQ4ZDE2NWI1YWMwL3RleHRyZWdpb246N2QwYzJjNDI3MDIwNDkwMmI5ZDZlNDhkMTY1YjVhYzBfMTExMDg_83c66f4f-8510-4ff9-8dfb-d265636a670b">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Provision for Warranty&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide for the estimated cost of product warranties on our Sleep and Respiratory Care products at the time the related revenue is recognized. We determine the amount of this provision by using a financial model, which takes into consideration actual historical expenses and potential risks associated with our different products. We use this financial model to calculate the future probable expenses related to warranty and the required level of the warranty provision. Although we engage in product improvement programs and processes, our warranty obligation is affected by product failure rates and costs incurred to correct those product failures. Should actual product failure rates or estimated costs to repair those product failures differ from our estimates, we would be required to revise our estimated warranty provision.&lt;/span&gt;&lt;/div&gt;</us-gaap:StandardProductWarrantyPolicy>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RleHRyZWdpb246ZTY1ODljMGJlNjk3NGNkYzkzNDAyNDExMjAwZTJmYTFfMTM0MA_cd1dc4e2-cd9f-4745-9e6d-a226f0e31032">Segment Information&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have quantitatively and qualitatively determined that we operate in two operating segments, which are the Sleep and Respiratory Care segment and the SaaS segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate the performance of our segments based on net revenues and income from operations. The accounting policies of the segments are the same as those described in note 2 of our consolidated financial statements included in our Form 10-K for the year ended June&#160;30, 2022. Segment net revenues and segment income from operations do not include inter-segment profits and revenue is allocated to a geographic area based on where the products are shipped to or where the services are performed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate headquarters costs, stock-based compensation, amortization expense from acquired intangibles, net interest expense (income), loss attributable to equity method investments, gains and losses on equity investments, and other, net. We neither discretely allocate assets to our operating segments, nor does our Chief Operating Decision Maker evaluate the operating segments using discrete asset information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, effective in the first quarter of fiscal year 2023, we updated the extent of allocation and method of attribution of certain shared costs that are principally managed at the corporate level as part of our evaluation of segment operating performance. As a result, certain shared administrative costs, including shared IT, legal and other administrative functions, which were previously included in segment operating results, are now reported in Corporate costs within our reconciliation of segment operating profit to income before income taxes. The financial information presented herein reflects the impact of the preceding reporting change for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents a reconciliation of net revenues and net operating profit by reportable segments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net revenue by segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;844,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;806,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software as a Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;950,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;904,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Depreciation and amortization by segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software as a Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of acquired intangible assets and corporate assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net operating profit by segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;352,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;336,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software as a Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;377,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;358,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reconciling items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss attributable to equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(Gain) loss on equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;261,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;258,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RleHRyZWdpb246ZTY1ODljMGJlNjk3NGNkYzkzNDAyNDExMjAwZTJmYTFfMTAw_daa9e3ef-4910-45bb-84ba-ac269440f436"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RleHRyZWdpb246ZTY1ODljMGJlNjk3NGNkYzkzNDAyNDExMjAwZTJmYTFfMTM0MQ_4d050007-5d1b-429e-b73b-6a68bfc0cd60">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents a reconciliation of net revenues and net operating profit by reportable segments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net revenue by segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;844,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;806,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software as a Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;97,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;950,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;904,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Depreciation and amortization by segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software as a Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of acquired intangible assets and corporate assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net operating profit by segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sleep and Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;352,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;336,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software as a Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;377,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;358,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reconciling items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss attributable to equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(Gain) loss on equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;261,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;258,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib78c1fac3c4347a38db050a74046fbb0_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMy0xLTEtMS02MjExOQ_44cad4d3-3074-46b8-9d11-922ce2621e7d"
      unitRef="usd">844443000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8c22fc714d74cffb6b2a777dedeb592_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMy0zLTEtMS02MjExOQ_3cb8df4e-1927-4eb7-8b78-cb4d58dcd2d8"
      unitRef="usd">806499000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c3bb7515a714bb0922f36fa159ea208_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfNC0xLTEtMS02MjExOQ_c08cce73-8878-461e-87f3-ae21c18ba81a"
      unitRef="usd">105851000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b9cb77e265a44399ae4e1c4466f9da9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfNC0zLTEtMS02MjExOQ_136bad03-3b54-45ad-8bb9-87095df2dcbc"
      unitRef="usd">97516000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfNS0xLTEtMS02MjExOQ_54adcbab-fc94-4e85-8e34-15ff7ca2a70e"
      unitRef="usd">950294000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfNS0zLTEtMS02MjExOQ_dfd55e62-1aec-4945-a488-08d1a73e7c14"
      unitRef="usd">904015000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie76543872e91484aae4ea6e093ade66c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfOC0xLTEtMS02MjExOQ_9452d438-a8c4-484f-85ba-200c91d89cfa"
      unitRef="usd">19767000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i94a674e4585d44dfae6658ddd3dfe6fc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfOC0zLTEtMS02MjExOQ_0fe521c3-0c82-451c-b17c-03ab1f52ed5a"
      unitRef="usd">18017000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i640cd8511e9741ad923b981271756f3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfOS0xLTEtMS02MjExOQ_8fabc69f-1097-4084-a3d2-1583a54ba3cb"
      unitRef="usd">1913000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id4b603503f594377ba49d4d341fc0c76_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfOS0zLTEtMS02MjExOQ_3e785b07-6325-4218-9fdd-1aab61403551"
      unitRef="usd">1701000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iff46fa3403a545618690423df187e3f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTAtMS0xLTEtNjIxMTk_62274861-2323-44ac-88a8-73af35d24ea2"
      unitRef="usd">14593000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8c07d72c891a46a795fddf79d7928217_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTAtMy0xLTEtNjIxMTk_f826c737-8e8b-492a-b348-b217c605e312"
      unitRef="usd">19384000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTEtMS0xLTEtNjIxMTk_4009531a-71fb-4a4e-990a-a029e1f86e44"
      unitRef="usd">36273000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTEtMy0xLTEtNjIxMTk_22a937ef-3fc5-41a2-892b-f1f369870772"
      unitRef="usd">39102000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie76543872e91484aae4ea6e093ade66c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTQtMS0xLTEtNjIxMTk_74f8b687-3eaf-4287-8671-a8c2573e8d72"
      unitRef="usd">352560000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i94a674e4585d44dfae6658ddd3dfe6fc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTQtMy0xLTEtNjIxMTk_41b3d86f-0478-437b-acd2-a3c938a2c1d3"
      unitRef="usd">336996000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i640cd8511e9741ad923b981271756f3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTUtMS0xLTEtNjIxMTk_44cadc5a-3bd0-443f-9857-5b25ad6119ba"
      unitRef="usd">24441000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id4b603503f594377ba49d4d341fc0c76_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTUtMy0xLTEtNjIxMTk_e28b6ed7-9903-44d8-8084-b5eef04b5187"
      unitRef="usd">21907000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9147d5a65f12434291bdbb355c876cb4_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTYtMS0xLTEtNjIxMTk_5d77e139-9d59-4998-8648-551953d2c2c9"
      unitRef="usd">377001000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3822bb4d001f4343bad4507eaf24339d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTYtMy0xLTEtNjIxMTk_9677b7fc-3d01-43fa-99f2-c1835f573af7"
      unitRef="usd">358903000</us-gaap:OperatingIncomeLoss>
    <rmd:UnallocatedCorporateCosts
      contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTktMS0xLTEtNjIxMTk_633921c7-67e5-4c45-88a8-7d0b6e4c4532"
      unitRef="usd">86938000</rmd:UnallocatedCorporateCosts>
    <rmd:UnallocatedCorporateCosts
      contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMTktMy0xLTEtNjIxMTk_283b94c5-9677-42c0-9e21-8ab45b7dfaa8"
      unitRef="usd">78224000</rmd:UnallocatedCorporateCosts>
    <rmd:AmortizationOfAcquiredIntangibleAssets1
      contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjAtMS0xLTEtNjIxMTk_4dc3a377-e676-4bfd-ba4e-a4f2ac989369"
      unitRef="usd">14324000</rmd:AmortizationOfAcquiredIntangibleAssets1>
    <rmd:AmortizationOfAcquiredIntangibleAssets1
      contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjAtMy0xLTEtNjIxMTk_399f1013-68fc-40c2-b556-c351ea330825"
      unitRef="usd">18766000</rmd:AmortizationOfAcquiredIntangibleAssets1>
    <us-gaap:InterestExpense
      contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjItMS0xLTEtNjIxMTk_7f6dad1c-8726-4d9a-9ed3-fc3cdbb0981b"
      unitRef="usd">7134000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjItMy0xLTEtNjIxMTk_74a23a27-5c58-4922-a38a-816e0b44683e"
      unitRef="usd">5360000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjMtMS0xLTEtNjIxMTk_64ba380d-69d8-4722-a7b1-2779935b8506"
      unitRef="usd">-2028000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjMtMy0xLTEtNjIxMTk_e997c47b-c603-44c0-bc15-febe53308cb2"
      unitRef="usd">-1386000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss
      contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjQtMS0xLTEtNjIxMTk_096c2645-bdfa-46bf-9305-6dd03b734bbd"
      unitRef="usd">-3280000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss
      contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjQtMy0xLTEtNjIxMTk_7661db0e-6df3-4df9-9e56-18a881c44431"
      unitRef="usd">5612000</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjUtMS0xLTEtNjIxMTk_c9093f50-c5bf-4e26-93bb-9b00536299a9"
      unitRef="usd">1504000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjUtMy0xLTEtNjIxMTk_8f8cd0dd-d3f6-4a90-9f9d-71daa0a1835a"
      unitRef="usd">1991000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6b1828eec4794c4a815e2575c90a0f94_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjYtMS0xLTEtNjIxMTk_0b4af4c1-d2c1-4ea7-93f7-bdcb7971b735"
      unitRef="usd">261793000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i759637b4e24642d0af3b47249b185359_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zMS9mcmFnOmU2NTg5YzBiZTY5NzRjZGM5MzQwMjQxMTIwMGUyZmExL3RhYmxlOjM0YTdmZjNlZWI0ZTQzMDRhZDFiNDVjOGI3ZTY2ZTJkL3RhYmxlcmFuZ2U6MzRhN2ZmM2VlYjRlNDMwNGFkMWI0NWM4YjdlNjZlMmRfMjYtMy0xLTEtNjIxMTk_c44d713c-0319-4f0d-9882-31009dd8074f"
      unitRef="usd">258788000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <rmd:SupplementalBalanceSheetInformationTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfNDc4_c667307b-26e0-470a-b986-f500a3b42921">Supplemental Balance Sheet Information&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of selected captions in the condensed consolidated balance sheets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;398,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;355,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;461,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;385,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;864,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;743,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;92,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;99,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prepaid inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;122,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;107,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses and current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;126,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;341,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;337,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,107,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,131,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(620,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(633,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;487,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;498,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Intangible Assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed/core product technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;354,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;350,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(244,255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(239,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed/core product technology, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;110,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;111,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;258,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(97,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(91,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;161,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;194,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(128,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(134,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other intangibles, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other intangibles, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;338,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;345,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist of developed/core product technology, trade names, non-compete agreements, customer relationships, and patents, which we amortize over the estimated useful life of the assets, generally between two years to fifteen years. There are no expected residual values related to these intangible assets.&lt;/span&gt;&lt;/div&gt;</rmd:SupplementalBalanceSheetInformationTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfNDc5_66767b5d-7e5d-4819-b3a7-925b782deb22">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of selected captions in the condensed consolidated balance sheets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;398,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;355,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;461,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;385,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;864,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;743,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfMS0xLTEtMS02MjExOQ_7af373f6-2f5e-48e8-b373-7dddd7a3efd5"
      unitRef="usd">398520000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfMS0zLTEtMS02MjExOQ_ccabfe0f-dc28-4b05-8f13-466b0b477cd2"
      unitRef="usd">355225000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfMi0xLTEtMS02MjExOQ_e5551609-1d31-4f57-8f2f-562114451796"
      unitRef="usd">4491000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfMi0zLTEtMS02MjExOQ_7f473995-a033-4c7b-9b29-af0103ff02bd"
      unitRef="usd">3077000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfMy0xLTEtMS02MjExOQ_e066f7de-0de8-4eb3-b020-98abc624ccf8"
      unitRef="usd">461841000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfMy0zLTEtMS02MjExOQ_64323b2b-ae95-460f-8eb2-b93bcda7de54"
      unitRef="usd">385608000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfNC0xLTEtMS02MjExOQ_ca3b96e4-9a84-4cc4-af18-db8756440a69"
      unitRef="usd">864852000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmQwMWJhMzM3NzgzYjRmZDI4Zjk0YmU2NDQ2MjA2YTM0L3RhYmxlcmFuZ2U6ZDAxYmEzMzc3ODNiNGZkMjhmOTRiZTY0NDYyMDZhMzRfNC0zLTEtMS02MjExOQ_29821c1e-a50b-446d-9f14-c045fc55c3cb"
      unitRef="usd">743910000</us-gaap:InventoryNet>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfMjE5OTAyMzI1NjAzNg_2ab2a46a-8183-46c1-b2fa-3b41ac4e3b51">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;92,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;99,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Prepaid inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;122,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;107,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses and current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;126,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;341,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;337,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:PrepaidTaxes
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfMS0xLTEtMS02NDU5Ng_271d2b1f-6f8c-4d86-b3e3-f25a18e06a42"
      unitRef="usd">92226000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfMS0zLTEtMS02NDU5Ng_29ddee1c-1b13-4721-8291-924801f88bf2"
      unitRef="usd">99352000</us-gaap:PrepaidTaxes>
    <rmd:PrepaidInventory
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfMi0xLTEtMS02NDU5Ng_907a79c7-fc87-4af2-8836-f77e51b23ac9"
      unitRef="usd">122839000</rmd:PrepaidInventory>
    <rmd:PrepaidInventory
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfMi0zLTEtMS02NDU5Ng_77268b46-63dc-4cc1-adad-40e93eb4a870"
      unitRef="usd">107291000</rmd:PrepaidInventory>
    <us-gaap:OtherAssetsCurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfMy0xLTEtMS02NDU5Ng_b2e7477c-41d3-4aa8-ac2d-203e94754a17"
      unitRef="usd">126134000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfMy0zLTEtMS02NDU5Ng_b3fc4187-742a-4a9e-80d0-c28b7fba225d"
      unitRef="usd">131265000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfNC0xLTEtMS02NDU5Ng_aa60b06f-5da6-4b3e-9159-ba2fc005389c"
      unitRef="usd">341199000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjAwMWY0Nzk1ZTFhMzQ2ZjViMzkxMjQxZmNlZDI0NWZlL3RhYmxlcmFuZ2U6MDAxZjQ3OTVlMWEzNDZmNWIzOTEyNDFmY2VkMjQ1ZmVfNC0zLTEtMS02NDU5Ng_6d90e827-d194-487d-8301-e7f9456928d3"
      unitRef="usd">337908000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfNDc2_35b70b62-c8be-47a9-a2c4-82f43cf2f516">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,107,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,131,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(620,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(633,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;487,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;498,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjVmYWY3MTNkYTYxNDQ0M2FhNzA1MWJjOWNhODM4ODBlL3RhYmxlcmFuZ2U6NWZhZjcxM2RhNjE0NDQzYWE3MDUxYmM5Y2E4Mzg4MGVfMS0xLTEtMS02MjExOQ_d75aa0de-e90b-437c-a583-2ca46073e6a1"
      unitRef="usd">1107564000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjVmYWY3MTNkYTYxNDQ0M2FhNzA1MWJjOWNhODM4ODBlL3RhYmxlcmFuZ2U6NWZhZjcxM2RhNjE0NDQzYWE3MDUxYmM5Y2E4Mzg4MGVfMS0zLTEtMS02MjExOQ_928b850b-d9e7-49a7-ab6c-fbd7b307d54c"
      unitRef="usd">1131295000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjVmYWY3MTNkYTYxNDQ0M2FhNzA1MWJjOWNhODM4ODBlL3RhYmxlcmFuZ2U6NWZhZjcxM2RhNjE0NDQzYWE3MDUxYmM5Y2E4Mzg4MGVfMi0xLTEtMS02MjExOQ_006ec7bb-74f5-482b-9f4a-5d9750368ee8"
      unitRef="usd">620188000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjVmYWY3MTNkYTYxNDQ0M2FhNzA1MWJjOWNhODM4ODBlL3RhYmxlcmFuZ2U6NWZhZjcxM2RhNjE0NDQzYWE3MDUxYmM5Y2E4Mzg4MGVfMi0zLTEtMS02MjExOQ_c5f7f889-dbe3-4413-b631-8fec48658b4f"
      unitRef="usd">633114000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjVmYWY3MTNkYTYxNDQ0M2FhNzA1MWJjOWNhODM4ODBlL3RhYmxlcmFuZ2U6NWZhZjcxM2RhNjE0NDQzYWE3MDUxYmM5Y2E4Mzg4MGVfMy0xLTEtMS02MjExOQ_d8e99e59-b875-445b-94bd-f514d904e23c"
      unitRef="usd">487376000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOjVmYWY3MTNkYTYxNDQ0M2FhNzA1MWJjOWNhODM4ODBlL3RhYmxlcmFuZ2U6NWZhZjcxM2RhNjE0NDQzYWE3MDUxYmM5Y2E4Mzg4MGVfMy0zLTEtMS02MjExOQ_75ef903b-23dc-4e9b-8ad6-98327b0e6062"
      unitRef="usd">498181000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfNDc3_d5a741e5-7b37-42d4-b42b-b9483fd24245">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Intangible Assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed/core product technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;354,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;350,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(244,255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(239,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed/core product technology, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;110,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;111,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;258,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(97,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(91,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;161,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;194,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(128,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(134,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other intangibles, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other intangibles, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;338,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;345,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i69e86a0970d447abaac8ad86f67160f7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMS0xLTEtMS02MjExOQ_47f652ae-ee0d-40f9-930e-efdc1bcb5b2b"
      unitRef="usd">354770000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i84b7e50d4346433e95666fb6afc046da_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMS0zLTEtMS02MjExOQ_b4ea6727-b9a2-4c7a-be25-9bc5eb9e05fa"
      unitRef="usd">350671000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i69e86a0970d447abaac8ad86f67160f7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMi0xLTEtMS02MjExOQ_5fd73f42-135a-4cda-a0d0-8f9b4766c70d"
      unitRef="usd">244255000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i84b7e50d4346433e95666fb6afc046da_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMi0zLTEtMS02MjExOQ_e8e1d8a8-b6cb-4512-bfec-4583e1bd4a76"
      unitRef="usd">239647000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i69e86a0970d447abaac8ad86f67160f7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMy0xLTEtMS02MjExOQ_d1238895-a944-4be6-9833-0d84f52d0fb6"
      unitRef="usd">110515000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i84b7e50d4346433e95666fb6afc046da_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMy0zLTEtMS02MjExOQ_6863ba6f-a5c1-45bf-ab8c-e8f541385399"
      unitRef="usd">111024000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1159ad451e6e4aeb9d34a0012448665f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNC0xLTEtMS02MjExOQ_a7086172-2c5c-47c1-9c4b-7f7dff545515"
      unitRef="usd">258312000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if69726299ae44abb98de417d5a419afa_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNC0zLTEtMS02MjExOQ_5718226a-6474-4192-8690-e70a9203db88"
      unitRef="usd">257034000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1159ad451e6e4aeb9d34a0012448665f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNS0xLTEtMS02MjExOQ_1c023d24-83b5-4c46-808b-44072406afdb"
      unitRef="usd">97143000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if69726299ae44abb98de417d5a419afa_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNS0zLTEtMS02MjExOQ_9d737d77-b0bb-4b12-95fc-663ccf62bc4a"
      unitRef="usd">91731000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1159ad451e6e4aeb9d34a0012448665f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNi0xLTEtMS02MjExOQ_05af9cb1-0674-4a19-8035-50c7353d918b"
      unitRef="usd">161169000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if69726299ae44abb98de417d5a419afa_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNi0zLTEtMS02MjExOQ_9727dfbf-35c3-41d5-bde1-47b0fda289c3"
      unitRef="usd">165303000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0408bf19028f4072a1d8dd44df5a9ea3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNy0xLTEtMS02MjExOQ_306a5ae3-7b87-45ea-9c30-273e6238e3e6"
      unitRef="usd">194970000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i72f4980bc58d49c2966d8c1aa7bc905d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfNy0zLTEtMS02MjExOQ_47de8c7f-b05a-4d69-8ec3-a5d3227ea498"
      unitRef="usd">204580000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0408bf19028f4072a1d8dd44df5a9ea3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfOC0xLTEtMS02MjExOQ_6112a773-242e-44f7-b9a0-00da6d9dc5ad"
      unitRef="usd">128503000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i72f4980bc58d49c2966d8c1aa7bc905d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfOC0zLTEtMS02MjExOQ_c72931b8-5e74-44fb-8d20-1c07fa7f64b2"
      unitRef="usd">134963000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0408bf19028f4072a1d8dd44df5a9ea3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfOS0xLTEtMS02MjExOQ_016d4109-4597-442b-b5c6-3c38fff36d99"
      unitRef="usd">66467000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i72f4980bc58d49c2966d8c1aa7bc905d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfOS0zLTEtMS02MjExOQ_27c7b19d-db33-4811-95bf-763bb141f6cc"
      unitRef="usd">69617000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMTAtMS0xLTEtNjIxMTk_ac322193-71b2-4f07-9d04-43abfefbeb7a"
      unitRef="usd">338151000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RhYmxlOmRlODE3OWQ3YTg2NjQ5ZWU4ZWE4YmI3N2VlZmQyOWQ5L3RhYmxlcmFuZ2U6ZGU4MTc5ZDdhODY2NDllZThlYThiYjc3ZWVmZDI5ZDlfMTAtMy0xLTEtNjIxMTk_26886218-98eb-44b3-bc5c-bf42e46e069d"
      unitRef="usd">345944000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i64b8ab9a3e3045bdae18cd12d207e6f3_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfMzk0_fb1225b3-9a29-4bfd-8b0a-d99dd87a6a53">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if328dc4c5e254ff8962ff04237432117_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNC9mcmFnOjAwODg2NWMyZDZlODQ3NzA5MjE5ZTZiOGVhMTI1M2YxL3RleHRyZWdpb246MDA4ODY1YzJkNmU4NDc3MDkyMTllNmI4ZWExMjUzZjFfNDAw_982ce830-020f-4478-8f70-10ada9262ff0">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RleHRyZWdpb246OWQ0ODFmYmYzZTgzNGU5ZmEzNzdkYTJjZTJmZTY3YjdfMTE1_9c5c861c-fad7-4452-9ef8-c9988655e505">Goodwill &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of changes in our goodwill by reportable segment is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Sleep and &lt;br/&gt;Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SaaS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;641,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,294,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,936,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;644,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,294,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,938,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RleHRyZWdpb246OWQ0ODFmYmYzZTgzNGU5ZmEzNzdkYTJjZTJmZTY3YjdfMTE2_7b372e1a-126d-4f1d-baed-a2a16342e8f1">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of changes in our goodwill by reportable segment is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Sleep and &lt;br/&gt;Respiratory Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;SaaS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;641,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,294,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,936,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;644,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,294,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,938,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i14ad6e094e8c4c7a80ada79f330a56c5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfMi0xLTEtMS02MjExOQ_05162d92-8abe-4308-9653-52946507a562"
      unitRef="usd">641724000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i92f6ff0f41fd4e56a622577a92df8168_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfMi0zLTEtMS02MjExOQ_6e366b92-b53e-410b-b0d4-cdae56546693"
      unitRef="usd">1294718000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfMi01LTEtMS02MjExOQ_41765919-6aea-43a6-b471-5d1e9e3acdb8"
      unitRef="usd">1936442000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib78c1fac3c4347a38db050a74046fbb0_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfMy0xLTEtMS02MjExOQ_e98b089c-451f-4dbb-a357-373955d042ec"
      unitRef="usd">19281000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i3cb35257bd8b437e92849ecc0592453e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfMy0zLTEtMS02MjExOQ_9bc6685d-f8f5-4366-89c7-97f0f39149c5"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfMy01LTEtMS02MjExOQ_1319cfe5-6a5e-42f0-9627-a5a9dcbcf9fe"
      unitRef="usd">19281000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ib78c1fac3c4347a38db050a74046fbb0_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfNC0xLTEtMS02MjExOQ_8e36075a-e46a-4d3d-a129-536ccceb2362"
      unitRef="usd">-16880000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i3cb35257bd8b437e92849ecc0592453e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfNC0zLTEtMS02MjExOQ_a561709f-8d46-4cc9-84e6-4e49c648cb04"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfNC01LTEtMS02MjExOQ_efae9698-079a-415a-b4d9-5caa6138cce6"
      unitRef="usd">-16880000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i15dc957f85fb4fe890100775f942c978_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfNS0xLTEtMS02MjExOQ_d9b92fad-2d24-421a-8cbb-349d28689ad3"
      unitRef="usd">644125000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8e9f732c1100497b8985d47b059e8339_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfNS0zLTEtMS02MjExOQ_919e42c7-9e04-44d7-b108-a4788e20922d"
      unitRef="usd">1294718000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M18zNy9mcmFnOjlkNDgxZmJmM2U4MzRlOWZhMzc3ZGEyY2UyZmU2N2I3L3RhYmxlOmE0NjY4OTI1Zjg0MDRmNmJiZmFmMTNlMjFkOTBjMDcwL3RhYmxlcmFuZ2U6YTQ2Njg5MjVmODQwNGY2YmJmYWYxM2UyMWQ5MGMwNzBfNS01LTEtMS02MjExOQ_f03b86e8-7379-402c-adcd-4a6063498228"
      unitRef="usd">1938843000</us-gaap:Goodwill>
    <us-gaap:InvestmentTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RleHRyZWdpb246NDgwN2Q4MzFhZWU0NDZlOWE1ZDAxZDRjYjAxNTNlZDFfMjkyOQ_3fabf0ac-4073-4114-808a-79b589f38e9c">Investments&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have equity investments in privately and publicly held companies that are unconsolidated entities. The following discusses our investments in marketable equity securities, non-marketable equity securities, and investments accounted for under the equity method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our marketable equity securities are publicly traded stocks measured at fair value and classified within Level 1 in the fair value hierarchy because we use quoted prices for identical assets in active markets. Marketable equity securities are recorded in prepaid expenses and other current assets on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values and are recorded in prepaid taxes and other non-current assets on the condensed consolidated balance sheets. Non-marketable equity securities are reported at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. We assess non-marketable equity securities at least quarterly for impairment and consider qualitative and quantitative factors including the investee's financial metrics, product and commercial outlook and cash usage. All gains and losses on marketable and non-marketable equity securities, realized and unrealized, are recognized in gain (loss) on equity investments as a component of other income (loss), net on the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity investments whereby we have significant influence, but not control over the investee and are not the primary beneficiary of the investee&#x2019;s activities, are accounted for under the equity method. Under this method, we record our share of gains or losses attributable to equity method investments as a component of other income (loss), net on the condensed consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity investments by measurement category were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Measurement category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Measurement alternative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show a reconciliation of the changes in our equity investments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions to investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unrealized losses on marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss attributable to equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying value at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions to investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Observable price adjustments on non-marketable equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unrealized gains on marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Impairment of investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss attributable to equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying value at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net unrealized losses recognized for equity investments in non-marketable and marketable securities held as of September&#160;30, 2022 for the three months ended September&#160;30, 2022 were $3.3 million. Net unrealized gains recognized for equity investments in non-marketable and marketable securities held as of September&#160;30, 2021 for the three months ended September&#160;30, 2021 were $5.6 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentTextBlock>
    <rmd:ScheduleOfInvestmentsTableTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RleHRyZWdpb246NDgwN2Q4MzFhZWU0NDZlOWE1ZDAxZDRjYjAxNTNlZDFfMjkzMA_e26600db-b876-4238-8ab9-8fc141dbf126">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity investments by measurement category were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Measurement category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Measurement alternative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rmd:ScheduleOfInvestmentsTableTextBlock>
    <rmd:MarketableEquityInvestmentsFairValue
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfMS0xLTEtMS02MjExOQ_96a31994-a42b-4a82-954a-3cee839dbd6b"
      unitRef="usd">5887000</rmd:MarketableEquityInvestmentsFairValue>
    <rmd:MarketableEquityInvestmentsFairValue
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfMS0zLTEtMS02MjExOQ_d19536c0-de24-4201-b3bc-0644f68ed8d8"
      unitRef="usd">9167000</rmd:MarketableEquityInvestmentsFairValue>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfMi0xLTEtMS02MjExOQ_81e4e6c6-1d74-4ac5-800d-3ce42f59cf46"
      unitRef="usd">43581000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfMi0zLTEtMS02MjExOQ_6e1f9460-32b1-40e1-868c-e77b1db6e68e"
      unitRef="usd">39290000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfMy0xLTEtMS02MjExOQ_52f67564-aa8e-4ce7-ae95-9556eee25b73"
      unitRef="usd">7890000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfMy0zLTEtMS02MjExOQ_1d9cb857-86e0-4722-8aa1-97d90b6e4b4b"
      unitRef="usd">9918000</us-gaap:EquityMethodInvestments>
    <rmd:EquityInvestmentsTotalByMeasurementCategory
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfNC0xLTEtMS02MjExOQ_dedc2050-83c6-4baf-ab1b-c5cb5d1ab8b3"
      unitRef="usd">57358000</rmd:EquityInvestmentsTotalByMeasurementCategory>
    <rmd:EquityInvestmentsTotalByMeasurementCategory
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOmM3ZWFhOTgwYjZhMDQ0ZWRiZDYyYzM2MWUzNzIyNDYwL3RhYmxlcmFuZ2U6YzdlYWE5ODBiNmEwNDRlZGJkNjJjMzYxZTM3MjI0NjBfNC0zLTEtMS02MjExOQ_ae225cc3-21b0-4818-b977-c98f810d5373"
      unitRef="usd">58375000</rmd:EquityInvestmentsTotalByMeasurementCategory>
    <rmd:ScheduleOfChangesInEquityInvestmentsTableTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RleHRyZWdpb246NDgwN2Q4MzFhZWU0NDZlOWE1ZDAxZDRjYjAxNTNlZDFfMjkzMQ_39ed5e20-bd5a-42d5-938d-08f03cb4edc7">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show a reconciliation of the changes in our equity investments (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions to investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unrealized losses on marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss attributable to equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying value at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Additions to investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Observable price adjustments on non-marketable equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unrealized gains on marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Impairment of investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss attributable to equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying value at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rmd:ScheduleOfChangesInEquityInvestmentsTableTextBlock>
    <rmd:EquityInvestments
      contextRef="i70a87039741047098a43d0ed149675b0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfMi0xLTEtMS02MjExOQ_fd70cb8d-faaf-4237-8d1e-da9f06f1ce88"
      unitRef="usd">39290000</rmd:EquityInvestments>
    <rmd:EquityInvestments
      contextRef="i754cf4a776a241f191b33f0081cd2afe_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfMi0zLTEtMS02MjExOQ_63151e66-5fe2-4da7-91b2-5236b1a560aa"
      unitRef="usd">9167000</rmd:EquityInvestments>
    <rmd:EquityInvestments
      contextRef="i5e7b9f80be8c4d2394bb2681a276056a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfMi01LTEtMS02MjExOQ_e4c4904c-ae4b-4c4e-8203-6755b8a381c1"
      unitRef="usd">9918000</rmd:EquityInvestments>
    <rmd:EquityInvestments
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfMi03LTEtMS02MjExOQ_09ddce1a-e42e-4155-a1b4-e955b42b0e58"
      unitRef="usd">58375000</rmd:EquityInvestments>
    <rmd:AdditionalEquityInvestments
      contextRef="idc6e99edaebb4a609919407282c99506_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfMy0xLTEtMS02MjExOQ_38992657-41d3-44bb-9d45-14cda6823206"
      unitRef="usd">4291000</rmd:AdditionalEquityInvestments>
    <rmd:AdditionalEquityInvestments
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfMy03LTEtMS02MjExOQ_ac8c33b0-ef4e-4e75-b7bb-9d477ac7b89f"
      unitRef="usd">4291000</rmd:AdditionalEquityInvestments>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i40e4bbc8f424443797674f57dc109757_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfNS0zLTEtMS02MjExOQ_d64bf72b-6675-4cdf-8e61-2d1abfdf5b97"
      unitRef="usd">-3280000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfNS03LTEtMS02MjExOQ_ef077a47-2a72-4598-b760-391683bf6e69"
      unitRef="usd">-3280000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i670bbe1c2cb64cd2b590c0fadd7844ec_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfOC01LTEtMS02MjExOQ_00859a95-0751-4995-bbfe-5d6b514d43d2"
      unitRef="usd">-2028000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfOC03LTEtMS02MjExOQ_1dd7e753-e0ac-4499-afbb-b8658c103c1b"
      unitRef="usd">-2028000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <rmd:EquityInvestments
      contextRef="ieadf15b970044d0a838558a15de8430f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfOS0xLTEtMS02MjExOQ_9b0bf5e2-9415-402e-9405-8b3148f33ade"
      unitRef="usd">43581000</rmd:EquityInvestments>
    <rmd:EquityInvestments
      contextRef="ia4eb3627d8824fc0afceae4d64ab2a10_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfOS0zLTEtMS02MjExOQ_f686bf17-0739-4749-b62d-4042d0a70bff"
      unitRef="usd">5887000</rmd:EquityInvestments>
    <rmd:EquityInvestments
      contextRef="i40bb05a82f774f53aabc2ee8e712ed5d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfOS01LTEtMS02MjExOQ_e0ae5a62-fbe0-4b7c-a201-41072535af8d"
      unitRef="usd">7890000</rmd:EquityInvestments>
    <rmd:EquityInvestments
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjExM2FjZmViMTkzYTQwMzA4NDM5OGE1ODZkMmJmMzIwL3RhYmxlcmFuZ2U6MTEzYWNmZWIxOTNhNDAzMDg0Mzk4YTU4NmQyYmYzMjBfOS03LTEtMS02MjExOQ_3b41154b-0929-4164-930e-942a1310e6b0"
      unitRef="usd">57358000</rmd:EquityInvestments>
    <rmd:EquityInvestments
      contextRef="ifadb68bbd9524af8a7d16266b166a2cf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMi0xLTEtMS02MjExOQ_543bacef-782f-492a-b056-94d25973d910"
      unitRef="usd">23002000</rmd:EquityInvestments>
    <rmd:EquityInvestments
      contextRef="if4d7015735be42eb89bbf6e16b348801_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMi0zLTEtMS02MjExOQ_b63f3c85-e0e1-472a-b2c1-e0761e3a4809"
      unitRef="usd">29084000</rmd:EquityInvestments>
    <rmd:EquityInvestments
      contextRef="i4f2c400950d04ed1912934bd2c201d82_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMi01LTEtMS02MjExOQ_dd567264-5dd9-4c48-813c-e32ddb9575e3"
      unitRef="usd">17154000</rmd:EquityInvestments>
    <rmd:EquityInvestments
      contextRef="id4c1bec761d343199bfb5656845fee5a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMi03LTEtMS02MjExOQ_3c2968d9-1734-467d-bc1f-9d8b3ebc26d9"
      unitRef="usd">69240000</rmd:EquityInvestments>
    <rmd:AdditionalEquityInvestments
      contextRef="i398d34a58e00477c83fa76e1309cbf0c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMy0xLTEtMS02MjExOQ_5b0fea08-9911-4178-8ce1-8263a1258a02"
      unitRef="usd">3000000</rmd:AdditionalEquityInvestments>
    <rmd:AdditionalEquityInvestments
      contextRef="i790d1b42ed1c4ff3bb9c53be9acff926_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMy0zLTEtMS02MjExOQ_d2d83def-34f1-46e6-b642-6c8af6d25670"
      unitRef="usd">3600000</rmd:AdditionalEquityInvestments>
    <rmd:AdditionalEquityInvestments
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfMy03LTEtMS02MjExOQ_d45e76dd-d974-4031-9ec4-dd4b905c154d"
      unitRef="usd">6600000</rmd:AdditionalEquityInvestments>
    <rmd:ObservablePriceAdjustmentsOnNonMarketableEquitySecurities
      contextRef="i398d34a58e00477c83fa76e1309cbf0c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNC0xLTEtMS02MjExOQ_516d3190-be6c-4dec-abec-4e5a1932b881"
      unitRef="usd">5367000</rmd:ObservablePriceAdjustmentsOnNonMarketableEquitySecurities>
    <rmd:ObservablePriceAdjustmentsOnNonMarketableEquitySecurities
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNC03LTEtMS02MjExOQ_9d86a0f4-4820-40bb-adcb-dff1e395ff67"
      unitRef="usd">5367000</rmd:ObservablePriceAdjustmentsOnNonMarketableEquitySecurities>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i790d1b42ed1c4ff3bb9c53be9acff926_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNS0zLTEtMS02MjExOQ_291d4559-9674-4788-9065-0979d393811d"
      unitRef="usd">454000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNS03LTEtMS02MjExOQ_7645971e-3352-4084-b950-c765af303c9f"
      unitRef="usd">454000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i398d34a58e00477c83fa76e1309cbf0c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNi0xLTEtMS02MjExOQ_99258b06-58bf-42cc-9320-97193fe4e6d8"
      unitRef="usd">209000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNi03LTEtMS02MjExOQ_ac923b30-1a71-437a-87e4-e8dee2a4ab65"
      unitRef="usd">209000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="id077d5ad4d284fe9b8c598b153545a40_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNy01LTEtMS02MjExOQ_b1b56edb-cc58-4dd8-ba8a-7bb1049ac505"
      unitRef="usd">-1386000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfNy03LTEtMS02MjExOQ_6d237f15-63b6-4b84-80fc-35401d8b398b"
      unitRef="usd">-1386000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <rmd:EquityInvestments
      contextRef="ia4567248f80c40ab88a38b16d19ad029_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfOC0xLTEtMS02MjExOQ_023ae869-a1ec-4239-8a98-fd4cd94bd537"
      unitRef="usd">31160000</rmd:EquityInvestments>
    <rmd:EquityInvestments
      contextRef="ie62277cf19044d9fa1cd841612748260_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfOC0zLTEtMS02MjExOQ_b31643c7-4742-41bd-a72f-3bfb29287544"
      unitRef="usd">33138000</rmd:EquityInvestments>
    <rmd:EquityInvestments
      contextRef="i212dd8da8d734d648e06f65c84619472_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfOC01LTEtMS02MjExOQ_50074cab-e3af-4c96-8138-ef52f43cea35"
      unitRef="usd">15768000</rmd:EquityInvestments>
    <rmd:EquityInvestments
      contextRef="iee72006a6fb24b64994718e79dad7dfe_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RhYmxlOjllNjRiYTA5MjMxOTQ3ZTU5YmQwNDdjZDliZjU2OTJjL3RhYmxlcmFuZ2U6OWU2NGJhMDkyMzE5NDdlNTliZDA0N2NkOWJmNTY5MmNfOC03LTEtMS02MjExOQ_998e6279-1977-4dcf-8f22-270e24f6aaaf"
      unitRef="usd">80066000</rmd:EquityInvestments>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RleHRyZWdpb246NDgwN2Q4MzFhZWU0NDZlOWE1ZDAxZDRjYjAxNTNlZDFfMjczNg_dc6a9817-5c78-4465-b065-b4aa21941c57"
      unitRef="usd">-3300000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180MC9mcmFnOjQ4MDdkODMxYWVlNDQ2ZTlhNWQwMWQ0Y2IwMTUzZWQxL3RleHRyZWdpb246NDgwN2Q4MzFhZWU0NDZlOWE1ZDAxZDRjYjAxNTNlZDFfMjkwNg_bbdec40c-a6c1-4254-9249-b1be65e99eeb"
      unitRef="usd">5600000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180My9mcmFnOjQ0MzlhZmRjYmE5MjQyN2E5ZTU2NjU3N2E5ODAwYzliL3RleHRyZWdpb246NDQzOWFmZGNiYTkyNDI3YTllNTY2NTc3YTk4MDBjOWJfMTUzNw_7831d07a-e436-4d08-8daf-a430ce70d9c1">Income Taxes&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 740 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, each interim reporting period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 19, 2021, we concluded the settlement agreement with the Australian Taxation Office (&#x201c;ATO&#x201d;) in relation to the previously disclosed transfer pricing dispute for the tax years 2009 through 2018 (&#x201c;ATO settlement&#x201d;). The ATO settlement fully resolved the dispute for all prior years, with no admission of liability and provides clarity in relation to certain future taxation principles.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;28, 2021, we remitted final payment to the ATO of $284.8 million, consisting of the agreed settlement amount of $381.7 million less prior remittances made to the ATO of $96.9 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <rmd:IncomeTaxExaminationRemittedFinalPayment
      contextRef="i5f0fabb698be42fb98ac32d821f1a373_D20210928-20210928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180My9mcmFnOjQ0MzlhZmRjYmE5MjQyN2E5ZTU2NjU3N2E5ODAwYzliL3RleHRyZWdpb246NDQzOWFmZGNiYTkyNDI3YTllNTY2NTc3YTk4MDBjOWJfMTQ0MA_a72c672b-a35c-48c0-a530-40e362adbaf1"
      unitRef="usd">284800000</rmd:IncomeTaxExaminationRemittedFinalPayment>
    <rmd:IncomeTaxExaminationGrossSettlement
      contextRef="i5f0fabb698be42fb98ac32d821f1a373_D20210928-20210928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180My9mcmFnOjQ0MzlhZmRjYmE5MjQyN2E5ZTU2NjU3N2E5ODAwYzliL3RleHRyZWdpb246NDQzOWFmZGNiYTkyNDI3YTllNTY2NTc3YTk4MDBjOWJfMTQ5MA_2d65a419-6170-4670-a102-545fc2a90806"
      unitRef="usd">381700000</rmd:IncomeTaxExaminationGrossSettlement>
    <rmd:IncomeTaxExaminationPriorRemittancePayments
      contextRef="i5f0fabb698be42fb98ac32d821f1a373_D20210928-20210928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180My9mcmFnOjQ0MzlhZmRjYmE5MjQyN2E5ZTU2NjU3N2E5ODAwYzliL3RleHRyZWdpb246NDQzOWFmZGNiYTkyNDI3YTllNTY2NTc3YTk4MDBjOWJfMTUzNQ_f2fa8362-5d24-4ff0-9ae5-0e37b86aaca1"
      unitRef="usd">96900000</rmd:IncomeTaxExaminationPriorRemittancePayments>
    <us-gaap:ProductWarrantyDisclosureTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RleHRyZWdpb246ODQ0MTFkN2VjODIxNGNjMDhmNDExOWRhN2IxYjM5MmNfMTg4_203ad088-5bc3-43a6-84a8-9334704ed8fe">Product Warranties&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the liability for warranty costs, which is included in accrued expenses in our condensed consolidated balance sheets, are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Warranty accruals for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Warranty costs incurred for the period &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RleHRyZWdpb246ODQ0MTFkN2VjODIxNGNjMDhmNDExOWRhN2IxYjM5MmNfMTg5_7a2c1f32-80f0-4329-ad16-f6a13f8c572b">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the liability for warranty costs, which is included in accrued expenses in our condensed consolidated balance sheets, are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Warranty accruals for the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Warranty costs incurred for the period &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfMi0xLTEtMS02MjExOQ_c9673b3e-b338-40fb-8e55-b8e5013eb3ce"
      unitRef="usd">25889000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="id4c1bec761d343199bfb5656845fee5a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfMi0zLTEtMS02MjExOQ_2fdb0b9b-6e9c-49aa-9a42-98c2d5b2e7b6"
      unitRef="usd">22032000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfMy0xLTEtMS02MjExOQ_2b3b30e5-ae96-4bd1-bd79-4cdfd6ae5197"
      unitRef="usd">2088000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfMy0zLTEtMS02MjExOQ_f20fe125-ab3c-4118-9c2e-e438cbe918c9"
      unitRef="usd">5413000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfNC0xLTEtMS02MjExOQ_debf09da-e84a-427d-9195-15bfcec4a560"
      unitRef="usd">2612000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfNC0zLTEtMS02MjExOQ_398a713f-9dbc-4243-8df7-a278714843ba"
      unitRef="usd">3972000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfNS0xLTEtMS02MjExOQ_c04e7dd5-a044-4225-a532-461a047a5df8"
      unitRef="usd">-1272000</us-gaap:StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss>
    <us-gaap:StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfNS0zLTEtMS02MjExOQ_3ce42e28-db26-4e11-8a49-231c03aabd64"
      unitRef="usd">-513000</us-gaap:StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss>
    <us-gaap:ProductWarrantyAccrual
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfNi0xLTEtMS02MjExOQ_d6332fdc-c8f3-4581-ae12-347650e7c0a6"
      unitRef="usd">24093000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="iee72006a6fb24b64994718e79dad7dfe_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180Ni9mcmFnOjg0NDExZDdlYzgyMTRjYzA4ZjQxMTlkYTdiMWIzOTJjL3RhYmxlOmNlZmI2NWNlYmZhMDQ0YzlhNDJmNDk5M2VkZWFhMTNlL3RhYmxlcmFuZ2U6Y2VmYjY1Y2ViZmEwNDRjOWE0MmY0OTkzZWRlYWExM2VfNi0zLTEtMS02MjExOQ_0245d77d-7b02-4959-a7b4-7052dd3eb0bc"
      unitRef="usd">22960000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNjMzOA_ef7528e4-f959-4e01-9f92-09bc53c0363c">Debt&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt consisted of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term debt &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred borrowing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;790,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;770,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred borrowing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;785,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;765,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;795,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;775,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;29, 2022, we entered into a second amended and restated credit agreement (the &#x201c;Revolving Credit Agreement&#x201d;), as borrower, with lenders MUFG Union Bank, N.A., as administrative agent, joint lead arranger, sole book runner, swing line lender and letter of credit issuer, Westpac Banking Corporation, as syndication agent and joint lead arranger, HSBC Bank USA, National Association, as syndication agent and joint lead arranger, and Wells Fargo Bank, National Association, as documentation agent. The Revolving Credit Agreement, among other things, provided a senior unsecured revolving credit facility of $1,500.0 million, with an uncommitted option to increase the revolving credit facility by an additional amount equal to the greater of $1,000.0 million and 1.00 times the EBITDA (as defined in the Revolving Credit Agreement) for the trailing twelve-month measurement period. The Revolving Credit Agreement amends and restates that certain Amended and Restated Credit Agreement, dated as of April 17, 2018, among ResMed, MUFG Union Bank, N.A., Westpac Banking Corporation and the lenders party thereto.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, on June&#160;29, 2022, ResMed Pty Limited entered into a Second Amendment to the Syndicated Facility Agreement and First Amendment to Unconditional Guaranty Agreement (the &#x201c;Term Credit Agreement&#x201d;), as borrower, with lenders MUFG Union Bank, N.A., as administrative agent, joint lead arranger and joint book runner, and Westpac Banking Corporation, as syndication agent, joint lead arranger and joint book runner, which amends that certain Syndicated Facility Agreement dated as of April 17, 2018. The Term Credit Agreement, among other things, provides ResMed Pty a senior unsecured term credit facility of $200.0 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our obligations under the Revolving Credit Agreement are guaranteed by certain of our direct and indirect U.S. subsidiaries, and ResMed Pty Limited&#x2019;s obligations under the Term Credit Agreement are guaranteed by us and certain of our direct and indirect U.S. subsidiaries. The Revolving Credit Agreement and Term Credit Agreement contain customary covenants, including, in each case, a financial covenant that requires that we maintain a maximum leverage ratio of funded debt to EBITDA (as defined in the Revolving Credit Agreement and Term Credit Agreement, as applicable). The entire principal amounts of the revolving credit facility and term credit facility, and, in each case, any accrued but unpaid interest may be declared immediately due and payable if an event of default occurs, as defined in the Revolving Credit Agreement and the Term Credit Agreement, as applicable. Events of default under the Revolving Credit Agreement and the Term Credit Agreement include, in each case, failure to make payments when due, the occurrence of a default in the performance of any covenants in the respective agreements or related documents, or certain changes of control of us, or the respective guarantors of the obligations borrowed under the Revolving Credit Agreement and Term Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Credit Agreement and Term Credit Agreement each terminate on June&#160;29, 2027, when all unpaid principal and interest under the loans must be repaid. Amounts borrowed under the Term Credit Agreement will also amortize on a semi-annual basis, with a $5.0 million principal payment required on each such semi-annual amortization date. The outstanding principal amounts will bear interest at a rate equal to the Adjusted Term SOFR (as defined in the Revolving Credit Facility) plus 0.75% to 1.50% (depending on the then-applicable leverage ratio) or the Base Rate (as defined in the Revolving Credit Agreement and the Term Credit Agreement, as applicable) plus 0.0% to 0.50% (depending on the then-applicable leverage ratio). At September&#160;30, 2022, the interest rate that was being charged on the outstanding principal amounts was 3.5%. An applicable commitment fee of 0.075% to 0.150% (depending on the then-applicable leverage ratio) applies on the unused portion of the revolving credit facility. As of September&#160;30, 2022, we had $1.4 billion available for draw down under the revolving credit facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. As the Revolving Credit and Term Credit Agreements&#x2019; interest rate is calculated as Adjusted Term SOFR plus the spreads described above, its carrying amount is equivalent to its fair value as at September&#160;30, 2022 and June&#160;30, 2022, which was $300.0 million and $280.0 million, respectively. Quoted market prices in active markets for similar liabilities based inputs (Level 2) were used to estimate fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 10, 2019, we entered into a Note Purchase Agreement with the purchasers to that agreement, in connection with the issuance and sale of $250.0 million principal amount of our 3.24% senior notes due July&#160;10, 2026, and $250.0 million principal amount of our 3.45% senior notes due July&#160;10, 2029 (collectively referred to as the &#x201c;Senior Notes&#x201d;). Our obligations under the Note Purchase Agreement and the Senior Notes are unconditionally and irrevocably guaranteed by certain of our direct and indirect U.S. subsidiaries. The net proceeds from this transaction were used to pay down borrowings on our Revolving Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the Note Purchase Agreement, we agreed to customary covenants including with respect to our corporate existence, transactions with affiliates, and mergers and other extraordinary transactions. We also agreed that, subject to limited exceptions, we will maintain a ratio of consolidated funded debt to consolidated EBITDA (as defined in the Note Purchase Agreement) of no more than 3.50 to 1.00 as of the last day of any fiscal quarter, and will not at any time permit the amount of all priority secured and unsecured debt of us and our subsidiaries to exceed 10% of our consolidated tangible assets, determined as of the end of our most recently ended fiscal quarter. This ratio is calculated at the end of each reporting period for which the Note Purchase Agreement requires us to deliver financial statements, using the results of the 12 consecutive month period ending with such reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. As of September&#160;30, 2022 and June&#160;30, 2022, the Senior Notes had a carrying amount of $500.0 million, excluding deferred borrowing costs, and an estimated fair value of $455.7 million and $477.7 million, respectively. Quoted market prices in active markets for similar liabilities based inputs (Level 2) were used to estimate fair value.&lt;/span&gt;&lt;/div&gt;At September&#160;30, 2022, we were in compliance with our debt covenants and there was $800.0 million outstanding under the Revolving Credit Agreement, Term Credit Agreement and Senior Notes.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNjMzOQ_6d83af72-b83e-43d9-995c-42c30ea7cd5b">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt consisted of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term debt &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred borrowing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;790,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;770,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred borrowing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;785,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;765,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;795,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;775,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <rmd:ShortTermDebtGross
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMS0xLTEtMS02MjExOQ_caa1f0d7-90a4-474f-86e1-9d2485fce9cc"
      unitRef="usd">10000000</rmd:ShortTermDebtGross>
    <rmd:ShortTermDebtGross
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMS0zLTEtMS02MjExOQ_51f29391-3ea7-4a35-be66-b39ba2b4a488"
      unitRef="usd">10000000</rmd:ShortTermDebtGross>
    <us-gaap:DeferredFinanceCostsCurrentNet
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMi0xLTEtMS02NzcwMQ_422839e9-20a2-420b-8014-5d969f307f94"
      unitRef="usd">94000</us-gaap:DeferredFinanceCostsCurrentNet>
    <us-gaap:DeferredFinanceCostsCurrentNet
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMi0zLTEtMS02NzcwMQ_036c129d-4bae-4319-a1aa-b47f7b05b167"
      unitRef="usd">84000</us-gaap:DeferredFinanceCostsCurrentNet>
    <us-gaap:ShortTermBorrowings
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMy0xLTEtMS02NzcwMQ_31b2fc06-2a86-417b-81ae-3c83a835c036"
      unitRef="usd">9906000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMy0zLTEtMS02NzcwMQ_e8482e30-04d0-4bb1-bc31-7f4e2cc83f90"
      unitRef="usd">9916000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMy0xLTEtMS02MjExOQ_c4a7dab9-746b-4281-9687-ac51bdcefdde"
      unitRef="usd">790000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfMy0zLTEtMS02MjExOQ_6ee232d1-531e-44be-b40c-670f3275a6ec"
      unitRef="usd">770000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfNC0xLTEtMS02MjExOQ_d028af45-dc1c-4532-bb61-826697abfa53"
      unitRef="usd">4564000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfNC0zLTEtMS02MjExOQ_0697965b-4e33-4f87-a568-af39db45f852"
      unitRef="usd">4675000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:LongTermDebt
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfNS0xLTEtMS02MjExOQ_5badff6f-9fe5-4f87-a3c7-d48d624f8c44"
      unitRef="usd">785436000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfNS0zLTEtMS02MjExOQ_1fafa85b-09f7-4dd6-9d9b-8360e2b8bd40"
      unitRef="usd">765325000</us-gaap:LongTermDebt>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfNi0xLTEtMS02MjExOQ_f55c0b41-9e58-4893-8a44-f89aa4dd8c9c"
      unitRef="usd">795342000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RhYmxlOjZjMjY2OWNlNjZmNDQzNzliNGFmOTFjN2M5OWU2YTNjL3RhYmxlcmFuZ2U6NmMyNjY5Y2U2NmY0NDM3OWI0YWY5MWM3Yzk5ZTZhM2NfNi0zLTEtMS02MjExOQ_758bf7b5-0698-4848-99fb-b92fb027b336"
      unitRef="usd">775241000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5b783cdf50e346eaa8a19a835c62bd94_I20220629"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNTQ5_68ab2297-540c-4faa-a5eb-cbc20613cfb7"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <rmd:UncommittedOptionToIncreaseCreditFacility
      contextRef="if40a26ace8cb428880b197363318cec6_D20220629-20220629"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNjM5_92714ca5-5646-4ced-8cac-10dc8e0d3ca4"
      unitRef="usd">1000000000</rmd:UncommittedOptionToIncreaseCreditFacility>
    <rmd:DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod
      contextRef="i5b783cdf50e346eaa8a19a835c62bd94_I20220629"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMjE5OTAyMzI2ODUxMw_2f4bd6da-5a79-4baa-b069-fba2d6e5bf35"
      unitRef="number">1.00</rmd:DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if612b91bc22e4ac586b695411b41fcc0_I20220629"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMTA4NQ_1c1a5b25-e77c-42ca-a7dd-a1818f699da0"
      unitRef="usd">200000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal
      contextRef="i3e7585e7a6994d2f9e4c76acb9f9385c_D20220629-20220629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMjg5OQ_4f1ef8dd-7226-4b68-a0db-eb8dd6e122f8"
      unitRef="usd">5000000</us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i5f41dcaf8ccd46709b5faa04c5fea871_D20220629-20220629"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzA1MQ_9ba468e9-ac6e-47c5-9d16-390034e626aa"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9f70c29ca1d548b5ae6f93b716b75536_D20220629-20220629"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzA1Nw_e0e40e9c-5ef3-4c27-89c4-d01e3525f292"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i22e4bb0fad4d40c5af0492d1dc204cbc_D20220629-20220629"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzIyNA_0f31b16d-f802-413d-9125-1fb2a3528bea"
      unitRef="number">0.000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i34f25e5e32fb41b9b7fb9e569b16cbdc_D20220629-20220629"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzIzMA_420fb4f1-3da9-4f6e-848d-3f71da4fd796"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i1297f32638a142a0ba72932abf60d77d_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzM3Mw_d01a8b23-8993-4b1c-9341-37e0789e4066"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i8a573e957f98484584a0734afd58d57f_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzQwOQ_fc769db2-1172-4b8d-aa5b-d2f346c496a0"
      unitRef="number">0.00075</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i52939f1db3354c2c83c55393bca89e73_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzQxNQ_7d6a18c8-40ed-4095-84a4-1852a6e9a4e0"
      unitRef="number">0.00150</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="ib7d3d056a48b41ffafd0825a2500cd15_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfMzU0OQ_eae11480-6837-4c63-9fd8-890c6d828be9"
      unitRef="usd">1400000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LongTermDebtFairValue
      contextRef="iaf532dad3c0a4d5cb85816567efdfe50_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNDAzMw_0b1d7198-ead2-412a-a68d-a4f0550477ca"
      unitRef="usd">300000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i0a79621ce364424f8da12a47723d1717_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNDA0MA_723a1d56-97d1-479c-92e6-a62df763d21a"
      unitRef="usd">280000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i48ec36cab3dc49749081f5531f83adae_I20190710"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNDMzNA_e410f610-7207-4d04-8f07-aae0bb1e7b74"
      unitRef="usd">250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i48ec36cab3dc49749081f5531f83adae_I20190710"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNDM2MQ_9061028c-f35a-407e-8748-16795680dcaf"
      unitRef="number">0.0324</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3220e912ac0c4ec792285781acd932a8_I20190710"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNDM4OQ_8740b83e-e710-4dbb-a211-adfeba08b204"
      unitRef="usd">250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3220e912ac0c4ec792285781acd932a8_I20190710"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNDQxNg_d1c616ca-fe8f-48b6-99a8-282168d7e8bd"
      unitRef="number">0.0345</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <rmd:DebtToConsolidatedEbitdaRatio
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNTE3MQ_c6950e6c-d092-41ae-9fe5-4365324811cb"
      unitRef="number">3.50</rmd:DebtToConsolidatedEbitdaRatio>
    <rmd:LineOfCreditFacilityCollateralPercentageOfCompany
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNTM0Nw_2222b2ae-2c71-4db5-bce7-6ff47c47cef8"
      unitRef="number">0.10</rmd:LineOfCreditFacilityCollateralPercentageOfCompany>
    <us-gaap:SeniorNotes
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNTk2Mw_c29eb759-75dd-4605-b9cb-c391cf11c00e"
      unitRef="usd">500000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNTk2Mw_fcb73fe4-d7f1-4bb6-996f-c61db741685c"
      unitRef="usd">500000000</us-gaap:SeniorNotes>
    <us-gaap:LongTermDebtFairValue
      contextRef="i1345482cbeee4a25a7bde5fd11f5d59f_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNjAzNA_4f4377b8-d3a7-4ca6-9ac1-2eaf3e85dffb"
      unitRef="usd">455700000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ia97609d461e84c708a6451bc44ca5926_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNjA0MQ_2877f495-c6c6-4fff-beca-9fdeeb5a37f1"
      unitRef="usd">477700000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i52c4dfffd15a49a6932fb065ffdb3d23_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M180OS9mcmFnOmIzODdjZGZlYmM2ODQ4NDg5ZmEwNzQ0ZTQwYjBlZDE3L3RleHRyZWdpb246YjM4N2NkZmViYzY4NDg0ODlmYTA3NDRlNDBiMGVkMTdfNjI0Ng_a45df58e-a180-4d31-908f-5ac3b4acb3b5"
      unitRef="usd">800000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RleHRyZWdpb246MjY2YzZiMWFiZGFmNGRhOTk2ZWIwMGY0ZjdmZmZhZmVfMTA3Mg_28f61624-06a2-4826-bc53-2758f46e6450">Earnings Per Share&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed by dividing the net income available to common stockholders by the weighted average number of shares of common stock outstanding. For purposes of calculating diluted earnings per share, the denominator includes both the weighted average number of shares of common stock outstanding and the number of dilutive common stock equivalents such as stock options and restricted stock units. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average number of outstanding stock options and restricted stock units not included in the computation of diluted earnings per share were 113,167 and 1,322 for the three months ended September&#160;30, 2022 and 2021, respectively, as the effect would have been anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings per share are calculated as follows (in thousands except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;210,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;146,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;147,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;146,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RleHRyZWdpb246MjY2YzZiMWFiZGFmNGRhOTk2ZWIwMGY0ZjdmZmZhZmVfODAx_b0b6eaaf-876e-4a25-8c3b-4ace4f7ca259"
      unitRef="shares">113167000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RleHRyZWdpb246MjY2YzZiMWFiZGFmNGRhOTk2ZWIwMGY0ZjdmZmZhZmVfODA4_21f19137-a382-4e30-9ddf-d9bbe0f88ba2"
      unitRef="shares">1322000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RleHRyZWdpb246MjY2YzZiMWFiZGFmNGRhOTk2ZWIwMGY0ZjdmZmZhZmVfMTA3Mw_74c81ab9-ac65-4ed3-bf9c-a2c281678c9a">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings per share are calculated as follows (in thousands except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;210,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;146,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;147,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;146,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfMy0xLTEtMS02MjExOQ_bd62ef60-5504-42de-ba88-0a036add620a"
      unitRef="usd">210478000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfMy0zLTEtMS02MjExOQ_8efc67ab-0f68-4d0d-975c-f0d626bb86a3"
      unitRef="usd">203613000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfNS0xLTEtMS02MjExOQ_c4f21b77-35f6-4a15-96ba-180aaa0d0117"
      unitRef="shares">146431000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfNS0zLTEtMS02MjExOQ_4a2db0a5-aa4c-499f-8eee-3a5e6dff6753"
      unitRef="shares">145680000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfNy0xLTEtMS02MjExOQ_362a1854-b57c-4380-a1fa-f0a671c7bbd2"
      unitRef="shares">703000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfNy0zLTEtMS02MjExOQ_b77c3a74-9137-42f5-8f3e-873e8306a811"
      unitRef="shares">1180000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfOC0xLTEtMS02MjExOQ_46f7e21e-dfea-4a49-8592-bae364210336"
      unitRef="shares">147134000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfOC0zLTEtMS02MjExOQ_0047c3b6-1e4c-4679-b311-dc81e761701e"
      unitRef="shares">146860000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfOS0xLTEtMS02MjExOQ_29b00252-3c9d-4798-ba84-91b1393b8121"
      unitRef="usdPerShare">1.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfOS0zLTEtMS02MjExOQ_92ca737e-e373-4e62-bdb4-77cee6f8e779"
      unitRef="usdPerShare">1.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfMTAtMS0xLTEtNjIxMTk_f14fc46a-d371-4dfa-b831-ade69d0fd5c2"
      unitRef="usdPerShare">1.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181Mi9mcmFnOjI2NmM2YjFhYmRhZjRkYTk5NmViMDBmNGY3ZmZmYWZlL3RhYmxlOmE4Yzk5MjIwMWE1MDRkZjVhZjgyZWU2Zjg5OGFlNTkwL3RhYmxlcmFuZ2U6YThjOTkyMjAxYTUwNGRmNWFmODJlZTZmODk4YWU1OTBfMTAtMy0xLTEtNjIxMTk_34f38a52-8c5d-4255-b78f-a501be372d94"
      unitRef="usdPerShare">1.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNTI1NA_a1b5dd2a-99f0-47c9-99ca-e3abba6a5103">Legal Actions, Contingencies and Commitments&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, we are subject to routine litigation incidental to our business. While the results of this litigation cannot be predicted with certainty, we believe that their final outcome will not, individually or in aggregate, have a material adverse effect on our consolidated financial statements taken as a whole.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 2, 2021, New York University ("NYU") filed a complaint for patent infringement in the United States District Court, District of Delaware against ResMed Inc., case no. 1:21-cv-00813 (JPM). The complaint alleges that the AutoSet or AutoRamp features of ResMed&#x2019;s AirSense 10 AutoSet flow generators infringe one or more claims of various NYU patents, including U.S. Patent Nos. 6,988,994; 9,108,009; 9,168,344; 9,427,539; 9,533,115; 9,867,955; and 10,384,024. According to the complaint, the NYU patents are directed to systems and methods for diagnosis and treating sleeping disorders during different sleep states. The complaint seeks monetary damages and attorneys&#x2019; fees. We answered the complaint on September 30, 2021 and filed a motion to dismiss the complaint on the basis that the patents are invalid because the subject matter of the patents is not patentable under the Supreme Court and Federal Circuit precedent. The motion to dismiss was granted in part and denied in part. We have also requested that the court dismiss the case based on NYU&#x2019;s license of the patents to Fisher &amp;amp; Paykel and Fisher &amp;amp; Paykel&#x2019;s prior settlement with us. The matter is proceeding to discovery while the court considers our request. We have also filed petitions for inter partes review with the Patent Trial and Appeal Board (&#x201c;PTAB&#x201d;) of the United States Patent and Trademark Office seeking to invalidate the asserted claims of the patents-in-suit. A determination by the PTAB whether to institute the petitions is expected by early December 2022. If the petitions are instituted by the PTAB, a final written decision determining the invalidity of the challenged claims is expected by December 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 27, 2021, the International Trade Commission ("ITC") instituted In Re Certain UMTS and LTE Cellular Communications Modules and Products Containing the Same, Investigation No. 337-TA-1240, by complainants Philips RS North America, LLC and Koninklijke Philips N.V. (collectively &#x201c;Philips&#x201d;) against Quectel Wireless Solutions Co., Ltd; Thales DIS AIS USA, LLC, Thales DIS AIS Deutschland GmbH; Telit Wireless Solutions, Inc., Telit Communications PLC, CalAmp. Corp., Xirgo Technologies, LLC, and Laird Connectivity, Inc. (collectively &#x201c;respondents&#x201d;). In the ITC investigation, Philips seeks an order excluding communications modules, and products that contain them, from importation into the United States based on alleged infringement of 3G and 4G standard essential patents held by Philips. On October 6-14, 2021, the administrative law judge held a hearing on the merits. The administrative law judge issued an initial determination on April 1, 2022, finding no violation of any of the Philips' patents asserted in the ITC. Philips sought review by the full ITC. On July 6, 2022, the Commission affirmed the administrative law judge&#x2019;s determination that there was no violation of asserted Philips' patents. The Commission terminated the ITC proceedings. Philips did not appeal the ITC&#x2019;s decision. On December 17, 2020, Philips filed companion cases for patent infringement against the same defendants in the United States District Court for the District of Delaware, case nos. 1:20-cv-01707, 01708, 01709, 01710, 01711, and 01713 (CFC) seeking damages, an injunction, and a declaration from the court on the amount of a fair reasonable and non-discriminatory license rate for the standard essential patents it is asserting against the communications module defendants. The district court cases have been stayed pending the resolution of the ITC proceedings. Philips has not yet moved to lift &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the stay following the termination of the ITC Investigation. We are not a party to the ITC investigation or the district court cases, but we sell products that incorporate some of the communications modules at issue in the cases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 16, 2022, Cleveland Medical Devices Inc. ("Cleveland Medical") filed suit for patent infringement against ResMed Inc. in the United States District Court for the District of Delaware, case no. 1:22-cv-00794. Cleveland Medical asserts that numerous ResMed connected devices, when combined with certain ResMed data platforms and/or software, including AirView and ResScan, infringe one or more of eight Cleveland Medical patents, including U.S. Patent Nos. 10,076,269; 10,426,399; 10,925,535; 11,064,937; 10,028,698; 10,478,118; 11,202,603; and 11,234,637. We have moved to dismiss the action because Cleveland Medical sued the wrong ResMed entity. We have also moved to dismiss all claims based on U.S. Patent No. 10,076,269, as well as indirect and willful infringement allegations as to the remaining patents asserted against ResMed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on currently available information, we are unable to make a reasonable estimate of loss or range of losses, if any, arising from matters that remain open.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingent Obligations Under Recourse Provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use independent financing institutions to offer some of our customers financing for the purchase of some of our products. Under these arrangements, if the customer qualifies under the financing institutions&#x2019; credit criteria and finances the transaction, the customers repay the financing institution on a fixed payment plan. For some of these arrangements, the customer&#x2019;s receivable balance is with limited recourse whereby we are responsible for repaying the financing company should the customer default. We record a contingent provision, which is estimated based on historical default rates. This is applied to receivables sold with recourse and is recorded in accrued expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September&#160;30, 2022 and September&#160;30, 2021, receivables sold with limited recourse were $39.9 million and $49.5 million, respectively. As of September&#160;30, 2022, the maximum exposure on outstanding receivables sold with recourse and contingent provision were $22.4 million and $1.2 million, respectively. As of June&#160;30, 2022, the maximum exposure on outstanding receivables sold with recourse and contingent provision were $24.2 million and $2.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commitments&lt;/span&gt;&lt;/div&gt;In June 2022 we signed a definitive agreement to acquire MEDIFOX DAN which is expected to close during our fiscal year 2023. The MEDIFOX DAN acquisition remains subject to regulatory clearances and other customary closing conditions. Upon closing, acquisition consideration of EUR 950&#160;million will be paid, in part, with funds available for draw under our Revolving Credit Agreement.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <rmd:ReceivablesSoldWithLimitedRecourse
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNDk2Nw_b42db16a-0afc-4f08-ba18-8f6f7e348a9e"
      unitRef="usd">39900000</rmd:ReceivablesSoldWithLimitedRecourse>
    <rmd:ReceivablesSoldWithLimitedRecourse
      contextRef="iafa955e7227a4ab9b6180247ed62cafd_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNDk3NA_9c40c550-0bfc-4a50-8121-0f67457e4dda"
      unitRef="usd">49500000</rmd:ReceivablesSoldWithLimitedRecourse>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ief4927d3a2364a12bd6b170de6d43c70_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNTA5OQ_e1a205b1-195e-4abb-8e55-ed5d75a32931"
      unitRef="usd">22400000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNTEwNg_07c57796-0466-4fd4-a334-4cfb52e765aa"
      unitRef="usd">1200000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNTIzMQ_a50ce6b7-52d4-4f96-9286-f836feeee6c0"
      unitRef="usd">24200000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i543df4c733354c07b6ce1628c05bd511_D20210701-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfNTIzOA_b8921fec-0103-4ab2-94ed-f9f851eedcf2"
      unitRef="usd">2100000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:ContractualObligation
      contextRef="i6d7f9870a68040f5b5a48ed02743e7e2_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlOGFjN2EyZTEzYjQ1MmNiODdlMTU1ZTc1MmU5MzkzL3NlYzpiZThhYzdhMmUxM2I0NTJjYjg3ZTE1NWU3NTJlOTM5M181NS9mcmFnOmNiNjBlZTY3YjYwYzRlYWY4OTYyOGQzZGQ3YjM2NzJjL3RleHRyZWdpb246Y2I2MGVlNjdiNjBjNGVhZjg5NjI4ZDNkZDdiMzY3MmNfMjE5OTAyMzMxMDQ4NQ_978c72ef-7178-4c04-b813-c4584396c892"
      unitRef="eur">950000000</us-gaap:ContractualObligation>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>58
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M@OM"F0?@_D)*O3LQ/U!NS(_^!U!+ P04    " !:DUM5Z1\L#/H'  !Z(P
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MTBC2#UFF6PO,YHQ,6937I5J"RN8W?0-D:;.0B]/&W;W"9"D2WIGEKC%+@33
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MU'KU^8X)(J9H U*VR YC)0,GDC@G_NN \FEID/@DQP6C9)H(0W()(W@F@,G
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M:7&Y%3P2N1& ]VL):\OJQGR@/G><_P=02P,$%     @ 6I-;581]4Z ' P
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MRE!*-[EX)J?:]-HJJSR,@[ZP9PXV.;V0:"$H6C1R1&*HJ')Z.]$1FU7'I[<
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MD81=$[2,QEGH2K_DC="G)#&[+G?+\ [W.Z_NN2OV0]\]RB0*4[$67:09Z?#
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M_WH/)1'K/XLT6K(UUD>FE,;YA IX"[C )BU!3YA<PZS;A&T5%A#KN*.LN=Y
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MJ^F%\2AMJAD-8CAVY:(#<RA1K[T%&BJAEK;QB7:T==G+QER>TAN+OF::]M6
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MX(BLJ#1@4A%J;$,KFG):@PW6W>MW1TG22Q#?BX+%XC.7&@124Y:Y9_>>LX!
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M>X^3+<3@ $C%(3+NVQ!8:M>#8MPD_&ZH6>81%XJB/FO4/]TTXJ*5XE-EX?@
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MN[#\E$(H!& -#0RI:8"R3&/I=53\PAN-I=ZO'E<0B>7P@O7C'B 8O;(K&.4
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M^,H>;KR9\Y?MB?%(!GPY0SVH+"W ^ZF!6>(-,6C^J\/YOP!02P,$%     @
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M965T,3DN>&ULK5MKD]NVDOTKJ+FINW85K=%CI)F)'U5CYW%?V7@]R>;#UGZ
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M-*><0:K0^$#N%;6A],4+7NDQ5!@?T -(K?Q@-!^ZM3#3!#D> 7P!3CA-P,<
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M'N0!E+@5G7(?S.XM[O5<>+S"*.I_83?X7DP"*#IRIMD',X-&ZN%?_-SGX4%
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MXA(&:1+POA!"'PZF0+_6DW]02P,$%     @ 6I-;55$B89;Y @  EP8  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C<N>&ULC55M;],P$/XKIX 02&5Y75=*
M6ZEE0_!A4*T#/B ^N,FEL>;8P7;6\>\Y.VG7B:[B0^*WN^>>N_B>3+9*WYD*
MT<)#+:29!I6US3@,35YAS<R9:E#22:ETS2PM]28TC496>*=:A$D4#<.:<1G,
M)GYOJ6<3U5K!)2XUF+:NF?ZS0*&VTR .=ALW?%-9MQ'.)@W;X KMMV:I:17N
M40I>HS1<2=!83H-Y/%YDSMX;?.>X-0=S<)FLE;ISB\_%-(@<(1286X? :+C'
M#RB$ R(:OWO,8!_2.1[.=^@??>Z4RYH9_*#$#U[8:AJ, BBP9*VP-VK["?M\
MSAU>KH3Q;]AVMMF[ /+66%7WSL2@YK(;V4-?AP.'4?2,0]([))YW%\BSO&26
MS29:;4$[:T)S$Y^J]R9R7+J/LK*:3CGYV=D5TY++C8$E:EA53".\OF5K@>;-
M)+04P)F%>0^VZ,"29\!2N%;25@:N9('%4_^0B.W9)3MVB^0DX J;,TBC 211
MDIS 2_?9IAXO_?]L?\[7QFJZ'+^.Y=O!9<?A7,.,3<-RG ;4$0;U/0:S5R_B
M8?3^!-EL3S8[A3Y;40,6K4#X6L*"&9[#7!9PR45KL8!_4SG&_V2$X_R[4(Q"
M%7THW(5J*)3Q57-/SD3>"N8LF(%2"6IP Z^Y!%NIUA"" 7S(L;$'C@5=TC=C
MN*TTXI/;XC^Q>\7PI:U1,ZOT&+Z0+'&9JQKA)21Q-,@N1FX6I8-AG,(E2D5-
MT=EVQ+>^#[%XR^X)9$,T55U3^_OP!DB7C"5JE _$V7"0I3&-YX/A*(*KLB2M
M %5VF9-:@,&\U=QR-&-8697?@6J<FAA?( *TFN>N L8?MI); Q=1"O$@)L3=
MQ]J1@AVIGDV<70SB-/-,1L.H3^%(O5]"?)9EW? (^YQAZH?T'1R[A>&!6%"=
M-UX2#96IE;;3C?WN7G7GG=@\FG>2?<WTAE,M!);D&IU=G >@.QGL%E8U7GK6
MRI*0^6E%?P[4SH#.2Z7L;N$"[/]%L[]02P,$%     @ 6I-;56 P4H0I P
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MJ$KT,+,JK7LBR&Q:L#THRFBI5KZH:E.-EMDD>;F,<U'(3Q,Y3LSFA^4#?ZS
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M1XXOP5#&<?2!W,\OR?'1.W)$F"!W:UEI*G*=N 9![79NUD%=M%#^:U!0GI#
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MC4.;;"BWNSC7TGRE!J>S>5/7#,RV:,+0#6&$YX#FKG[N>%LDUNW3N2F?HF&
M[A=H)J$FM$"?-Z:6%"A$>('N=0D231LI#1>Z5@JT.D.GMZ )96;T$3W-;]'I
MR1DZ092CQU(TRN#4.-0F#2LFS#O)-ZUD?$@RU.<HB3X@'&'L@4^/P[\U_! \
M-.;U#N+>0>SXD@-\6S=@UPWAW,@[-XASPY=I2SWP4]L3?*5JDL,D,$=4@5Q!
MD+U_%Z?1)U_>_XGLE0M)[T)RC+UW09,->#-MX:F#V]:RRD88XW0<KG93\$2-
MDB'NHUYI&_3:!F_21OG*[(:0U*^P)1GN_#O&^#(9[4GTA$47>!3[-0Y[C<.C
M&MOC4_MJZ=]5-/0H3^-DL*?<$Y:8P*%?>=HK3X\J?Q2V=7B5O_44I'_M>C*(
MX]&^\YZPY&(47>[I#W>ZH;V)OA.YI%PA!@L#C,XOC .R[>[M1(O:-<AGH4V[
M=</27(@@;8#YOA!";R>VY_97;/8'4$L#!!0    ( %J36U4#P5K]IP(  -H&
M   9    >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;*U574_;,!3]*U<9FD "
M\M6TA;612MDT)DVKZ-@>ICVXR6UKX=C!=EK8KY_MI%EA 4UB+XGMW'-\[O'U
MS6@KY*U:(VJX+QA78V^M=7GN^RI;8T'4J2B1FR]+(0NBS52N?%5*)+D#%<R/
M@J#O%X1R+QVYM9E,1Z+2C'*<25!541#Y<(%,;,=>Z.T6KNEJK>V"GXY*LL(Y
MZIMR)LW,;UER6B!75'"0N!Q[D_!\FMAX%_"-XE;MC<%FLA#BUDZN\K$76$'(
M,-.6@9C7!J?(F"4R,NX:3J_=T@+WQSOV#RYWD\N"*)P*]IWF>CWVAA[DN"05
MT]=B^Q&;?)S 3##EGK!M8@,/LDII431@HZ"@O'Z3^\:'/4#8>P80-8#H7P%Q
M XA=HK4RE]8ET20=2;$%::,-FQTX;QS:9$.Y/<6YEN8K-3B=SJNR9&B.11,&
M%X01GB',7?U<\;I(K-N'4U&4@ILP!5^6,).FC*1^.(:906B8\!S>WU6TM$1'
M<'B)FE"FCN $;N:7<'AP! = .7Q=BTH1GJN1KXUX*\'/&J$7M=#H.:%8GD(<
M'$,41%$'?/HR_%/%GX/[QK+6MZCU+7)\\>M\^S%9*"U-K?[LRKC>HM>]A;V_
MYZHD&8X]<T$5R@UZZ=LW83]XUY7_?R)[Y$;<NA&_Q)[^J8?2U8,Y8L!=/1P#
MT9 )I;LLJ'G[CM=VG$T:AL$@Z?=&_F8_NZZX.(S.DC;ND?!>*[SWHO!)EE5%
MQ8C&W%Q^XTQ&ZX.S&9!"2$U_N84N[35ULJ?II!\%X7#X1'M77!R'8:];>])J
M3UYC.L=.PY._C.P-!_&@_T1S1]C9,!R&3R3[>YW'=OW/1*XH5\!P:8#!Z<#P
MR+J3UA,M2M>,%D*;UN:&:_/S06D#S/>E$'HWL?VM_9VEOP%02P,$%     @
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M'$R.">OB?-=Q>PBWK@ /VX(3*6A9&O4!IM"Z%;=. +^K%<!&O8 IM&XO6C>
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MR@VPW]=2FEW#)6@O6XO_ %!+ P04    " !:DUM5,</@):$"  #T!@  &0
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M*]WT[##7UQ(($Z#7EYRKMXGI?.U%E_X!4$L#!!0    ( %J36U4U$Y$W#@4
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M:)(?K@D."5,&\OZ24O%ZHAY0?;&9_@=02P,$%     @ 6I-;53SNV"M\ @
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M5T09#3[0U.O&2)J-596?Q:6R--E^69#WHG8!=+]2RNXW+D'KYND?4$L#!!0
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M:-JF3:I*NSU,>S#)A5AU[,QVH/OWLQ,:43!LE<H#\<<]YY[C:\<9K;EXE"6
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M+/5W!@@3H.<7G*OGCKG*^B^7["]02P,$%     @ 6I-;5:1F:]:6"0  ?%X
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MW]8XD$$[ WROE+*'@W,PC/C\+U!+ P04    " !:DUM5KC2#,($#  "%"P
M&0   'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6RM5MMNXS80_15"#8H$V(VN
MEIW4-A#'*=J'W0;KIGUFI)%%1")5DK*W?]\A)6ME1Q8"U"\V+S.C<WC(F9GO
MA7Q3.8 FW\N"JX63:UW=NZY*<BBINA45<-S)A"RIQJG<NJJ20%/K5!9NX'FQ
M6U+&G>7<KCW+Y5S4NF <GB51=5E2^>\*"K%?.+YS6/C&MKDV"^YR7M$M;$"_
M5,\29VX7)64E<,4$)Q*RA?/@WS_ZUL%:_,5@KWIC8JB\"O%F)K^G"\<SB*"
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M$P2PJI@W[ K&D2C"$*A%>XV&(3([(7SMZX-=)4$0178$,+N#(, 0N!IQ!',
M'C D",KGX-;SR%L_I[SF_].C/U!+ P04    " !:DUM5EXJ[',     3 @
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M<*&\$JJZL2S^=-O/Y6G<35KOE;H(95_UM1'UX8OPX6OVN[]02P,$%     @
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MJO^4]=V8Y5__^&KO::W+YI#/NK^+TT]02P$"% ,4    " !:DUM5!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( %J36U75N_J;[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( %J36U697)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M6I-;546E,.W@!0  I!\  !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( %J36U7I'RP,^@<  'HC   8
M          " @2,.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M    " !:DUM5(?2M<W(#  ! "P  &               @(%3%@  >&PO=V]R
M:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ 6I-;54<E3R28!@  @QP
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M965T."YX;6Q02P$"% ,4    " !:DUM5G<C]N>01   X,0  &
M    @(&L-P  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @
M6I-;5<7TC8"+!@  Z0\  !D              ("!QDD  'AL+W=O<FMS:&5E
M=',O<VAE970Q,"YX;6Q02P$"% ,4    " !:DUM5N YUPLL$   J"P  &0
M            @(&(4   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4
M Q0    ( %J36U5P(>ACX0(  $8&   9              " @8I5  !X;"]W
M;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ 6I-;51TS;.;#!@
M6!,  !D              ("!HE@  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6Q02P$"% ,4    " !:DUM5^E)\F@D$  #>"   &0              @(&<
M7P  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( %J36U4P
MA]5FZP(  (<&   9              " @=QC  !X;"]W;W)K<VAE971S+W-H
M965T,34N>&UL4$L! A0#%     @ 6I-;53/(,4X#"P  ]B   !D
M     ("!_F8  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %J36U45N$H<Z0,  *0(   9              "
M@8J9  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ 6I-;
M5?Q>902G!   ]PL  !D              ("!JIT  'AL+W=O<FMS:&5E=',O
M<VAE970R,BYX;6Q02P$"% ,4    " !:DUM5LS!(Q 8#  !P!@  &0
M        @(&(H@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0
M   ( %J36U4RTM>;(00  ! +   9              " @<6E  !X;"]W;W)K
M<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ 6I-;56O03N\& P  G@8
M !D              ("!':H  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q0
M2P$"% ,4    " !:DUM5ZZ-%0Z("  #B!0  &0              @(%:K0
M>&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( %J36U51(F&6
M^0(  )<&   9              " @3.P  !X;"]W;W)K<VAE971S+W-H965T
M,C<N>&UL4$L! A0#%     @ 6I-;56 P4H0I P  F0P  !D
M ("!8[,  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !:
MDUM5=1,49G(&  #]+@  &0              @('#M@  >&PO=V]R:W-H965T
M<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( %J36U7BCPRH[0,  +$4   9
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M970S-"YX;6Q02P$"% ,4    " !:DUM5 \%:_:<"  #:!@  &0
M    @($UT   >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    (
M %J36U7T=U/[F@0  -07   9              " @1/3  !X;"]W;W)K<VAE
M971S+W-H965T,S8N>&UL4$L! A0#%     @ 6I-;5?E1722" P  > T  !D
M             ("!Y-<  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"
M% ,4    " !:DUM5,</@):$"  #T!@  &0              @(&=VP  >&PO
M=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( %J36U4U$Y$W#@4
M +T9   9              " @77>  !X;"]W;W)K<VAE971S+W-H965T,SDN
M>&UL4$L! A0#%     @ 6I-;53SNV"M\ @  V04  !D              ("!
MNN,  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " !:DUM5
M.U*IT7,"  "%!0  &0              @(%MY@  >&PO=V]R:W-H965T<R]S
M:&5E=#0Q+GAM;%!+ 0(4 Q0    ( %J36U4ZXDX@+0,  -$(   9
M      " @1?I  !X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%
M  @ 6I-;5?7$0.O, @  Q0@  !D              ("!>^P  'AL+W=O<FMS
M:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " !:DUM5I&9KUI8)  !\7@
M&0              @(%^[P  >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+
M 0(4 Q0    ( %J36U5RVA&O=@(  .X%   9              " @4OY  !X
M;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ 6I-;5:XT@S"!
M P  A0L  !D              ("!^/L  'AL+W=O<FMS:&5E=',O<VAE970T
M-BYX;6Q02P$"% ,4    " !:DUM5@@^X+6<#  !O#   &0
M@(&P_P  >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( %J3
M6U6IF[/390,  *P6   -              "  4X# 0!X;"]S='EL97,N>&UL
M4$L! A0#%     @ 6I-;59>*NQS     $P(   L              ( !W@8!
M %]R96QS+RYR96QS4$L! A0#%     @ 6I-;5<0-QU.Y P  41\   \
M         ( !QP<! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( %J36U6Y
M(]HWL@$  %0<   :              "  :T+ 0!X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( %J36U5EX9FUMP$  &4<   3
M      "  9<- 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     W #< ^ X
' '\/ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>141</ContextCount>
  <ElementCount>229</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>45</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements Of Comprehensive Income (Loss) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited</Role>
      <ShortName>Condensed Consolidated Statements Of Comprehensive Income (Loss) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements Of Changes In Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited</Role>
      <ShortName>Condensed Consolidated Statements Of Changes In Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements Of Changes In Equity (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements Of Changes In Equity (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements Of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements Of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Summary Of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary Of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2107102 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2111103 - Disclosure - Supplemental Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SupplementalBalanceSheetInformation</Role>
      <ShortName>Supplemental Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117104 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2120105 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2125106 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2127107 - Disclosure - Product Warranties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/ProductWarranties</Role>
      <ShortName>Product Warranties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2130108 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2134109 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2138110 - Disclosure - Legal Actions, Contingencies and Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/LegalActionsContingenciesandCommitments</Role>
      <ShortName>Legal Actions, Contingencies and Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary Of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary Of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Summary Of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary Of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2308302 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/SegmentInformation</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2312303 - Disclosure - Supplemental Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SupplementalBalanceSheetInformationTables</Role>
      <ShortName>Supplemental Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/SupplementalBalanceSheetInformation</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2318304 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/Goodwill</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2321305 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/Investments</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2328306 - Disclosure - Product Warranties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/ProductWarrantiesTables</Role>
      <ShortName>Product Warranties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/ProductWarranties</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2331307 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/Debt</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2335308 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/EarningsPerShare</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Summary Of Significant Accounting Policies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary Of Significant Accounting Policies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Summary Of Significant Accounting Policies (Summary Of Net Revenue Disaggregated By Product And Region) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails</Role>
      <ShortName>Summary Of Significant Accounting Policies (Summary Of Net Revenue Disaggregated By Product And Region) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Summary Of Significant Accounting Policies (Summary Of Contract Balances) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails</Role>
      <ShortName>Summary Of Significant Accounting Policies (Summary Of Contract Balances) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Segment Information (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/SegmentInformationTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - Segment Information (Summary Of Revenue By Segment And Reconciling Items) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails</Role>
      <ShortName>Segment Information (Summary Of Revenue By Segment And Reconciling Items) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/SegmentInformationTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Supplemental Balance Sheet Information (Schedule Of Inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails</Role>
      <ShortName>Supplemental Balance Sheet Information (Schedule Of Inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/SupplementalBalanceSheetInformationTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Supplemental Balance Sheet Information (Schedule Of Prepaid Expenses and Other Current Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails</Role>
      <ShortName>Supplemental Balance Sheet Information (Schedule Of Prepaid Expenses and Other Current Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/SupplementalBalanceSheetInformationTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2415408 - Disclosure - Supplemental Balance Sheet Information (Components Of Property, Plant And Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails</Role>
      <ShortName>Supplemental Balance Sheet Information (Components Of Property, Plant And Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/SupplementalBalanceSheetInformationTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2416409 - Disclosure - Supplemental Balance Sheet Information (Schedule Of Other Intangible Assets, Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails</Role>
      <ShortName>Supplemental Balance Sheet Information (Schedule Of Other Intangible Assets, Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/SupplementalBalanceSheetInformationTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - Goodwill (Schedule Of Changes In Carrying Amount Of Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails</Role>
      <ShortName>Goodwill (Schedule Of Changes In Carrying Amount Of Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/GoodwillTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - Investments (Schedule Of Investments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails</Role>
      <ShortName>Investments (Schedule Of Investments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/InvestmentsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Investments (Schedule Of Changes In Equity Investments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails</Role>
      <ShortName>Investments (Schedule Of Changes In Equity Investments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/InvestmentsTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - Investments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/InvestmentsTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2426414 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/IncomeTaxes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2429415 - Disclosure - Product Warranties (Schedule Of Changes In Liability For Warranty Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/ProductWarrantiesScheduleOfChangesInLiabilityForWarrantyCostsDetails</Role>
      <ShortName>Product Warranties (Schedule Of Changes In Liability For Warranty Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/ProductWarrantiesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2432416 - Disclosure - Debt (Schedule of Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/DebtScheduleofDebtDetails</Role>
      <ShortName>Debt (Schedule of Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/DebtTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2433417 - Disclosure - Debt (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/DebtTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2436418 - Disclosure - Earnings Per Share (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/EarningsPerShareNarrativeDetails</Role>
      <ShortName>Earnings Per Share (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/EarningsPerShareTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2437419 - Disclosure - Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/EarningsPerShareTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="rmd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2439420 - Disclosure - Legal Actions, Contingencies and Commitments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.resmed.com/role/LegalActionsContingenciesandCommitmentsNarrativeDetails</Role>
      <ShortName>Legal Actions, Contingencies and Commitments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://investor.resmed.com/role/LegalActionsContingenciesandCommitments</ParentRole>
      <Position>47</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="rmd-20220930.htm">rmd-20220930.htm</File>
    <File>rmd-20220930.xsd</File>
    <File>rmd-20220930_cal.xml</File>
    <File>rmd-20220930_def.xml</File>
    <File>rmd-20220930_lab.xml</File>
    <File>rmd-20220930_pre.xml</File>
    <File>rmd-20220930xex311.htm</File>
    <File>rmd-20220930xex312.htm</File>
    <File>rmd-20220930xex32.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="503">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>63
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "rmd-20220930.htm": {
   "axisCustom": 0,
   "axisStandard": 16,
   "contextCount": 141,
   "dts": {
    "calculationLink": {
     "local": [
      "rmd-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rmd-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "rmd-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rmd-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rmd-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rmd-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 366,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 27,
   "keyStandard": 202,
   "memberCustom": 23,
   "memberStandard": 20,
   "nsprefix": "rmd",
   "nsuri": "http://investor.resmed.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://investor.resmed.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107102 - Disclosure - Segment Information",
     "role": "http://investor.resmed.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rmd:SupplementalBalanceSheetInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111103 - Disclosure - Supplemental Balance Sheet Information",
     "role": "http://investor.resmed.com/role/SupplementalBalanceSheetInformation",
     "shortName": "Supplemental Balance Sheet Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rmd:SupplementalBalanceSheetInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117104 - Disclosure - Goodwill",
     "role": "http://investor.resmed.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120105 - Disclosure - Investments",
     "role": "http://investor.resmed.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125106 - Disclosure - Income Taxes",
     "role": "http://investor.resmed.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127107 - Disclosure - Product Warranties",
     "role": "http://investor.resmed.com/role/ProductWarranties",
     "shortName": "Product Warranties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130108 - Disclosure - Debt",
     "role": "http://investor.resmed.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134109 - Disclosure - Earnings Per Share",
     "role": "http://investor.resmed.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138110 - Disclosure - Legal Actions, Contingencies and Commitments",
     "role": "http://investor.resmed.com/role/LegalActionsContingenciesandCommitments",
     "shortName": "Legal Actions, Contingencies and Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rmd:OrganizationAndBasisOfPresentationPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary Of Significant Accounting Policies (Policies)",
     "role": "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary Of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rmd:OrganizationAndBasisOfPresentationPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Summary Of Significant Accounting Policies (Tables)",
     "role": "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary Of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308302 - Disclosure - Segment Information (Tables)",
     "role": "http://investor.resmed.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312303 - Disclosure - Supplemental Balance Sheet Information (Tables)",
     "role": "http://investor.resmed.com/role/SupplementalBalanceSheetInformationTables",
     "shortName": "Supplemental Balance Sheet Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318304 - Disclosure - Goodwill (Tables)",
     "role": "http://investor.resmed.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rmd:ScheduleOfInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321305 - Disclosure - Investments (Tables)",
     "role": "http://investor.resmed.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rmd:ScheduleOfInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328306 - Disclosure - Product Warranties (Tables)",
     "role": "http://investor.resmed.com/role/ProductWarrantiesTables",
     "shortName": "Product Warranties (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331307 - Disclosure - Debt (Tables)",
     "role": "http://investor.resmed.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335308 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://investor.resmed.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Summary Of Significant Accounting Policies (Narrative) (Details)",
     "role": "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary Of Significant Accounting Policies (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Summary Of Significant Accounting Policies (Summary Of Net Revenue Disaggregated By Product And Region) (Details)",
     "role": "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails",
     "shortName": "Summary Of Significant Accounting Policies (Summary Of Net Revenue Disaggregated By Product And Region) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i98d3fc3d460b4652ad6b75c8adc858c4_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Summary Of Significant Accounting Policies (Summary Of Contract Balances) (Details)",
     "role": "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails",
     "shortName": "Summary Of Significant Accounting Policies (Summary Of Contract Balances) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ibc375d0ba418427f8b2b60d529de7690_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Segment Information (Narrative) (Details)",
     "role": "http://investor.resmed.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410405 - Disclosure - Segment Information (Summary Of Revenue By Segment And Reconciling Items) (Details)",
     "role": "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails",
     "shortName": "Segment Information (Summary Of Revenue By Segment And Reconciling Items) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i9147d5a65f12434291bdbb355c876cb4_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Supplemental Balance Sheet Information (Schedule Of Inventories) (Details)",
     "role": "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails",
     "shortName": "Supplemental Balance Sheet Information (Schedule Of Inventories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Supplemental Balance Sheet Information (Schedule Of Prepaid Expenses and Other Current Assets) (Details)",
     "role": "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails",
     "shortName": "Supplemental Balance Sheet Information (Schedule Of Prepaid Expenses and Other Current Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415408 - Disclosure - Supplemental Balance Sheet Information (Components Of Property, Plant And Equipment) (Details)",
     "role": "http://investor.resmed.com/role/SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails",
     "shortName": "Supplemental Balance Sheet Information (Components Of Property, Plant And Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416409 - Disclosure - Supplemental Balance Sheet Information (Schedule Of Other Intangible Assets, Net) (Details)",
     "role": "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails",
     "shortName": "Supplemental Balance Sheet Information (Schedule Of Other Intangible Assets, Net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i69e86a0970d447abaac8ad86f67160f7_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i6d7f9870a68040f5b5a48ed02743e7e2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - Goodwill (Schedule Of Changes In Carrying Amount Of Goodwill) (Details)",
     "role": "http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails",
     "shortName": "Goodwill (Schedule Of Changes In Carrying Amount Of Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rmd:ScheduleOfInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "rmd:MarketableEquityInvestmentsFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - Investments (Schedule Of Investments) (Details)",
     "role": "http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails",
     "shortName": "Investments (Schedule Of Investments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rmd:ScheduleOfInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "rmd:MarketableEquityInvestmentsFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rmd:ScheduleOfChangesInEquityInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i6d7f9870a68040f5b5a48ed02743e7e2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "rmd:EquityInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Investments (Schedule Of Changes In Equity Investments) (Details)",
     "role": "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails",
     "shortName": "Investments (Schedule Of Changes In Equity Investments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rmd:ScheduleOfChangesInEquityInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i6d7f9870a68040f5b5a48ed02743e7e2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "rmd:EquityInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "role": "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - Investments (Narrative) (Details)",
     "role": "http://investor.resmed.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5f0fabb698be42fb98ac32d821f1a373_D20210928-20210928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rmd:IncomeTaxExaminationRemittedFinalPayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426414 - Disclosure - Income Taxes (Details)",
     "role": "http://investor.resmed.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5f0fabb698be42fb98ac32d821f1a373_D20210928-20210928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rmd:IncomeTaxExaminationRemittedFinalPayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i6d7f9870a68040f5b5a48ed02743e7e2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429415 - Disclosure - Product Warranties (Schedule Of Changes In Liability For Warranty Costs) (Details)",
     "role": "http://investor.resmed.com/role/ProductWarrantiesScheduleOfChangesInLiabilityForWarrantyCostsDetails",
     "shortName": "Product Warranties (Schedule Of Changes In Liability For Warranty Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i6d7f9870a68040f5b5a48ed02743e7e2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "rmd:ShortTermDebtGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432416 - Disclosure - Debt (Schedule of Debt) (Details)",
     "role": "http://investor.resmed.com/role/DebtScheduleofDebtDetails",
     "shortName": "Debt (Schedule of Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "ief4927d3a2364a12bd6b170de6d43c70_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "rmd:ShortTermDebtGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rmd:DebtToConsolidatedEbitdaRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433417 - Disclosure - Debt (Narrative) (Details)",
     "role": "http://investor.resmed.com/role/DebtNarrativeDetails",
     "shortName": "Debt (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rmd:DebtToConsolidatedEbitdaRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436418 - Disclosure - Earnings Per Share (Narrative) (Details)",
     "role": "http://investor.resmed.com/role/EarningsPerShareNarrativeDetails",
     "shortName": "Earnings Per Share (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437419 - Disclosure - Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details)",
     "role": "http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails",
     "shortName": "Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rmd:ReceivablesSoldWithLimitedRecourse",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439420 - Disclosure - Legal Actions, Contingencies and Commitments (Narrative) (Details)",
     "role": "http://investor.resmed.com/role/LegalActionsContingenciesandCommitmentsNarrativeDetails",
     "shortName": "Legal Actions, Contingencies and Commitments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rmd:ReceivablesSoldWithLimitedRecourse",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements Of Comprehensive Income (Loss) (Unaudited)",
     "role": "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited",
     "shortName": "Condensed Consolidated Statements Of Comprehensive Income (Loss) (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i82486906991d41c1bb227364f4e66f47_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements Of Changes In Equity (Unaudited)",
     "role": "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited",
     "shortName": "Condensed Consolidated Statements Of Changes In Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i82486906991d41c1bb227364f4e66f47_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements Of Changes In Equity (Unaudited) (Parenthetical)",
     "role": "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnauditedParenthetical",
     "shortName": "Condensed Consolidated Statements Of Changes In Equity (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements Of Cash Flows (Unaudited)",
     "role": "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements Of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Summary Of Significant Accounting Policies",
     "role": "http://investor.resmed.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "Summary Of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmd-20220930.htm",
      "contextRef": "i5581874fa50a4abba0b6a9282be13d0b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 45,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://investor.resmed.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "rmd_AccountsReceivableNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable Net [Member]",
        "label": "Accounts Receivable Net [Member]",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_AdditionalEquityInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Equity Investments",
        "label": "Additional Equity Investments",
        "terseLabel": "Additions to investments"
       }
      }
     },
     "localname": "AdditionalEquityInvestments",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_AmortizationOfAcquiredIntangibleAssets1": {
     "auth_ref": [],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of acquired intangible assets.",
        "label": "Amortization of acquired intangible assets 1",
        "terseLabel": "Amortization of acquired intangible assets",
        "verboseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfAcquiredIntangibleAssets1",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_BusinessAcquisitionContingentConsiderationRecognizedLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Contingent Consideration, Recognized Liability",
        "label": "Business Acquisition, Contingent Consideration, Recognized Liability",
        "negatedLabel": "Fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationRecognizedLiability",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_CombinedEuropeAsiaAndOtherMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Combined Europe Asia And Other Markets [Member]",
        "label": "Combined Europe Asia And Other Markets [Member]",
        "terseLabel": "Combined Europe, Asia and other markets"
       }
      }
     },
     "localname": "CombinedEuropeAsiaAndOtherMarketsMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_ContractWithCustomerAssetAndLiabilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer, Asset and Liability [Line Items]",
        "label": "Contract with Customer, Asset and Liability [Line Items]",
        "terseLabel": "Contract with Customer, Asset and Liability [Line Items]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityLineItems",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rmd_ContractWithCustomerAssetAndLiabilityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer, Asset and Liability [Table]",
        "label": "Contract with Customer, Asset and Liability [Table]",
        "terseLabel": "Contract with Customer, Asset and Liability [Table]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTable",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rmd_DebtAndEquityInvestmentsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt and Equity Investments",
        "label": "Debt and Equity Investments [Roll Forward]",
        "terseLabel": "Debt and Equity Investments [Roll Forward]"
       }
      }
     },
     "localname": "DebtAndEquityInvestmentsRollForward",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rmd_DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, EBITDA Multiple of Trailing Twelve-Month Measurement Period",
        "label": "Debt Instrument, EBITDA Multiple of Trailing Twelve-Month Measurement Period",
        "terseLabel": "EBITDA multiple of trailing twelve-month measurement period"
       }
      }
     },
     "localname": "DebtInstrumentEBITDAMultipleOfTrailingTwelveMonthMeasurementPeriod",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "rmd_DebtToConsolidatedEbitdaRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt To Consolidated EBITDA Ratio",
        "label": "Debt To Consolidated EBITDA Ratio",
        "terseLabel": "Debt to consolidated EBITDA ratio"
       }
      }
     },
     "localname": "DebtToConsolidatedEbitdaRatio",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "rmd_DeferredPaymentObligationsForAcquisitions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Payment Obligations For Acquisitions",
        "label": "Deferred Payment Obligations For Acquisitions",
        "negatedTerseLabel": "Deferred payments"
       }
      }
     },
     "localname": "DeferredPaymentObligationsForAcquisitions",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_DeferredRevenueCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Revenue Current Liabilities [Member]",
        "label": "Deferred Revenue Current Liabilities [Member]",
        "terseLabel": "Deferred revenue (current liabilities)"
       }
      }
     },
     "localname": "DeferredRevenueCurrentLiabilitiesMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_DeferredRevenueNonCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Revenue Non Current Liabilities [Member]",
        "label": "Deferred Revenue Non Current Liabilities [Member]",
        "terseLabel": "Deferred revenue (non-current liabilities)"
       }
      }
     },
     "localname": "DeferredRevenueNonCurrentLiabilitiesMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_DevelopedOrCoreProductTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed/ Core Product Technology [Member]",
        "label": "Developed Or Core Product Technology [Member]",
        "terseLabel": "Developed/core product technology"
       }
      }
     },
     "localname": "DevelopedOrCoreProductTechnologyMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_DevicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Devices [Member]",
        "label": "Devices [Member]",
        "terseLabel": "Devices"
       }
      }
     },
     "localname": "DevicesMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_EquityInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Investments",
        "label": "Equity Investments",
        "periodEndLabel": "Carrying value at the end of the period",
        "periodStartLabel": "Balance at the beginning of the period"
       }
      }
     },
     "localname": "EquityInvestments",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_EquityInvestmentsTotalByMeasurementCategory": {
     "auth_ref": [],
     "calculation": {
      "http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Investments, Total by Measurement Category",
        "label": "Equity Investments, Total by Measurement Category",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EquityInvestmentsTotalByMeasurementCategory",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_GlobalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global [Member]",
        "label": "Global [Member]",
        "terseLabel": "Global revenue"
       }
      }
     },
     "localname": "GlobalMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_GoodwillAcquiredDuringPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Acquired During Period, Increase (Decrease)",
        "label": "Goodwill, Acquired During Period, Increase (Decrease)",
        "terseLabel": "Goodwill on acquisition"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriodIncreaseDecrease",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_IncomeTaxExaminationGrossSettlement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Gross Settlement.",
        "label": "Income Tax Examination, Gross Settlement",
        "terseLabel": "Tax settlement, gross amount"
       }
      }
     },
     "localname": "IncomeTaxExaminationGrossSettlement",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_IncomeTaxExaminationPriorRemittancePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Prior Remittance Payments",
        "label": "Income Tax Examination, Prior Remittance Payments",
        "terseLabel": "Tax settlement, prior remittances"
       }
      }
     },
     "localname": "IncomeTaxExaminationPriorRemittancePayments",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_IncomeTaxExaminationRemittedFinalPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Remitted Final Payment",
        "label": "Income Tax Examination, Remitted Final Payment",
        "terseLabel": "Tax settlement, remitted final payment"
       }
      }
     },
     "localname": "IncomeTaxExaminationRemittedFinalPayment",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_LeaseRevenuePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Revenue [Policy Text Block]",
        "label": "Lease Revenue [Policy Text Block]",
        "terseLabel": "Lease Revenue"
       }
      }
     },
     "localname": "LeaseRevenuePolicyTextBlock",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rmd_LineOfCreditFacilityCollateralPercentageOfCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of credit facility collateral, percentage of the company",
        "label": "Line of credit facility, collateral, percentage of the company",
        "verboseLabel": "Line of credit facility collateral, maximum percentage of ownership interests held in subsidiary"
       }
      }
     },
     "localname": "LineOfCreditFacilityCollateralPercentageOfCompany",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "rmd_MarketableEquityInvestmentsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "rmd_EquityInvestmentsTotalByMeasurementCategory",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Equity Investments, Fair Value",
        "label": "Marketable Equity Investments, Fair Value",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "MarketableEquityInvestmentsFairValue",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_MarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities [Member]",
        "label": "Marketable Securities [Member]",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_MasksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Masks [Member]",
        "label": "Masks [Member]",
        "terseLabel": "Masks and other"
       }
      }
     },
     "localname": "MasksMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_MufgUnionBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mufg Union Bank",
        "label": "Mufg Union Bank [Member]",
        "terseLabel": "Mufg Union Bank"
       }
      }
     },
     "localname": "MufgUnionBankMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_MufgUnionBankNaAndWestpacBankingCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mufg Union Bank Na And Westpac Banking Corporation",
        "label": "Mufg Union Bank Na And Westpac Banking Corporation [Member]",
        "terseLabel": "Mufg Union Bank Na And Westpac Banking Corporation"
       }
      }
     },
     "localname": "MufgUnionBankNaAndWestpacBankingCorporationMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_NonMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-marketable Securities [Member]",
        "label": "Non Marketable Securities [Member]",
        "terseLabel": "Non-marketable securities"
       }
      }
     },
     "localname": "NonMarketableSecuritiesMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_NoncashPartOfAcquisitionFairValueOfAssetsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of an asset or business acquired in a noncash acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash Part Of Acquisition, Fair Value of Assets Acquired",
        "terseLabel": "Fair value of assets acquired, excluding cash"
       }
      }
     },
     "localname": "NoncashPartOfAcquisitionFairValueOfAssetsAcquired",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_ObservablePriceAdjustmentsOnNonMarketableEquitySecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Observable price adjustments on non-marketable equity securities.",
        "label": "Observable price adjustments on non-marketable equity securities",
        "terseLabel": "Observable price adjustments on non-marketable equity securities"
       }
      }
     },
     "localname": "ObservablePriceAdjustmentsOnNonMarketableEquitySecurities",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_OrganizationAndBasisOfPresentationPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization And Basis Of Presentation, Policy [Policy Text Block]",
        "label": "Organization And Basis Of Presentation, Policy [Policy Text Block]",
        "terseLabel": "Organization and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationAndBasisOfPresentationPolicyPolicyTextBlock",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rmd_PrepaidInventory": {
     "auth_ref": [],
     "calculation": {
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Inventory",
        "label": "Prepaid Inventory",
        "terseLabel": "Prepaid inventories"
       }
      }
     },
     "localname": "PrepaidInventory",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_PrepaidTaxesAndOtherNonCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Taxes And Other Non Current Assets [Member]",
        "label": "Prepaid Taxes And Other Non Current Assets [Member]",
        "terseLabel": "Prepaid taxes and other non-current assets"
       }
      }
     },
     "localname": "PrepaidTaxesAndOtherNonCurrentAssetsMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_ReceivablesSoldWithLimitedRecourse": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables Sold With Limited Recourse",
        "label": "Receivables Sold With Limited Recourse",
        "terseLabel": "Receivables sold with limited recourse"
       }
      }
     },
     "localname": "ReceivablesSoldWithLimitedRecourse",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/LegalActionsContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_ResmedLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ResMed Limited [Member]",
        "label": "Resmed Limited [Member]",
        "terseLabel": "ResMed Limited"
       }
      }
     },
     "localname": "ResmedLimitedMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Agreement, Term Credit Agreement, And Senior Notes [Member]",
        "label": "Revolving Credit Agreement Term Credit Agreement And Senior Notes [Member]",
        "terseLabel": "Revolving Credit Agreement, Term Credit Agreement, And Senior Notes"
       }
      }
     },
     "localname": "RevolvingCreditAgreementTermCreditAgreementAndSeniorNotesMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_RevolvingCreditFacilityAndTermLoanCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility And Term Loan Credit Agreement [Member]",
        "label": "Revolving Credit Facility And Term Loan Credit Agreement [Member]",
        "terseLabel": "Revolving Credit Facility And Term Credit Agreement"
       }
      }
     },
     "localname": "RevolvingCreditFacilityAndTermLoanCreditAgreementMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_SaasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Saas [Member]",
        "label": "Saas [Member]",
        "terseLabel": "SaaS"
       }
      }
     },
     "localname": "SaasMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Changes In Equity Investments [Table Text Block]",
        "label": "Schedule Of Changes In Equity Investments [Table Text Block]",
        "terseLabel": "Schedule Of Changes In Equity Investments"
       }
      }
     },
     "localname": "ScheduleOfChangesInEquityInvestmentsTableTextBlock",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rmd_ScheduleOfInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Investments [Table Text Block]",
        "label": "Schedule Of Investments [Table Text Block]",
        "terseLabel": "Schedule Of Investments"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTableTextBlock",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rmd_SeniorNotesOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes One [Member]",
        "label": "Senior Notes One [Member]",
        "terseLabel": "3.24% Senior Notes Due July 10, 2026"
       }
      }
     },
     "localname": "SeniorNotesOneMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_SeniorNotesTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Two [Member]",
        "label": "Senior Notes Two [Member]",
        "terseLabel": "3.45% Senior Notes Due July 10, 2029"
       }
      }
     },
     "localname": "SeniorNotesTwoMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_ShortTermDebtGross": {
     "auth_ref": [],
     "calculation": {
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-Term Debt, Gross",
        "label": "Short-Term Debt, Gross",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermDebtGross",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_SleepAndRespiratoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sleep And Respiratory [Member]",
        "label": "Sleep And Respiratory [Member]",
        "terseLabel": "Total Sleep and Respiratory Care"
       }
      }
     },
     "localname": "SleepAndRespiratoryMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails",
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails",
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_SoftwareAsServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Software As A Service [Member]",
        "label": "Software As Service [Member]",
        "terseLabel": "Software as a Service"
       }
      }
     },
     "localname": "SoftwareAsServiceMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails",
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Line Items]",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rmd_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rmd_SupplementalBalanceSheetInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information [Abstract]",
        "label": "Supplemental Balance Sheet Information [Abstract]",
        "terseLabel": "Supplemental Balance Sheet Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationAbstract",
     "nsuri": "http://investor.resmed.com/20220930",
     "xbrltype": "stringItemType"
    },
    "rmd_SupplementalBalanceSheetInformationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information [Text Block]",
        "label": "Supplemental Balance Sheet Information [Text Block]",
        "terseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationTextBlock",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rmd_TermLoanCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Credit Agreement [Member]",
        "label": "Term Loan Credit Agreement [Member]",
        "terseLabel": "Term Loan Credit Agreement"
       }
      }
     },
     "localname": "TermLoanCreditAgreementMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rmd_TermOfContractUnderRevenueRecognition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Of Contract Under Revenue Recognition",
        "label": "Term Of Contract Under Revenue Recognition",
        "verboseLabel": "Deferred revenue recognized, term"
       }
      }
     },
     "localname": "TermOfContractUnderRevenueRecognition",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "rmd_UnallocatedCorporateCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unallocated corporate costs.",
        "label": "Unallocated Corporate Costs",
        "terseLabel": "Corporate costs"
       }
      }
     },
     "localname": "UnallocatedCorporateCosts",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_UncommittedOptionToIncreaseCreditFacility": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uncommitted option to increase credit facility",
        "label": "Uncommitted option to increase credit facility",
        "terseLabel": "Uncommitted option to increase credit facility"
       }
      }
     },
     "localname": "UncommittedOptionToIncreaseCreditFacility",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rmd_UsCanadaAndLatinAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Canada And Latin America [Member]",
        "label": "Us Canada And Latin America [Member]",
        "terseLabel": "U.S., Canada and Latin America"
       }
      }
     },
     "localname": "UsCanadaAndLatinAmericaMember",
     "nsuri": "http://investor.resmed.com/20220930",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r112",
      "r147",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r167",
      "r171",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r268",
      "r270",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r112",
      "r147",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r167",
      "r171",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r268",
      "r270",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r248",
      "r277",
      "r298",
      "r328",
      "r329",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r419",
      "r465",
      "r468",
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails",
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r248",
      "r277",
      "r298",
      "r328",
      "r329",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r419",
      "r465",
      "r468",
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails",
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r174",
      "r246",
      "r247",
      "r317",
      "r319",
      "r421",
      "r464",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r174",
      "r246",
      "r247",
      "r317",
      "r319",
      "r421",
      "r464",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Products and Services [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r238",
      "r245",
      "r246",
      "r247",
      "r248",
      "r277",
      "r298",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r419",
      "r465",
      "r468",
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails",
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r238",
      "r245",
      "r246",
      "r247",
      "r248",
      "r277",
      "r298",
      "r327",
      "r328",
      "r329",
      "r332",
      "r333",
      "r334",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r419",
      "r465",
      "r468",
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails",
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r175",
      "r176",
      "r317",
      "r320",
      "r467",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Segment, Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r175",
      "r176",
      "r317",
      "r320",
      "r467",
      "r475",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r43",
      "r388"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r180",
      "r181"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net",
        "verboseLabel": "Accounts receivable, net of allowances of $23,867 and $23,259 at September\u00a030, 2022 and June\u00a030, 2022, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r21",
      "r428",
      "r447"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "verboseLabel": "Income taxes payable (note 6)"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r24",
      "r428",
      "r447"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Long-term income taxes payable (note 6)"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r15",
      "r235"
     ],
     "calculation": {
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r57",
      "r58",
      "r59",
      "r450",
      "r473",
      "r474"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r56",
      "r59",
      "r66",
      "r67",
      "r68",
      "r114",
      "r115",
      "r116",
      "r358",
      "r385",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated \u200eOther \u200eComprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r335",
      "r336",
      "r337",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional \u200ePaid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustment to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r33",
      "r182",
      "r199"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance for credit loss, current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r97",
      "r227",
      "r232"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r19",
      "r109",
      "r155",
      "r162",
      "r169",
      "r195",
      "r260",
      "r261",
      "r262",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r271",
      "r273",
      "r274",
      "r356",
      "r359",
      "r367",
      "r386",
      "r388",
      "r426",
      "r446"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r42",
      "r109",
      "r195",
      "r260",
      "r261",
      "r262",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r271",
      "r273",
      "r274",
      "r356",
      "r359",
      "r367",
      "r386",
      "r388"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r109",
      "r195",
      "r260",
      "r261",
      "r262",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r271",
      "r273",
      "r274",
      "r356",
      "r359",
      "r367",
      "r386"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Non-current assets:"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AustralianTaxationOfficeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Australia.",
        "label": "Australian Taxation Office [Member]",
        "terseLabel": "Australian Taxation Office"
       }
      }
     },
     "localname": "AustralianTaxationOfficeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r12",
      "r99"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r93",
      "r99",
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r93",
      "r368"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r51",
      "r433",
      "r454"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Commitments and contingencies (note 10)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r249",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Legal Actions, Contingencies and Commitments"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/LegalActionsContingenciesandCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividend declared per share (dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnauditedParenthetical",
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r114",
      "r115",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value per share (dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r26",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common stock, shares outstanding, ending balance (shares)",
        "periodStartLabel": "Common stock, shares outstanding, beginning balance (shares)",
        "terseLabel": "Common stock, shares outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "verboseLabel": "Common stock, $0.004 par value, 350,000,000 shares authorized; 188,295,266 issued and 146,459,032 outstanding at September\u00a030, 2022 and 188,246,955 issued and 146,410,721 outstanding at June\u00a030, 2022"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r62",
      "r64",
      "r65",
      "r77",
      "r438",
      "r459"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Summary Of Contract Balances"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r304",
      "r306",
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Unbilled revenue, current"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetNoncurrent": {
     "auth_ref": [
      "r304",
      "r306",
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent",
        "verboseLabel": "Unbilled revenue, non-current"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability [Abstract]",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r304",
      "r305",
      "r318"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "negatedLabel": "Deferred revenue, current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r304",
      "r305",
      "r318"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "negatedLabel": "Deferred revenue, non-current",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
        "label": "Contractual Obligation",
        "terseLabel": "Contractual obligation"
       }
      }
     },
     "localname": "ContractualObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/LegalActionsContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r171",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate Costs"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r73",
      "r74"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.",
        "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization",
        "terseLabel": "Cost of sales (exclusive of amortization shown separately below)"
       }
      }
     },
     "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r81",
      "r421"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "totalLabel": "Total cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in debt and equity securities.",
        "label": "Debt and Equity Securities, Unrealized Gain (Loss)",
        "negatedNetLabel": "(Gain) loss on equity investments (note 5)",
        "negatedTerseLabel": "(Gain) loss on equity investments"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r107",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r287",
      "r288",
      "r290",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "verboseLabel": "Credit facility interest rate equal to reference rate plus"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r22",
      "r291",
      "r429",
      "r445"
     ],
     "calculation": {
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r275",
      "r294",
      "r295",
      "r377",
      "r379",
      "r380"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r48",
      "r293",
      "r377",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Interest rate on outstanding principal amount"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r48",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "calculation": {
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "terseLabel": "Outstanding debt",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails",
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFinanceCostsCurrentNet": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Current, Net",
        "negatedLabel": "Deferred borrowing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsCurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "negatedLabel": "Deferred borrowing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Deferred Income Taxes and Other Assets, Noncurrent",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.",
        "label": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r97",
      "r150"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization by segment",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r317",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Summary Of Net Revenue Disaggregated By Product And Region"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r301",
      "r444"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r78",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r127",
      "r129",
      "r131",
      "r132",
      "r133",
      "r137",
      "r138",
      "r365",
      "r366",
      "r439",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings per share (dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r78",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r129",
      "r131",
      "r132",
      "r133",
      "r137",
      "r138",
      "r365",
      "r366",
      "r439",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted earnings per share (dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted, Other Disclosure [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r66",
      "r67",
      "r68",
      "r114",
      "r115",
      "r116",
      "r118",
      "r124",
      "r126",
      "r141",
      "r198",
      "r300",
      "r301",
      "r335",
      "r336",
      "r337",
      "r345",
      "r346",
      "r364",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r385",
      "r469",
      "r470",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r193"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "negatedLabel": "Impairment of investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r13",
      "r156",
      "r194"
     ],
     "calculation": {
      "http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "rmd_EquityInvestmentsTotalByMeasurementCategory",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "verboseLabel": "Equity method"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsMember": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in the stock of an investee which is adjusted for the investor's share of the earnings or losses of the investee after the date of acquisition.",
        "label": "Equity Method Investments [Member]",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r190"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Gain (loss) on equity investments (note 5)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r190",
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "verboseLabel": "Equity securities, net unrealized gain (loss)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r187"
     ],
     "calculation": {
      "http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "rmd_EquityInvestmentsTotalByMeasurementCategory",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "netLabel": "Measurement alternative"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r184",
      "r185",
      "r187",
      "r188",
      "r189",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r289",
      "r299",
      "r363",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Intangible assets, estimated useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r17",
      "r231"
     ],
     "calculation": {
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r228",
      "r229",
      "r231",
      "r233",
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r231",
      "r423"
     ],
     "calculation": {
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Other intangibles, gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r228",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r231",
      "r422"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Other intangible assets, net (note 3)",
        "totalLabel": "Total other intangibles, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r16",
      "r212",
      "r213",
      "r220",
      "r225",
      "r388",
      "r425"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance at the end of the period",
        "periodStartLabel": "Balance at the beginning of the period",
        "terseLabel": "Goodwill (note 4)"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r214",
      "r225"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Business acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r221",
      "r223",
      "r225",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "verboseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r80",
      "r109",
      "r155",
      "r161",
      "r165",
      "r168",
      "r171",
      "r195",
      "r260",
      "r261",
      "r262",
      "r265",
      "r266",
      "r267",
      "r269",
      "r271",
      "r273",
      "r274",
      "r367"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r71",
      "r155",
      "r161",
      "r165",
      "r168",
      "r171",
      "r424",
      "r435",
      "r442",
      "r462"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r72",
      "r97",
      "r152",
      "r194",
      "r434",
      "r456"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Loss attributable to equity method investments (note 5)",
        "negatedNetLabel": "Loss attributable to equity method investments",
        "terseLabel": "Loss attributable to equity method investments",
        "verboseLabel": "Loss attributable to equity method investments (note 5)"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails",
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r110",
      "r340",
      "r342",
      "r343",
      "r347",
      "r349",
      "r351",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r111",
      "r125",
      "r126",
      "r153",
      "r339",
      "r348",
      "r350",
      "r463"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "netLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued expenses, income taxes payable and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses, net deferred income taxes and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r70",
      "r149",
      "r376",
      "r378",
      "r441"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "verboseLabel": "Interest expense (income), net"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r440"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "verboseLabel": "Interest (expense) income, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r92",
      "r94",
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r34",
      "r209"
     ],
     "calculation": {
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r40",
      "r388"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Total inventories",
        "verboseLabel": "Inventories (note 3)"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r36",
      "r209"
     ],
     "calculation": {
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r35",
      "r209"
     ],
     "calculation": {
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in progress"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r186",
      "r191",
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r45",
      "r109",
      "r163",
      "r195",
      "r260",
      "r261",
      "r262",
      "r265",
      "r266",
      "r267",
      "r269",
      "r271",
      "r273",
      "r274",
      "r357",
      "r359",
      "r360",
      "r367",
      "r386",
      "r387"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r109",
      "r195",
      "r367",
      "r388",
      "r430",
      "r452"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r47",
      "r109",
      "r195",
      "r260",
      "r261",
      "r262",
      "r265",
      "r266",
      "r267",
      "r269",
      "r271",
      "r273",
      "r274",
      "r357",
      "r359",
      "r360",
      "r367",
      "r386",
      "r387",
      "r388"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r11",
      "r22",
      "r23",
      "r109",
      "r195",
      "r260",
      "r261",
      "r262",
      "r265",
      "r266",
      "r267",
      "r269",
      "r271",
      "r273",
      "r274",
      "r357",
      "r359",
      "r360",
      "r367",
      "r386",
      "r387"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Non-current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r44",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "verboseLabel": "Commitment fees percentage rate on unused portion of credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Available for draw"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r44",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payment applied to principal.",
        "label": "Line of Credit Facility, Periodic Payment, Principal",
        "terseLabel": "Principal payment"
       }
      }
     },
     "localname": "LineOfCreditFacilityPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r44",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r22",
      "r285",
      "r292",
      "r294",
      "r295",
      "r429",
      "r449"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      },
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Long-term debt, net",
        "verboseLabel": "Long-term debt, net (note 8)"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Long-term debt, fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r49",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Contingent provision"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/LegalActionsContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r245",
      "r246",
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Maximum potential contingent liability"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/LegalActionsContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security.",
        "label": "Marketable Securities, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized gains (losses) on marketable equity securities"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Reconciling items"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/ProductWarrantiesScheduleOfChangesInLiabilityForWarrantyCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) / provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r93",
      "r95",
      "r98"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash (used in) / provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r60",
      "r63",
      "r68",
      "r75",
      "r98",
      "r109",
      "r117",
      "r119",
      "r120",
      "r121",
      "r122",
      "r125",
      "r126",
      "r130",
      "r155",
      "r161",
      "r165",
      "r168",
      "r171",
      "r195",
      "r260",
      "r261",
      "r262",
      "r265",
      "r266",
      "r267",
      "r269",
      "r271",
      "r273",
      "r274",
      "r366",
      "r367",
      "r436",
      "r457"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "netLabel": "Net income",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited",
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited",
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1": {
     "auth_ref": [
      "r101",
      "r102",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of [all] liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Value of Liabilities Assumed",
        "negatedLabel": "Liabilities assumed"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (loss), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (loss), net:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SegmentInformationNarrativeDetails",
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r155",
      "r161",
      "r165",
      "r168",
      "r171"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "netLabel": "Net operating profit by segment",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "auth_ref": [
      "r140",
      "r383",
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Operating lease revenue"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r41",
      "r388"
     ],
     "calculation": {
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other prepaid expenses and current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Prepaid taxes and other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation (loss) gain adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r61",
      "r64",
      "r66",
      "r67",
      "r69",
      "r76",
      "r300",
      "r369",
      "r374",
      "r375",
      "r437",
      "r458"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "verboseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other intangibles"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "netLabel": "Other, net",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.",
        "label": "Payments for (Proceeds from) Derivative Instrument, Investing Activities",
        "negatedLabel": "(Payments) / proceeds on maturity of foreign currency contracts"
       }
      }
     },
     "localname": "PaymentsForProceedsFromDerivativeInstrumentInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r85",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "verboseLabel": "Cash paid for acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Patent registration and acquisition costs"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments (note 5)"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value per share (dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r25",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r25",
      "r388"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets (note 3)",
        "totalLabel": "Total prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r5",
      "r210",
      "r211"
     ],
     "calculation": {
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock, net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from borrowings, net of borrowing costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantiesDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Warranties Disclosures [Abstract]",
        "terseLabel": "Product Warranties Disclosures [Abstract]"
       }
      }
     },
     "localname": "ProductWarrantiesDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyAccrual": {
     "auth_ref": [
      "r255",
      "r256",
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.",
        "label": "Standard and Extended Product Warranty Accrual",
        "periodEndLabel": "Balance at the end of the period",
        "periodStartLabel": "Balance at the beginning of the period"
       }
      }
     },
     "localname": "ProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/ProductWarrantiesScheduleOfChangesInLiabilityForWarrantyCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Warranty costs incurred for the period"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/ProductWarrantiesScheduleOfChangesInLiabilityForWarrantyCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.",
        "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued",
        "verboseLabel": "Warranty accruals for the period"
       }
      }
     },
     "localname": "ProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/ProductWarrantiesScheduleOfChangesInLiabilityForWarrantyCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyDisclosureTextBlock": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.",
        "label": "Product Warranty Disclosure [Text Block]",
        "terseLabel": "Product Warranties"
       }
      }
     },
     "localname": "ProductWarrantyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/ProductWarranties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r14",
      "r234"
     ],
     "calculation": {
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Property, plant and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r236",
      "r388",
      "r443",
      "r453"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net",
        "verboseLabel": "Property, plant and equipment, net (note 3)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationComponentsOfPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Components Of Property, Plant And Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repayment of borrowings"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r338",
      "r420",
      "r488"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r301",
      "r388",
      "r451",
      "r472",
      "r474"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r114",
      "r115",
      "r116",
      "r118",
      "r124",
      "r126",
      "r198",
      "r335",
      "r336",
      "r337",
      "r345",
      "r346",
      "r364",
      "r469",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r146",
      "r147",
      "r160",
      "r166",
      "r167",
      "r174",
      "r175",
      "r178",
      "r316",
      "r317",
      "r421"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenue by segment",
        "verboseLabel": "Net revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails",
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r106",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule Of Basic And Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r228",
      "r230",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationScheduleOfOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r228",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule Of Other Intangible Assets, Net"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r224",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r224",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "verboseLabel": "Schedule Of Changes In Carrying Amount Of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r8",
      "r37",
      "r38",
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "Schedule Of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "verboseLabel": "Schedule Of Changes In Liability For Warranty Costs"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/ProductWarrantiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r155",
      "r158",
      "r164",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r155",
      "r158",
      "r164",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Revenue By Segment and Reconciling Items"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt and Equity Securities, FV-NI [Line Items]",
        "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]",
        "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r142",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r171",
      "r178",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r225",
      "r239",
      "r240",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails",
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r142",
      "r144",
      "r145",
      "r155",
      "r159",
      "r165",
      "r169",
      "r170",
      "r171",
      "r172",
      "r174",
      "r177",
      "r178",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general, and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r432",
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior notes, carrying amount"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation costs"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r20",
      "r388",
      "r427",
      "r448"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term debt, net (note 8)",
        "totalLabel": "Short-term debt, net"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://investor.resmed.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r105",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary Of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the standard and extended product warranty accrual.",
        "label": "Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/ProductWarrantiesScheduleOfChangesInLiabilityForWarrantyCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Provision For Warranty"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r142",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r171",
      "r178",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r225",
      "r237",
      "r239",
      "r240",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/GoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails",
      "http://investor.resmed.com/role/SegmentInformationSummaryOfRevenueBySegmentAndReconcilingItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r53",
      "r66",
      "r67",
      "r68",
      "r114",
      "r115",
      "r116",
      "r118",
      "r124",
      "r126",
      "r141",
      "r198",
      "r300",
      "r301",
      "r335",
      "r336",
      "r337",
      "r345",
      "r346",
      "r364",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r385",
      "r469",
      "r470",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited",
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r141",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited",
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r25",
      "r26",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "verboseLabel": "Common stock issued on vesting of restricted stock units, net of shares withheld for tax (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r26",
      "r300",
      "r301",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Common stock issued on exercise of options (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r300",
      "r301"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "verboseLabel": "Common stock issued on vesting of restricted stock units, net of shares withheld for tax"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r25",
      "r26",
      "r301",
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "verboseLabel": "Stock-based compensation costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r53",
      "r300",
      "r301"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "verboseLabel": "Common stock issued on exercise of options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r26",
      "r30",
      "r31",
      "r109",
      "r183",
      "r195",
      "r367",
      "r388"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r184",
      "r185",
      "r187",
      "r188",
      "r189",
      "r289",
      "r299",
      "r363",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/InvestmentsScheduleOfChangesInEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "negatedPeriodEndLabel": "Treasury stock, common, ending balance (shares)",
        "negatedPeriodStartLabel": "Treasury stock, common, beginning balance (shares)",
        "terseLabel": "Treasury stock, shares (shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r54",
      "r302",
      "r303"
     ],
     "calculation": {
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "negatedLabel": "Treasury stock, at cost, 41,836,234 shares at September\u00a030, 2022 and June\u00a030, 2022"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r52",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsOfChangesInEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "netLabel": "Stock options and restricted stock units (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r128",
      "r133"
     ],
     "calculation": {
      "http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted shares outstanding (000's) (in shares)",
        "totalLabel": "Diluted weighted average shares (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r127",
      "r133"
     ],
     "calculation": {
      "http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic shares outstanding (000's) (in shares)",
        "verboseLabel": "Basic weighted-average common shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://investor.resmed.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://investor.resmed.com/role/EarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL77927221-108306"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "https://asc.fasb.org/topic&trid=75115024"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=123583895&loc=d3e30768-111565"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126903467&loc=d3e32787-111569"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org/topic&trid=2196965"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "https://asc.fasb.org/topic&trid=2197064"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "https://asc.fasb.org/topic&trid=2155896"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919311-209978"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r489": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r491": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r492": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r493": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r494": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r495": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r496": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r497": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r498": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r499": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r501": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>64
<FILENAME>0000943819-22-000019-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000943819-22-000019-xbrl.zip
M4$L#!!0    ( %J36U5RH.Q2S(,! ([>$@ 0    <FUD+3(P,C(P.3,P+FAT
M;>Q]:5,;R=+N]_=7Z'+.?>^<"!6N?6%FN,$8[)>YEAB#&!_XXJ@5A+5PM-C
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M:46C(5QSFREJ92[=MB%*Z9=,2I\,O=]]>]X!>MWM]+NM9BC,KFT8Q*T6M3M
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MV%/C+0F":R=LE( W3A'IE!!LD8RSDE&?[W"UYV?4;(LYE]/1>.#8"YLP-S0
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M8%%:CL 7(H@+S9!E.J&(C=(D8F%2+F10K,IIF9*QO"(\L92,4H2G+L*W=U6
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MS+BOIBQ;=#_3ULFUWC@E,DT<F>ZVN)(!1^E31$D(CS@&>++>QMQ<DS/KA6)
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MR:C/Q:BWP_\ADGP()#)6,L0-F*_6.X:\5< 8G#NEXH.,^@(\V;U!UW\Z[K9
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M%'%<2>PVMAB%#9EC-;+4+Y9:9:E?E-1/<2E"O++2$B =C0H5#P08I!S06L%
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M,B8^<TQ\4)YM(61@5 EI#)5*FPB$"L<O$>$,AE^ 8F9LRT#'Z3S;TBANL+/
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M0;"26$JUL-Z4&1NPG"VML/(.:%FZ%V$N^7WISM3C]P5[BGH@#77$80E2(DU
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MP2GGMZPA.<I+R;5KKN#O='F8NV7ZDBQ@H+-Y$J:=!SV"JP,P^ +JJU=.GUZ
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MC#[E8?[78%@^?]#-'P\FP\;9<! F?@RS,(:7G0TZ_7&CTV^,86A>-%X/KEP
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MZ4VZ136K$,^&H QE_;5,5FUO  W]6E5O>TZAU+_] I9V92JVK\P$_-Z-^1?
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M$[%(-@,=;L+RM19 ]\QBJNH0JA4A95<FY6I018U>2T.OQ6 ID8)BB5-$F+"
M7L$BFQ/5Z&0<5U)ZF.^-3<IYDXK%B- Z6.HIJ/9/H"&U:C^^:L\3DZ@C"=IJ
MY*1WB M"D4O1PV^:1>("MTJ":C/3E%RMAFK7CK'CBQM#H^Z3#^\!!N3*P=AJ
M$93GL7/]LQ#KAL ?0IG61B!K.$?<Q6+3FB$<-$^"!@R+TL8F(;@IR'H<3_D%
MZ3"?J?K_!!)3J_]RU7^>L$@MF;,R(2L\ 9KBX#>G/8HZ"4Z8%LSD!/J$-#%=
MCV.XS\"3\FHR@G?'86,8NP6G'YUTSAY4U>.9 A@APM@ -#W*R&UT)C!N,29@
M>VLI1:IWO58-PJZF@ZP@S"JL)5$442_ TE* 8\9SAU12(0&*"2 N8',)W63D
MP56)[J4O:^1M>:8 D*115%)C;.0YVM#H$#E105A.C$WU;M J L \AQ&*:$JE
M19(K,&&(H4A+@U%4V!J*67!:9P!03?SPO/T_!0">@4]FJ;M!:UN5X#XNXY]
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ME48Z*8P(ML$:6DS"QF;JI'%6RQMG]D5C'RQVT&;X?W_0B%_.HL\*/XRC3IB
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MD74=9)V)]NM^TQ<';SYRQM(HLQEAH62$LU"1-*2<")/%61Z%P"KYDV<9WXR
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MEJ?#9J&N>K(9:A>H,_/LG> 8-NSJG8+[^L =@B'L*S9SQM#Y3G!>#K\4CAB
M.F"+2N!40"9CI)IR\JQZ*?/ZA.#J_F.=)H4J22-M<A':B,=6RE32S.7%Q* V
M9+SA<"R;Y7#[W5=+)A_8[,/<SZPYK@?R:]$?3_,!7DC89?C^9HPNWDY&=_OB
ME<=OQ,<XE8JQ+"$"(XUX+B61PBJBE89=H)'.58(M P664%QB4P% 6,\1HCOE
M$K=>#_O]8N3J19X[:@"\*09 -K*RKG[DU;2D+O$1R(QJ6I=.3@GL_X[A'W41
M9"!B61_K=0@OYZ%DL=0VU8JS-$U#1;,DBJ.(IMKJN"Y\"H1'OD.!6)GFW72:
MAVZ6Q\/]>H[S)-F2WA5U4\7'C"64:RF(B'E,N+:&I%IJ0D.C4QN:2$N.I!=>
M2WH.+J^D UAP9<N[QB"D@/DHR9?/]X_W=@_&O5%QCI5QCTL)VS\X/;ZPO2_V
M -Y^=@#$ 5B*5__EFL)-=C]\9+L/$K(X/-Z]//BV#^^ \5U\9#E7)C:2")ED
MF+(NB0+!F>1*,A-;H?)( "WLK(A[#$9.@$)H\+L0_(9<T>:HZ 2N0NUUO/ I
M'E!WS:C>LV#D-HWT<=>"_G3;ZF9^W^.N7JBJ9F4J')X<!1H$: DCVIV1NMXV
M4M<RD_;5W6$R '6[YV71"VB"$AU-&P8.-Q]8T[E*K+I&SG'OQEDWDMFY+ &!
M42"PH^'.U@F^NQ.FT;OL!,/58K!?KN OF.B?11]KSR^*Q4=>+'8;Y/:R9CI'
MM?B&U?8;;C6SX0,LPE]6H_D;D4D,)KSL]5BZ+E$S]\W*U>B^NB^1>D86G1.K
MO22ZIJR\UALNS@I]UAR8N3-R_8I??33\Z5RYFM>*O=4L=:R0@%V@S@\*OWE,
MF<HHB%;,<JE%&JLX$YQ2Q6FN==@*O[^.!QWO\NZ;CU13*103Q":)J]<.XF]B
M#)$TI6D>9YF1X9-G[%H)9.>F=<\W!RT/QR _*QB(.[=5X!HK?8=1PED&X=N#
MF,5(^,O)685C,(0GFJ*TVJ-A,:C_\6[G:">HQJHJ3"'+PE:=ANLM(+'KJY/\
M45TQKI4'>L60QI[OWF9DW^?K</OJ<> IQ]=IV%78G1*69OC%#F!8,%]0?GIC
MM*_AQ\!* #P->@(L1)!/.K<TUWL0+$'C@5'6D'AA@SX\W;U!PD=WS@%?O]@2
M$#=P8(PSS<=.JG#UIH']W$8:NGJ.GJ.<G_< E%7//O6K!3_ . %#89+%^41C
MJYI> 5?K>D[^6(&ICCZ65FH -V!W1=SD\0CHXEP6CFE;E+!@34!YM(B9/>FX
M>;\/#P4>T;L,S-BZEYW+2]=TH,A1R83%@]G"*&%I)(CMP5 #SE?>HK+6:EU)
MG0LKMA.\Q'=6LR^]V;F[[B4U==G%%<M!E@6^A730EY\MSM[U!0*.:P>X)AWW
M3#=K[-/N^J/)R<#JJ8/ ZYA'\_M@AK";:V #SN$\>0FC'A5,L@Q<FT&DQ]I
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M#/=8LXM"J+5A'!IK1)SEW JCL!)@&$=1KB,6\^A*CKQ1/O/WUD4-3=R"0 S
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M9R9/XL@P"MO-TNOSRZ;18+W+G>#->(AX!#SFLQVA/T%;%X\F?;R8_][C=%7
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M"0\32]*$IX3&22;B-,3 ./11LF7;\#^;O)^!4Q0Q=!PAR$N<'H=8W%E;^(A
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M1B*=&>P#FF)(,&KWBD99I%+*4)W?X3\L5ZYW&C8\5+@%M$<(:#\H1[> ]C,
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MKPH@0HD)G>>E=6A7YVX.7*39%SNWP'E0C?79_,6^I@762'$%7(#TKUG3F<C
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MG[O6+%J>>[>O\RI,XR9GIC*L&9!;_%I><;6K:GFUD5-=5Q;O87^!3L/1D+Q
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M&"((^>5+?'L8F5$<^<$T'5+'FOY%,YG>P@,- DT#ZY9<'O33F]ID%I\=SQZ
M%A+9^LQC WA:2:XDBZN!:#WP?@M,/&11Y*97+),[S$HX G)=]$E9S6<SL$-N
MU).[E&B0_1F:[,"F;+6Y>9J*156]"EVM8<HELM";IO?;AZ[?A^UQ[/RDB9N!
M!RL**W=5D O] \S=G !'\^SD?S*%+@\J%K\V3G0>H7MD3L7E<O@ 5 4XB&R8
M!/XP,,<AT,R,0!I $L (.P'1\1E^R)#K\#?H UW5? +*^W&HV/ J_!7X;L.1
M\H_88X))1EU<$@T('@"IG5ZT!9NB]"PP[<_ ;Q ,Y!T*'V[.],#("4&\T3%+
M683Z"'.FG2UW[7T*WPLQR;U<ZY#<!0S%'80^CN( -\V)"?MC>M?/,L.1,F(N
M785%L4S?'\;]T+$=6"->5$5JB-O^(&R>'X&&X"-_@@RCS-%/!LS&!W".L&4-
MLI<Q>S6.4FF%R\LIG=9-[FX_TX5=O)6,RH:&*#,#YA#TEOXB3PR_[<4(B. Z
M,'_@."?[W6#@6."1HD+J]4^]Q[MW6'_.51@?$+9F$K G%#"T94YH@7_#"!#!
M"\$4HNI;* %XPRW.&P\0+)2($"9<[Z9BB0*1?V5NWO2A]NF<VZG9[T!N7+(N
M$%<\B17GWX@B"S.!O^B=*E^YYQ,:!,?0 "F#]?<=%]TP5#M0M"?'!DY9+D@7
ME3#,K#W15R&R44(W>(]G.1.7A1*5*T/E:DA4KB*7QR4JET3EDJA<2_-2$I5+
MHG(=;%>3J%Q;N*-Z)^>.!FSL1!@^#!Q$]YF84W+<A!.)[AREKCJ-6B=#&1*@
M,Q3*\JB$G%=[QIT=^S$/;M\;'2V'U $>6"B\/OYRH#ZL=&S:;/ZUW5:6+5WB
MM17,&G4JE36Z95&"WH%2>)U$;R""R@-F!RH7"RT)8@>F!>$I?-[WGR"\I- 1
MUBTR3YMG,M[K6KW67)%8SXU,LEPWMLT<+X)OY024P+>,7RJ:";$=#%CL+%N
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M;!?F>%W3\PCC%-.GEDFN$N?;'#^"S,G,+4"DWCD^820F13]WDLT-!W#(3YO
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M[9&4$9054^*XR_SU@[E:00IM-)7I<]_HU+KUU5]OVS-\@V%?2NIL&;$N2^P
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M8@X;P9<U"TG)R="7^(9Q[PJ/D.\"B4__\I%+1@0[8 DN5E@O-8A]+1$?8_F
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M.M;XOSH*_3J.@,S/0S^^_ =02P,$%     @ 6I-;58NQE(OI&P  KP4! !0
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M[+-FM3JO+5>.11'Z>@Y<6\H(%JNO8&(P7E/OJ5_IK-^O0MQ5WA>ZKVXYR_0
M/EE-RXD104O-(Y/)MB9]DC/OLV'.9>Y-CCF5P3HMGQ(Q*M5%+?/=IGP?P4;K
MYA$D\J2@)6ADV[0$J"PC;]($$6TB;Q]XRV"#B,_/,=\S^-!!GO8XP)]GT*-L
M7AX?+KK5]#_]^Q,GC0Q%M^Y=OJ"THV.A@F9*2,&KK!$2=>GZ[E2/26T28>U6
M(=MPHJ5+.I^AX%7]NM_RQ$MGI2F&2=&BV)(">D=&L9@5Z!1=L9+\<.NU%(TI
M(3T0E A%0I<!6,P7YVW/B<68"$"38- W2(X;#'L<<JIY8DB+KRJX9 HU0JXD
M9O= :A/&G7MH:YP(.*^Q>,U*4KK5W@$R610K1NC(J\_.9/)(ZG):QJ1+:5!Q
M,:HBD )Q<'V:+=CLE?\.JX-%>='O<O0;%Q-3C3*XZ%F6!M=[59*%UEF3>YLP
MCDS:PC"A]@V$C4E=#H46:OF006=#S%O(ZZZO=W]^],?TMSB=]VX[-TH"K^BQ
M.]7G'?HC*VCW<PZJ2,C64.O-Z^@94VGD,$ ADP9M8Z&KF=7..QPWHR"];,V.
M7&MU(A"SP9A0, IWU/LLUU,TIIK(83!"*)$!TR(\&B&TX<Q8Y3%::-D9$2S+
M3D0NT2+FX2Z@NCPMLL5Q&>@3Y[_!'!\\:Z%0.9S.I\M5&^;HBS K>LU]:WIH
M->Y<8DR44+82@L\&'5Y7J$L_;T?9F-RPW1!RX405O60(J\F7@(]I5QP\@R.8
M+?I[XDY)*L7(HEQEKMT=I;U5+$@)K#C()7'C)?GAW&L)&I/S18L1.CGL#(WN
ML'P5,3_.:.F[BY='B4FH4<< [;8XI=IAF<2" \Y\5$IEQRTO7R7/+E1/W6&X
M,;E4-.(?:JX'"M9HMW8Y%T78'%M3 O03/<:AR3C%JO8@2PA<#Y #V-/6/LUN
M8PHFH*L<F3(M@6FK8RU@9]DG)]&G#HJ\K<J-NXWW:YG'@L<K]WVVE-X>\HHX
M)@@5#0- -UN+C*HC1,]*E;X(Z3%0(Z\RVB7PV9<A'RND:"1YSS76K^H5)U<&
M++B^Q9C[J;Z^*_-$I=B7#/KYG) ,5KB8$N,<8:A=]JSU]6!9%&V+,X4;:B5P
M#3FT992\^-;?'/6M@-1VVA/J6]^N,U8J*7R)O]U?&>5];\K28.""4MIZQFF3
M?%<LK.>HIZ?OYYM31_GX71?GRYA/]H;[5R<2*?^[WF2R/\\*Q%25KI&ETM]<
MPU&I:M%N,$TIZ"!<48-T'B?G9$RV=2@8C@ #]V]8X_+@^6SQ<6!3>G&4O1G/
M&Q@D,I?MRD8<Z76W.)KBTYX<_[ELX?=S=.[FN9T<0>P<G;2IS;PD'S@+M=WB
MYJ1H]QD99G644><JK:*NG;H]=;OW)5ID@-)[P2^6RS4^'WH/YG._BY*2"=ES
MIG)K.EI;42_RCXK?6G1K=9&:_E+!&X@:D]$="$D7>QE1"HKN6LIXW"_<-] ?
M6W^W0(W:CF*U0_'(/*KEMP>Q@R>Q7_*'+90Y*=-*&+(([E#-2LNT"AG#F9*9
M33)Z4ZR5DCK+L2VMHZI=W1?<]B%7PLM1+UL<YVZ\,+QJR%"9B8ZWLD#%/,<9
MR4%( U9P7J@]O9NI&E-N^U[UV-:B(MP3^W "^:^H"3&%5*QAWJ5VL7T-+-I8
M&*_!92@<M2HU<*ZBY8Z5 ]^%(B*1"[FY>U6?31O;\[*<R%)BR+E50?%VRR\&
MQ4'$@)BM285:C0#J I-+R!A52Z4]&ZEMI4%W\@*9;?^WXJBC.-L8SN6JFV:T
MG>T7&(2>?^/,)U]#-VUE=KDUCH)GL/F.KS=%[[]^R@=Q_A[>H!W^M5;(JXE/
MI8)5E=D0[>:J/YRLR+1(E7NAP$7J,LG]<DB0(KP,?Y_W:\[@3PFM='"R-2QQ
M[;X8SS#J5RSR6B6 3+E2WYMZ>^K&%.>,&..7Y"N'$#]E(X#+Z-M4VIZG+SH1
MDVD;_L;U5VL'%G0V3$IMN,_1A41M7&Y/W:B2CM\\/'<5_]#PO,QZM^.LT"J3
M=%$"F6_E*:W-EVA':U)-!=R>M.>-N;'[C:Z^?7CN*GZZ\P ]BZ_J6;9?S7>:
MX(E7M04-@CDGVN:Z0#/@"V!$(;D3R4MKJ%LY#<#&F"K+OR' WS>@[L.O0-)"
MWPW+M4OR=#(1YTM7EBT/7!DE WF1V;9^Q?91^KO%26$ECHF^W^KX]2S.5RBW
M)JF^UG:212S0!,--+$R;6C#\3)E)+;7-WLHJJ1?^[:F[H_M_+S']KN"Z*J8G
MEAUY!N@S?1=.%HML:\9UCHQSS33HP+QM9*4(&I6"CL-#:L?SWM\GDG:2U'
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ML]'%TU$\\ :_G8\,!9T$9.)TPG6.>4N"<9QHJK7 )8PG*6^KWWRMSMG/0ZN
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M(OH(\[/QK'SP^[O6 QI1!MS$<CXH9US>O.'$LE(:JBA+1G@'\88YWUAJNW6
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M'"'." P1\X1?I'$HD40Y01EDX4&GH&LO,+NC/&YUZIFU'NJ,MR#^#S\YA\V
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MQM<CO]BC/NF[R+7R^OL+M$!6"PR/$)C@BM!D H8+0I%@72 0C0-(,868.RS
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MS(BGP6*L'07Q4C&BN (1@U7H20RH,I?(?C"MV9.2'MI*;$)YL11?R & V=(
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M?DPVRF?@1H+?NW-'YL^.>;8#=P9:;ZME4?#"&OF#_;6U$WSH].T+:ZOY 'X
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MU$3A#?*,)HDQ\0T]-WCC/,-YX0S>(TP)3U"[>#IH6IO95/#$1/]IX.GK Z:
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M5'#(4XP@R15)J1!YIIVN<%R@P]SHJVM&?=6U"4 VRX^N*>[G=T.[YOS9Z 2
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MRV9T1M[<:* 3]6?T!4\4'K:B. >X&UT$A'%DVK@(P0M")'MQ"1X1>5S:=PJ
M[#7]=+QC_VL#EQ[%[:K0A;"IV82PP7U&4IW%J%#5?H[4B*54H@AJ$6.;B(1
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M5&<*BEPEC-$T9\)K*^FTJ+F1P%Y3L%5U<'QU#\#.)UX!8!O_R&L(8D,.O<Z
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MT@U)0M,\IP+2-+75+B,%":(<1C32..=I8OC>Q^D/W0V3Q3_>NW9&^#YP8_W
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ML\.R57F;2@)TE!X05.@*J7L0X0C03A0T& 9BKP!!3[!Z @)=6YHL -#3M&[
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M'1-]L KW,UP (I;_X-PPX_H%+BA[M-^_='U??RS?:/?@LG<>7\@9GW]>5LV
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M:#4M>*H)T@:J5!&[=\ZT921E8*$$S7"2%6D>V/SYS$@WN&.N! .Z%AA\LQ9
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MP!QCQM,$495[138]?^RM<9Z5[&M XMP>GLN4UD_I@2G,"=4G8W"O>$"28"\
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MU%$(P$NQ9O'[77QES9Z[[>9QN=IG)2G[^<]44<#,Y *BW-6WIB*#A50ZL\9
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MU<]ISE".!,(PYRX8$I,",H'L'ZG,K*VCDC3G/@=E@>/>Y.G9%0%_'0AW$\&
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M7@-=A.95QY@,UL"J-=0+-[$Z5OIR(ZL3]_0CD5VFA8M4+GL/F>7J!U^I]>X
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M!A7E\Q_ZUOBFD=Q]%2K982D\V$M?[0'7/<L)^T^*'R\- _7 +!41Y? ZQ<&
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MC!(FM:%$X* D@' 1;HU,#NN)F$;TZ/5$NN;%CX"&17M@7KI03V2GQ O5$_$
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M6O/4J 0JG6"I%&AI!3Z//T_^@6?CSM=(\6BCS%M0J%H\F#LBV"(,,EI@6SQ
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MI"P3T )#0E@.46%RR%)+$)BD22XXIFFB^Y8;< /<&B$<I-0[$:\H-5!"Z$<
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MYG\.UUN.VSJM:U='XW,K]*)'KY[^<^+'=<-B/0[QU7%?>R7 CTH+4*L!VGH
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M#+0=?.TGRS-%'FA,:R =?F*=(FO5V@8=+?5QY:XFVCNA)5>0?;T=*IL).3X
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M'_,PVWP"\W5\\W*Q6J\FR8=<M%/ -:OY6J7 !67 :1FB$\[9^\7FC\^BV;7
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M;/I/S-<UPXPGEF0,H%6MMBK.UF'M#J1-VH9L9.&M+^>Z43;,C7V?\.M1,R/
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MO*F1JG9-*F6@&MFH='I"=_ 3>'3ZMY-?*A5VKL(\@=2R4 .W$+'<B/26?8K
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M?7*[VN4++^<7G_YW NX7"Z?_ U!+ P04    " !:DUM5( BF!4\(  "4,
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M^SO^^'T,*S?>%\SC\E-]T84'2#^Y7>WRA4ORQ:>_K^_^Y\#9_P!02P,$%
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MK2SAD(ZBIM:OD)!*NWLL9+RY9>F_EFHI!7A"PWGSS9!.B$!=,D-]-L'1FZ(
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M[;;X3%XSIU]X=_0?4$L! A0#%     @ 6I-;57*@[%+,@P$ CMX2 !
M         ( !     ')M9"TR,#(R,#DS,"YH=&U02P$"% ,4    " !:DUM5
MK<8S448.  !AD@  $               @ 'Z@P$ <FUD+3(P,C(P.3,P+GAS
M9%!+ 0(4 Q0    ( %J36U6+L92+Z1L  *\% 0 4              "  6Z2
M 0!R;60M,C R,C Y,S!?8V%L+GAM;%!+ 0(4 Q0    ( %J36U6B41FP8S
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M,C R,C Y,S!X97@S,3$N:'1M4$L! A0#%     @ 6I-;52 (I@5/"   E#
M !8              ( !_?0" ')M9"TR,#(R,#DS,'AE>#,Q,BYH=&U02P$"
M% ,4    " !:DUM5,GI'R14'  !+3P  %0              @ & _0( <FUD
H+3(P,C(P.3,P>&5X,S(N:'1M4$L%!@     )  D 3P(  ,@$ P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
